inb10q_201109302.htm

0001016504-11-000017.txt : 20111121 0001016504-11-000017.hdr.sgml : 20111121 20111121171816 ACCESSION NUMBER: 0001016504-11-000017 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 28 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111121 DATE AS OF CHANGE: 20111121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 111219795 BUSINESS ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 10-Q 1 inb10q_201109302.htm inb10q_201109302.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

____________

FORM 10-Q

X Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2011

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

Commission File Number 001-31668

INTEGRATED BIOPHARMA, INC.

(Exact name of registrant, as specified in its charter)

Delaware	22-2407475
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.

225 Long Ave., Hillside, New Jersey

07205

(Address of principal executive offices)

(Zip Code)

(888) 319-6962

(Registrant’s telephone number, including Area Code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x

No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer 		Accelerated filer 		Non-accelerated filer 		Smaller reporting company x

Indicate by check whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o

No x

Applicable only to Corporate Issuers:

The number of shares outstanding of each of the issuer’s class of common stock, as of the latest practicable date:

Class	Outstanding at November 15, 2011
Common Stock, $0.002 par value	20,965,074 Shares

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

FORM 10-Q QUARTERLY REPORT

For the Three Months Ended September 30, 2011

INDEX

		Page
	Part I. Financial Information
Item 1.	Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2011 and 2010 (unaudited)	2
	Condensed Consolidated Balance Sheets as of September 30, 2011 and June 30, 2011 (unaudited)	3
	Condensed Consolidated Statements of Changes in Stockholders’ Deficiency for the Three Months Ended September 30, 2011 (unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2011 and 2010 (unaudited)	5
	Notes to Condensed Consolidated Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	21

Item 4.	Controls and Procedures	22

	Part II. Other Information

Item 1.	Legal Proceedings	23

Item 1A.	Risk Factors	23

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23

Item 3.	Defaults Upon Senior Securities	23

Item 5.	Other Information	23

Item 6.	Exhibits	23
	Other
Signatures		24

Disclosure Regarding Forward-Looking Statements

Certain statements in this Quarterly Report on Form 10-Q may constitute “forward-looking” statements as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Act of 1934, as amended (the “Exchange Act”), the Private Securities Litigation Reform Act of 1995 (the “PSLRA”) or in releases made by the Securities and Exchange Commission, all as may be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Integrated BioPharma, Inc. (the “Company”) or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words, “plan”, “believe”, “expect”, “anticipate”, “intend”, “estimate”, “project”, “may”, “will”, “would”, “could”, “should”, “seeks”, or “scheduled to”, or other similar words, or the negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions. These cautionary statements are being made pursuant to the Securities Act, the Exchange Act and the PSLRA with the intention of obtaining the benefits of the “safe harbor” provisions of such laws. The Company cautions investors that any forward-looking statements made by the Company are not guarantees or indicative of future performance. Important assumptions and other important factors that could cause actual results to differ materially from those forward-looking statements with respect to the Company, include, but are not limited to, the risks and uncertainties affecting its businesses described in Items 1 and 1A of the Company’s Annual Report filed on Form 10-K for the year ended June 30, 2011 and in registration statements and other securities filings by the Company. Although the Company believes that its plans, intentions and expectations reflected in or suggested by such forward-looking statements are reasonable, actual results could differ materially from a projection or assumption in any of the forward-looking statements and are subject to change due inherent risks and uncertainties. The forward-looking statements contained in this Quarterly Report on Form 10-Q are made only as of the date hereof and the Company does not have or undertake any obligation to update or revise any forward-looking statements whether as a result of new information, subsequent events or otherwise, unless otherwise required by law.

ITEM 1. FINANCIAL STATEMENTS

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

Note 1. Principles of Consolidation and Basis of Presentation

Basis of Presentation of Interim Financial Statements

The accompanying condensed financial statements for the interim periods are unaudited and include the accounts of the Company. The interim condensed financial statements have been prepared in conformity with Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and therefore do not include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011 (“Form 10-K”), as filed with the SEC. The June 30, 2011 balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The results of operations for the three months ended September 30, 2011 are not necessarily indicative of the results for the full fiscal year ending June 30, 2012 or for any other period.

These condensed consolidated financial statements reflect the classification as discontinued operations of our branded proprietary nutraceutical business which is operated by AgroLabs, Inc. (“AgroLabs”), a wholly owned subsidiary of the Company, which distributes for sale through major mass market, grocery, drug and vitamin retailers, healthful nutritional products under the following brands: Naturally Noni, Naturally Pomegranate, Pomegranate with ACAI and Reservatrol, Coconut Water, Naturally Aloe, Aloe Pure, Naturally Thai Mangosteen, Peaceful Sleep, Green Envy, 1st Choice Multi-Vitamin, ACAI Extra, ACAI Immune, ACAI Cleanse, and other products which are being introduced into the market. These are referred to as our branded proprietary nutraceutical business and/or products. (See Note 3. Discontinued Operations).

Nature of Operations

Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily in the United States. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in 1995. The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.

The Company’s nutraceutical business includes: InB:Manhattan Drug Company, Inc. (“Manhattan Drug”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and The Vitamin Factory, which sells private label Manhattan Drug products, as well as our AgroLabs products, through the Internet.

The Company also distributes fine natural chemicals through its wholly-owned subsidiary IHT Health Products, Inc. and is a distributor of certain raw materials for DSM Nutritional Products, Inc.

Significant Accounting Policies

There have been no material changes during fiscal year 2012 in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

Investment in iBio, Inc. - Restricted. The Company accounts for its investment in iBio, Inc. (“iBio”) on the cost basis as it retained approximately 6% of its interest in iBio (1,266,706 shares of common stock) (the “iBio Stock”) at the time of the spin-off of this subsidiary in August 2008. The Company reviews its investment in iBio for impairment and records a loss when there is deemed to be an impairment of the investment. There was no impairment charge recorded in the three months ended September 30, 2011 and 2010. Pursuant to the Forbearance Agreement with respect to the Notes Payable, proceeds from any sales of the iBio Stock will be used to repay a portion of the outstanding principal of the Notes Payable. (See Note 2. Liquidity and Going Concern and Note 6. Debt).

Supplemental Statement of Cash Flows

Earnings Per Share. Basic earnings per common share amounts are based on the weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible preferred stock, subject to anti-dilution limitations using the treasury stock method.

Stock options and warrants to purchase or otherwise obtain shares of common stock were not included in the fully diluted computation for earnings per share as their exercise prices were greater than the market price of the common shares as of September 30 2011 and 2010.

Note 2. Liquidity and Going Concern

The Company’s condensed consolidated financial statements have been prepared assuming that it will continue as a going concern. The Company has cumulative historical net losses and cash outflows from operations. For the fiscal year ended June 30, 2011, the Company had cash provided from operating activities of $390. As of September 30, 2011, the Company had cash of $931 (inclusive of cash of $368 included in assets from discontinued operations) and a working capital deficit of $9,033, which is primarily attributable to the Notes Payable in the outstanding principal amount of $7,805, which matured on November 15, 2009 and are currently in default (See Note 6. Debt), the Convertible Note Payable in the outstanding principal amount of $4,500, which matured on February 21, 2011, which are secured by pledges of substantially all the Company’s assets (See Note 6. Debt). These factors raise substantial doubt as to the Company’s ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments that might result from these uncertainties.

The Company has defaulted on all of its outstanding debt instruments in the aggregate amount of $12,605 (see Note 6. Debt) by failing to repay them on their respective scheduled maturity dates. The Notes Payable and Convertible Note Payable are secured by pledges of substantially all of the Company’s assets.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

The Company defaulted on the $7,805 outstanding principal amount of its Notes Payable, issued by the Company under that certain Securities Purchase Agreement, dated as of February 21, 2008, by failing to repay the Notes Payable on the scheduled maturity date of November 15, 2009. The Company’s failure to repay the Notes Payable on the scheduled maturity date constituted an Event of Default under the Notes Payable and triggered the right of the holders of the Notes Payable (the “Note Payable Holders”) to give the Company a notice (an “Acceleration Notice”) to accelerate the payment of all unpaid principal and accrued and unpaid interest (including interest accruing at the default rate). The Notes Payable are secured by a pledge of substantially all of the Company’s assets. As of November 21, 2011, the Company has not repaid the Notes Payable or the default interest accrued on the Notes Payable.

On October 4, 2011, the Company and the Collateral Agent for the holders of the Notes Payable, entered into a Forbearance Agreement extending, among other things, the due date until December 31, 2011. (See Note 6. Debt).

The Company defaulted on the $4,500 million outstanding principal amount of its Convertible Note Payable, issued by the Company under that certain Securities Purchase Agreement, dated as of February 21, 2008, by failing to repay the Convertible Note Payable on the scheduled maturity date of February 21, 2011. The Company’s failure to repay the Convertible Note Payable on the scheduled maturity date constituted an Event of Default under the Convertible Note Payable and triggered the right of the holder of the Convertible Note Payable to give the Company a notice (“CD Acceleration Notice”) to accelerate the payment of all unpaid principal and accrued and unpaid interest (including interest accruing at the default rate, if any). The Convertible Note Payable is secured by a pledge of substantially all of the Company’s assets, which pledge is subordinated to the security interest held by the Note Payable Holders. As of November 21, 2011, the Company has not repaid the Convertible Note Payable or the default interest on the Convertible Note Payable. The holder of the Convertible Note Payable, CD Financial, LLC (“CD Financial”) is a significant shareholder of the Company and has not made any payment demands on the Company with respect to the Convertible Note Payable, nor has it converted the Convertible Note Payable into common shares of the Company. In March 2009, the Company and CD Financial entered into an oral agreement to suspend the cash interest payments on the Convertible Note Payable until the Company returned to positive cash flows in its operations. In this oral agreement, CD Financial agreed not to give any default notices or increase interest rates due to such default (the default interest rate as defined in the Convertible Note Payable is 18%). In connection with the Company entering into a Forbearance Agreement with respect to the Notes Payable (See Note 6. Debt), CD Financial has agreed to not receive any principal payments until all of the Company’s obligations to the Note Payable Holders have been repaid, including any interest payments at the default interest rate.

There can be no assurance that the Company will be able to repay, restructure or amend the Notes Payable by December 31, 2011 or the Convertible Note Payable prior to receipt by the Company of a CD Acceleration Notice from CD Financial. In the interim, the Company has continued to make timely interest payments to the Note Payable Holders at the non default rate of 8% per annum and is exploring its strategic alternatives, which may include business divestitures, developing business and sales strategies to increase operating income, the sale of some or all of the Company’s assets or operating subsidiaries and/or capital restructuring plans.

If the Notes Payable are not repaid by December 31, 2011, and as a result of the events of default that arose based upon the Company’s failure to pay each of the Notes Payable at maturity, the Note Payable Holders have the right to give the Company an Acceleration Notice. As a result of the event of default that arose based upon the Company’s failure to repay the Convertible Note Payable at maturity, CD Financial has the right to give the Company a CD Acceleration Notice. Each acceleration notice would (i) accelerate the payment of all unpaid principal and accrued and unpaid interest (including default interest (if any); with respect to the Notes Payable, only default interest arising subsequent to December 31, 2011, (if any)) and (ii) require the Company to pay an amount equal to the sum of all of the respective amounts described in the preceding clause (i) in same day funds on the payment date specified in such notice. If the Company is unable to raise additional capital, sell certain assets or successfully refinance the full outstanding amount of the Notes Payable and the Convertible Note Payable upon acceptable terms, it would have a material adverse effect on the Company, including the possible foreclosure by the holders of the Notes Payable and/or the Convertible Note Payable of all or some of the Company’s assets, which would impact the Company’s ability to continue as a going concern.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

Note 3. Assets and Liabilities Held for Sale and Discontinued Operations

The Company is seeking to sell the net assets of AgroLabs. Accordingly, the Company classified the business assets and liabilities and the results of operations of its branded proprietary nutraceutical business as discontinued operations. The operations of AgroLabs for the current and prior periods and the associated results of operations, financial position and cash flows are separately reported as discontinued operations for all periods presented.

The net assets classified as discontinued operations were comprised of the following:

The Company’s net sales, gross profit (loss) and results of operations classified as discontinued operations were as follows:

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

Note 4. Inventories

Inventories are stated at the lower of cost or market using the first-in, first-out method and consist of the following as of:

Note 5. Property and Equipment, net

Property and equipment, net consists of the following as of:

Depreciation and amortization expense was $80 and $75 for the three months ended September 30, 2011 and 2010, respectively.

Note 6. Debt

Notes Payable

On February 21, 2008, the Company entered into a Securities Purchase Agreement with Imperium Master Fund, LTD. and three other parties (collectively “Imperium”), which Securities Purchase Agreement was amended on October 14, 2008 (as so amended, the “SPA”), pursuant to which the Company issued, and Imperium purchased from the Company, an aggregate $7,000 in principal of senior secured notes (“Notes Payable”). The Notes Payable matured on November 15, 2009 and bear interest at the rate of 8.0%. Interest is payable monthly. As of September 30, and June 30, 2011, accrued interest of $47 for each period is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

An additional premium of $805 was granted due to the amendment noted above. The additional premium is subject to interest payments commencing October 1, 2011.

The Notes Payable are secured by a pledge of substantially all of the Company’s assets.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

On October 4, 2011, the Company and the Collateral Agent for the Note Payable Holders, entered into a Forbearance Agreement (the “Forbearance Agreement”). The Forbearance Agreement provides that the Collateral Agent shall forbear from exercising rights and remedies arising from the occurrence of Specified Defaults (as defined in the Forbearance Agreement), including the Company’s failure to repay the Notes Payable which are due and payable. The Forbearance Agreement will terminate on the earlier to occur of (i) December 31, 2011, (ii) the date the Company fails to comply with the covenants, conditions and agreements contained in the Forbearance Agreement, (iii) the date of the occurrence of any Event of Default, other than the Specified Defaults (as defined in the Forbearance Agreement), under the SPA, the Notes Payable, the Certificate of Designation (as defined in the SPA), the Registration Rights Agreement (as defined in the SPA), the Subsidiary Guaranty, dated as of February 21, 2008, by and among the Company, certain of its subsidiaries and the Collateral Agent, the Security Agreement, dated as of February 21, 2008 (the “Security Agreement”), by and among the Company, certain of its subsidiaries and the Collateral Agent and all other agreements, documents and other instruments entered into by the Company or any of its subsidiaries in connection with the SPA (collectively, the “Transaction Documents”), or (iv) the date the amended Notes Payable are paid in cash and all other obligations under the Transaction Documents are satisfied. Additionally, under the Forbearance Agreement, among other things:

(1)

The Collateral Agent may cause to be sold by the Company, shares of common stock of iBio, pledged by the Company to the holders of the Notes Payable pursuant to the Security Agreement as soon as commercially reasonable and apply the net proceeds from such sale first, against unpaid principal obligations under the Notes Payable and second, to any remaining obligations under the Transaction Documents. As of November 21, 2011, there have been no such sales.

(2)

The Company shall not, prior to the payment in full of all obligations owed to the amended Note Payable Holders under the Transaction Documents, make any (a) principal payments in respect of the $4,500 outstanding principal amount of the Convertible Note Payable which matured on February 21, 2011 (the “CD Financial Debt”), (b) past due rental or lease payments under the Company’s lease obligations to Vitamin Realty Associates, L.L.C. (“Vitamin Realty”) ($686 as of September 30, 2011), or (c) any rental or lease payments, including any past due rental or lease payments, in respect of any other personal or real property leased or rented by the Company or any of its subsidiaries from E. Gerald Kay or any family member of E. Gerald Kay; provided, that, so long as no Event of Default (other than the Specified Defaults) exists and is continuing, the Company shall be permitted to make interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt and make current rental or lease payments under the Company’s lease obligations to Vitamin Realty. If an Event of Default (other than the Specified Defaults) exists and is continuing, the Company shall not be permitted to make any interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt or make any current rental or lease payments under the Company’s lease obligations to Vitamin Realty. Any breach by the Company of (a) (b) or (c) shall constitute an Event of Default under, and shall trigger a termination of, the Forbearance Agreement.

(3)

If the Company fails to repay all of obligations under the Transaction Documents prior to December 31, 2011, then on December 31, 2011, the Company shall pay to the Collateral Agent, for the ratable benefit of the Note Payable Holders, a fee equal to $1,000, which shall be in addition to all other fees and expenses payable by the Company to the Collateral Agent and the Note Payable Holders under the Transaction Documents.

(4)

The Company has absolutely, unconditionally and irrevocably released, on behalf of itself and its subsidiaries, and its and their respective successors, assigns and other legal representatives, the Collateral Agent, the Note Payable Holders, and various other Releasees (as defined in the Forbearance Agreement) from all Claims (as defined in the Forbearance Agreement) arising at any time on or prior to the date of the Forbearance Agreement, in connection with the Transaction Documents, on the terms and conditions set forth in the Forbearance Agreement.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

During the period from October 4 to November 21, 2011, the Company and the Collateral Agent continue to discuss the options available to the Company to repay the Notes Payable by the extended due date under the Forbearance Agreement among other strategic options, including retaining an investment banker as contemplated under the Forbearance Agreement to assist the Company in selling its propriety nutraceutical business, to repay the Notes Payable under agreeable terms. When and if it is determined that the Company will not be able to satisfy the payment requirements under the Forbearance Agreement, the Company will recognize the forbearance fee of $1,000.

Convertible Note Payable – CD Financial, LLC

On February 21, 2008, the Company entered into a Securities Purchase Agreement (the “CD SPA”) with CD Financial, a significant shareholder of the Company, pursuant to which the Company issued and CD Financial purchased from the Company, a Convertible Senior Secured Note in the principal amount of $4,500 (the “Convertible Note Payable”). The Convertible Note Payable matured on February 21, 2011 and bears interest at the rate of 9.5%. Interest is payable monthly. The Convertible Note Payable is secured by a pledge of substantially all of the Company assets.

In March 2009, the Company and CD Financial entered into an oral agreement to suspend the cash interest payments on the Convertible Note Payable until the Company returned to positive cash flows in its operations. In this oral agreement, CD Financial agreed not to give any default notices or increase interest rates due to such default (the default interest rate as defined in the Convertible Note Payable is 18%). The Company resumed interest payments on the Convertible Note Payable in August of 2009. In March 2010, CD Financial orally agreed to defer the interest owed for April 2010, in the amount of $36, until the Company returned to positive cash flows to assist the Company in meeting its short term cash flow requirements. The Company has made timely monthly interest payments, beginning with the May 2010 monthly interest obligation. As of November 21, 2011, the Company is in default under the Convertible Note Payable for the nonpayment of the principal balance due on February 21, 2011. In connection with the Company entering into the Forbearance Agreement with respect to the Notes Payable (See Note 6. Debt – Notes Payable), CD Financial has agreed to not receive any principal payments until all of the Company’s obligations to the Note Payable Holders have been repaid.

As of September 30 and June 30, 2011, accrued interest of $253 with respect to the Convertible Note Payable for each period is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets, including interest in arrears of $217 in each period.

The Convertible Note Payable may be converted, at any time and at the holder’s option, into shares of the Company’s common stock under the terms and conditions set forth in the CD SPA. The conversion price is a formula that bases the conversion price on the greater of (i) 90% of the average Volume Weighted Average Price (the "VWAP") market price of the Company’s common stock for 20 trading days immediately preceding the conversion date and (ii) $2.00, subject to adjustment in the event of a stock dividend, stock split or combination, reclassification or similar event and upon certain issuances below the conversion price.

Also, in accordance with the CD SPA, the Company will issue and deliver to CD Financial, for no additional consideration, 50,000 shares of common stock, on a quarterly basis in arrears, until the Convertible Note Payable has been repaid in full, after which the Company's obligations to issue shares of common stock will no longer be applicable.

Debt discount of $324 in the three months ended September 30, 2010 was recorded in interest expense in condensed consolidated statement of operations.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

Notes Payable, CD Financial LLC

On November 24, 2009, Manhattan Drug, a wholly owned subsidiary of the Company, entered into a $300 promissory note (the “CD Note”) with CD Financial. The CD Note matured on November 24, 2010 and bears interest at the rate of 5%, which interest is payable quarterly. Interest is accrued monthly and is payable upon maturity. As of September 30, 2011, the Company is in default under the CD Note as a result of the Company’s failure to repay the CD Note on its scheduled maturity date. Interest is paid quarterly. The CD Note is expected to remain outstanding until the Company satisfies the Company’s obligations under the Notes Payable. (See Note 6. Debt – Notes Payable).

On July 29, 2010, Manhattan Drug entered into a second promissory note in the amount of $40 (the “CD $40 Note”) with CD Financial. The CD $40 Note matured on October 29, 2010 and bore interest at the rate of 5%. Manhattan Drug repaid the CD $40 Note on October 29, 2010. Interest was accrued monthly and was paid on maturity.

The weighted average interest rate paid on the Company’s outstanding debt was 8.49% and 8.48% in the three months ended September 30, 2011 and 2010, respectively.

Note 7. Significant Risks and Uncertainties

(a) Major Customers. For the three months ended September 30, 2011, approximately 80% of total net sales were derived from one customer as compared to approximately 87% of total net sales derived from two customers in the three months ended September 30, 2010. Accounts receivable as of September 30, 2011 from this customer represented approximately 39% of total accounts receivable. The loss of this customer would have an adverse affect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales.

(b) Other Business Risks. Approximately 56% the Company’s employees, located in its New Jersey facility, are covered by a union contract. The contract was renewed in August 2010 for an additional one year term and was extended in August 2011 to December 31, 2011.

Note 8. Commitments and Contingencies

(a) Leases

Related Party Leases. Warehouse and office facilities are leased from Vitamin Realty, which is 90% owned by the Chairman of the Company’s Board of Directors, a director and majority shareholder and certain of his family members. The lease provides for minimum annual rental payment of $324 through May 31, 2015 plus increases in real estate taxes and building operating expenses. On July 1, 2004, the Company leased an additional 24,810 square feet of warehouse space on a month-to month basis.

Rent expense for the three months ended September 30, 2011 and 2010 on these leases were $184 and $202, respectively, and are included in cost of sales in the accompanying Condensed Consolidated Statements of Operations. As of September 30, 2011 and June 30, 2011, the Company had an outstanding obligation of $715 and $738, respectively, included in accounts payable in the accompanying Condensed Consolidated Balance Sheet.

Other Lease Commitments. The Company has entered into certain non-cancelable operating lease agreements expiring up through May 31, 2015, related to office and warehouse space, equipment and vehicles.

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2011 AND JUNE 30, 2011 AND FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

(in thousands, except share and per share amounts)

(Unaudited)

The minimum rental commitment for long-term non-cancelable leases is as follows:

Total rent expense, including real estate taxes and maintenance charges, was approximately $276 and $294 for the three months ended September 30, 2011 and 2010, respectively. Rent expense is included in cost of sales, selling and administrative expenses and income (loss) from discontinued operations in the accompanying Condensed Consolidated Statements of Operations. The Company has a remaining lease commitment of $170 ($139 remaining in the fiscal year ending June 30, 2012) in relating to operations classified as discontinued.

(b) Legal Proceedings.

The Company is subject, from time to time, to claims by third parties under various legal theories. The defense of such claims, or any adverse outcome of any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows. The Company believes that there are no significant legal matters pending that would have a material effect on the Company’s liquidity, financial condition or cash flows.

Note 9. Related Party Transactions

The Company has a verbal consulting agreement with Eugene Kay, a former employee of the Company and a brother of E. Gerald Kay, the Company’s Chief Executive Officer, Chairman of the Board, President, and majority shareholder. This agreement is on a month-to-month basis and provides for payment by the Company of a fee in the amount of approximately $1.3 per month. The total consulting expense recorded in connection with this verbal agreement was approximately $4 in each of the three months ended September 30, 2011 and 2010.

See Note 6. Debt for related party securities transactions.

See Note 8(a). Leases for related party lease transactions.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION

Certain statements set forth under this caption constitute “forward-looking statements.” See “Disclosure Regarding Forward-Looking Statements” on page 1 of this Quarterly Report on Form 10-Q for additional factors relating to such statements. The following discussion should also be read in conjunction with the condensed consolidated financial statements of the Company and Notes thereto included herein and the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.

The Company is engaged primarily in the manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s customers are located primarily throughout the United States.

Business Outlook

Our future results of operations and the other forward-looking statements contained in this Quarterly Report on Form 10-Q, including this MD&A, involve a number of risks and uncertainties—in particular, the statements regarding our goals and strategies, new product introductions, plans to cultivate new businesses, pending divestitures, future economic conditions, revenue, pricing, gross margin and costs, the tax rate, and potential legal proceedings. We are focusing our efforts to improve operational efficiency and reduce spending that may have an impact on expense levels and gross margin. In addition to the various important factors discussed above, a number of other important factors could cause actual results to differ significantly from our expectations. See the risks described in “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q.

In the third quarter of our fiscal year ended June 30, 2011, as a result of our ongoing negotiations with the Note Payable Holders (See Note 6 to Condensed Consolidated Financial Statements – Debt), we have determined, in order to repay the Notes Payable, which matured on November 15, 2009, and to effect the Company’s strategic business plan to revert to our original core business of solid dosage manufacturing, to seek to sell the assets of AgroLabs, Inc., (“AgroLabs”), a wholly owned subsidiary of the Company, in order to repay a portion of the defaulted balance of the Notes Payable with the proceeds of such sale. Accordingly, we classified the business assets, liabilities and results of operations of our branded proprietary nutraceutical business as discontinued operations. As such, the operations of AgroLabs for the current and prior periods presented in the financial statements contained in this Quarterly Report on Form 10-Q and the associated results of operations, financial position and cash flows are separately reported as discontinued operations for all periods presented.

Our financial results are substantially dependent on net sales. Net sales are partly dependent on the mix of contract manufactured products and other nutraceutical sales, which are difficult to forecast. The net sales from our branded proprietary neutraceutical business are included in loss from discontinued operations and continue to influence our financial results. The varied sales pricing among our products and promotional support in the form of consumer coupons and other sales price allowances, along with the mix of products sold, affects the average selling price that we will realize and has a large impact on our revenue and gross margins in the operations of AgroLabs. Net sales in our operations of AgroLabs, classified as discontinued operations, is also affected by: the timing of new product introductions and the demand for and market acceptance of our products; actions taken by our competitors, including new product offerings and introductions, marketing programs and pricing pressures, and our response to such actions; our ability to respond quickly to consumer tastes and needs; and the availability of sufficient raw materials and production lead-time from suppliers to meet demand. Factors that could cause demand to be different from our expectations include: customer acceptance of our products and our competitors products; changes in customer order patterns, including order returns; changes in the level of inventory at customers; and changes in business and economic conditions, including conditions in the credit market that could affect consumer confidence and result in lower than expected demand for our products.

We believe that we have the product offerings, established and developing business relationships, facilities, personnel, and competitive and financial resources in place for business success; however, future revenue, costs, gross margins, and profits are all influenced by a number of factors, including those discussed above, all of which are inherently difficult to forecast.

For the three months ended September 30, 2011, our net sales from continuing operations increased by $1.6 million or 25.0% to $8.0 million from $6.4 million for the three months ended September 30, 2010. Our operating income increased from $0.05 million for the three months ended September 30, 2010 to operating income of $0.7 million for the three months ended September 30, 2011. Also, in the three months ended September 30, 2011, our gross profit increased by approximately $0.5 million and we cut our selling and administrative expenses by approximately $0.2 million. We continue to focus on our core businesses and on maintaining our cost structure in line with our sales.

Critical Accounting Policies and Estimates

There have been no changes to our critical accounting policies in the three months ended September 30, 2011. Critical accounting policies and the significant estimates made in accordance with them are regularly discussed by management with our Audit Committee. Those policies are discussed under “Critical Accounting Policies” in our “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of our Annual Report on Form 10-K for the year ended June 30, 2011.

Results of Operations

Our results from operations in the following table, sets forth the income statement data of our results as a percentage of net sales for the periods indicated:

For the three months ended September 30, 2011 compared to the three months ended September 30, 2010

Sales, net. Sales, net, for the three months ended September 30, 2011 and 2010 were $8.0 million and $6.4 million, respectively, an increase of 25%, and are comprised of the following:

For the three months ended September 30, 2011, approximately 80% of total net sales were derived from one customer and as compared to approximately 87% of total net sales were derived from two customers in the three months ended September 30, 2010. The loss of this customer would have an adverse affect on our operations.

The increase in our net sales is the result of an increase of approximately $1.5 million in our contract manufacturing product sales primarily from increased sales to one of our major customers in the amount of $1.5 million. The remaining nutraceutical product lines had net sales increases of approximately $0.08 million compared to the prior period.

Cost of sales. Cost of sales increased by $1.1 million to $6.6 million for the three months ended September 30, 2011 as compared to $5.5 million for the three months ended September 30, 2010. Cost of sales decreased as a percentage of sales to 82.6% for the three months ended September 30, 2011 as compared to 85.1% for the three months ended September 30, 2010. The increase in cost of sales was primarily the result of increased sales. The cost of sales as a percentage of sales decreased as we benefited from spreading the fixed manufacturing costs over an increased amount of products manufactured and sold to customers.

Selling and Administrative Expenses. Selling and administrative expenses were $0.7 million for the three months ended September 30, 2011, as compared to $0.9 million for the three months ended September 30, 2010, a decrease of $0.2 million or 24.3%. As a percentage of sales, net, selling and administrative expenses were 8.6% for the three months ended September 30, 2011 and 14.1% for the prior comparable period.

The net decrease in selling and administrative expenses of $0.2 million was mainly due to a decrease in our stock compensation expense, which decreased by $0.2 million primarily due to the significant decrease in the market value of our common stock at the measurement date of the stock option grants (the market value of our common stock is one of several factors used in determining the fair value of the stock compensation at the time of the award and ultimate expense to our consolidated financial statements) and due to no stock options being granted in the past two fiscal years ended June 30, 2011.

Other expense, net. Other expense, net was approximately $0.1 million for the three months ended September 30, 2011 compared to $0.4 million for the three months ended September 30, 2010, a decrease of $0.3 million. Interest expense represents substantially all of the other expense, net in each of the three months ended September 30, 2011 and 2010. The decrease in interest expense is primarily attributable to the lack of any accretion on our Convertible Notes Payable in the three months ended September 30, 2011, compared to $0.3 million in the three months ended September 30, 2010.

Federal and state income tax, net. For the three months ended September 30, 2011 and September 30, 2010, we had minimal amounts of state tax expenses. We continue to provide and maintain a full reserve on our deferred tax assets as it has been determined that based upon past losses, the Company’s liquidity concerns and the current economic environment, that it is “more likely than not” that the Company’s deferred tax assets may not be realized.

(Loss) income from discontinued operations. In the third quarter of our fiscal year ended June 30, 2011, as a result of our ongoing negotiations with the Note Payable Holders (see Note 6 to Condensed Consolidated Financial Statements – Debt), we determined, in order to repay the Notes Payable, which matured on November 15, 2009, and to effect the Company’s strategic business plan to revert to our original core business of solid dosage manufacturing, to seek to sell the assets of AgroLabs in order to repay a portion of the defaulted balance of the Notes Payable with the proceeds of such sale. Accordingly, we classified the business assets, liabilities and results of operations of our branded proprietary nutraceutical business as discontinued operations. The loss from these discontinued operations was approximately $0.2 million for the three months ended September 30, 2011 compared to net income from these operations of $0.4 million for the three months ended September 30, 2010, a decrease of $0.6 million.

Net income (loss). We had a net income of approximately $0.4 million for the three months ended September 30, 2011 compared to a net loss of approximately $1,000 for the three months ended September 30, 2010. The change from a net loss to net income of approximately $0.4 million is primarily the result of increased operating income of $0.7 million, a decrease in other expenses, net of $0.3 million, offset by a decrease in the net income (loss) from discontinued operations of $0.6 million.

Seasonality

The nutraceutical business tends to be seasonal. We have found that in our first fiscal quarter ending on September 30th of each year, orders for our branded proprietary nutraceutical products usually slow (absent the addition of new customers or a new product launch with a significant first time order), as buyers in various markets may have purchased sufficient inventory to carry them through the summer months. Conversely, in our second fiscal quarter, ending on December 31st of each year, orders for our products increase as the demand for our branded nutraceutical products seems to increase in late December to early January as consumers become health conscious as they enter the new year.

The Company believes that there are other non-seasonal factors that also may influence the variability of quarterly results including, but not limited to, general economic and industry conditions that affect consumer spending, changing consumer demands and current news on nutritional supplements. In addition, our recent growth has caused additional variability in our quarterly results. Accordingly, a comparison of the Company’s results of operations from consecutive periods is not necessarily meaningful, and the Company’s results of operations for any period are not necessarily indicative of future periods.

Liquidity and Capital Resources

The following table sets forth, for the periods indicated, the Company’s net cash flows used in operating, investing and financing activities, its period end cash and cash equivalents and other operating measures:

At September 30, 2011, our working capital deficit was approximately $9.0 million, a decrease of approximately $0.5 million in our working capital deficit of approximately $9.5 million at June 30, 2011. Our current assets decreased by $0.2 million and our current liabilities decreased by $0.6 million, as we were able to pay our suppliers quicker as a result of our increased sales in our contract manufacturing business.

Net cash provided by operating activities of $0.2 million in the three months ended September 30, 2011, includes net income of $0.4 million. After excluding the effects of non-cash expenses, including depreciation and amortization, compensation expense for employee stock options and consultants and changes in the fair value of derivative liabilities, the adjusted cash provided from operations before the effect of the changes in working capital components was $0.8 million. Cash was used in operations from our working capital assets and liabilities in the amount of approximately $0.7 million and was the result of an increase in accounts receivable of $0.8 million, a decrease in accounts payable and accrued expenses of $0.7, offset by an increase in inventory of $0.8 million. Net cash of $0.2 million was provided from operating activities from our discontinued operations.

Net cash provided by operating activities of $0.5 million in the three months ended September 30, 2010, includes a net loss of $1,000. After excluding the effects of non-cash expenses, including, depreciation and amortization, compensation expense for employee stock options and consultants and changes in the fair value of derivative liabilities, the adjusted cash provided from operations before the effect of the changes in working capital components was $0.2 million. Cash was used in operations from our working capital assets and liabilities in the amount of approximately $0.4 million and was the result of an increase in inventory of $1.0 million, offset by a net decrease in accounts payable, accrued expenses and other liabilities of $1.3 million. Net cash of $0.8 million was provided from operating activities from our discontinued operations.

Cash provided by investing activities was from the sale of machinery and equipment of $2,000, offset by the use of cash for the purchase of fixed assets of approximately $1,000 in the three months ended September 30, 2011, compared to the use of approximately $145,000 in the three months ended September 30, 2010 for the purchase of machinery and equipment offset by a gain on the sale of machinery and equipment of $30,000.

Cash used in financing activities was approximately $11,000 for the three months ended September 30, 2011 for payments under our capitalized lease obligation. Cash provided by financing activities was approximately $29,000 for the three months ended September 30, 2010 and was the result of proceeds of $40,000 from the CD $40 Note (See Note 6 to the Condensed Consolidated Financial Statements – Debt), offset by payments under our capitalized lease obligation of approximately $11,000.

Our condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. We have cumulative historical losses and cash outflows from operations. As of September 30, 2011, we had cash of $0.9 million (inclusive of $0.4 million of cash in assets from discontinued operations) and a working capital deficit of $9.0 million, which is primarily attributable to the Notes Payable in the amount of $7.8 million, which matured on November 15, 2009, the Convertible Note Payable in the amount of $4.5 million, which matured on February 21, 2011, with respect to each of which we are in default. These factors raise substantial doubt as to our ability to continue as a going concern. The condensed consolidated financial statements included in this Quarterly Report on Form 10-Q do not include any adjustments that might result from this uncertainty.

As stated above, we have defaulted on all of our outstanding debt instruments in the aggregate amount of $12.6 million by failing to repay them on their respective scheduled maturity dates. The Notes Payable and the Convertible Note Payable are secured by pledges of substantially all of the Company’s assets.

On October 4, 2011, we entered into a Forbearance Agreement (the “Forbearance Agreement”) with the Collateral Agent for the Note Payable Holders. The Forbearance Agreement provides that the Collateral Agent shall forbear from exercising rights and remedies arising from the occurrence of Specified Defaults (as defined in the Forbearance Agreement) including our failure to repay the Notes Payable which are due and payable. The Forbearance Agreement will terminate on the earlier to occur of (i) December 31, 2011, (ii) the date we fail to comply with the covenants, conditions and agreements contained in the Forbearance Agreement, (iii) the date of the occurrence of any Event of Default, other than the Specified Defaults (as defined in the Forbearance Agreement), under the SPA, the Notes Payable, the Certificate of Designation (as defined in the SPA), the Registration Rights Agreement (as defined in the SPA), the Subsidiary Guaranty, dated as of February 21, 2008, by and among the Company, certain of its subsidiaries and the Collateral Agent, the Security Agreement, dated as of February 21, 2008 (the “Security Agreement”), by and among the Company, certain of its subsidiaries and the Collateral Agent and all other agreements, documents and other instruments entered into by the Company or any of its subsidiaries in connection with the SPA (collectively, the “Transaction Documents”), or (iv) the date the Notes Payable are paid in cash and all other obligations under the Transaction Documents are satisfied. Additionally, under the Forbearance Agreement, among other things:

(1)

(2)

We shall not, prior to the payment in full of all obligations owed to the Note Payable Holders under the Transaction Documents, make any (a) principal payments in respect of $4.5 million outstanding principal amount of the Convertible Note Payable held by CD Financial, LLC (“CD Financial”) which matured on February 21, 2011 (the “CD Financial Debt”), (b) past due rental or lease payments under our lease obligations to Vitamin Realty ($686,000 as of September 30, 2011), or (c) any rental or lease payments, including any past due rental or lease payments, in respect of any other personal or real property leased or rented by us or any of our subsidiaries from E. Gerald Kay or any family member of E. Gerald Kay; provided, that, so long as no Event of Default (other than the Specified Defaults) exists and is continuing, we shall be permitted to make interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt and make current rental or lease payments under the Company’s lease obligations to Vitamin Realty. If an Event of Default (other than the Specified Defaults) exists and is continuing, we shall not be permitted to make any interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt or make any current rental or lease payments under our lease obligations to Vitamin Realty. Any breach by us of (a) (b) or (c) shall constitute an Event of Default under, and shall trigger a termination of, the Forbearance Agreement.

(3)

If we fail to repay all of the obligations under the Transaction Documents prior to December 31, 2011, then on December 31, we shall pay to the Collateral Agent, for the ratable benefit of the Note Payable Holders, a fee equal to $1,000,000, which shall be in addition to all other fees and expenses payable by the Company to the Collateral Agent and the Note Payable Holders under the Transaction Documents.

(4)

During the period from October 4 to November 21, 2011, the Company and the Collateral Agent continue to discuss the options available to the Company to repay the Notes Payable by the extended due date under the Forbearance Agreement among other strategic options, including retaining an investment banker as contemplated under the Forbearance Agreement to assist the Company in selling its proprietary nutraceutical business, to repay the Notes Payable under agreeable terms. When and if it is determined that the Company will not be able to satisfy the payment requirements under the Forbearance Agreement, the Company will recognize the forbearance fee of $1.0 million.

There can be no assurance that we will be able to repay, restructure or amend the Notes Payable by December 31, 2011 or the Convertible Note Payable prior to the receipt of a CD Acceleration Notice from CD Financial. In the interim, we have continued to make timely interest payments to the Note Payable Holders at the non default rate of 8% per annum and are exploring our strategic alternatives, which may include business divestitures, developing business and sales strategies to increase operating income, the sale of some or all of our assets or operating subsidiaries and/or capital restructuring plans.

If the Notes Payable are not repaid by December 31, 2011, and as a result of the events of default that arose based upon our failure to pay each of the Notes Payable at maturity, the Note Payable Holders have the right to give us an Acceleration Notice. As a result of the event of default that arose based upon our failure to repay the Convertible Note Payable at maturity, CD Financial has the right to give us a CD Acceleration Notice. Each of the Acceleration Notice and the CD Acceleration Notice would (i) accelerate the payment of all unpaid principal and accrued and unpaid interest (including default interest (if any); with respect to the Notes Payable, only default interest arising subsequent to December 31, 2011 (if any) on the Notes Payable and the Convertible Note Payable and (ii) require us to pay an amount equal to the sum of all of the respective amounts described in the preceding clause (i) in same day funds on the payment date specified in such notice. If we are unable to raise additional capital, sell certain assets or successfully refinance the full outstanding amount of the Notes Payable and the Convertible Note Payable upon acceptable terms, it would have a material adverse effect on us, including the possible foreclosure by the Note Payable Holders, and/or the Convertible Note Payable of all or some of our assets, and would impact our ability to continue as a going concern.

As of November 21, 2011, we have not repaid the holder of the Convertible Note Payable, CD Financial. CD Financial is a significant shareholder of the Company and has not made any payment demands on us with respect to the Convertible Note Payable, nor has it converted the Note Payable into common shares of the Company. In March 2009, we entered into an oral agreement with CD Financial to suspend the cash interest payments on the Convertible Note Payable until we return to positive cash flows in our operations. In this oral agreement, CD Financial agreed not to give any default notices and that default interest does not have to be accrued at the default interest rate. In connection with the Forbearance Agreement, CD Financial has also agreed to receive no principal repayments until the Note Payable Holders have been paid the obligations outstanding under the Transaction Documents, including any interest payments at the default interest rate.

Our total annual commitments at September 30, 2011 for long term non-cancelable leases of approximately $508,000 consists of obligations under operating leases for facilities and operating lease agreements for the rental of warehouse equipment, office equipment and automobiles, including $175,000 relating to our operations classified as discontinued.

Capital Expenditures

The Company's capital expenditures for the three months ended September 30, 2011 and 2010 were approximately $1,000 and $145,000, respectively. The Company has budgeted approximately $0.5 million for capital expenditures for fiscal 2012. The total amount is expected to be funded from cash provided from its operations and from lease financing.

Off-Balance Sheet Arrangements

The Company has no off-balance sheet arrangements.

Recent Accounting Pronouncement

None.

Impact of Inflation

The Company does not believe that inflation has significantly affected its results of operations.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

Item 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized, and reported within the time periods specified by the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of its disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2011, and, based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures are effective in providing reasonable assurance of compliance.

Changes in Internal Control over Financial Reporting

No change in our internal control over financial reporting occurred during the three months ended September 30, 2011 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

None.

Item 1A. Risk Factors

The risks described in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the year ended June 30, 2011, could materially and adversely affect our business, financial condition and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not presently known to us or that we currently consider to be immaterial to our operations. There have been no material changes to our risk factors from those disclosed in our Form 10-K for the year ended June 30, 2011.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Effective August 21, 2011, the Company issued 50,000 shares of common stock to CD Financial. See Note 6 to the Condensed Consolidated Financial Statements – Debt.

Item 3. DEFAULTS UPON SENIOR SECURITIES

The Company is in default with respect to its $7.8 million outstanding principal amount of Notes Payable and its $4.5 million outstanding principal amount of Convertible Note Payable, as a result of the Company failing to repay the Notes Payable and Convertible Note Payable on their scheduled maturity dates. See Note 6 to the Condensed Consolidated Financial Statements – Debt.

Item 5. OTHER INFORMATION

None.

Item 6. EXHIBITS

(a) Exhibits

Exhibit

Number

31.1	Certification of pursuant to Section 302 of Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer.
31.2	Certification of pursuant to Section 302 of Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
32.1	Certification of periodic financial report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer.
32.2	Certification of periodic financial report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
101	The following financial information from Integrated Biopharma, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended September 30, 2011 and 2010, (ii) Condensed Consolidated Balance Sheets as of September 30, 2011 and June 30, 2010, (iii) Condensed Consolidated Statements of Changes in Stockholders’ Deficiency for the Three Months Ended September 30, 2011 (iv) Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2011 and 2010, and (v) the Notes to Condensed Consolidated Statements.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INTEGRATED BIOPHARMA, INC.

Date: November 21, 2011	By: /s/ E Gerald Kay
	E. Gerald Kay,
	President and Chief Executive Officer

Date: November 21, 2011	By: /s/ Dina L. Masi
	Dina L. Masi,
	Chief Financial Officer & Senior Vice President

EX-31.1 2 exhibit31_1.htm exhibit31_1.htm

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, E. Gerald Kay certify that:

1. I have reviewed this quarterly report on Form 10-Q of Integrated BioPharma, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 21, 2011	By: /s/ E. Gerald Kay
	Name: E. Gerald Kay
	Title: President and Chief Executive Officer

EX-31.2 3 exhibit31_2.htm exhibit31_2.htm

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Dina L. Masi, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Integrated BioPharma, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 21, 2011	By: /s/ Dina L. Masi
	Name: Dina L. Masi
	Title: Chief Financial Officer & Senior Vice President

EX-32.1 4 exhibit32_1.htm exhibit32_1.htm

Exhibit 32.1

CERTIFICATION OF PERIODIC REPORT

As adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the first quarter ended September 30, 2011 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), E. Gerald Kay, the President and Chief Executive Officer of Integrated BioPharma, Inc. certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to his knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification accompanies the Report pursuant to Section 906 of Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Dated: November 21, 2011	By: /s/ E. Gerald Kay
	E. Gerald Kay
	President and Chief Executive Officer

EX-32.2 5 exhibit32_2.htm exhibit32_2.htm

Exhibit 32.2

CERTIFICATION OF PERIODIC REPORT

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the first quarter ended September 30, 2011 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Dina L. Masi, the Senior Vice President and Chief Financial Officer of Integrated BioPharma, Inc. certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to her knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Dated: November 21, 2011	By: /s/ Dina L. Masi
	Dina L. Masi
	Chief Financial Officer & Senior Vice President

GRAPHIC 6 inb001a.gif begin 644 inb001a.gif M1TE&.#EA6`(2`O<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*U>H/%`H4,?YI.GOHGS\X:)6=G8NBD3\F=%7$$@COK(IM MH]R:I;MB&\&W>P<2HWLVUCVX??Z6XQ6X+W*`RG/%:/6[RO( M:0OG_FV-MA]> M^7NK7[\]MO_0?G#\)9!9*226RC^AW`)@6O!8]I8*X(6RUV+`P='>/\1\]P\S M[/'7UPT$,1/+6[;9TQ:``A:S%RAZE09B0;2U11N$__1#B8!]X3`@"K+]LPP* MA_BS5I":M/A8#/S]\R%!&8+WXX7S^VE=!G M.@Y$H(%FMKC6BP,!V%99:0F9VC\'\L6CDM9M8^.;H"#Y'(V@;+FF>RN`9R>; M`V[Y8UHH&O9@A`K"\:8F<_IGZ4]OO?9/,S_.UZ5[5`8GH&<=#A280,08"<>< M_J0"AZ:J4?]2::9)*J.A?2T21!MPE&A(JWV:/IA87WOUY4-9MS(1JJNPIIK? MJ@,M`X>OHD!+$"HW)ED0K9MR^-JGW,X>'8CKIII]OX\^D_MH*'*WSVB=EJ M>1>21^J;`<82+VNI.)HMN\FV*&IQS-::K&W<#MPF$_+V>^G#/34J4+]FW=!J MFZOR]V`MGSZ)4(;%UC70/:M0N&W&&*N@S;HL:F96CU621IN?C2ZJVLL"A5E: M6YIL>0\3E?93,I"*;=F7>LW@',\K0/.7',X(24S>8CBHFS-:VHX9"]1T;E/Q MQ0,*S+5@9_4(YVT.XTE:7W%2!O.C_[1,=H4T_D.RR6GNI;/$&Z__PMIO$`?. M4[C4I`N7&.N2J+%P=[*+@@\?CU:0,=O,O*VLAT$F)L"WK07S/[3-!3FAE9?J?"_[S>V4"8$4UZ]M`'I[W@[-LD M,9V>X<7F@IFK4(O?<;-7(VJH?C>!K=&L=&93#P"`M&C9,+ MO@H3KC?B"3[(RS#@L\Y&1"84:"/!^1(5;'&D@\3#4CSZG&C9N*EI6JA$@ M#>66,2FR<5@LGD"Z9T>!],,0(X.#93012*O=*W9B^&0H+8,EPW`R7\$3T!GQ MM+EV/49`5HSE;:BARO`DD(K`3,G[TH:A^:',/4::4!$M)*4M<0A)_LB#&9E@ MKK=8L(=[$5H25Z0_.%KF9T23V(_*Q#6=$:1G^0$::Z09GBP9#6NZTU/3?D8S M=L800K0!96%F,9 M>_2H+VT!)W*8$%%?!7&;^7O1HZ*)T-O(;5%Z"I"CII4?Q\"AH^,*IDQ'0I_H MY(DUGZK.^(R#P;[4QE&L&Q%GSA(GQ@G(/C^U&V1(.)GT7(8Q(N/-^)!J'>6( MID>44<%IB+J\HI*0#W,1*@I6H(W%D)48J;S/#;0A'(1!9@6G&!]L>F.68`&" M()\YRVM^I![U$6>$*I#"3;GD/=`4Y).ADPQK.(.]H8;5+8;PZ0O-@Q[#KL<& M>/%JGD0S2A>"M3[W\8N^#)'8K,WTM*B]"CSTF=K6NO:UJ+6'%F%+V]K_VO:V MN,VM;G?+V][Z]K?`#:YPATOY,M%I*O&')^F1[4XV M0H$-*KL^2>9EB66[8'OT$XO;A=:%.)2.R*AS'S&0K$K=)2(*0-G5^+DP%COT M:6/^1D)#U30^SBFHI)@$U4-0U2_@M2Q>\5*@`['NL1A+H&//4HBEWI<^%X6J M:.5+7^B8HL#V;?!!]+M>^EP/CMT%,(\.7%45F\L]ZBG?^LQC&!+K!L/BW08X M10Q=F\".6%)6,<`C%X&!BSDY5)B(-OF=ULRV2JD!LB;Q MAB'T"@1<[YF>8<:Y20EV+U:C.O):L&>WQQ%D_\EJ!)UF'+ED@.'0+%=>C5IL M(R+%W4,];9XMG#%GCQ']:\J.NY!?G[#620RZSDRLMYA[3Y'V@RR@U;P.@ M$J:B4SBL4Y/NF4V5$B05'$JH)SG*FE$8KFXSC.$+/6GLV1SB9W5[2PF;$5=/ MA:='SKXEKZ=E*+DULFX@DV0)_8&*:C?RFK@&Z6-\J%1PC[M2K&GWBY]C0;@1 MY!0L=8LHU!GO374[78D[9KU-E21Q4]M7%#0(KOP+2SQ9)D<%3[=]KLGNC[Z; M/XUR>`\-A6SK@.=`$/]EN*UG\J&LM;PYLBF<7([UJ2.WQD&OT@9UR3-S?U"# MO^F[40')-UGH@'L'M388Z:T48W9=5E'B/,V745UX3CQD$I?P5 MTX&.:`AAEQ!U1X1>OXXHAAVF?IGAS1O96!M!1!WJ@9@T'`K"D'#)H;HULC$W M,DT-\<89XQ9?2I+9J1U[D!+QERWLT8*T=?SD"[`XFCOV-/9XNXRE'F;*@PO_ M[QO9N^@7Y/=FT6=6X?,DJC>.0^O[/H&;/Q!1;`.@H`*Y2M$_WXFE=+YU8GZ< M%Q.5-S)(5W7V4AVCDW7+M`+W(T@H!!=7]F@XQ'8$(79&5X!'9WCF4R=(Q6:R MYA@'&$-Y(!A5W2,%(+YESDJ>'5KIS)MUPP=]$&U8SB+ MIT/+IFHL^%2Y0BI4@CIE\1>#IRMRA4!7DT:O\H"*H41F`2^,TV*2UX(Z-H*7 M%X%N=H%8.(`N(7)N47?OTVL&-VQO]#X_MT.>UTLQ%"0>]W-QLR6]1GC8 MIC'5X&_:EAA81&9VPUKVT0AG&'`@M2%TB&Y`M"7Q_Y`8BY0Y\%9M/R)\11D'S&^G,/K2B&,+%"_B`'PJAIZE$]J+*`+>)T?Y(? M===/Q#`Z*6R$2-J+*.J1%-H30J%T&YECI%0B.BD[8`"NYU7IE!1%$YE:AA1H:0EC.)D_[%.H"V,*)% M=HWSDWLA&D1B'=H`'?^7)SIE032F5%A)-CLYB(!)DYS9F9[YF:`9FJ(YFJ19 MFJ9YFJB9FJJYFJS9FJ[YFK`9F[(YF[19F[9YFQYQ#V%`"2"H$.HSDR0!CC>A M/K_T$+_)$M+H$9\D01O,N1'+`"M`<0]R$)@'Y9Y;(5%;@S5'H@V7EB3PQR.:@`,`@BBA M\Q=]\1WBF1A3XC`9T@=I<4B4PA^#`2AH04P/E5DZ!A=VT2>&$3HO`DY(\B3) M%@M5V7]7`T\=JH:'``\^9!8QX#`9NJ%IT@<7\IWH&4/PM*3CI4X5&CN#=34W ML*-7:1O+(`80:D,MFAT6`P>-E0(F&BU#ZC-M61`L8J+R=`/98"&)6%TT\J&Q M$*(A1*%IT:.D8:2KYP0"ZJ!14:%O`3EOT0.;P`?X%AP@_Q(<8B`*4M"D*&!H MI+%0]W=4#$.,[/(7FF"H<("HBAHMA:(,)_I2_;`%"!&@EEHCLH(*WO@=EAJ@ MH-`>GE.>P0&".71'CGITA=!%$-4/7!`\CQJIAD$,9#6KI`(+KS)0?[&JJ'*L M2?:IB9IES8IIM3I@/E(8I/H9R@HKO\H%;V$(T[I)G#HZM-&K?W&@VT"J!6&L M=:DCC(IGQ.`'+\17Y3D@MA&@C`JI;H6-IAJL(2JH6/$SI/$SNN9!9'I8S/8S M5'`:LO$S.F(?8E`6%E.E-R=)J?122I4"REHF$"4D\`I!!O$SC<"+Y@20,52R M1&.P,727G_,6I&$?.D*P;A$'?_^0GA#T,W[@L"T+LYYDLRBDB;SXL=@Z;QT; M0X8@)+;'LC1KL$?3#W+0H-VYLDQ`!$:0WZ0"DPP M!8U`HS$$(C2KM'(B3REP&FJKL6X!0@(4^:G]GH)2V"D8R0GSD3 MC7I1B+1!D:FR#%$B-V\KYP4`A_<,$!&\,"=[SZ0@FV M][U1T0^`2A\WT"<1I+J*<18]T*G5]4WBT4@CJTD0*H4#9<7)7Y,59Q MA0(]H`I:5R7JH5,5A5XS$J/3H<>"\0)P(:)G,5O=:YE%*,:'_V''YB/&/H4< MUM$';%$6V`/(!J@"D@R];]P8,]+&0@@*@NS%WC6IE&P0ZJ)UI0S':^S)I*'( MHZR[D7P6AE"A[*J`WC5M?7'&*E6ACXP951V$/UZ01;P&\ MAX&L3;',@:,)[3G,3.%H2=$/5?`1GRN?3)`*R-L4VWPIRV">U/P4U2O$D8HSI2ND2'?&(MMWT]V4=1MX1<4;+AUB#\(X80 M*',6`W&:KD`B:D*BOTP`KT&DJ6%"4!)+V:Y=%'>1&/2!/3^2`G$W')^!R9'4 M%X%E)6LQ!5:2SMGA9GDU)[]M)>'\VLKM$Q3+$\2PT,L=W3E!NSDQG\8LW=CM M/E)K$_[`"2K_G=W@'=[B/=[D7=[F?=[HG=[JO=[LW=[N_=[P'=_R/=_T7=_V M?=_XG=_ZO=_\W=_^_=\`'N`"/N`$7N`&?N`(GN`*ON`,WN`._N`0[A$3!B3X MUWE1NA%(M=<:%>$"FR!Q5FAB5!-6,Y`;`60)P=(<[J#6A'WJ[!++`"+TXQ&\ M>!`?G>(".X1J%&MK_)ATA!?HZ./GAQ8?U@C)694RPAYFH6F.:2%0@QD+_8&% M]V&CPQNIH+I0[CU(;>."NGS+T]EL;1W2H#*2XB8PNRI&?G6YGQ6OHS[GBH$*A M;)TKCGUTYFE-V1$#JNXD0!(C]*/F(;0_T5$W(90D2.P>LF[I((-1OYXHQ,O. MIEZ;B!X=BJY8NF2"V?)>"*D6."#IA8B[;MW`]H'I;WT/@*`G_8EF.K8*@SUF M=4$L`_->Q(+BR3Z;:XDG*>`JR$U4GT94-994`P%_0'W4L5>5M^M"3*,_K8$# MM1WP-W`/\*MJ]=XAG2+O(8L"P`TB/M4>K0'<+MWN&)_Q&K_Q'-_Q'O_Q(!_R M(C_R)%_R)G_R6Y';L."B'F'=%%';AC)OU_^-\O=\#R&-T0[!G0[QAQ.AVC`> M!XX!J#3/S_Q"3AD"2,"'=EJ.(E! M]_Y@]\N35M=F]#V(N0+!]Y8`"\(Q@<2I)+*A#-,,]]0<O&:_O&8+O M^4;?]*CR)K4_G_?I#Y>@8U$_]:I_MS;O1G&07FO#2MF+S"G%)\MO-YXO4)I/ MNPKJ1G:I)"`-G/;_`.,+>N?%7_.J0!FN*X'AX;L[,K/F7QJ,4(5D1AF!=/[' M4E=)XE.53&Y/&/[__/D\,4OZ3_0`(2?6/X(%#1Y$F%#A0H8&[>'8UE#B1(H5 M+5[$F%'C1HX=/7X$&5+D2)(E39X4V8\2"A6W4+Z$&5/F3)HU;=[$F5/G010] M??X$&E3H4*)%C1Y%FE3I4J9-G0+=&57J5*I5K5[%FE7K5JY=O7X%&U;L6+)E MS9Y%FU;M6K9MW;Z%&U?N7+IU[=[%F_>?/TTH4@S\=X_)7X/+O7\"" M4[@L:+B@8!6`]5[&G%ES0V8NE<78:RE6/R<1_RU#D?AT:KN=_WT./;HT_T'4 MB?W%N75OCNG-O7W_OGM/SBU[-_:".A39!^*\NHD;YYN<=F)XR_DV`IY=^_:T M_:J<7OZ/F/1_\%27/U_7.WB"XPN:)PC_M1CN]>W?SPJ/OO[V]*^8).BVW/[@+4@MMV20&)\(<\PR>WI:?A39::=VZ9T[NJK7T'I9@ M227+R02:EDYE>NH1)M10*)>@>^!XS"!B`/-GI9ZL-6E<=&OJ*]WV`$,M!=[, MU!>M?IJ(Q1]08O#VGW[8=;.D)\.EZYX8IHG%&'I+ZD>@>YIHN)\X9#--,.GP M@[QUQ]1 M"L8MWJ+Y9LN>OV.*E\8!2_SG\GE"^UQ7;S; MSUJ8\X+&K&SCW-PFER!0WEY(](U'`Q^%0UR^'O>=4P$W)GA@.1AM0\07(QZ7 M$">HPYGN@5_R/B*V?^2H(,43#]F6H;T"KDF`8*'9<;"C$AQ8*6A,0TB\&'B0 M_X&YI(,\*XCMW">7>]R"?R=9C\'(!C4)VJLG!;(<34IHP)?`8TG`*X@+R5']HV0+&"[!RRX!I/' MW8)]!LE8+.Y1!=[P#VPRP:(6%6>2\]WF8F9$TYLVN)9[J*(O*(@>2Z2@`BFP MY'5V"P_K6(.:'NEM!=H8'T3:=K=QA<>*;+'7#TERK@L1,F;M*LCP"F(,N=6K M)Y(\WKQHF3VT,!:!R$K4?^AI4Y>>558GF366ZI.)ULI:-N>9]=YM*7 MOP1F,(4Y3&(6TYC'1&8RE;E,9C;3F<^$9C2E.4UJ5O_3FM?$9C:UN4UN=M.; MWP3G59CQPI5A;"6@-(CWPLF6Q=!+;Y4\S[E,U!:7^3$A((+'"X441TAJ+Y\/ M#%'R9#<:CDW$9;M;YUEZMSI*J*8V(4120>'B&H6T;2`6C%\^'\1"DYKP@3W*M0RLJH48",L@U_SF13E$!!\161C9KB,>[764(!ES23-Z M5M
F^@-O5'7?]Q5ZEF91G_-EB%8-8*V;'^IR`+P^E;$INE&(+(9>FQX5N6 MH52$=%!A!1U7Y>#P-'`]T5I>,M&8'G/!]%THM8W5RN\6I-L='9!^JIR+8-,Y M$$UV1A.DI4U;TV(/POQU%>4YF^CV`H>6*$QF#@$3P4Y+K^SU[&4>$R/!C1:N"A#>_[(0Y7@L!R) M[>6Y3'2)R^:TT(=$1+I5NES-!G)+C`Y$OX%1XH&+8=[SYL0?'',:&)M0.L!H MB&<*GHM:%3(\JC:-$OM5KEM[LD'!V+.>=WL-CO%679C&]*]VD]QT_<*'%$2N M)35>_]*-8]QAG9A).N/$CI-#M+=1[O`M/W4H'C,IG9\6",M,YEL_`(H9,8/9 MF"C#I6_0;.96)`\YT.QV];QG/O?9SW\&=*`%/6A"%]K0 MAT9THA6]:$8WVM&/AG2D)3UI2F]&3;&XFE3J:8,75WHD&D+(6?WB)H!AYEQY MW&F7WW*PB(`"N3O9A!CC=T9/=R2?,%M7S2U/ M3^`:MW3*(15N(U(3RMT(F+*)3-Z[(SJAS1`9'81R8"1CS?^61(RPRJ5PTEE7 M@32!`WBPERW$("WK<*"-E83'V:_YKV+ONMG%\D;BVT"V-NP6-5!@AQC5"]I! M"[;:?7-$V@2!GD.F5ST+`5M[.#Q=YP;\%O^&3+OF^WG\O$0>V"(DB'D=:=*U MJ_314.*C+:=(OP\X$&60IQ]YX$U]T8T7-6U=%*8Q[JO5,J8+<=RTL/.@1*>[ M4Y?M]*\%K;`RRO>,R+U@X!(;/=PN.[2/!=D M-VQP?RU-Z-VB)M88TL%V8SN0K:/_>PZ"KWJ;PZO;_@OD6/0%-%[ZN^BGO-75 M]&AX+CS;F(`+[-2$3*CQT6>*F*U\6-Y=F*;E?I/%_LQZSC'\YT=_^M6_?O:W MW_WOAW_\Y3]_^M??_O?'?_[UOW_^]]___[>U4?,?H^.8H[NNER@IB=B^@_BB MA)`]CVA`,WNG=+,R2C*UGHB1\UB7K5,+T3FNA#FH5Z`$3.(=ZA*@>"%!D;B' MI_,W[_NF>$FRT&DM+,&@O%@/$'JH*D&2V>"HV>"0BA*O^)$)OVJ(!?R("VL( M^,(S))H,)_"BCZD9_R`XO5@&]C*@?G,1)5P+@RDJ,'(;^KB@$3NMUY$#6*BX MY<-`?U.W_[DQ0^9KMAFSEG.!B+WHNFTH#M00@WRZD#`4N;L9F(B(JCNRCB9( M!3R20T0ZI:`9%]?1EN58I'GRAR\T/!1@!$H`0[JQF\9X*G4IPS-K#&ZA: M0V0A#:NRN+2JI/"HN;R0#QS2$+9JCRH2"[VI+H*(M<(J0"AB%Q%D">+XBWXP M'=+;+(_AQ99@+L``A<,X1C`:CF^#N/)(`5XTA(1[G&U8F!2P!;OA'&1;N;_@ MN(UCN7HRCGZXA">?N#R?K,FZVXL76Z3PH;NB,RJ?L"T?0Q;>"CO3L)<4O`LU\2F' MJA`6)`O4JY(+J\;+"D*2#"^74*<:,[_/PD6Q_#PFB+>.@8,;<*-Y"#"_(=XX`/_&*FW_+7)^#R)ZJ[Q M8L#R0I:#PR_#*Y>7PPL7B<@LI*$.+$G38<*R"D.\RD6P!+"%:+"X$QV#:2HA M#`S0"+&%L\8"W(T6N2C(W.; M%V"7R&&$OCB$<:J@OK`!.YA/H#*^&TL,_%P,SJFW/3*AU%B,B!,%-^E)&BE1 M@[D!ROB>&8,,)`LJ%;C/,\D&((L3MTDR($N^79$R"O2/,1F_N\BGZ8.3R6`7 M%]2+"`L,A^,2(P3`.T&0R,!*%0FB)NV3.[(R+BF_@J32+;T+.O-209&S+Q73 MI>#2,C73,T73_S15TS5ETS9UTS>%TSB5TSFETSJUTSO%TSS5TSWETS[UTS\% MU*\P$Z8LB`CLOQXCI02:C#;)#L0YER@E"V3S+DFMB.W44\;ZA[ZS*!T$ MF=_HU-C@3;$RMC>12HW8JSX=P)F2#L^TU+I@U<&T1BAD"YWR.$NIAG;^1F'$Z!#S\*TF$M@@J*TV"14;M MC6'3)!0%*[<(MRQ!*9A"&$H]+-R`J:@AK(_Y(I>)1FWTQ=$`%ZF[QF3=1L(` M+[X0`_B:*VX3C&ETPM&15R,=M'+JK">;R-XXV,MJ2]%RNWBYQ(LBRO_:.DY3 M>@R:_+"1%$K2`%6PZ+GI0CB]W"7MK$Z=!!W@O)`/LL[45(B7-"WC M5`67(3!5:DF6%,_F3%E`PU1W@1=3&N$V6B?1$4,(1\00WC>$]H^[K2X27>XC7>XT7> MY%7>Y67>YG7>YX7>Z-6304TIX\R,?Q2I`\P(I"M5A;!>N^B'PEL4P&(/=[$Z M;:R%`:0+[-76L8F,GC"$\-72KZ!4L)T,[,B7X$B7$"M!A,J(LOJ(O94*$/*3 M$,O!:;4,!%*7W:`+_@U5H^I;@LH-!MX9M5M&S)PNF$T+)-PR&5*[C-#"C4C5 MJ=!,/('4\XA5(?.R'"4+Q$GA?TCAE@*7$A8+6PTA7!7$>&&$1#*-1YR;>2-2 M'^N+2A2#@7D%>`OB"6J"9,TR>PS%MNU$YNO)"Q'$RYJ27,W$TYH&%$B%X90& M]9%64P(J+>;B85T)_]=I&[?CPY$+*M;@5>$L1+:A5F!UPVDEGR'&5>'054TD M)>$@UBHCK31H5Q-4)W^`1V)DXQ#2QR&RDE2H)X19H`0K97L%.7S]-<$Z5Z6!*6/TQE). ML*"U+)A2*F90@3YT2Q/DMK:9QF8D+%T\$Y6KRP,<-H;%1FT$N;,)O7.%!;M! MDUN$(L6BAJ;1Y4$>V%.NQW+EG%FN95^,Q\#*1]IQDVQSTGBR#>%1'/)M7]%Z M9T9=V!^+(W:NX8?%51&*%T[NM)Z<%V8K2A_;SEN6BVCP$V@MNZVA3)>5 M9AN):LV)54JA%)V&3I\8V5T?&9#XB).610A.HHV=#HL!P9;A.>H$_BTHW1FU M],J+TLM.GB#"),(N(AXI`,.E@T*KSLF*C/HNO;4!_[C1_GD+2 MA$W#FQDB>4Y]9(*Y`RZR'5DQ7*+L7&V@05JR=6G_(5$-YWD311)#DM7HIBF- MU8P#TT1NZ=*6.?38V?8NP*#.C)UD^B@K?ZB&[G2Q_<5;U(-.WQ[;VW:MVK:P MVRXE/@$U$>';<2N01+ZR]&!O33HQP67OLQBG\"D(_/22RLAOL1PY6NP8&SV. M&V@;%=!5>[)CXP`^XZO'($/!^&1HQ0E1"N4F3>Q#?(>U@,483Z(P+"W??)/]$]@+EO.T-\',<*I_9KJ8) M9?N*U^T(%O*3^;8(,)<+_S&_5!:NCRG]M!]%52A,0/G1X*FP79"HP3ZQ*8S@ MZ[BX\XO(77HX8TTI/ MBC"U]$P7BDGG]$[W]$\']5`7]5$G]5(W]5-']517]55G]59W]5>O4ONNB<3* M!C$$8?4=*AW3B>]-0L&U"E[7""L'*4_$B/%4D3^?$%$2,`/?$,7*\DOBC0$O MF`!C"XBTB=O(1@X<\\,66"^'"5I;+J)F")5+PMEY\ZYX&+28Z\#`$JBE*+SX MMIA)CL+RP=!I6L,,;$1=HP(/(^5BL/;8"SWRDL.RK"0&K3@MA$A".!A M'?]Q-XM$IK9[P)$HL[BY0_.L`(7[V9ADK7!X-=!(C@'4B-8=JC$3,7('BY]S MXQ=U,PUVFW)U`1_2]55S(RJ70)EQ$H,P]D(#K[>Y:P)=C9I\.Y^-J6;)N<;1 M*%*X7F)K?H^?4-):5NR@=QOI\&&]GC=V(_JET\:I/_HE8:HLV9A4L!O_J#&. M!Y^HN7FLOY>K?SM9$_I&M3&B*K$8.(6W(7E%ENSZ,HZDRB\4*`0XZ'(FH(_T M:E2('XN4]RCW,/S0(I"](/*T*)$L19[84&U_J+F3X^:W&2L0@D?^[:U1O;B> M\YR(B-UOA,H>F6GF&_U?+OM(O"\*KI+C9D*I.3F*:YW_UVD7!4-!5Z[\)S+# M%!AT.SP;`Q:\S'>=5#Z-ZB$=IZFGJ/F<;^/]$?0BY-]\SD$>U.=/)E"J2"P8 MB[D-Y&XVJG-]'&M^=SRH-F3$H@I_)FQ]%U.?A&.:6>;/TH[^XQ:B;4#2KBC] M>[BY!0$(?W*V_2MH\"#"A`H7,FSH\*%">#@,JOI'+-8_>V(**MNXK%%!8B`M M8H1H\B1*DZ`,_>O7!*-+C/9N'+S7Y-8_FSCO.=G&\U:_GO?@H"A:LN"RC3GE M8+39E.D_4"B4AIQZ<-DA@S$+.EW:]&50GW)N\21H4"+"K3'O064+$TY6MSIS MWJ2[\Z9;M2\+;L((CZ;!N8+K__J#T^@>DZ(H0&XM:`^%"IB4XC(=?/>R1119 M$;H-*0:QXKA[.SMM#+KH2+ND]Z(-W+;M'+)"G0!-7'1SP<*I[T$N.3Q\\TFS'R^'MS MMH55S[YG1*4N=R)O6?>?/THJS!=>818>59W91Q].\[G7WGHUQ8"0/>CE5==\ M^,$!$UZO/76A@186U$]B^QW4X(7C^6-)+&'5!%5^./@3!TZ%47@+B.EI**%_ M!T5HT2'NV5C7/?5E6)*)G#$5883W+!B8CQ`*M1Z"YAV4'T@IKIC5F0)B5=1R:=$&5G%YZZX9=* M81/9$P-![8U5EC^:;`1/:O\L,]%X_VVEISTIQ"(7CX3EL9"J?P;*A)N`LGDH M2'/]V5(<;\':*Z#V45CB*@6%PAQ=3='VCZ$94?86J#[=-^P_B&KU$FE0O8KJ MI^$V^Y.@MQ2:E3VX21@L>VT!XL\F=>JKT5DJ4!NNO/H*G-*B"%6';(E5$+3B MK7^8=?#`$<-9%".:0+:-Q4=RB$)]_G1HEL6,2!7+,BA,-!3_"E_:6`5^4M6( MR/<2MH(U6HF=T` MM1T79WPF"B_`D0(?*-Q0]7Y7^ZQ8HAM[F!-1%W-%E,H6[R>S"E+4:-P-=+/W M\<1AHQ##SBH?9/'/9FV\)B6HH1TXMFH?[G?B,+C\M-<$H>Q@T`N/;'$C\*2L MM-$(*9,RW'(_C0.'$G_'6^>\1>V8S::[_E`_+!]TT=HIF,=ATO]L\N_KO0\, M\7#[[3W+".TH"B=D^_WB%*G:E0HY"!C_]_?O_/P#]\;Z4]&,L M`#P@`A.HP`4RL($.?"`$(RC!"5*P@A:\(`8SJ,$-X+Q5R;Y*2"B-.%1BB9,5^A8"#&%SRBL3@!C2BL<4>#5(R1QY.BUQIPBL* MQRA/X@=PC/^B(RPK>`^6M%$,-=M/C-*GB4.P"23$\$_-,LF$'"5H=^DSB(OP M,Y#TC0@6QL./*'K&(ORP2!4U6]`R8A;-%8'R8KF\!$&H`4UI\DYF_NF1N[8Y MS63&LIT3G,X=18,9X8WK62T1RJ"$8IO%V$B2X>(8E:`2F'UNQC+SZF-H]*(I MJR#T-N&ST&DTTQ)_NK.B#-Q2!<53+IFL[CPA.M"2)%4JA"2S,#XXYCVDD*CU M!<9*(B)13A+$E1GA1S\^D>E"B-2$FSJ)G19]X>K_/W*&K8V8 M44A?P8@FRIJ5<_VTK@AL:P0!9PBW86QO&TJ,C_"6.)'QK&0G8UM"Z%8SKH7- M!T,Y&^?6!(H;<&@%TT@;9#=&$[Z*K7"=&YRB))H;E]D":G?SFD&,\TJ[LK9] MQ(FE\LATC^RUMK:V3:#XQF0/',SOMK[];?GTYR_@$K>XQCUN0="DW.4RM[G. M?2YTHRO=HC1GNM:]+G:SRUSD[WOTN>,,KWO&2M[SF/2]ZTZO>];*WO>Y] M+WSC*]_YTK>^]KTO?O.KW_WRM[_^_2^``RS@`1.XP!C4'`IH"9J..D1/PQ-( M-O9RO5TII&9\;!Y=3>)@[F7XI[#IP6-R""-3TA$^ MS&(,GD*P&:@X6RIXI8D:+V]3L4T)/3D59-^QR90(++-M]=<=I1A50@SE(/!2 M<:?6;/E)7`K7:AD8CVTH8T%HQ4\B$[G> M-I%#\&*4&]&&O_\+'MDQL:!=:[+=$EKJCL0`;`9[,.F/+.-G=P7LF6'ZF0(] M7@P>MF81N-X5%174@BB?P619V@T4@1;D+QMZ"9I!,=P"XJ09+3$@NK&STER' M,N'^"B9B$&8<17H+W#/:&$$IE!FE'Y0`WX,*=),W[4CM9&'2DG;"XNS-*>T# MJ@I5C',E,XW+[76/K"0VH\(77^Q8C;IS>(&3*&^3[;$D2+J5D>]WF\1X#(ZXH%82!*R/= M\"EO-9J7^.H@+_?*4VECHH`GQ#M.@8<@N[*A6@N.^4@A=[6BC_RWYH0V3YWZ MJCXDR*VX"BRG\GQE=G\7W5,?-,/U/:YUWR*L$C_Z$[T!P\[EEI%'?S!`]M6P+)'K;<#'=D1,]8WHD46HLXGN7Y@SB9 MU*@AF3^$%'XTX)")DLJX!08:26Y0"M>A%==Q1*)XV@2V"!Q\"0GB1^#M&)2@ M2HID!&\97C*Y1*`T&P_68(R((&$X'BE0VPBR_TJ\E4?+L-6M"!0)8L\.[M0- M*N%&H>"8.5%;W0-D<04"5A#UA(23LH*)BT);Y M_4I1_-%`@0X:%DCAQ(V_&$^7.$2*0.7`0?;<9`_5(-6($]#^)B!/9`9JD^>/=&[/<=/ M>!#?*.98?\5<+2?%&T)M4&$/X#3!S%-:#18R\'C!(5)2L@/0!:D M01XD0B:D0BXD0S:D0SXD1$:D1$XD15:D15XD1F:D1FXD1W:D1WXD2(:D2(XD M29:D28K7BDB!0SE'/^3!_.">Z^A/.3;'7,!DEG28C3R'R0G,!V;)54I,5MH6]L`3 M,82*/[!$Y&T=0?09DBT9$X3AVYD%!M[12-09>'PA\S3&34H8G:`9F=BEP.CE M;4G/]O#+B>`$76:0G%75FM29OE'0/;Q8+R7$8B7'M!5<41Q)N46@2W038`S_ M8DV1WE\PFFAQSI5L3,H8VV)$IF/<`&AJ$>"D7VA%SE^I#6IFIA^.#>E42"IM MCLE=)HSO*9"N!7+IIAG_2(RCX"5%N38FT)S7UC%$1 M8-')6KUM7\EM3<_Y2ZW8DU,\'L-@!X-FC[[MIR,QP]NH4XG4YD#T`U8%G8-B MBX&*7-)!Z!15G4$(9C`A!#S@AM=9$%$=C'>T&3S8_T`U#`53)M"05I\I.9$IR5MN"DG5V<%@O!/4;'@7][>I]F-T60M$R0-]K/>@4FW:>A@`A>NQ23D0)*`@LB;Y@!@Z%FT0-Q)HK>8CE.G&> MO"*LOP[LNE(1]2P#3)!;-HK+/;3K.&X0[3R9I.7:-#4JR]B/8IS-Y`#2(>X, MS6Q:;EB,*>H-JW0(D"P-YNBAYJQ28JR6_B28V\C=_K328BBM4!W."XAB)GH- M,!XB0E'.U'KBD7`B"L!`UXRB5#0+*(IB;20CUK)M3>`-:9Z?9E'MQ062%'@( MV1;MU/9BVG:MVTI18Q)$`")'LJ56SCH9T,)908GB42`8I2*0-=*)FK06.*+7 MRZ;_1.6*EXM28W`(WD_I)'I-R>?N&'C9(Y80)&M]6!-IE^N^+NPJ5W7%+NW6 M[G2=).[FKN[N+N_VKN_^+O`&K_`.+_$6K_$>+_(FK_(N+_,VK_,^+_1&K_1. M+_4>T3T8I0G=PSLF$8(I!#+]R M1;049IW,Q`%/B_DJ=C_2`:\&5)P+M&5I:(#(%VB)1J:'Y(:`I#J7-_P1HIL:CX<_@BD@M M'D6R$<1D/IY'*H/M<`^E;*`I#!K_NHX48R^&<2=2,,XF<''_H)NCV!*[;57G MXI[9L1S*D1,+T]R^U4+A]"?``:B[R6/!;2;"Z2K`$#+YX&@>-^,#@=U0B!T;&D4-8F;CP0B6;O*_ZHB7TMUQQHK? M94;>01JA;N0]O,)]/$\VN1SK[=VS"LPJMS+WI/*X(D62_H_L+0/M;.]-3)_[3=39S*HN?^1L->#_#D35M9G4*?#I?%L7 M.@_L*=9+JO>&7*,SJSAX3"*&XY6V2#8S[ZT$0'TU[7HU6JU M7=\U7N>U7N\U7_>U7_\U8`>V8`\V81>V81\V8B>V8L]U<"K&,>(CYV$)7S;I MJXCN25S_+G#PI.D4T"O0J?END&83]F.RB4(/S%:2%"4\FX3D6$TP:GZH=E2" ML&E;`JO!MHYU=0+YC$_W=7HF,?%8MO(=W)BEYS>.,#Y>:O,<3'`'1YA94&@/ M-I,JPRM-9A.G1^5\2&4>G(6^TF^2U*MU3(74MJ2D=D.W3BEI-'2Z1K3UH6CU M<&Z$=ZOYJFRJ6FH6L7'^X7L_YQ13IE_]4W^/DVOT7"(&FFF6#=XLEED0\50\ M1ER06B2^V:_)P7H7GZ5)RH1<#5)4N$N`&DP0N#"G->"X+!TO%G]`2.T]TJY1J2*U,X2%?L8P054KU1R_'5V'VDB)KQSEP<3/Q0&]\='.[?;S1C=D:1Y&2$6`5(8- M\ZG?S4<_P%1ND:["QNM-F-U(Y*FBV_)&Y6G!MEWAI:GGP1U/4?I9R(>;"DB4 M0FEH%ER@.]ED7![/^)A0$UIZQ$:3O#I\+#I-X5UN^&EDYT1OW$@HUW5OG\JG MD*XT]V`L1`ID,M4Y;A1BB#"U9%S]@46H7HB#J3E7#%,TJZI32'NMKY2S4]\Q MK^KX59^HR(98P(_Q\5[RX66GUOKY8?^=F$4HN+?[ASSVF[L*/HG[3UP?8:9? MJ]CR\AG=7/GZHSR9A$FU6D?W%#\AB1"L"$:V\>R6I,1!#T8\FU`L0FB"6*[I MPC>%[;!SG7&LQ4N*I&M(QY_K"G[ZOD8)-4RAO](SE8W\A]`,!?I)#FYC012# MI+1K`D/I;B3AS'M@$]+6O!ZLS$N.IKL'F6IZ/%_LK%MA27$>PDO@:-TS8WL6 MV1"B+UNY'1B]8;)J] M6UK,"OBB3R0&'V6T_:3]S]C]X3B('[5('FH&22/4)#J,_>S'SM;Z3/?-0?1% M+$XM&ZK(+![_C7!:HOW$@M7>@,4\8JDE8ROZ+2D1(FI)!7*@X8'&30JHI,XF M!@S^ZF)34>8V!Z9[=NQG)+#G9%,#Z^UWY%8+1S[VU#_V/O$7O_$?/_(GO_(O M/T3&L`LYOSMUKY)=SZT_A$]QS_479%#)-IT\8TUL#7-H#FL+S/8_V'MZ_R0] M6R#VS/G"K(=H#O?C%0/)_T'"<"Q8RO(P#+9W[C*396EC"4#8BW$O5K%8_Q`F M5+B084.'"OW%.1@QUCTYMQ+VD]C/R;9_\`Z"NK'M7L>')U&F5+F2)<)^33`B MO->HY3]-!VOFU*GSYDZ?/X$&%3J4:-&4]FY,\VBTI3T?"'O*Q/'/_Q\HF@GO MB6':$.FTF%L?$L/I%"K.?_>F^B-VU:5)M&#A^ERFXJO"?G!0I#AH\17>J391 MH,!QKTFLE[#PWOAW5R_CBG(J-K&5."&\P($/V<6K`N?+5TQ09%X,6NO9)JA0 M-%H6>"1@P18/WD7!^:RD#E"YPJM>_0GRBQQ\_^4[698-3.Q%=HHH5AQZUX*C/[@ M&*:48O+L;?!H@ZTV6/;K3X5M[*'-'TL.6N:IA*JBR;UM\$-AMV56\&B36Q:, MI4+%_+F$PCCNR\^?_3BT"KGWXLNPOOOD\/\(GZ7.J]'&&XU*L#SSEA&-F.?@ M*4V9TBI4KC<=B8/GK^5\!%)(([-*2"P<@3..QHP*,^VQO2!;#([,8",,(\+V M@DE+,E\J$Z=-#LH.O"S%U)(J.!JY![3`:$HS(7MFB^W+VB(KDSXXLT0.!4.H M3%31156Z)Y5"SV.FM.T06J8T4(R4HLMJF+\35QR?V/U'W.C M.BNMM1(RYLIEU@7_ERABC$T5(?R>$DA.`>\"$S(]]<2/IOJVC#-.@1O";RJ! M;&6")HRKT@J>A\TT6",_P2S,XGECV)7+V%9!*)1-_8U99J+N.>0>6+ZK,2+Z MKLL(,NL64M(W>VS&^;E/E]SYGC]H[(=!H"O=*U1X9QY*F<",=:E8"D&13YNN M6R,&A1O`ML,_32Q$Z&H47H`C!3[&-OM`M'>KZK+4[-I:)KS\VQN%!]$^\,39 MI.A6;++'WJ:?K>U^#VP*^7ZPZLDIWVGM)6M_IE_TC` MXIEOWOGGS>L0J'OFN!+ZZ['/7OOMN6=I/)A9ZN>B[LDOW_SST4]?_?79;]_] M]^&/7_[YZ:_?_OOQSU___?F',+Z[GX.?WPWE1,G;R4O`!Y<"]H^!P/%'NS2W MHWNHCCM/H1CY(KB0";:.*EVC3OHHQ2?,,>5C1L'/<'A#M`:NT($2H8I$+/*5 MD7%D*:LY3DFLASV*Q#`C&S$)2/XADAR2CVHO`DN$F(+`WM2+A4T$RY3F!3AT MI45%E9+<6[A'KRE2!5\9:1;Z2G47K0@(=*VQTVQB4J'6$:8_(.K:V,3$%[_, MB3,GW`M>CH:V/D$$+RBT2"KPA"INXYR;D:+(Y1PN/^H*GB4.1#G]8I$8'C\1")2/44(R:DEH*+ST@`1"'R[&QP M%HS1LJB%']HT$Y?^`=!$1/2/9E22G)594H](Y22U:5)RR!G@\]")''6B!TI& M.E\8X3#&+'6M-$C1(*$,`]`Y@6Q+@#)HF.Y$R)')J9`K,VC"SH@9AGXD+X;Y MTYF2%9DQ%8J?Y?1H//\A*5)I\E3<\61([7D]5I7*4MY!E:K6U\5YM4Y;`Z/$ M@9!R)2-J2UA4H<3#%J;_JVK92JBUHMZ5B#41,\DD!41UZ@M)4CV(9`L./L`F M3L+4U*'VU*99\V@3Y:5%K-R++0Y2"+^R*,6Q#HDT24S\C35+D=JZ!O@!%L%"4FF,%,D=Y/CMI@"?^D0EZ=\(5W\CV? MB"^!&/;PA_MW-Q&/F,0E-O&)49QB%0?&)RMV\8MA'&,2@YC&-;;QC7&<8QWO MF,<]]O&/@1SDWMVCP_$CLHYEQYQ/<*3[4D M592$WI5G]D8#`L=._CT+$SZ(-C/#1"3M2""+1F[WTQ>W83+:.ZLHUB%#DN':(AA%XK569X)#U# M2\HM)DT=]+RHS@4SCT4=R(Y#2HNM"4EHHPR[V5N#E3W^HTIQ4L;6TJ7U@XB$1/>>< MY'*^W2N\7%=4NG&)9.8(%:SMR&Z_K19];(,B/^OQ08,43;O]RY?XU!N/Z@[= MN>']BGUG1&]JC`E25B,&RXC&W@MQ[[OGY.YRIXVB%*<*>9QU&[/X=HR&Q!O! M^V9PA"#E%"A0."'O$8.X'B+A_MNC18#9SDI-4H#%G7GB7I(*%,2&-,11AJ*K M]""J#6](=IDM;W[.;`7/UJSR7.TZER-TT=AWVWJ,I$LNB2 M]XE(I&/3EM"!9&,S)H@!AW)W(7?^(EA;`TP\[:(&A2Q/HRK*)F71_.37;S-" MBDQ;*Y-'/%X8G\^2=)/QB^X*H@EK]UX;`XNZX7A&4]#FTE72E)7?J124U*^;GCMBUI=(\]BDTY8=+SR//RU%I) M+\`[HTJV@A54IRYP-)=IA/EKZJR5:1=O[!]8^AUJKH8>M'K,2C7]U\4>B`3_ M#`H]Y,H`^T5>!&2!!BDP"NI8VJFGCHJ&CLK_)M`D;L6H,FHAN&]@LHE:9*)/ MXJ\!_W>N.JB!UGCD*F1*`*%N8$9!U8SB'DY0Z89"7M`*.=B"!>EI.53P*FZP M>'3-3C)CL^;.2XQ%3")K/>``!Q:J5PIC:YOC>J&0>@*(4)KKD"P MKDYQ1#""F&`BL;P0*D:"%^&M[/:BE7Z*F<"$)C0A&%&PI_^H3=#L[]UZ:H'H MZD0NQHRJYQ`E*QD58GB*"5IRD2I:QJXX9!Q#36W8(K_"L6/FY0']AR:J$1QS MZBRRD0WK\?],@F#.8C>X:F!`BQAQ91^I@D$6C!WMX=F&XB")C(E$C2"/3FE< M[2,>9ASC0B%O@2'CXL`L[2%?R]4V4DH04F:2S/U[NZL+370!I%PPRDUJ&>&ZXSN,.)PHT)PX_=DZ$[& MTBJC)7#BS)&L\@[MAA&VTH;0QA#UND8UKLZW!"=P;`%M6J,D62.(*LJ#NBXO M3E(*^J9SSO(WWNC[W(4)UDACSHPZ^&N/>N,QJR,BSVPR'P;-T$4RTPCCA`R, M0O(H(E#6;$Q<].?(S`.*I@*!@M,XF=-\9.PYH3,Z1:S%I+,ZK7/%FC,[M7,[N;,[S^,ZP3,\ M1XPZQ;,\K],[T3,]U7,]V;,]W?,]X3,^Y7,^Z;,^[?,^\3,_]7,_^;,__?,_ K`31`!71`";1`#?1`$31!%71!&;1!'?1!(31")71"*;1"+?1",;1"`P(`.S\_ ` end GRAPHIC 7 inb002a.gif begin 644 inb002a.gif M1TE&.#EAS0(1`O<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J7_P+7O5>XK?/G MT*WB70'9,N&[JOX5BR6YM#W5<*AK_R]LV3@(VBYJW)38]\]A^Y5GV%^=,:+)=8&QUQX*^_V37F'K;6,9>Q?Z=AJ$ M"-5GFG6%^9/=AK(=]EET**:H8E$>_M/,88^).-MYOK7X('O^C%(=@TS@B$J` M-=(HT'0:2LCC=;L5]UL*L(0'66`"2J;>7P.B<,."A358XX\"3IAY*6) M`S%GX)\X!C@H:&3"95>2_NFE#9!5XBAIE8TDB.67#BJJI)$44MD,7W;=`UNH ML2Q:D(U[6O^&@XP5XFGKK;BRU.*>QXDQXEU"_JF;A!P:%-JH`QDS'W+`XI@7 MLJ3>M6F2?;TG9ZW2*GE87YW:%I>#RJ*&7E^3NC@-F,V<"^ZR#LXHGHO;])I= MH;G6:^^]'.GYI&`1RN?NH\1:2\FW%C()UXG'Q86DO[\E]FNTG96[H7E,8BJN M:1%S.MNG6JZY&7D&4^DB8TRJTC&P'QL$Z[X<8HOORS#'K-"NIM';;(V8_D/- MQ;^A1QB4IC%WX*1X.?LN-?B%2`F2#TYJ61ALVBAEJ0AS?&9RS1UFUX2!B;?G M853$US56(_/;<-NK[T#$]`MHD`R2IV31.Y;_6IH_>03- MA'@,3XUUT@$7A!IERC&2,[V+(CJDU;(!+CAUA_:VIY8=6RY0U](@NS+=^]7J MSR5ABASWZJQ#M]I<;V(,R.>QL9QRE02OAJ"W?S^[PKD$*_>Q[G'12>QE"A), MN\(AVF:<:[!]>VEO":>F.VZ:B"'\<`/W[E?EI.46Y>P/QB6>Y*VGK_[ZMMIC M-OOPQR\_S/9$./_]^.>O__[\]^___P`,H``'2,`"&O"`"$R@`A?(P`8Z\($0 MC*`$WR8\[35G0]S*UMZZ1YP,"D]AH]&-9)"C',*D2S,@]);J"E)!LO&F>),3 M8?>V4<)8I`V#,-1@I.("N]2H#`Z?.59?_S(S&.ZHT'A"1`'3?E,;YKT*B#'< M(`DUH[U4H%")%UR>"8GSFM@`;S/1^U@2J53#&T[PC$#AF>0@-RH088=N^>&0 MG+9#+#*-B#;2^ANFZ#BASMCO1I!!%!O+Y489X:4V)2J6J[QTMK[Y47'%B@^- MZ,,F.I+JD?Q1$FH$M*$(,3*3]BODB-2(H#UF\9!YC!?E(#-'[IA2DM[I%!3? MTBXTVC(G:0=$3-)37GDRWR$C31),V>8NC\V+6;!SUL"A:=)7`PLT=>1J9E8:TH$B]BGD7('4ILJ1O%F$>O6IP[/DM;(YT6.#'E4(V&:Z1W$Q:TVOI2O]CO MK3[+XC_P:IJGEK5*?T09M&9$+@WVQ9_#2IC$&";8P2;UL2TY*"!C:)>T*<>3 M7F5IFU@66!!=M*%>9:I.)YNM25F67P4!44Q)RLA[-$D\="7:P)QXL[/_8?2D M$F.GX:IWG=:Z\G:G;=EH&W9;8V'Q+?UD97@`]MFBUK*.>H6L=%'"MMFX+9=X M^67-B@6QI;E20$B[(;WN88A$,4&61X.8+[-8W2%50VK>W:S:DE->VG4J9X8K MZ3(<9Q^'KK>F0POHG\"+N.RNLXU*(IO6]`N8K(U*O!SJYEW>*TVD):J^7^I6 MB8?>;?ULS^'T(<'J;-OA+_]#"#*-,C8KY8 MF@\>]XBIO4PIJ7=64>=NMBF0`@H>7;[8>7J)@V;>:KKXK2\J+(Q.W-Z3#!'I M.?OZU\`.MK"'3>QB&_O8R$ZVLI?-[&8[^]G0CK:TITWM:EO[VMC.]J_M$09* M!+9#>2$Q2';$8^KB:;;)P@]_^H0LD?[NQ\9ZA!C&G7MN(R*SA$B#WE!'X#S7"RKL,"MO0PKH M81)#OI7CH/2`'>::P!!BMAMP+"XO!EA'TH6VWO501KTT<1>;8,I^=QKV2!LV MCQ;.=1Z+@J,=[Y>)02JFX825LWS9M(Q7X/%R@TU(H5V2J;D8+)_(^XJ!&'@7 MSS+OP05B)$837:_\Y0.)N4[KD_0\?@SH+Q6#4("L5:&W$.RH2HEN]ROMVY7E M%%#`"#:-7@N4V/SJ*W-Z'*"&OZ>0/8::#RS5ETCZ8BW.P0-(#D7&(,4&'@7R'[V M56,@2'PUN#%_\8(5>((2F'PTR()!^!DYJ(!4`!M3T`B@=RX,V!JS`GQ?4C%7 MV!F4L0QQYG_,5G!@6!B+HTW\L7,IP`@95X9&`AMBQUUOL0*G\#,4=X8E6(8B M-X=%LBWO$H#;ASJF,/]E&&ELA.D:$)*P");"@RDWB':+5JER@V%#<.@> M5:9-!<>'IN=X8GALA5@=YT,=_2+A%@Q"`>Q;!Z_;&+""5WPE@<%E&Q,@8 MTE@=VOA-T"=W]TARQ`@9EF1Z\HB/)+=, MN]@?R;B,@5APX:@-[=@D]M:+R'8/C;<:5X)X*W0L[[$M$>AV,'(NR20IJ!%U MAY4Z?_$?IQ`7/:`*+*DZPO_C!UBT25]D9<2G"2\@&)01&@7RAX*1'_8C(I+" M?B:Y(2[9='?6B4HD=<4!?":Y23,I1T`IE$ZG($EIDU59DC#4DE19+,)S(F19 M%\!'?\H1E"CY)BJI2B))A8C!DF'(DAC&!MY($/IE]'9G:P#B,:9 M-NO_P1<9V'3K$3I/!A8.L&!J/<5DQE`I40IG>69]OXX;AJ5P_>8Q4&".` MTI`;0I?=DAA6^!M4!46+8QF[))KVV:"XTE;LD3;=`:#0532,T5^B_P MJ*"G(5LNFCH*PAGG<2F?^!?R1XI^9RU.(F(F@B@AFJ-0:BN*N!H1`G718WXN M*9:III4H,'QM9RGZ@4'@TZ4<0I]1>J;1@8$[07]HVJ9U`&JB".JB$6JB&>JB(FJB*NJB,_]JHCOJHD!JIDCJI ME%JIEGJIF)JIFKJIG-JIMM22L*`C'B&G#@%US3%.-N&>P8D0IDH[=^FIKEF< M6K@0#-<0^25QY;4,UA('8M-X2I6=#,&DN]JKJPJKI>F1K"2J,Z,)[W80I/H0 M[G,:&=BLD06LCND?TVJLLHE18OSEA5N4>8`ZE8H]=X MG,,$C%"P2)87?V1N`^(T`'L2\7IRPB.,3`*QT:0M%ANPLSD=MA:9(0)$@/E! MA<"P+$M#DDD,),@MSVH8CV&9$O]RL2:1L:\XF*:4QU=2$KLK%:7V^Q MLD'SBC3('5"4'+[JM#34LG`*LT^;',\9&:A3/])"K2RALS[;LU;["E6K,F.F MM6_!M41[F2='@Z/A'R)X&GKT&=-I#TB+K':[LT[`&/X!&%>[&\/*F#51-Y:) M1S<&MA/7MJ=!8F;+JX";MJQ)7HUA9?JG&5UBEH)Q)3]II'W2&/9Q69W!2=L2 M(>-TG2Z!+:'AEJN6&T&'6B+%7:.[0HX+FS,;$V1S%;4;N[+;MS'1E\6:%+R+ MN[$Y0A<'O,1;O,9[O,B;O,J[O,S;O,[[O%#1&4B"J@-B/_$Z%=)[JM^(G05Q MO=#;GR9C7&YK]6[VVJW(!/"G\2\#^ZYW1:K,"K,`#/!4-/+0)G,`+/+)- MYL`(;+WWBQ2>H\$1;,$7')O*TA[9"L$H+!4E+*U;&$=/,*FN0R,8PA+V[C\ M*$.([!<4\<5B/,9D7,96?,9HG,9JO,9I09AL_,:=1!'" M!,?/ZP_R-+P-@<-TG+PI13<$$QJNYZ%%!\B]N\>PRE=6*S95_S`-%)=R@,=[ MC%"@&]>XAER\6B5W(L.C+P0A'$HL:%O)VJI@*'4F#1(ZY=+)H%+(H)RI=@HT MC,FS*G>X0$)>'/K*NKO*`7L]I"+4\U@DYU:SY0J"K1*IF?KW!&[)!USY&:UE8++I,5C2)6K^, M6G;M1\3,NB7*UH9]V(B=V(J]V(S=V([]V)`=V9(]V?MSNV5AV?"S+6*0O@D! MF)3]$:$ASMT\,'JF@:U*$J']$L*;??OK=E)1HJ0[BK#[V1K1E],0"XKI$IR] M)OLAK"1AV[C-S2:QV\`BNKEJSD`AI[4:',!!VQT!W#+1*Y/S/M%*9T$GW"8A MW=)R;M4-%0C_V;T$0W6`ESS%#:Q@H[;N)Z$JSPJM!=2FJT=P8;A&* M\N#[!IP'/!LI1A(S#A-X&B;_&AE6'14E:CF\R[8C4@Q-8N$Q7A'?X5KT*Q/1 M6IPL;L*_#1BC<>$?$>44M[3\@=Q!<="L-#!;6BT@`M$?ON3'X^7/#948](5L M/A)$Z1)+W.8'8LQHCBN8/19Y?N=\WN=^_N>`'NB"/NB$7NB&GA81_^<3GHT0 MNJ%[3:5-&,)WX1RWT2^76K%O'IU'R^K^RKF3]YJO`X.YPJ53$^>N)ZF`KJ:N&V?F[D%UC!P]WZJ] MCB7+^ZI]C:'FH`SL_^J1$UV2/U[LC&[`\_YF4B$T:\NK;Z&"1M0:0[FA.ZL9 M')OD=Y'?O21'$`L+_)X]"R_M3U[K8T:#J^)W)GL7'AL9I)V/L."QWFS-%OR+ M-[L,/<#@-UCB3('#$RRO6,OJ/B%$V.JWB?^RLXU,\X9+[4$T6!J+0GX0U3+[ MBKSK0DJDX3`[\$#[.3:/0O=UZ\!:M1]?S7JLM0>L MOT\APBO,][.1IU&QV[2!2G9\T?+T'D4.'(4K]A=]Y)*FM-ES&HZC&JDP^4TN MF1E7Y'%@N$[`R,VSMRPD]IB_]+]N;Y[X)%O.[XS;P_3>O3/,PQK2W4XQL!JT MNEA40\I1N2B`NMBC%^29,+\7.W?&@+G/+YU1.7EZ'*DVYJ='_)>.;?Y=@?XFAO:3S?YBX?Z''O_R M/__T7__V?__XG_\>?%0DL>CZ/Q$`0:S1/X(%_5%"L6+;OWM,4L0BN`P%BH$% M+5[$F%'C1HX=/1J$@T+%PH(2'QK41/'?P8DJ/[Z$&5,F1F)B9FJT5_'F3IX] M??X$&E3H4*)%C1Y%FE3IQX8Z"S*#2-!?G%CWG&R[5P7KU:5=+T+%>,_0OV4X MI,(Q2Q`?26,DO;XM6!.H/TU.X=[%FU?O7KY]_?X%V@R477\A;?ZS9Y9NHV6' MY0(.RO(P1GLVZ4ZVZ&^46\A#Y=YK`BLD#F()M]E#@:,A"IN@1:.XD3+U_TJ$ M#T&C0E&H2=35-B6BB,&Y\W#BQ8T?1XX\I\",#7VGK5F6X./D,YUC]*>*H%4^ MLRV*K>ZS9F&1IU/`JDNPF;9-L::^'FGO/*6!B_^5GHBC\$E_[=_+68@:X<(C ML$`##T2PNNSNL\N@2[9I;#HQ[!GI/LP2W,@?`#-#R#<;JFG*(K`P?.FSW1C: MS9[@[JF*B98:`0TBU^`8*$847SG1QM4F:J2T"TD$,D@AAR3R)189W*BM""V\ M;Z*3BKRH+8R6&6E)ZC0;$$HF==QML6:VF8E`H0.?\E1#%-B%"K3Q.;-N%,E3*S8IP*U)SD MI*O.E%30)J7@_B1I-?UV[14X4&9;C5=B?5U(6/*\*S5:::>5]E2)&D$-VH9. M0BVX-[--Z]K?TD*,1XNDI#9====EM]V@CG2W('CCI;=>>^^]5\4LU=477W__ M!3A@@0-`E447->:6=0>SZ4NIYN M/?KDC^RCBUR8C$8*Z8__I,8.CB=OQKKD57<#BY@5QQI4U%IC[-I;\,*&$^J; M[..)[9G89E4FM8MRNZ.ZPSHQ:[T[LVJ;6N5=$[&8W^S[[^T"%[SHUD)#B+3R M4%/-Q<-^@\&._%242(S,MY,`M-%"K."\+403"\,7*2E.>]M2G/P5J M4(4Z5*(6U:A'16I2E;I4IC;5J4^%:E2E.E6J5E5OV?(@RI1F5:X.#&VY>JCQ M0C6H9[F$:'+2XD(.`Z49+`S2 MR\L&\C*%J0\#77.^TAGD?UKPG?`4N!+_K"Q]IE0C@-Y3P`-NZ(#G6Y\_N,M) MW99W2N'Z4(A&"-P-CJB#D!429L^R/PC6MQ!%A!$TE:C+)J#)F#(JHF[25$S* MH("C'EQA"AE!PR;!U[P/+DFX'#,9^8[JJY1MK4BA%*+_(I>%DRI$'/5K12[Y M5Y=KDJ,:T?*W0JH5#BN8QIH\;!!*Y`_"-SYO1*`S&?&25TM?-51V?0PD8K1I MK;2I_T]]FRE*P7XXF622CXEM!$P!>X[!?/I5'*6)R&3V/6G!%2/DI')>Y MM7?MTA/#R=[*-FB_>GU17%)3F@/#>*(1_<[O)CB1?TY$(;FJT&K<:<\8',MI MY`%>2^BY3H^RDWX5S:N9RPLN/IG+I:2BM%_=I)SDXVE/JCX:DIS:T9B1^HZB>5]@`[)MD.=E(!JT9;2F5K$ESD MAL'FM+[^HRUE6PB\0[6>PL(DL33>*J_SYNV;\#O<1+5L*/\!YS>J].G>0PJX M5##,$,2EVT_:\1I)8`O;WHS,++`]2V=G^]E,R<9,,51,;?YHT(G?]E(`SNJ_ M@_I;P)F"?IK`0:H&-3^,5PB2Y-[W1;1Z8LUNF"A@S[U<*4!3"K?*]9JFM;43_D<77XOX MR]I8X6X!(VF26$26SI:?!`^GEF@JS_Z2@-.4CN-=F8MSS,+R-FE`GD,OP2F#)5 MYM=^*]KWZFX)?9^-&9!8/YTH7P_4-R=J;%<)_JIXKJ7N&[\DUXP(^M^$YY'U M>='"$]9TZ`EI.1]8!0NEYZXV'E*_K8R)Y<&SH]LLU@F>\HB_[>.I2[N68D7#M3`#U28G6H7$03!$C3!$T3!%%1! ME5.T%G3!%X3!&)3!&:3!&FR)G;#!'-3!'>3!%ES!'P3"(!3"(23"(C3"(T1" MA&D[S0A"=[N!V+GB&1+,DZ1L[!C#6Y0`55D#0\CCV;B%6JL+"-JD]&I@I/+BO#9GY1A1WCTQ5]`<@G MF:5%4;20NTA2;`@ADDCYJXC2&`BL2HV0)$E])!A^/#Q$P8^34+Q\-(YD%**9 M/)7C+"R0XQ9T8J#,Q";W+6R/"QTVJ1U64AF7`;;"$J) M:";Y(464D1\_H(2+?+&%V,CIX(^^!(\QQ$BH;*UWT@0SJOC!>P[#`UHY!F`3]=2Q"T_([-U`FU"\1+BJ%``II3/_O3/_P30`!70`270`C70`T70 M!%70CYF?ZB2.R;2;>EM01]0FEGB5L+'"R(+$Z\%-)HQ#!S40N0"EH2C#G0`W MR"C1:IM0G%G.Q/.9O9),UT/&Y72O&%6K.\20@(2YH3!+ZX"FONC1##FL%46. M*?2ZL"0+QOLQ@S0,2?PA\%.S!/D,)B`?WDFN+SP3%\$CR0$M>$(!&^#0AI@= MU[J4STF+XL$A_^+Q.-$8+&850H,Z?Y$WAZ9:B)1!*NQ;GG$[J3$@B@5".P!*EV#I?FJ9* MO%L$&<]UB5SQ_%&82%$>C5+&)=&N?%P@2<]T^5RW#(F=Y`B[54.1PS8.[=S5 M9=W6==W7A=W8E=W9I=W:5<_>A(6%DPF3C8G_PWT9G]T)WT4RVR41##47:%,I MXFW"/:W#JY`W"P/?-+)1 M#+E9W5V;(?4(X5T:]@W>RD6))(/5N8!?[^6)0;$2K911M"([)ME?#*$+JNP< M:/W"_2BMWD&/`33`KX4\CVN1U.HO+=7:EC*YT+#%UOQ02PF-T3BH=*W@!5XT MC>L-%+$=ZGRMVXHMJV2-VM)@_&W"<-FQG?/;XI5A1)FYPBT9_=,Z[WFNZ)H_ M^:$A2_49ISL/_ZBH456K^V&C`I(&AW`/&HH]`9$*[4I5\Y@@3M4V)FXCVD@Z M\**Z[]DN\/$NOWE5_UHUH!KVWD%)6NK@1+VR58!\E&_48>,H)/SCD?TJL6,J M+,OS&V7]FRSEUFO=V03KDL+RNV6=6<_).T=*,72$`[N3H0;IE*.YG-%C/SQ)N&RYLIRO*1%7T.0C?__ MNRL](]NI[5K319)=`RDFL+.4/-LP>A9R0;0"?%O\^R<;2Q:_ MG+,O+(W[NS/]`XFM9=233B='HRC6*NBIX=O!QJKQNJLUFJ`Z<&N]NJO=D$L+6L+F_0B)H#9=7NLY\="C,%[J/15D8][Z_0G\`.R9D$(0)F>5L-!@ M@6)U$<.>3%%G+$I4:=&E:<.[!@J0C04RT^L]73=#A=FJ<*'P5>.7P&S-'@HX M'#>[>HKJ0UBWW$M.4D2ZT+`G(]V.*%?+KEY+(>C__)UF.Q&,D[2]`$X*S$:* M*;2L2'RO3;0]T<6ME=JGVHKL7;/D6RQI%3[`4-R&7L1M\:#>TSZTREZ.;MJQ M'%Z*O]1K@R2NWA*=0T547'W&UW;-"3D/=F24(DLE#6N+OH5'>:P"!**O4;I' M&QJ_[;Z)IRMNE.X0-8*X;IHP7JUCG>ING_BJ)BV)]!([J2@@X4X7:/1);`'* MB#S@0Q2.LAI;ES!)!H2_H&R2P2;PC;@'$SMO,7*$V&.`&[7KGCQJ)9P(3(\ M)\55*=%P:GG+./3PAU0,J23*N_R.J*#3JI0HK$RYK1P>I&[Q]IV@!Y=F-2H@ M3ZX3@SLLBS4*%J&Y'<<._TMJ[RL!%"]G\?7KR?B.RQ;)SKJTGVP,H^&!L<5\ MA<9<9O"(S,7<[2KG$QC1GJ2HV+QBCK'1.8<>;D&_WY\P;J=QUDT\#$0?;2'9 M$=-T0-3LS=]L39;XE97Y4N%4SFJ<3M2\AU$'])O`C]'T"<#UZ0G,:+\VZO+V M:1*5P%N73I6XSN&)\%07JK?&\3_W"F!'"F+W=5L+W6E)]F-G]F9W]F<'F;*6 M]FE_0;&F]FL?:VB')&SG=K*V]FX'=QO4]G$G]XD)]W/?P6]']W4/ZW)W]W>' M]WB7]WFG]WJW]WO']WS7]WWG]W[W]Z9&T[B8;0J?#MC\1D2T[VFBX#S[PB_Y MWO\Q'=R,H&N0ENN7V=$/CK,`\N"$=YW:_G>(,>^"SY**%/C[]DM>[A3\J72- M@/7AI8N6J6Q#M#$.%U+':_FJ=IHDGVRO\6.5IXDT_'B0[_5EM9/HECVZ:MY` M3=S;KL79&7)#W**;_PBC^4N_I@F/#_J-"7DG7.*@G@+9FGC9+BB`]#-4#+3B M1%?C0%_MRZ9'X2`V'+,K/%W%_8$>Q M+XS_QL=EW7R1;B;L,2*Y9HDZ$?V@E,;1BIS](45@88G_U9\M^9[(A:AOBE@K M#P-'5;2-`0?,7TH)^JI'[<6\VT<+YPA]2EC^W+]+;6P(+;A*K.A]R[_$[D' M]+`QB73(D"3]V[]+E2Q*E'2TDY%(IQ3QC1Q1FL#2N?S)"4VCV'!_NM*D.1+AUUCT,2J]:`_2BJM M;MNZ4*VAAET;F?T7LU%(BP1'_TX4^#'NW(U_0Y(L>-`B8(H/#^IEPO:FU+B/ M)1-NB79@YY(B1\I=>55P91O5H+)N[?HU[-BR9].N;?NVSP;Y=Q2R#2PDN(+%= M4\!*N7*Y]_+7>R_\BW(C<\<(G4.7CIDR,:#=!YTAC8FEV75_T#4@<]B]QQ%* MZ!5T54$MX78AAAEJN"&''7K(H40FH9!"'P*Q91&)`]G32(`$Q81"#"_&:.)8 M`\E8$HS0^<$$:`VA6"(.,:7P"H]?H3!%CPDQ]R)E(;HHT&A=H:`81A9=-&21 M?D&I9?^.(2))D)4GTGC/CDDV%*))#"44YC8WWBCE"J?0R*:01/8H94OW<-$0 M,11^^">@@0HZ**&%&GHHHH+>,UVBC3KZ**212CHII94"10P.U+1E*:>=>OHI MJ*&**FJ`HXUZ*JJIJKHJJZVZ^BJLLRRRR2J[++._2DG1HK&A25E"Q%CH4%R<54OE57UN6NVUS8H[+KGEKIFC MEFH^Y8\J-4G%IY\.I07N6"U92Q.[VWYK+K_]^LOK@#ZJZ]0R@_%)+4_S8EM< M307_^S#$$=L:TV4-PRC-E"6Q1XE`[,&QPC19:AD#**`%B,+_M>]J>16:8!Z9 M8TR'@14S1R>K(.=54@YV2!9FW@C&V(-@;^7,U= MM9488948=,=--MT]O/D9('!F'9@<67U]=A%!`0X<-^212PY55W[ZLYJ#2%,K ME<*9PX?UNU21A=);L7#E%7%B%ZU!S=W0)A*5]7//F3>Z> M7]UT]?5W1[L5YYLFP$%VN,QY'C?<[\T]E_:]M%M_/?8N7>2GD%*H.">-VJ-; M9Y%.$B9BBCG^J"*+H,GX/HU.WLCF_SVI9.EM]OGKOS___?O_/P`#*,`!$K"` M!CP@`A.HP`4RL($.?"`$(RC!"5*P@A:$`8SJ$%116M7'82(Z8?0'[OZA M*3XQKB-RJ*3:F*`F-**SDD1B2U<*,<9RDI&8+`2/&U^C1T#"83#+&`TAS_1. MV`!T-@,]4T&G@E!.UG.;'.D*(]HES":TAR'/NDNIW`5-[5%F&:P$A(]&](H5 M$D,+TOFH(/U)P7NL-*"L`:5-F,$;MART6IR4XVMHNDC7X-0A.M4$3R=:$Z"" M:B9324$3*1,=6(RS+'C$%B521M&"]C.0>HQ+1N)0TVJYM(QMDVG_!1>54-GX M`Z4UX4\@20G.D7#BK$Q1ZTBATM:W/B>NF!R8/^HJ*J`:LB,17:,VX"`U3311 MDTG,8BWEQ`:!S*6,FZ3ZFN;(":W1.N9SK=_5=1IZM>O=CTF.V] MT`=K$U\0PG:]]JW-97&5W\BUZ+[^_2^``RS@`1.XP`8^,((3K.`%,[C!#GXP MA",L80%C*E*)+,M0)ZQ!Y-H$AV'AF`^U_]LI(GZKF89%&80F@C!1^6,315R* M;-<%AQO.^+T:EN!>^L,D"5F/J[1KI9J1V/H69:ZLN?"% M;XS!9H#B<9L$I"1%25E.32VOS;QR:9$\J7P=.8C1Y9'91G2=&D=HI51%P0T* M\R1T*=).:GK1"WB$'R9<14:^!*8P><1:*3-P11RVB3:5E!=#+A-4B89)T1Y= MEMN&*EHI)*-$PG!.QHK66X%V+D@$K6%KO/$/!7;.\%(I'E&!'>JMDS?]'D= M?FZ9T`\DE0GVQ(IUV2PC8IQ/[_,+$>KJA!H M7EJQYSJ(2-_#0B]%;0[![0DZ=-UWB MB#OA/37`?%%*%J8V)\6*2%7 MRPK1E-S"P-#UHC<*N<_$L9P)$7#%#U7P74E\A)77V'V^"U-D*T72[#THB#=] MC85?_4$^7TUK1KYA),]Q>K9&.XQ"FFME4NL&`,&U2(58`$&H,`(Q01V M'I59V2E]QU_)%0!:2@8:#6=X($.08*@L0PZY4GAPU"DU#HH)ABQ%!RJ8!`[H MVR\)&@4.DR*]V5F$W7S$$@[6&8^H"YZA6=_P_Q*,_!D.?MJ@^44*.I/P<5)" M61JTM8?[]%*T_981II"?12``3B`*(EF_W8F@R1GH&9H@W5(S$=(:-N&CH"&B M>8=?8-,<^A3RD5`I*81AA-I\J(F2\1.(G45MU=A:]`U?[),Y1<3PA=IK5:LWC@").>!A`M9@Y416351ZNY2+N])0S$>,#4DHP=M@P M*I4QNF&D9-M;0=O*(<1E+=1+L50PO12/^%`./INSK9E'?2/T59NZ MH$@L9-M><1LWZILYPO\6-(9B%(9?68QC.%*C2D$;*D3:"J$(+4K@!\YC3C#; M1S&"OWG>N,&6%S5C,W;*0N)$0S*C4H%*0RF)Z4B5.%)@(,T$)2F2(FICL_F4 MOC$<2&(8*FCDZWF427(D92%*T)\TT'`\J'/09<.%(5 M3?(C[-313"8P^45QI&@"7+*5'9879G@58(*_L!; M6)S<9E&@]BQ6$V%CR-G@?IA1'3$6T)WD5,VD(X6E6;ZE<92@94V6/N8E9JUE M?W"6748%R\2;'6H)-#T@LZ&DS54AR:E"VLB<6'FAFJS(7"W@8.X+LXVB/2#_ MY"]>7O+AEFW!$W]XI2`U6FCJWVB2"JB9F0I`5VM.Q&5@G)G%6=4%"&W.!:B% M"'P(5]-I7A0\)@7Y8?#V%%+5MKTF)&150S1I(J2R>A=K:BBJ"DX MW1YN%&"`&MZ%72"6'D5Z-5I7CLI#*@G#F1B+M0LHPLESJH`OS2!"GJ+42<:T M"&`95D=61(>=F5DW6J%!C0D.TA)UY$A<"DAA#)%R_N!)4$)5:*J@R2#TF5DI MMED3S*`^S2!?+&$6TB9_;B-"O,D-0@NM3I6<)=(P86J=Z@0UM5(;ILJP*@FE M^6FEX2.F:8*F@>I@;!0L>&*%,24O@I$KPH(J3,VIA04@[N$NDIHVT!HLD!J^ MI-IN+")`3>L-=9K86!L43?]5MZ[=LI85<8:J@(@KNHH:[E$57%1B/&VBFO7; M*6J2E%;K;J13J?UJ3ASZ;.3("94%9 M/"8FVI@C-J902,%42!U=P%;AQZY09I(48E#'< M/4B!+?F'E])$8AH6R)ADP!A66(TDI%YBSZIDR+TM'!1"UM*LU4KCS7XD7++@ MP*@E3(ZDMP4M.>:@V685_95H.RH42/P5JV@LN]7AJ'S<($K-R$E-*.1>RH%G M$U7_!3YYX5ER`2_"'"NYI3V4[!@]%F]DKLNMB5Y"*U+]Y;^!"=.G\A6VJ<&GSYI\@ MI](IL,P?+8P:%Y(F=/!-(#$"7M@2,2!3%N8T228C)V"#]K%MX&D'*NZJ@'(> MYJFGJ!(K)='4@.?[SE+XV*$:FHAX[AF5).&M=N-^!&'#O!@#=I-(-:4-4BHN M]8(_T).YWE.L(6(_N?^+A/:R6Y*BFFF&%7Y$*U9B/3/BILVSO\ZI M,@\,+C8S)'$,,TW4GJ+*E3WD05OS13'!\?8NSC*$T6)R2I74255T37Y;/-H$ M0486:1RF+8UC8OHL/R[;/ZYL,I_?P'2T0-M&&#HDTZ+*2U,D19\R391'5#E; M1UG5MYPM%`I?VI;25Q%<1K_4E_K(3OZT7^P=8M(JA@GECSD;*M3MZZ6M/ZNT MO"1U2W\2[EBE**M*/7'E5W\*83TR5L"N.-4E9:8N10-O97$$9-Y'2`5/\':*=ONF MKRQ#<'-Y1GE*<''JX9$J-L&`\/%Y,;'Z-O/]-K_\W5`H*&\GMZ%CRE19VY]8(?AL?9I$7/[W7X'^!"5GS?[ M;0DI>'P[RIA^$1WY1YFB9A)#.$($-%@!=4-HZ?,>"IV.=R1K\A.AZ7J3)8H; M!7P_N**8I)9-1S.]N*,QW"@2!E4.*-/Y;JUB(3#Q[#;"TD`P_^$P"]^H`BPN M5S&U/$L/KJRK#AG,8&$N&S&+$TIJ5A/2;;8U@6DH.8$I_!:7KYT=>XJ30=&P M:6+?,$(LQJ5Y:!*;B2O"ML6[+,.AV]\Y@_&CP.E)#\D[#J^UP2-U3C16R*[,7H2L]9,DAR,M MLM/$[B/5@>.?$\I=OU^ZM=O]K;J80ZU$^=1!&_>(`6",#B5/XC+?#JU1?Q'A MNJAAR:W8>J-(`F6^;62'?8PXX3K>GKJA-.ZDC<6=/6O%/>FA-&X;1O/A@DIE MUFA<9Q9;4KI(:N;Q_D/R9CI6T*Y+=/]ZZW[ZAJ_16&++8TUU7VJFM3M[;4RO M'0O=M//I(QJ1T@5<5+=S8$[V1;1O8A47<\H,!5MP-[H)2PW6E7W=UW?E[).MZ%E4RFJ7,\S_\\T,^PB`P]T1>]T1\]TB>]TA,]42R]TS\]U$>]200] MU5>]U5\]UK?=T%M[3.RV;-",O@`20:=?FWQ\]3S$$V9]3^0W<(/\78@QJTL* MV\?]D#D@V:$BK&01=H!$KBVRUJ3]32UR8SCBX:'2O8A%V+<2_JB]4$3X(2>$ MAQ,R=;CWH$3_^.2_U1\OFSDW>JT@AEU9[^!_?=$@ODZX#F&\F/4R_G&;D2F/ M!(Y?N:4T>^K_7`BZDC,B=$IL"A"IYWEB4@"CF9S$`,;8\RMUW<80JLA03,FX MX,C_$1Q6 MQNU+K5R$DG>T(MEPC>K$"TJ<+RSRC4*H@#2H0)Y5 MD=B09DV;-W'FU+F39T^?/X$&%3J4:%&C1Y$F59K3GIA_RYS^(Q:U_R:S6`P% MHJ"Z;.%2KT.;TN1J,ZM3?ZJD-JKI3\[,KV_A-O0')X;;91<]WCO)D!B*%+%( MNOWG$2M=;1`E$OO+=[%%%(\7SHUQ.*+>KE@IHIS9]V]>A8$#3]1H6?3&QQRE M7HR[FG5KUZ]AQY;=VE\>B5#Y4I4[2O"RB`S'SHY;N_?EFKZWW;M*3&U-8X*% M1R=+J6[#NXT\1X8C1C'@S`TM=A4X.7-WQE<)RZ5^>/1>S+]%SN7>6:OE^)D# MDPZZM(!#%#``0DL<*GG&+(G,DV:H\D?0-:Z9*;@#"P*0;&,PSQ)PZ89++)G@83 MO(Q"+'?2\A\NK`@UX!H5-`9I_`*T(XQ0TU33;30]+-!&(4TN%4KI M;-755V&=C4._KM)KL3R;NU#0RQQS$]99;^T5UUUKBG,PR&)-5MEEF6W6V6=A M4PY:KZ2=UMIKL>_'-5]]]^>W_U]]_`0Y8X($)+MC@@Q%.6.&%&6[8X82122[9Y)-13EGEE5ENV>6788Y9YIEIKMGFFW$&T,[Z MKO**F-^HM)/,0O6L5JB,QE4*Z9R9;MHUBR)5S6>-'$(KJ;.4NHXFJ&^3NB>L M^0(:KI^3=MKLLX5JTJTQ5SO3*+>+TKHPJA,<6B>XT"0L($4Z=IGD1W$A4]G.: M2V$0@#7$F5[HYI!JX*J`$&1/_7RHO!*V\("4>:&#>%09]_C'+?+ICF2,V!TC M]8<).?3'#D6X$@;Z:'T,S!.M^+,C!H8',Q($7$V8:$,UTDR`_I!0H4[4(@4R ML()>%,D#R>-"M;&I@NW!GDRR9YWJR=&%UY$;[,E&\D83H6B#+N3B"?4((KG` MP4D.(>%<6O2'$^9H38"4TAI!";,)YK!T7PP="E*A)T&=,I6`*Q6?<""H5I[2 M*:G*4PHFQ1%+W6]5ETI0ITZ%2TI9:@J^_.5C2*FG6^:R4K#\8@PD1:F=@3%W MT42-G1R'JMS=HY>^"N4WP6DOSB$KG.4T9\44!![=G).=[4P8]Z3G_WTYS\!&E"!#I2@!37H01&:4(4NE*$-=>A#(1I1B4Z4HA6U 'Z$7_$1``.S\_ ` end GRAPHIC 8 inb002b.gif begin 644 inb002b.gif M1TE&.#EAS0**`?<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J7//JW8X(B1:QFVR`N0Z$BLL#),2PCG+S"\F(4C2+ZTX1#X&@4 MJ%&'3N@/#@HW;N&&V#CTZLVE5#$=W'NB/DF_6FF1?!BT:3NF! MQ!R??CX[QK(8H(8;)*8]M_?OX$,N_Q9C>I3E9=21*__7^CA"X9HGKX9(C#QT MQ_\6XY^]/KS__P!Z=!H*]@E$#&J=34:@0)^IH(TF":(6AG&@++C<@J-5=EHJ MS'WVG#V-P4*)"J:@EMD]L1`478JGV>?A/PI:A\)PGT5((V.E85;A$3ZP\DV2C)"9'Y,B!%E+/"!V,B! MC;0F1G&K';B"-(W%!^"V6(V@@>FFA<-,TP:)Q#PXG7Z:`KB@FB*D]-Z>< MS,V&7XO_H/^*&@[PA6DAG9W)^EI[#U:6*4'R02;IL,3"=8\A`RT6FJ4P8DH@ MB,\-.".6<,30:V2C$@B?J?/?_[???@`NRPTVX[Z+47M)M*:#;4N^8:0PXYS/*EI'IOV]@S M'VLC=AYK#-/$4@R8<;C).7'5;XYE]M=3+J>X'9&<>T/>8V^]9OYPO_WYZ9__ MM/KM:Q__]0>=MOQ(RMO_D?C"/Z[Z0,HSWO7\,8H'W0\AVE.(/:!7.7N49C3S M<2"=&B%!",Z+?B#YGV@H<:L*:B*"#_R@!RD8PN6-\(0E9$V>3&+!WWE$@_U3 MW#+$1AP..F:!DV'8@G!(H!P2QS6.R9B(_]:%KE?5B8A*JM2/IL$YS#QJ5>@Q M4(&B*">&JB*`Z%B M?>1H12D"ZXITI&-!B$8)+:$@,V5L`AB7Q9BAF2@^J'G!ZT@VI%FUQH^9(500 M!8F"0FA,5CPJ))U0(R0VQA!QQ`#?!%F%&C&,9W/:X*`I%37`#Y)R6OU"5^M^ M9\'8:*-ZH]$"YQJ'D'XMPS[UB2,P&39,J15(28`\E!RV-\3T6/`?S=#&);;W M"HW]3XB;H-[XV+-,&!7S,L/\I13%645@A?.<=B3.-/]!#6V42XC+)!02LYD^ M6*P3;J:99OJJ:?\Q3_6N.),<4F@.Y,ARL1-+Z_0'/:OGMEBA[I.%NTZ<9>;/"UEBRGQR%(3%"RAC4,*)Z'=TF1`,7R_R8JU(5Q:A?>NVLQ"R#6=C_:O6? M?BV.'^"Z6=$FBW[*2NM:$PQ MAWW,2UXXF9>__76O?[,W7N(`YQ_%$-%3_1!)S09O-/=EQ(&GAU-FTE=*7&UM M@UJJ8*1"O@V?T(FDDE$E)V^R%HFY)55MDD40HID,*T=/=924IYR@15Y`I\ MM*L16P95Z2E=LXY<.3'C;CEDOIV9:S@K2ATV_S6-N;)R/"1/ZEAY!7Q()!,Z MTS$W'T@%7'90G03]QVTH><;_0H$BHUQ8$SMZ)KQ,EEHQ\EZ4X,-Y!HDT1#2M MEDL_^M,U::_Q2GR2ACY$U!)!-5M,#>I6;X50-'2UK&=-ZUK;^M:XSK6N=\WK M7OOZU\`.MK"'3>QB&[M^=4)R[12T//TIJ3]B5M)/Y71`AVCP=&6>W1Y_2D7D MMJZ-LY-GJZBM$)IBQ(47J;0"0Y2YCJA;(9-1]GN2G6UP=?LR)]TTJ8]M&.^% MTKT8O%@"KRN0\KWO?)[^AV/5.Q'^_8][ M)@[/[_*.Y^6&X#3;X<`5.7\'HSV&.M-.T*8 MS7CC.0$UTPQ05+LA[]UY:)'*4BH2"F^@3>W0!5+THYO&NC5Y]S,9-,!VE]N5 MUMXW0_0;]:VCE'.,O?<;*_+NG!?F8GK$MQTW5R*2=NF.1]UKK,9TOT#"PC71 M.B+JX`['.!;^WFXT?-[3J[RQ;KO0Q8$DUDS4J4&J\4*"U5C5%+3H,RH10X)? M'=&.:&=-@$N->&4,;TA/52_)2(?D2;W."OG%C_OCP'%'()SBKG:UYPQZ36BF M+)?L]MN0?:G\DDTPE]&#:G2M70]O*KZ&]-%;#:?K_ M2?W136$>U7O4=[SU(P.W-`;_^K-BST+!=,_(B(_\[)ETZ]-W[ZU("Y MPC'0]5#%1QC&)51'14KXD8$*%WWI-'5N57U2DU5IU3[391K'Q8(J6#F^MW!, MMU^9@S;JYSG[E5OT18.?$35-I44ILH1-15%N4E:%@E8W=3E;53\?PV6H\57( ME6$^5DG-A3'!4Q])6$G[M@P/\WVZDX/?U('YA83^1(5B5X*!L7`\9UIK5TZF M\5F^]4S^``B>LR0_E%F;%5PW98=+)S74H7964AN,__6'!@)G>-,:A])5<.!: MA&A-G?4N<_9@*,.)_.(#]8GD36`#))>HU$(P`59:-4[HQB&&D2&K3@^ M_C!-=U@0B%A:;JA:F:A5I(AS=+@7RX!>``9`VG$\:-5]&5=@)P<=)M1@FX4\ M,%2,^:$R!!8G]K`>:D=VS?AE0]9L$P8F1LA@\L4BFG!?93*.#.)/$P8+[WAA MC2)B)-9`$6=NU!4']A4KA3"!SV-_796._"B+FH@E`FD/7.A=#Y2-FV&,#)F' MBBQ89&6DQ MVI8M[@%F-45$Q7-FC54D0__H;>OB9W`69:@A&R]29[)D+0U(*]A7&EFVDB_R M&5JF@''&9S.78U'C(4FX'AU#52]6*'728EWVDZZ#`EG)C19HDS7Y2AK90&,I MDVSFDS16)Q*HDOUQD;C!:=8FC&=CEVV$EV31=B]!EW(I.*H&$8%)$X-IX=M`91S.W<:YC=>66 M<@7_UX01-W"FD3UQZ";I:9XT)Q#>R7`>!YX=\8Q2(Y^Z8U#'F2_)F6KWE8B9 MAG:A=6_[>4')LW0L2':YZ'LP6'44D70`FEKYP3DNUSZYJ)H+:G3A:9\:87;L MHJ'S8I'Y>23H<7,`54U_US6:I#NX5WBZAS6'EQX#>IVYEWO4EX?=)9OSPGA\ M]WC`)WR;1'PRRJ)T@@-D-QI$.C1"BJ.IR"\[RJ/N)'F!9'DI6C4_%")HU(`@ MB1HP8`?QYW>`-WP_(XK!]Z6Z`G4A>AM1=$U-ECQ",G\7N(%ZJ($]IX<"6G,% M<7PO90_A5X08J(:^AW[`D9.W2"T(PJ9-.(*U@Z#J@FH,F@:W=1. M*2=$'QA_"J5-^'=0E24G@,93?[<:@\I.K`5]\N0K(CB30N(:J`H+:!6C9WH8 M:=I3/26%!X2&6*.&3\.&'`BC=DH5@P.B/ MA_AEB5A>'P2Q)`2A2@J)!PMUE)A=[])7OQBA14*)7\9;H&J<$E.JDJ6P:46* M[=IA#0*9\AH8;B-.WQJF_;2/]/]9=@]I$-88,@_9KPFQL]CH)@4&0'%903FK MI'O'5-%XCC7H9=7HD$(K4Q*:)_*3)\<8D4RJM"HJ$`EFB:DPD>BHCC5*8=>U M0!I;7P,XM@KVC[;5M"2VLC5[7"_K'4X4B2KYDS?&93`ZEF)6EF;IDONAEFI9 MEBUY9C")2%$Y.\6CEC>IM6MY93;FEBFI2,J7&F>)9CEC'Y)S.XL[EB,9J3H) M&VVB9'%6J%3U0$4Y+XP1?GJ&9^LBE!WS9'@KN4Q95EM*&45SN[0YMW7CEQ;A MNRBEEX:5$\"K$,4K%OX`8@P"-KP[-XMI$<^;7X>I0-/K$M%+O2X+%N0$(Q[: MO-X+*=+_8J;?.[[D6[[F>[[HF[[JN[[LV[[N^[Y6<3FPX'4A6+9>Q"PV9N;)&]8&Z_PFQ&.=YI?H7X,'+\CYT\E-W;=>W.:LYSG MV9P71Y[V9YT6UYX-AY](&Q$4XW36Z9PT7$P7!5FET`P M^'7=>X.G9A_YRG61D7:^RG:4!:L.X8T][+$\U[\MG!$,^EL!_!1-[,12H2"Z M6WKXNR"RIR?QIT8\!'OMR#6Q1WN4)(X1&:WS,EZ\%\0\*H;"-R"ATW(I5Z)C MBJ)7Q1X'9J/BFQ^[QZ)*O,30VZ0,,K1:T7CWDT50,:C5=3^G_Z$A"W6B">BM M%>B`K!09BV(UC,"`8SF;FJNK`+3)O8IW3Q-/^LA!(7A8B`K*:NJ5]>6FFOR# M":&H<=K'?MQP@6I">4P5Z7<_WB@5\HN*J@5HMCI35NM79R0JG`Q3Y]&&:GRG-@6JS8K*]=I1/O5Q,.+,V(J#*!C+TSS+#9JLP/K$3;&M MNXK.09&PH9JCZ&+,3,@>N+1"L7C,TT4,NN09^[:I/>R#0`S*@SA98,6P0\PC MV8Q7F[A^90>PNNBPJ27+Y$P?DMBX74&Z!?*Y3M%>]>3+,Z6/!]D(P<71N760 MQEQ7R&PQ3O`@]\7,`4O/42O`Z`73AO_69R1E"#IVNCZF'%?Y&5D98Z][1$#)&%G9 M'0H29HH+G)9;FCI%1(SK;5'FDY'[1US6E,WB'DDYNW#M-#E#UALY'X6[9H*; MR4DM$8Y7N$V=)F>=%O:[$L<+%8L=V)B9V)93O5!QO8Z=F8]9V9B=V9J]V9S= MV9[]V:`=VJ(]VJ1M('8*0T+DR_@8=GJ)CS>UVA8!V_-E<7#HR$FP MHSK%.9TM&TANQ!VI!$M"(LI3A4Q8,QR(#$2'ZE"K`U`GBJJF@TN:$`:76FBX M2J*Y%8!3%>)`D597N+X!^;OXN5!@=$9W%&N6J[DN"QB M"HP=5E,T.\_F!JXV>%,6'N=1-X-S#HO^A'7J:N7$:<[JC!`CZ8,S_\3.-%'H MA6X00=7HEV'M[ZI18'FM?XT5]+K[+%.1&%PWJK3UHI7 MK^[F9P1=]=A1@<6T#"=J-ZWI.EWAGGYM)2V-_BAJQ[-"TZ[>LFX3MGUT^%WN MV@T4OEUM^!V<$C04BVQ_1_26E!O79949!Y*5;ZDA!5@TBE2ZWW;5M&5#5R;O M3*`]$L#]\CB?\SJ_\SS?\S[_ M\T`?]$*?F:PF'B[_H;GS7H1BE(I3<#]P%A; M]7*']>Z^":*Y$=&MW.\APO0=.IF:F#?[]%^.5ABWPN2E>4B$TQX[ZW>SH'J'BU;AE*2`H&50SYT?T'"453,I72\7Z''+A3^&HL_%$:=>`I*&KOL=,!_3/#*$T9MXM>I^>ARI`*=J4(AXP_&Y&'`Y%IP M^Z7T@"FMS?X4@.__G*DV^'^K\W_O2CT<=7],WB:RO?L]P8C"GIR8U?Q]XK@[ MH:#E]]\Z:V?Q+]!:SA.U_OF?OU$`X63;/8$$M_V[UR06PB:O%/[[9P]%"EB4 M&B%D@D)C(W]Q%B9<^*_CQX89-19ZR#"6/1P05?JSZ%+F3)HU;=[$F5/G3IX] M??X$&E3H4*)%C1Y%FE2IS&5B:!H[^&]92YK,8&F*$76J2ZM8HTIUNE0LV)I0 M(?K+\]7E5HA=LZZE"K'I6+IG5:U]:^]MQ+T@&;XJ&/B@WX0.8\'$T1$6G(L& M7=YCTC@E9,F`H_I5J?>R0G^,ZWX&'5KT:-*E39^F.U>F/TY:XSZNLLV?_Z:+ M4JG>BSV[-EG4/U6O;@W1+$VVN&73ALLT;.^@S$**C`GSHC]4GJG'M)?"LD'' MTB-J5ZA9<71-3NUQ](IY=M:$5\VC#`G2N[]0G&,RQY]?_W[^_?T#9Y8+ M\#&!.JNMN`,]@XB8W?Z;J4"(!I2K,4,BO&W!W0IT$,*;9D-AA8-`1(&]C%*( M!;*)8B%&HQ=,8D03%!I9!@6J6D3A18U6T(:2B:18@0\;,1J2R!=%A$C%%U68 M)B,;?)P11!,UTBBK%E_S,$LMM^2R2RV-BTBCN"0JLL:+:D0A+#*I0G,Y?S9Y M;DLPPRP2QQ7-I)--C99;\RPXO00T4$$');100_\][)"G>^+TB:5`$]UI4:$< M/;122R_%-%--"QUI)\V"<@S03G7Z%*A0-T4U55579;55H%A3:RE_+HFU2UCK MFK565W?EM5=??P4V6&&');988X]%-EEEEV6V66>?A39:::>EMEIKK\4V6VVW MY;9;I$A\T"@TJ4P3T%/UJQ%%F2"5:Z,DF5#WW7AK0M!;>X7-%EG/N'&*?NN3"_\W*"205_;7IXJ(II8MBVQR*3R3B#1NK.HW-= M`C'<>T]F%>38N%M9((1 M5$UA1PU>6FB:ZD4Y:E;_.TQ:C*HGQ')5JL/2^6I*`P6:R+#0S(KL)DUV2>?' MFD!E1A6=(GL;LK6!`\7.P&M;(XDADY@IC6"P0TR1X%B12"8%JG&O"/\.O,AW M4>B[L\+1!%QPF_RY:\)&V&5+X<[AOG$YJ:KL,<82#S*;;;,@:K2A]1]J7N>=9!];$CX.6&A5K'CE M!WI(Q2$I:RO.7)6G>SKDB%%!&X]FTZ*@WT4J?KP'AR_/8/*UL?[X^^CUL?>[ MV+4'2<^YAAL`29:\X]4M19RA'N&&%+WI&8]YL8/@:-C2OX,HS7_+89>J)GC! M_XCT36T9Y!+0M#>CA)6KA**[B=J2E#V3D%`B*&I16`C3D)0L(RO^``1-8@@= MR9`$%7%)B!2R-I,7+N9!7U.)2G8(M9LL8V\+R2".4'2UJZ6M7/.YSPL-0Z2- M[#""7\3/;Z0(18W,ZS>K$F,90S)&N:`PA$Y[6:PZ@Z2(,4^%20P58CHU1^R1 M9(LBH0W"GD:)\GDF.S[L2Q/ZH+B9="8QTKL?7[YRR"3.L4=H6PVM[&1"F3BJ M:1?Y9",)&;[!<802C]SBN>H(1E::YHP1>0T27YFJ5R(1EFMQ(_"$=I[9F(YJ,3@?($$741C#Y M$;ENY"*3+#1A)@/ID*Y$)"2-T$82$1&>SD*X%$A!!:9P')'4I2(124ZE-I*I MP+!$M1E)1'&0F1=2O6?1%L$P1#T*:4>)5%'+_=.J=`&34:.BU=7\J559W>B$ MPBH2K_[3'Z-X(%$D%9JU]J2M5X7KU!I*Q"&F"H3HK.L7+S:64GVFKYZ29EP% MJZE1Y<1GJBILSV#FSY4.UK'_CY55<'YFO5[=:K)IA6QF-;M9SG;6LY^%$+E$ M.UK2EM:TIT5M:E5+):&LUK6OA6ULR05:VM;6MK?%;6YUNUO>]M:WOP6N#D<[ M5^)(=6,K:@9FVY70Q+VN1@M5$7$;J0FJ/#1@ER,<#LA7*V*8-+C?)0KQZ$:E M<*5K(2!2%WK/2S!+S0JJUSV+C,YT7C">:2T">.7)?=9)178L3`AJ#P;H,2"EX._V0D^(C*<))TH:T@ MK,+;,/%;#@LVCX!8.&J!,$):%A5!QO%?E%"P7.HZ&Y-")BQG15U>%QS@_;Z. MQU\)_VI/[DB,G<)K?=OM<)27PBX@UX1H25ILJ&PY*"JCE63EP66#>I<_`0FY M4IU17)M*"#EM:+2Z#(ZG1C&H-]3MZ7'E.[#<-!(&'(."DVJ>C<1`E`H2JH@J M120D3D_W5B:?5T8RE.CH2O15Z/`-/FCU[0^ MI"-]#&=822Y&??-QLO/\ZQ9Q!`YB\$X)5R"-%;6Z0>E]-'2PS9A`'T?0IUPV M'2DQ;E.B($8]A<-%F:`%)K"'F*+NK(1J[#Q.1D1T5SZIH?_T':=EV*`:E!%H M\TA&V;M>"LU:*6J:(!.7ICIZPU9$T<3;U0B)Z-J$/)[&0Q+<9B29J>/E;O2O MR62Y1C?(P3H$=[E6_M$\'[GC\>W;S!.SWS9+[.8;3RZ^<7O&*M?$B5'I%\GN MRQM"$=W+86X>&V4RG%EB"M<;[[C&82*&EA_Y,:^FC,9'Q_$T2>3-5()W#'I> M9[)C.\\ICS@*6_ZNP';=@&%R$[/A;/;X(NGGT%'[M!T'F1Y40^A#%QT./Y2\ M?XBX\;&JNI>(GD.FZ`YKC91LY-M;9%HO(^-,D+6[-0'NA/IX0I_OM-7L!NK# M_"'/2*U(X%O*!-4?!LYF,E,=,Y;_L)VN+"41)F-UX2`BAAW9^`;TA^LC-_R! M&`+-:X>)W7((Y7@`]X1?V M84AQ&S&:8JXG$_+TTB\EEW8B+>G6E:C-*)B"(2&3O'"=>_"#_?LRT3HBUR&; MN%$1%;@_`CR=='F%2..IP>""ZKLM4A,QW&,Y*G$J-;(=5G.G%]LX.@&EL>J3 M$=1`<[FW%LRL\WNK1C$S+FFX&>R)+8-!""$&'%B>':2MQ!*0'#.LQ>*4\2,B M(E0LY0)"U/"B)OPLRSJ*[VDOR3(**H3"+-3"+>3"+H0=V0+#,!3#T6JM,33# M,TPM+U3#_S5DPS9TPS>$PSB4PZ+`066I0\':)/C:B1HA*!*9%^H+IW[K+CWS MGPQ+F(L[BNCJF!.)A:#K"4KS&R+DPTQ[.9Z8C;BPKDH4)1L9Q)KHQ#FL"QR1 M+J(($/.RB411*H$9Q:(0Q=1X#5.<+A*JKTP+M53)+USK+[NX'&%+FU#[1"(2 M1$&#LT,DL+0QQ*,(JOGP"EV$F&%T'B+TNA-\L&L"/A"IJPJ[,$0D1E"D"[V8 MAEC(K[JHD=L@L2'B'I`IB!D##6\$QQ<,BG'\NMUQGKC8-W1D0D[A/)N0D"_; ML+DCE7[[L@S;Q[$(*M,3B:<;R.GRKH?[$&<<.Z#HII9+11TZ1O]N'`UV#`T) M`3B7,!I0@A[:J**ZP$A7I`F`0Z:S(+/+"YM4N3J!<0H#D2$1T20&+A#EW%)?7 MD*>2W)PS"9U9^PQ_%`L)J4L#P2D@HCT=$S-784B,T#6*.#9JHR.'Y+WG*#=J MRSG\<[N>JKD#TX9C`Z1S8S>0F!/)'!'">;9MH+9*3*DK.K9H6SUY$X.:"PYG M@S/5M#V?FY%J&QQLBXD640%NR[@2G(G_L"RV:Y,.JU0WUJPYX;0(V%P^>:,W M>X/+DJS%OL1$PD$A>=H:,:,@A5O'Z$2*`@$IT5F&PL,H]D$=`6J5EC0YB0,] MC',T[YJ[>[B*A:HXO)NXM,5NQ/3_[RS3+\K$IOCI.<;1BW%B,(ST9E8E&Y:"K^D+)>C$EW[R-W0 MP;&XTUR:RZ=AO-U1H5L)I?/$L5SSO!3!4M$#-_=,+^G)LQJ)$77IN%_;4',; MB"4]3N(S!(^I(4D]+Q"]U!DIR,'\CH]83Q][U+MI/?Q?3N^6S&^63#4)JO@8=$=93/$`TT?.`3SB23KHZQ>F`IPG1 MQJ60UJM819_81R02O^<@&IGY*I-0OZIDOXEPO]#;J$Q,`?K M$K+TOPF3-/XJP%1`P/;#5_VCN9P$(D.0/P;E5Z=\P/O#`3*)UXFH0/]\+9>Y MD9$`Q,G3&<"!`-BAP)$:#(H5G-D3)!,)?8V)=%EON4.X/%K22%KF6-K/:-JBC9H> M_$&HY8^_0A:KI=H(>L*LY=JN]=JO!=NPC2`T)-NR):TR--NT-4.Q95M>4=NW M/4.TA=NY7:VVM=N[Q=N\C1VZY5O8DMN^!5PRU-O!)=S"-=S#1=S$5=S%9=S& M==S'A=S(E=S)I=S*M=S+Q=S,U=S-Y=S.]=S/!=W0%=W1)=W2-=W31=W45=W5 M9=W6==W7A=W8E=W9I=W:M=W;Q=WX!7>X27>XC7>XT7> MY%7>Y67>YG7>YX7>Z)7>Z:7>ZK7>Z\7>[-7>[>7>[O7>[P7?\!7?\27?\C7? M\T7?]%7?]67?]G7?]X7?^)7?^:7?^K7?^\7?_-7?_>7?_O7?_P7@`!;@`2;@ M`C;@`T;@!%;@!6;@!G;@!X;@");@":;@"K;@"\;@#-;@#>;@#O;@#P;A$!;A M$2;A$C;A$T;A%%;A%6;A%G;A%X;A&);A&:;A&K;A&\;A'-;A'>;A'O;A'P;B M(!;B(2;B(C;B(T;B)%;B)6;B)G;B)X;B*);B*:;B*K;B*\;B+-;B+>;B+O;B M+P;C,!;C,2;C,C;C_S-&XS16XS5FXS9VXS>&XSB6XSFFXSJVXSO&XSS6XSWF MXS[VXS\&Y$`6Y$$FY$(VY$-&Y$16Y$5FY$9VY$>&Y$B6Y$FFY$JVY$O&Y$S6 MY$WFY$[VY$\&Y5`6Y5$FY5(VY5-&Y516Y55FY59VY5>&Y5B6Y5FFY5JVY5O& MY5S6Y5WFY5[VY5\&YF`6YF$FYF(VYF-&YF16YF5FYF9V9J`HHJ+G4J0@4"&=, MXYL%;8_G$:L^98C%6"`?D3#!>9M^'1&9!*E:O$"2/J"6/KMN8YV9IE@5\V@_ M?(X'3-8";0*C]NF@/J"K_M@[81R>;FJ-BA?MN2B%:(_L\NFQWIZ07M!^3>N/ MKAR*;>N6Z&F]0&F4?APQ,.O$D$GXTV@9Z2DX&1Z_1D+BD0WI.1]-"(/"=KN+ ML!.[ICV"&*^RH:,$@JAGXIA_L(JZ:>G]M)OQVXI9W+7Q@;?I`.P&NAZ4%!_% M1C#$'A^T(TUUZ<'O@`6_5B#-AH7ZD0W`9A%?BQ?_^&E-U(8JVJZ?-D/MD*N( M>'GM76L?2!+MP_"(XTXJ^^!*3-LUZI$>PO$YBBCL%`.D3LG+A;`A MV<@AS_SOP_B3XOCO5+*/*R6OK:V7&2)7($KP`N^4PF@A^%"BCJ821A@_S/@: M"(?P'9HAPSBF#G^((O*,$>)PDGCJ`H?PK<3JA+!OA_9OL+RB^T%Q!M\([M#O M"Z?P^]C:`=Z]V2B$+#/"P7DD5-B+OJ*DPM#O@A"Y\=,C?*+P0&+Q%X?J*,%#?"5>*A5DVB"5ER_RY7<$BM#)AY<3X*%>[Q\#*_\@(?G&TS<[%F(*<;9)I,,X)>ZF:.@HI.F(-_>Q,2R;F4AOG\$29A1!5ILJ>2$=.A$1O1GC[4:2G8D?][BPX!D@V*E_A8T7=(Y?>.GY(EB>\;X.O_TY$BT4HE80*"VGBH M!I&%+WFXEOC_JZF-0GD0M*G`G"HC80)UTPC3J1P\RY$3D8*9!_J()Q>U&WB( MXK>?VKE[Q_F*[W?Y@D<5$?F'/YTK\2EY.V@2ENB?&>C+H8;':-EGQI:N7^<] M))"M)_MB`:F*)%">W5*`7/NYI_NZM_N[Q_N\U_N]Y_N^]_N_!_S`%_S!)_S" '-_Q+"0@`.S\_ ` end GRAPHIC 9 inb003a.gif begin 644 inb003a.gif M1TE&.#EA!0-U`?<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J7//JW/'D"-+GDRYLN7+F#-KWLRYL^?/H$.+'DVZM.G3 MJ%.K7LVZM>O7L&/+GDV[MNW;N'/KWLV[M^_?P(.KU(2BN/%#__S!01%#H#+C MQG'T8P(=A8IM`N\M1X'#'Z!_Q*O[_S!(#`?V?\^K=Z<._7IXXRG.$WQ?/,4M M?\2@BU%N_+I`_-4=`F!Q/N177',#*8-@<@9"AP-XQ<5"T#($$D3,#?(91)]Q M8B1'"0H8#O1>(_Y(N)""(A:'''_-;1C?0?Y0%Y\QVPR(`HD?WF!'=2_^HYUU ML32#G8W5`9D<*/H-5-Z0#48'89'&K8#=CRH$F:%P6)JDW75(IF!B*@.%$HMV M7MYC2'+$K3C*+?]0&,.4W`E$88?^((G<0/W`89]`H=Q"II]<")1F8_ M>:)P)T%(=DBA?].I<(L]UK&9:",)WE@G"AT^]^`_2-Y`D')>$@0/IX*B&NI` MFWXJ4)ZE)O^T)7;Y59F<*GA2=V=^)B9$:J]=?CG0H8DN^A\<*VJR`IO_Y-?A MK0(UVJ9UV^1))RC^O^R=^S]S"Q+)YZ,OO/J<\2UV&XUVV*J3^<5`L' MG9IDF^6])$TG93./UH@K09'VNFFO/I;+ZG?G*BIGG`/%PP?#VMKZ'Y($)QPB MI?8ZIW#`!:N@S7*8"H3Q>?EAFM^#)VL\WD#-F(+"R@L_>^IXSTE\CQ00_^-P MS@;IBUTSS*`@Y3__\A=R=DE#;=<9Z:Z3FDBEPFLSTZN:0RQD+*JH4BNKCMJA0FZO"S6HZ M=^F?KOJJ*K,.J[`_]4J8BK3_S`[QT^R::U#K0I[\M-NB/]0/ZVF?U_??@4_[ M9G*9C[J=YOG=^?OFCH*(Z'96C[WM+9UC=RG;WX(%G5J/ZJ1LNS4R$X)\=D_FK%`1OSK5$-[ MB`8A]"QJR(]34#M5B/Q!P8+PISA6TYI`_[B6I/]\J#A)(QMSCH6JUOGH/BB< ME@=S-;3P%/"(#'2?%C$RJ\"%RWI4T]/D%%6YA2D.20>:EA@29RX#'N@\X4(@ MA`QGN24R+XO42UBI(A4Z>WVQ@DE#7;3`"#OHA"AAANB70%*AC33AXQ8E+*1Q M^%>0O:UP2M3YE"(=(LGBA,B+U/&<\IBH.26I*&LH.!.T\G@J.:+Q:)#3H?=` M]CG%N9$YV#E5(H-WOKF5L2"OW*(P+>(SL24,9A$3&,7^4S#"4>A3IT+.)FZ$P>W]+$;#61JFPLDDC[UG)7=@YL?,E';D(0@ M(=T#!3W`50G[P?_-YAU$A2QF8TZ"W&UL\-SF)8$',UG^`YTB6U3=2O>L MZ74M56*XA]6J]L#KE.V>0VL=/Z^IQLTA2%]L.IU`JJ'1!V9OF#!UR-[ZIB11 M9F=P;1S40Y%3MF?&[$CLBY?K0B0Y5NG4'CS%9:)>NCGD^`]3N<.8I6B)RD"6 M<%7^$(6Y+C>M9*$*3-]+&;SDTZUMQ+%7O),/*%R%,1/98WG*"5]RM.JZ-]$T M:Z*\W%(+0JF0P2-64FU3R%#XU&B*S'&YZ]ZW(G8?H2X,0Q3RZKI$B"2_-L*P M#W5<3#>KD`UE:WI&K(_WV`,?9OWHE$]:(I5PMB=*%0<'VCCBGF+$HVW_>/9N M&]HFD?:SG>#9*&0V*I!Q8(`D6U&H.,2-3K5(ZU$,I>=EQ'F1_T`40M+E-H;> M<9Z3C/C9XDKHN/TYS_1N:Q![Q,)``$P8:G,KH7LT(CT](E)UAG;+*;I6/$]N1MC.2SP]]VR`%RK<]%4,/_YX;G1G_K\70Z9$/9;0-K#'YM06YT'FN MS!V"LC@\!#NN#TX;)6T8B$X?,@^7715C8VKW_\G_:1(0?8C&;>+X/3AX[B&= MLZ`>O_B!K\TNF7=<,""YN;ZG9%'/9'0+*Q?)53R,TI5N7`T\EPZ?>'ZND;%( MXO?TN;9PVR^4H0,S@MH':\I18*JB/%I1Y]80]`G9B/P!BSI#R3V)/C&K&C2F M6+P'S=SY[V)^-%B%)0YS#.R2BI.GU_FE:D6%VMQLDV>M(V5K4%DUU!*+M3NJ M$E9T_%F4LI,3..4D:UP/K=3U"HH>GL42EXME5=IZU:<_W2-0>5 MCTWU+M>]`29&/HU)C&9"T^O6M#E1MDJ;(1-JS20T/3%)+N'7NU;&S*:X1/5* MB!C/CK<5IKK\()-Y`/\<-^#J*C6&N8M0\J+7QL,UKF`MTB#*466]`'[P,JGR MV'=<%+$'B1S:K7R0GO,4\/P3[H&HKJ[K]JJ:M'VM5#(O71V'`R6)U;Q"KHBN MM.O'F42JJZI^;EE>3P[#;5X[[2FTJ84493_R(&S%1)I@YKW[V"2X0J?E$$0M M;]8RF%7>7R)'8'9313N[X>LG\M7+I_22#_W_ M`O$NH8OVHPGF:B+A?R>?8OYJ)-,XUISF?!-S90 M15EOUS3;%UKD!S$P((J72B#VX"% M!0&'DIB$'%A(G_O`'E;%)$P).\28DWT(-`^%0D28@:(1`JC@_]1-I MJ&5`".2*/>0Z&S8?-O0MW,=$'6@_`&2*BV6*!/%<)-9N MZN&+0N9LR;=XTR@@W2A\_OAF[(,0NJ@HN"@?FG8>/D,I#]E1-9*1`C&0M&A& M-A9/K#<902-7PB=70Q>'H?^65[@4=(C8*S1%4(4X2`6UB0N#($W'BVG8>)%# M53\92N1Q2ICX1\@(>]S">-_328Q7A+I#E*/$DP=A($*'4Z-"'S!6<#KX@4DX M1X\4297%AO>(-CD3A&#(;@GC1V57.H;`A1DRDTG9<%.Y:F^$DT`I$'RY.6GD MA!GH="XF.(H#2F"$$&#Y0(XCB.94F`;1**<2@R47)WDX-G(36_)4&.S4?-B>LP4-9P71@7X#[[9?I1W'L2)5+FR(IN'3NLT-F18 M/!__)4$,.'[/J(;("9VIIYW:(E'J^"K]1#K@-WC==$GWU`-@,H[L%F(5&(.] MUU+=IUU'@T[$)YV]J3*H)$KEV0_&-YQ,TTS,XE/4-Q`LQ9POE5;*V3_NZ9Y7 M5(#BQYL$X9OM!HL,]'[?:9U;]J"(8@C[)WAO5Y^&-4U2LZ$)T:+'^9P7!7M2 M0E"!A#8NFIX.ZD[+<:#G:1FMA#@A`G1'V78UQ7+%?-XCE]Y3:`I6[?,Y5U<@B)!7B+E6U0%WUC="=9JE04 M*7Q^A5AF"7-4NCQWZ(%TBAQ]$U8NIU+P@"ENME:"(T>8_V6E%1-8:5HZ!*9' M2(H=F]F$T5:4?&,A.KD\$OIRYW)95:I9X,,F8GHAY550\`!`?TJE3">"1^HV M(2(ML&(BE[ITAXAT(M((6DHO59I4OGHF97HNZ540O?IL$95'C!EX;K4\D(.E M@BH?J`H\L0(/RR.GF&&+*JIC[D@!#-DGR5G^@4=].5=4K1$MCA;Z3JNZWI\Y[61(D8XT95+QG$# ML25:H19EM^"MV[`,:F8<8]9;_P,+^8%="*-C4M9?T>A#O76ORL6N%@N8>;:P M9F8DX`5GJR1RQP&S2`:RXSHJMO_FLE,H,@5K)`<+?)PV:>V*LO?T/SCS6B/) MK?":K^'UL*7E:86V`M*PL\7:CRS&M![DM(!I3D/&?C>;8A+['[48M!J)6AU6 MMF9[MFB;MFJ[MFS;MF[[MG`;MW([MW1;MW9[MWB;MWJ[MWS;MS6!:!4ULN>1 M6S%X:8;423>@9],0L'+5M3[@1CA09RBF'E_4'J_`N.;B9QT$:8*[:MRYD_@J M*N]Q`PWR)J9V"Z*0(8-F';:`1AV2*`SK6>V%L>KF(DD98\;@)XR;C4G"93?@ M932VF`L#(K9;F^W12(^6B8S6AB1H$/YS2/SQJL6A2E;HMYJ1H_=@3>+W>(P3 M10)1#'[_(G"J5$+O-W^.]0^5\S7X]G[+U[T@.7CQ8KX9LGR;`C/;"YSY03A0 M`[[V-KX,HW[F)B@G*;_M9BN@)4MO"K_G<2C'.$$:-[A:6XGM%GEVPK_B.Z%Z M*4C:I'R<$SRGD\'N*U%5D&[-424`F%%/)!M$,.3IZ(^B"@[A"@L1]?Q**[,0T M/Z2;VA0+;GE)[>0/^@B==T?)N@.:FV>++S4WY:DQ%/QVJYPBC1`/Y3C*S8=* MU7-[-Q+,W2M'!L3('5S(]N-4"D,I];>EF&7(E2&Y9F0NW!8T]<''X$,PH7N6 M2.S#>VJ8#C(0Y+S."B?/DD2J*P2.U;(*JE.:W(:/8:#*.IS.=W205`M`@SH_ M7(QL'4*.IQ@B>\6!MQB+NF-KJE1+8R3/]UP\U;29Q`A4!V0NTS6UA`DD@QPT M,'PN(=(V+HPNA.S-EH'(-`51/*I&,/]T4,4\E>7[R7W9>R:JR9Q2TZ;GEKH< MRA#2"(_T?C)==@$UF&$D1_F1=-L*D8$TU,GY(PW%>+FLTZA)4D_Y=G.#S`TY MG9#0@IZSI$#G MH(4KQZRLJ_"P4=:'Q8G-GT/%UQU5\+O8\$,;07F8%R&TBR%;G.M;`A\QQ)=M\JY5ZHK'>9 MC"FN92(13LU5=S3*T%KL5Q[-8AZ]-UU5Q,*N$X.4]2::-HPN^[6(PGL[CN$+ M6[J5@T;%NKHJ4&L0.(KSW!]LLKJE,K`1=:[&"Q_#3+;KML[`>[74L@Q(OK"Y M!54!FP*PX+1?-"[@936)HC@_LBA,%H)@&E[KT[PK/NAX=Z7+O%%*$P4(9?I MD+ZJ=8<0R"?7*J$=A7L2$HX0%`++/(%\!)&8JL[HK"X1RW!&-&D2PYH2OPZ9 MO<@3P9Z&RS#=O=[7=4-0[)V<#3-#O,8#N\C,TKC4TWH[MYPX'.YJNF2TR_/CL@XXM$:JJ M*!`&'"IOAFK/8!\M,1`WT2+55"#,T1[.>EC%6PN(>`\F@U+_>P!0E3"'[0\MIF M.#>2.'YP"WL,\J?(JXI"*23/!RGP"D[P,&;/IJ4M\]M0II12"#UO*&O/!#:/ M,*!PZAY/W=@N(C'T'.Q."92D++2B`E20#4PP'M,Q'O=T")2RT/MJ9W#P(,LP M-,7U,1CR^,@-16*M+;$PK`X^@D('!S"O6Z#0'-H1!MB2(2K5X7_P"I=?,)@_ M-,M@`[$P':-/EY[/ZL%.!1]C`U6`[B'T().?;I3/)K7"^7+#[O1I^'^/Z$$O M76[BP(YMPH/L`L0Q%HW_+4MSJ!^?&OX1;"J)`H2+6/XH4 METGT!P='PA2QX*%P^/$&LX[_B)4DIF*;P(4)8VS[*.;?/87__(%2^<\>"ID5 M??X$&E3H4*)%C1Y%FE3I4J9-G3Z%&E7J5*I5K5[%FE7KUI_^*!'\]Q$6()T\ M3:I`-9&B6$#W4,2ZJ6):+&4J=XK)Z,.>'Q2%R'+:9D^%E!7;E+V=B>+0/V4I M4C6JNXT8SU1X`DMTZZ-BY'_,)MXKI'':JI03BTDN_*_8K8NQ^C%I))"1_RJ* M_HYMNYY;C'-Z]AEY MC:1Y]>_7KV[=V_AQ]?/GQ-8$%%W'9VVTT4.'S>5PFG6S(R MZQXF(OH,COX$4JF?5!04PRT4IH`(!U!6&%`3%!;Z"`6^5'CE0;-?%WW@SRP3;["C6LX:ACEFF6?&:BNU$Q022Z>RP(=TZ;[WW[M;`."?[D:%5+.+)0!7].7(:)J!%O",# MH:6[\8G^56NYQQ.-J6#"K>:[<\\_]_5AKO$+"^.!QMX)Z!9[PZS%S/PY:<#8 M(^9-0YGLB25UUM5Z&73??P<^5GPK$@BBGN*66XRX;1!3PA?$/*S9XE\J:T," M^Z,(3"5M@H/SX+\'/WQ.B4$24'C%1S]]]16%IWPY$1]X??GGI[]^^^_'/W_] M]^>_?___!V``!3A``A;0@`=$8`(5N$`&-M"!#X1@!"4X00I6T((7Q&`&-;A! M_PYVT(,?!&$(13A"$I;0A"=$80I5N$(6MM"%+X1A#&4X0QK6T(8WQ&$.=;A# M'O;0AS\$8A"%.$0B%M&(1T1B$I6X1"8VT8E/A&(4I3A%*E;1BE?$8A:UN$4N M=M&+7P1C&,4X1C*6T8QG1&,:U;A&-K;1C6^$8QSE.$?)6U"1\2$II_NLYDG@XR`_LZE:GC$S+F>2$YYITF2AF0,LFFCC$399TCR;8XIO! MC&=`SV1,LL%!)OZX1'XTH99EW$`;?/K'.P4Z4?B$,DX=JM9D7O*:%$AA,"BP M)45%.E*2EM2D)T5I2E6Z4I:VU*4O1:2!(-((9CSS/16+03;(HA2!`2HAL9P) M-[S"2HWHA*D5T5#\W!2//L2K*TPPSY5R MDE:]SLEM6^&K7]-CMZ"LZZS_@*4J4Y9A,&K"*3YSO9)_9GF4O)8+#A-YC68< M:Q38(0:OO"$*8P4;6:'<`Q"LA:*!K+;*RUZ3(63Q95*R]:=13$.H/VDKV>00 M55`4=DX`U4IO?YN><`JEN&Q=KE3N,=PRH?6V)@$J+7Y1]!FP M[0ZEN<)=ZUG%FL76-%9!BK$))1AQGQM,0T'YE"]][0O?*\TTOH7H$><.0R9E M4@29%-'0AK117`+9DTWW6`5F*X*\U%0,/WN:2/$<"E&&O,A@<("%F/C3S/1. M!<(2KB:8EGDBB;RF,'324`SB%@9*'(0F*@%FG6SW$-=5R,`O"JR=EJN)$*M( M0A#K_Y),I)4*;=3X%C?>#R@`_*2B#78S_$T2M"S,K@0[=)L-C@K.>.PS#]=& MQ;V!2X^\S(@`J^N]UP&HA7-R9)N`@LTQ,`5U4@%;*3+#RA.^ID%@<2VTO<0> MRT*0X0(#K5)F.`6#CL@M&+4HB"QD&OBL31R*(^ALO881]3D4G^=3C(F``LD] MO<@VG'H16XAL(M0`M:MMUJIX(L_I"# MJJ\YS59'&JG(`4J,+#WN[A8$2JR$#:@1-94.^0?6U[DF2?]F-&PX%'LQ^T9< MCAA5[]:`TS7=L_>3Q5WL2&.;(=3=XC*"+$L'XQ-VUX%H*Q<,\L^XTAX=SR"AS02T7#32P5:K])GC)%EJGFOIK MSM/TH$#]9W[[74`/>DF!+Y$F_##_Y-`8]TSP4,MTU8)[JZM]N@-Z)_QL\LYZ M?CN?XU9K/YH`"TT[/"O`5]>SL__,5NK(FJ`-.KU#+H=J?X:ZYYWN*Y:*N(DP M`V'$?[R),2YLBR!L)DUX!40YXIKQ9\B[VX2W@%FOBX,%3#,]35">V=.$WN.N MG9JU`B2(9;`GQ($:;S.S,("X>V(ESHLY!(RH6#"^.;@%]_N)[7JZ+OJ(X/N1 MUU@,=(LRDMNZD;.)D',E%K2)=+N)E;NZKU`7E8`[FCBH2U@PB.&7XI*^$JNN M?4.P?>JJ&^,9T`(L;0"H'+2).#,HFT@H-"N^#8,Z)'R*4,,KJSF?G!E#ZR@+ M'S0836LZ_VWXK,18`2D#L+"0PSAXAS)1?(`J5=XEA+YKD\Y%X])DI)(B">Q$8[1$/&2E@3IJ(,0QR39QA,)J:C(F"4!$]-9'9I@1QNH-/_"08%\O(5/ M(1-%%$!F-$9#@XATB<:(L)%'$T>V"XI^``0P*8F#-,?:>"\5*$E^U+EK0<9; MS,7B&$AO1$C)4!)\"`4?@ZDO\H<]&TJM$*6D5,JE9,JF=,JGA$JY`:*HI,JJ MM,JK%*6C5*G)"#:M],JO!,NP%,NQ),NR-,NS1,NT5,NUW)NXD4-`H),V29F0 MS,04,QZ*.`QK9`@.JXJY!*GTBDN?B#^OR"[@\K":>D<>/"N^U(H$4T@OM##[ MJPU**,SS*!MM>!!W;(\MBP?-W`K'I$NBL##3HJ.>,AP-JB$@%[>1-ZFD,[T+-"H4#ZH%)L&@& M97S0#]P_**L>V%2*YC.)=.$/Y>$P"K,IKX,#1K`[XOG-.O.167N%`^F)[].P M=$+-Y>-0J+!.-Y,)#)40%+`!VTH9L-*T(F4/?3&S"-V7%-4$'541>?L2#4W2 MHZ@UO)$IU`*0_PUED5O4BF50++^1I4JSQ8UX-@S-"!T=I02S@0-1B:-!22>* MD7CQ#=S(B6YZKPH+G%'\$1=L4[FI$T.%B(T#Q/(T,"?PI@&90AI4-2ZH,]\3 M"JMZ5$M5D))IPTEYNW?!#WL(,E/53V^RA6#UFV@!H[$ M"ET-&(CK!V3MKL+JI60FZXT"N*C)3C@F.:2P)ZSP(HXKTY;KO_A(1B% MA0LUI$`DS5A]A;IB58HEG0DF$(.,\9+C"]BI\HEP&B_XH(EE&39XM5CEBSOF M&:6J2#6@>#UGR5-/E0J0)5"K`AIOMI3(@8?:(:`X5I,-1A-M8=[18KTI*6Q?2?-FR=; M9(0II+PYD(83:815Y!K0XMK]@*C3J\+)>=2QK4_TX-;-&)GX$;LX(SR`^D[U M\`<'!+U?M0G!#2]XL#^Z&U.CP$/"LCP$`PO,U;M<5=!R1)C@?"V(Y(4%*R0X*PM8Y4-9GV`11]RIVOVFKI(^M5#9<8.Y M;%@_B>**)<52?BJ.W@VJXHA8B.D'57"FC5T/LHH./IC=34O>R7%$/_0#WX7> MI(C.F7`(`LW.?B!@F6U3)`,<=='=F>!=ZLHQ]Z7@WB`(L0,%V&S:CPA>+:K? M3Y$('($%-5,U)O@H_TH,G?L'?$`%H;R*E%E(W90"NQ6*$Q5,%?:H&SX7@#0G M>4-)&HXJ&X[4CWE,GY`6GZP[%_Z))RT?&^:8'I$1V@D0)Y9B'\[-GA28QA-ND2RNXA:EAAC&GIHY$0>+D6F!X8ID M#'F\BB[^,WG;KX$XC.H`8Y,`J5=U8=#SXOYD2U*QKCP"PR["RJI$RDK&9*=< MBDSFY$ZFRO/P9*A&YFB6YFFFYFJV MYFO&YFS6YFWFYF[VYF\&YW`6YW$FYW(VYW-&YW16YW5FYW9VYW>&YWB6YQDV M2D(I2JP=E7O^''U.$WY&%<01I9O["9+Q6%+ZQ=WDWG9DJ_="VSAE4X88UO_B M&,DA96A<^107Y8\05A<^311^JI-/T6B`)E''M))&6XJ75`^31F0O48H.<67T M^#[!U+Z?`!/W,6D,/>F0+.A/[0F0#A<^?N*9EJFX\NCZ@PHPE>D^J9C=%&EE MK$:L=>EBM=RA+I&AWC3HC6JM<#^`UFF@^`AHY&CC!..5:&BC.`R"^`A)Q2N! MWHJ=T%JE6TBAL)FA,)D3\0_8\0]B(,^Y)IZ:G17'(E`J=-.N4$/-!V MF8@$G0EES$)T&5.18[+;4(_\!.PK1`J19LK#T]M/JYWTXZM15-U%9M?'9-V)L)[WMLXZR6_YQ4AGAMF)/N!Y7($FN< M+78*@=#H;V/KH*";H4!,%C&R4^P,JJG9`\X5GFNKF*Z(]@F[#,3O@VPY$;PX M/+$'V+2'0F!,S<7$U3Z/`C]PM3L*Z8.%48@/>&`$-5270IAIL;;&`E\J?"B1 MHR.EZ9/PJUB&.#E)G-5HE58]H:JWBB!!IL"'B@@%[L-P/+D'ZA&8[@MPE(UD MHX#P$9>4)D62G](\I$)=MA+Q7)7,>W!1B\"0_*8>I_)OXBGKH1@P$_&KC%$+ MNPDEN@H3U(J;=$FPRA0)_Y*AR64Z"$:.$#\>$\V]PO5>[S;OZRJ'E7OPC]X\]+6JAK/P+KA$ M=-Q."D:W"NORASZ/*CNG)417!LAA)T3'PD:?7F6T=)O"\S\'P9C3UJ+0]#E1 M0U?'\]J(UD4O]*D8]%D,&$IPDF32\TZ'[&K*=:70'BS[&:(9&J-)FX>@DL/1 M"#C5A(V"#:(P[][HB->@'LJ!Z'.AAE")%U.?WH$F0DPS,.H2!76SSXQX:ZS8=Y7V&IY-V/-&#V,8$-L*^`RW=XH( M^/]K&N^I&U%4]VJM;1^:UJL6ORN)OPJ$G;#D%`Q&P*98>!IY1]X4*^`K&S8$*:C^4*CL/A![ MZDW4&:71].N?$`G%L[$1A6L=21U_Z.XX34W`(!R9B/./L!IUMQ59)&XJ%%X6 M4\8#OX<_:)3"U<*UN)TTW.*BE`:UMHI9ZG%9Y"EGJ'N*9PK'TCJ\CP/6ZHL=4Z'NJN/'&8GNR&9Q0?R9_X((4=-H;+3JG$!W!#Y6,*0RW7ZBR MW_RV8WR[;ZV=0_LD`16\NBNZ1_VF>'RHM[\!3Z?%6WW_LHE\!+//!P7H%DR< MQ:FS-*_VUTA(Y4D;W=GH?Y=.ED@XGD^;Y\>K%-C]LZ_R4#`8Z%\,@]`1=6>1 MH$^5M2^1PD\GCZ=I,L'O"7.(M(I\C2]?42)XH!@%=XW_+TQVU!+_W);P\CH/ MKCX10P`(4"@&#FST[R#"@_<`^1-($(7!@_9N)*QH$:&_4?\T1;SH\2.\&]LL MWMN"\-Z?D1;[R8EUT)^:W#K(TB5&CA]W(H2'H^%#B!>)B?F'U5> MQJG)LV+&C1V?_@NI$B&H0Q6)8LSZ-*I.JF*M)O2WR2E">RI&^@M[$%31A/U, MOO0J%J$R%"[O%?QG#\4-OB(W_ZJ(Q=?'WQ@'X:$X=`^.XL:UA*X;W_9C5Z_YYPG/.[> MSX,/WQQ[](K,SHN/3HP]S^W^NG]OCW%\0L4X)9QY4(WG#R4&W=-??65=A:7"]*-UR MSZ$%$XP\M1548S8Q@8(-<*`@AFPHQ#"-D$$.><^/#Q7%&`HJU-2/D+L]-B1& M55Y8U?]`-OPH!C,#*?:2*/%1.=LM3&+YUD,Q("6DE/^<.9"4_E0998[^Z;DG M<$72.:60;LH)&9+\4[Z]NDLP:.VE>W_;Z"LD$J\%6EB M2,DQRXRPC,`UA/+,.>O\[\D[RXKS1R^#%]*^/?O\+-`6;7RT?$#?#-[23#.= MF]156WTUUEEKO37777O]-=AABSTVV66;?3;:::N]-MMMN_TVW''+/3?===M] M-]YYZ[TWWWW[_3?@@0L^..&%&R[VCGUIK2:U"C79"#.?RGQE#-D`TIN=[!Z^ M.>>=>_XY5?=(G#6.%?V%$S&=[8R@@G!<:$_+"6GR*NBUVWX[[G[#(^CB#CU]"5*P@A:L%UD68IJ8W(,+&]S&J1:4)B=H(PZP MF-U:X%$GG3"I$";9D*DVM0QJW<,)T5%ACC3EDAG"0B"&VHR;[`$#.R2+22*Q MAV)TR*D4]-!3:H&1^R@R#4UH18DS=(E.-L,(CF0$8A?\(AC#*$:C-&I\+S&C M:;+3#R>P!0Z=F8Z!R1:!YHFO?,T8'U(R0= MD9A'?Q!#072\R&,4`\<_;L0QCZS+%.0WQDURLI,3)(M-7F.\U]PBA#;L1Q-@ MT92V8$8.I?_B4G+=_"A(0QJWQ$'D'J)@H%%"@5)> MO<"53%*!%%(@A6F)[U%S2B$#(>0^:FU&<=42DTIVZA+L,5$@*JC%G51PPB@A M-7U^&0BUB/J*9;WD#]BSUO7,)]10THD/45HJR40JUK&2M:QF/2O_6M.JUK6R MM:UN?2M]\K6O?OTK8`,KV,$2MK"&_6CF2(?-45'I M7(T]+&0C*]GV9(9@L`-*[":KVC$-'&I:%/L1$#/O8RU@BL1.XS7))>%#8XS2J;TB`HDFO)*D;$VKW.4^;S3$ M,>HMGI@3!3&!$9N"!Q-1N`T5V@*%T55!-EZ8E64RR1!SW*W/WREW#^,(9O!3G'JPP8(M2/P!SJI9<4;!.16(6D9#S'YM0"1PW_^*2??:WQ"86G%EJ0MYFDAA8C:(B M#&M8DRPZX139:O$R4^SBE\#8*S)V62,>QA%1P',3`89O*_5[XB4S>:2B./)# MKQ)/?X@"#K-]D(B-R>`YK,208GE^/4G.0LXP()V=N,ISC M##?L24FJ5.4JGJ#4&1_6-`9&G2I@PF2^<.%)('X6EYY=PN<[DTG%9?J'44>" MO4,SD=%ROC2F,ZWI37.ZTY[^-*A#+>I1D[K4ICXUJE.MZE6SNM6N?C6L8RWK M6=.:N?2+QV?]W82K$OZKF)LC&`OK'H5CQ=K?307 MU4LVJE%&X](E//^YD%)VFISEFN3D+H_<8[1FK:?L#$*T$G%(0W!D!D58R2GU MY16_N9:VS^Q-L,=DJ[+RDA!4WI,0-H<,%:^JS$?NT]:\#*;`O+;)'NOC\.;L MD]IWM8=F^[$9(3)(F3$L\KOB1/G$11 M/K&(WXCMN;Y><2JGO*)W2*L!Z<(LX\53*3I;J+@[$#?BP';)Z_%.M7&M1;U4 M^UI&'RW2(.S>0KOVR'J((_?/-FN7&HV,T600E$"#?%A.'G0H0G!]O3XB'+4X M;XL_PQEBLQZG0S'29<.FXW=&-J(Z;=[KPZ`]=:TEWN/TBE^.G*Y,%N[_49'] M<)>K`)/CL%"9..,9KY%[3I",1<9!3V% M4RPYAYU@!A/`#([(FU$8U]B=%8`M$RU!17Q%C4[('@Q%#5\-'_!=C1*5S/U) MC/MT!E'90J`@!"<0F)ADU6LQW#;D11_E!9Z(_U.R/-6@+5#\@9-"0)533-H3 M&DE9T<\942%LU1(!"1ML86$`+2%?*5X,8HW[C6'./(P9IJ$:,LWNK:$;OB$< MQJ$YJ$>[B$?]N'G]%0,^,/E8`X.*+_:=UB;<;KF%MRK-89/:)OO)3&2+U M^-_>P<>>M!C7`)PI?@T.U2*?W.*>"(2PZ)9,5(EJ)$X,.)!HW)FFI`(:[8AJ M&%4J1-=*(8I[X9:NB)R=;)&13,.7P)S,+<9M52,:T9GU[`B1`%4(`>.@7%.X MX2+/P($?\)PZV@P[NO^C?[A/:^#=2[P'SF69/S!!+$S'?D"(G6@8/\91"9V/ M!\I!-KS=`RVB=&&(G#!!QOG%9,P.]Q"*/7@)%?Z%@NA=/^+)UX'0VV%9(5G" M_=0/>DW?#BF50/31/:S%._[+US$"IW#B2^;'"LAD/L8B$PRC72S=B!C"+6'2 MMTE=I-B)H3A*470*#B!34#(36DA>C@43"96*T&3>#:P8"`F)J%#)1$9$Y_GD M1AA"C+E23=:+(N%>66K'ZNW?5XP;^H68Y,FB)EP3>U!(:*&2+1S(]J!"MOQ1 MB[48\@42^"!2+;S'TS@?NT79)NZ%',"")?101YR%][W9%_5?V5@FZ'S=\K'_ MI=CHW]9XYM5@IM]\Y-^UR&)5A0ITEZ]T8$.=WDND0E8T(*N@9DT473:TQ`@2 M0R'0DV-8U$NI1&V0B0'*"5D2TZ:LD38LUDS4A&R.'>6=SS(:1R":$.<]67FU M)F;84%K2BR84A5)$6UK*VW>VB"I<%0YB(?JD(H+0B2E\E4!P(1!FG6EP!GW! M@L$Y512-A)^DXDL0D$?2R5!-2]=%27("B7\V(?HH1@X&BC^H%`H@AV3P00IX M%<<0X?E`(1(J%0$YVW;RB:.X9(>&")R`Y^$44XB>**H]'(JN:*CM"$VR*(S& MJ(S.*(W6J(W>*([FJ([NZ-;\VD]QJ$:5; M6H3"7>FHJ<1\+`:('H2)31,X5B=N/BA[O$"=Q MP`'+Q84P@A`U8I.Q]92T.!6<#I9/VDD[KE;1+1&=%*$SB@PLX< M5K9%1E&9E1%G`@+37CA!-G2L46`@N/H50F4K^T&(("E7:-G2=7C&OSY%^6@@ M!@:;I'DA$JZ`5Z5`@2K&>OYG$A)5K:I`@>)`@KYL7]V?!HZHZ^%I7_E)1ZQG MUFFMU'XMV(:MV(XMV9:MV9ZMCO*(VJXMV[:MV[YM4-P%W,XMW<*MW-8MWN:M MWL[MW>ZMW_ZMV_8MX.ZMX`ZNW8J%X28NX:(MXS:NXSXNY$8N6P'%0[RH;/`G MO:C_26$8P[#ZQ[(!QY64J=6J"U!QU0H`RD`X:I4DC>2N:&APB9]:1+%B[5T@ MR&SA%XGZ&V]L!I`^Q5$(AIFUAC(O6*"^N#\B52/2F M"_`@!.?RQI<&!V20Z$%0#/,R25).+[#4IOE4[PPY!?,:F"9V4E2@S2AP+]V\ MKUO);];0[]Z\+M5<[;+N$/WM',LMRH^D8OED4]*B#.46!?:\@)#48Y/XP`'O M'#KB`*7R+A$%'L^A#R.D#H3T+)=HQ5^D*;_U7%*N"6,L;SI>S575R.?.CY#$ MKB0"H;,!A;!1;A*B7V^D9^<"S'BD\`UCJ,ZHJ!A6A!%*_\Q5ZSY,$$VS<72 M%,@'D:G_"=,H:$,/EHR^;5OUB@5R:L0RYXRP)@1ZX0"%?%J-[%Z[ZP:PS:[!;O MF)3PK<+R2=S)"5N$0XQ8D_3*K3(O]FC&2?=("9\&@H`7(7NT2"?82*MOX;GT M^B;$-*LR"7/J35\-'A48O^)2&5%'G0KA2D2F]=`@5/<$\9*; M5".T?]P#(Y0?/%0U]8R.4@/J/_!I5,/"5&/*$B-A6%%;@Y`8K[TU+*UU;]QI M3X"UNB9(Q37%'*E8^?EN5H!"'+!LRL-)., M:I2VQ5&ZT52Y26@3$@DO@@V%8%'#+LK5Y374,]#(9F*"P MDJ;VBC\(W353]G.WX?54$2#,X+MX<;U4'7L8GEC(1D673)B::-2!R$L(735/ MMSP[1R]W=WFWA]2YM[[9Q.\=!#$HQC)L+8#L]S%M+8ID+.^D]WFX\R\AN-)= M-V?JQGQGB@Q=]R%D:E@@($^0-V-?!'?K["PYFWA+1+M:>&_D!3H)!6GS1;$5 MQF&4!IQ+#.0YQ22P M&AC&VD/@:2"*-%X.]^=5IPN;"W&#EP4EO'F]&`,\"5SC^X])BL0Z:8\C@G1WVUGDG-HJ8%V+Q!5!' MT.M%"#JZ$#I&#+BWX0L9YB/I.T#"Q%""0:*5NZ8^2B(%K$42EQDD_^"=% MJ,FE;,=599NC.-5FO,"/9%04%?N%,,ZFJH!7H<`+``*4+$J5I*O/]42L=Z%+ MJHFPW/%@G,GI$EHZ44929;B\=%A5M/\K\[B>E)QE<\M)%4#(EU_*,L",\/WU M78R"--3IO.3[H=`R561$0Y8,//A6=@B?>L_/O,M%P[-K>(P"Q>9B>2O%+N/' M7,B&!EI=23#&UK8[]KJ.7U31PEOY,2''AIP@6F*OQ/O[4X"2J\2)R=?%SF;$ MQ&,**!F8N:&K7-`RNN5$%6]-*-XPH9`-O.0-^UD'6^@[7@AYUD5?-LL[4SA% M!0(@_@U\*AC2OEC]HIP?YF0]F//,'>L%UWM$JLZ/RSKUUVO]GICZ26RSXY5. M1]WC0NN3$T??;]S#A92]FU91^_&U^C&]CH#]G"O$L57?5HB*JT,%X0^Z!%6@ MNBQ'TN-2SCK_9-D\3=[KMMAD*][,K)Q\F4ZH?(6P^P$^?%G790HVC,7/YEW0 M<4:@$NWVQ@RN_L\_!6J/PC0X\[KOG_`X$%0 M&'ZSQV/)I@T[=!2_!*JGS%0H_XCH7KN-B+KEL^T;?^[G,'<'9TYDC(BK"_@C MOYYLN.=[!/%[_I3."#&?O][`\5IEGDM&T!D9L29]Z/DH$$#X@W-CVS]_E%#@ M*/CO'[%##"'ZBW,+8D6+%NVAT!CK8D>/'S]*I)A1(PH5"T%"A%>28TJ7+SOZ ML]22H<2"`@GV8[*1X3TX&AO]6U8R*$R5+(V^7/;PGT^@$)VB"'HP_\8_DE)K M[D31\FI1H5Z3KN19T:;!@=)0I$!I$*'"FC^K)OTG=JM_GW]___\!#%#``0DLT,`#$4Q0P053>LS!!R&,4,()*8S0J`HQS%!#%"[< MT,,/0>S1QY=@ M#+)%F(1\T<4BD?SPR"29?&S))ITD$DH'GYS2R!^QS%+++;GLTLLOP0Q3S#') M+-/,,]%,4\TUV6S3S3?AC%/..>FLT\X[\W4TT]!#57444DMU=1344U5U559 =;=755V&-5=99::W5UEMQS57777GMU==?;PT(`#L_ ` end GRAPHIC 10 inb004a.gif begin 644 inb004a.gif M1TE&.#EA"P,N`O<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J%>A/$XJW<,7\\T<)18QM_XC!A8OC'I.] M*%;@_>?W+0Y_@-H"1H'C(+&[`_4"[OMW[PIM;BT/'JAX;XI8R+9IKUYLNOKW6-37RI]/UMYS MO=W]J1I8+);?S_=P@9IJ_G""EWVGV5?;,K>A5IMWW0G4WW_^":@8@0;^P^!= MA:E6D%YR,7C:/PCB12%P$>K52&D>YL680'H]B.)Q`C%(FEL/ZH5>:3+2%:%" M]JFP#7Z@Z4<0=BAXJ&)OE/SH8G[[#;3A-AT>"<>-(RJ&FY$NAOC<7)3<**1` M0>(U994D?LE6DS1JV*!B#R*(69)S&4B7F-#1I^>>5_DE9#.@O,;E0">NU^*, MA`KH)FX,RIAF@P05.F!!4[HY8FYR%>IG>'6U:!]D2\:86VVB#F0?I#5"VNA` MS-@1(3Y\O/]HZF@,^248H()&B9IY)!YJT*F\XMJA"96TSVM1U';'0_G@A M,\6SJX()[K]C$MPR MM)>6O)F-H2W,Q&5N-4+OFC>GJ_3227F\C<*PP"MI9RE.C.];(]]CB*3Q!IS9 MCY4BR:N+O^&\C;V;B>WBBG#\Z!I?A&X-L+=8M\GO-$PT5PW$6G/_?="Z3Z.0 M0M3>7EJKW!8'/CBQ88-,$(-OF=PE6S/OQ2OD5EN[,G`-;BI0WW.G6G=!?LXI M^,!P2<[TZJSW!+B+,!A">N@#'NVBZA1S'#%>SXKL=9*V;U[:V"`J-J*UV2(M MU]N'/@QN,[RC:J/N[.H;"SY#/A_]V`8Y#;OLJ=[+$/23[_[]X\(-/_M;E_;N M[&W&(UO9MIZ'[2[/@Y'?^Z*ZVRIN\-!ZB_A:1\`"SL1[+YN=O(J&OM.XYBXV MTM*11*.FKG&&@>B#3,%B9C/<;$IA-&(8G0SBO-KX9EL1=$NPSL:85+C(A!0T M7/>&M@WR\6A6(T.(;T9DP[K(2&,9.*<1[7/2.%+&'$#W:S$/D2Z2W M(.-&,IG'+^9Q7^4(I$(279()'F1"SH3C1LTY$HV+2I/0B+;&:MCCD]S+HBQG M^9$RF8L87:3='/]QM$]=:T&0TE%U,L0L]'AQA$>;$BJ'HYHRIFE,FO/1I(I0OE4IB&?&1YBWNY:N!$FMU0@+H'0RY\DRB$M)TK1 MB3AG6RHKS1\+XYGC<#1?J9LG*[\94HU*JS)P&1P%43#`BU:'@C<*:7IX-9O6 MP$4[?W0-3B,GTCD)9AEW<L"W.5VZXV]=22,)%<:X];T@2]= MC!A$@SN-?HEJL`@.K1IW.G.1-K.H7-*)L..V/P[J3#N;5#B)5,0UX4G"&8*P M'9&VSR;.C<$THC"7L(.EP2R83:/Z%4NOQ:$([]%)$P)8@##,8BJYV,*A&5., M`:2H%]-HQQ4R5)VBMZ/@7).!$W:PKH`\XSOE>+<+;MLTE0B^XW8X.O(*TY-3 M_,(W>E!V&DLCB!]I34!6YTJA:>Z!*1M',JUH_Z!I0H^PPJ.K2J%M4@29,Y?( M]8_X['*2UQ)?FWNU3%]&+%##^AP3E'7F(!JZR[,[C9TK"*P9+G##DS8-C6M_=JBKCH,/4[PHU/Q"-)T5&,)%4RM/A18.-2'37K M,).96\823C2CE.LU9[;3S@P@)%$&OSH+>V<"`V2[FHTT1T4[5>.T([+_J.@1 M?HS:G'-4LM'DZ_H].X@^8[4:C8:Z;!_JAI:VV\:L9L%U!^]B`LG8J8MV[VF' M+%*Z]&%"QKVSXHTB3YT&I+_@_<9=>]D?!R^S5;FM;`M6Z91&-C9G[XRO>UD1 M>E!S-G'O1S4:@5QPA/\3W<1*#N@.HF^`;O*XX_BEN)2[B:>I:B<2RTU#XH56 MS/ENXS[$NO/]7^TUNQ5Y/LJ10ZKNG]8EO]OM'BEV>\5IS//V`.ZD:Y_,>MB# M.O#T?C[.VXVC`R3\_0R>)[,7!/)]Q[S$P\QZBC[_ M\W%-SA/*K_-4W%VCJ-%E5-LPXZ8_2."Y)7W5S!KZ5:1@2V<.:=I;/ONJ1'P> M\A^P4`VE40CRYG+`QV;\]P_8\V>/%DD*TG+YM$ML)(&R\DK_$E,>PD:5DD_' MQ2L/2$41.!@3Z$D;F'R/!C%VI2TU1E"$<49\%']"-A?5T$:R9TDIJ&A.@G%! MM'2M1'-')7H=>(,8F$OX!$M+Y6BR9GFX1Q",Y(/-I(2SES2]!BXM"($KYQ9U M="\:J&A_M8"-E4[C1!XH5BZP<7QIM488=#3QE";VE!]M"!K*-(,3!U!EZ!X_ M\H80=4\>)4IGUF"U,2T!)2B&Y$X'E7EXEDR&N&%]_R@T\F)0"E5O-7@TW60] M[3>'?9:&5`>'_R1OT72&]X=_ZE10V707CQABLN)_Q)-'KH8_8.(D0"-)W!*' M"2B&CE53M`9V\:-4SG$\XZ52LL?J<89N5XQL@=R#A6NU6,638ZV`A5)25@$2)=PB@D0)4];R%>W.@6&$4L M)G48$,L0(5VYE24!43+QE0I!EC`AEB!A MED>AEI1RE%CYEA-$&6L8`YBA<[K1%G0)!\;T%]LB&6_6&#J2"B9X5G9P3@AFH6Y1V&`9N:5)[QI M0FJ%&9_A3:!1&"/BE]AQ&)6)&4*B48#9F%"DE'!YG;/23)!B'S>P"5)@1PPR M@*#_Y)UC8I28M$>"D2R8-&-P&)[IR>.:8?\J,(VJ<0M0Q[_SH[]T*G=MH7@:.=W-86UFH081.M#3*M^%BNC[(O MZJIK?O$"_I$WTM`@N1J>V"&IL3JKS=ERP'&DK=J3YWF>P*&EM=8L<`"8WT2H M^"@8$,.D=`@@^^FJJ?25=+%=$A6G)(0J4AH9AC.MY>F$>7&<%U6ZJR_0HT%GNG!#&M#J1I*O]+0OE1LA"K(2B;I1ZKCRW[(/D:KFDB!A`K MID\&3B7K1[=YCB$:L-@Y+5T)"X#@B4(I#9F4`J\@(/64K_2R##_EM/SI!RC` M"']@(($JE'/""%7K3U=KM`Y[&Z.@#6C;'2<((]W1'[AT#\@8`],`9GD+58'+ MLVZ%?5K;8]CDAUT+FD>CMF[!MH2+MZ#1'Q_"2I#KMBN`M7$*(A$WI86K)(/+ MED,6J(L;`_1"H&M;M6JYLY0;&6M5ME5;M"O+.X,#B&;I%_R9"K#KMBJ@N8>; MN%XI45#;DWWJ(DL:G3@R'*`2G22G5K$I!B*B#:DP3(*)X]"ML2 MH<)!(1DMF1:E.,,^_,-`',1"/,1$7,1&?,1(G,1*O,1,W,1._,10',52/,54 M7,56?,6'=0]4L!VC@9H806$[ZQ#X`0N;`)98?,:CM0S(VRSP8A'(:;*FPL$7 M1+)NB<9VS%E:240J%UZ(= MG\$@)Z4;?IDJD!Q6`$O(FBQ9N&LP%68I3F=CE*&O\]IBE$&HW4$-@6)_GV$/ MB'K*)VO&FSS+8\BQ;$PQL[H>I#RK*83*4[:K-M8(O5PO&T;+QOQ84ED^7&(C MN7Q/![K+'3K,?:PBMP6]\#.;N7K,VAQ\MBPSN-RAN,NOUL/+U^S+S%(<'>HM MUX'-Q;S-[FQ84+E09M)'MS&K"F)H$`MAGVG.+F*VG715](DRP2O+[US0>I4< M;1=*@'$=P6$#]U,86O`77I("WVG-I/0%D);W2@'4/[*H3_E#&+#W3-/]=TS9]TSB=TSJ]TSS=TS[]TT`=U(F% M.9:#'7(L$QX<$C",TI\3PT+]U&/91$[]2NDW$U>%:AWA.8=4IE#=U2Q!/DM= M1&UQU"ZQP:%!UC_IU`L1UE[=UBS!UJ'1J:C2%HR@EW@#+H5A;90@U\[9+.^Q M1W*=>ZRE"8$]'"O@F'U'G(7]6Z\%+N.+PVX=V5FMUD'C5OBX8OZ0!YU)()H] MUFHDL8)1BOX0!W18P*>3PGA!#9K`2:UL3'QZ"="1V9L]CJA]UAI"'IV]VK:M MQDPMV;ZM$7#MV6SMV41ML'!S001"VH01PSULU+8=UIXMW&I-L%=SE[H=UCT< MUL5-(AI$V;___=T>$=S7K=;$771_%=W*O=0D[%?/[=31/=[/VY9+)=5FTMUF M4G3V#=[Z/=EI`]^K,:0FI+H!/D')G9S,35:Z+=TOQ4GT/7&'L@P#KN`:DM\0 MSA:JF]_[G>$8(=X-_MRN=C33`D#H;>"$\J4\`IQI'(^$#"X@A MGIP(RJ4:?N,1L57,,CC,@5WB:AZ5-ASIR&PF_A?+B7*5262!,CA)[H"AH!L3 MMTU,?M%P%>2/@JTXGN5:ON5_N5@'N9B/N9D7N9F?N9HGN8!^Y+:$+LD M,=H$W910CAH=K>9V[I*:0*;6.7!H+7]21A&(<:DP$B)[?N>&WAO*_ST7;B[& M?2Y_B2X1C)07#>X/_WGHENX0;2%#>:FI M3A#MTQ0BW][J!U'AK$[LVX[F@<[IL8#M@0[N"=[J]EZUSP[#Z+[;$<[NOV+B M3@W7\?[J'ER*,PX<\SJ/&L*[\V9N MC4`?]$(_]$1?]$9_]$B?]$J_]$S/'C[_]%`?]5(_]4`RYXKAO0H9*5FO%:Y=Z>7>)C=_ M%71?(W9?'7@O\]"-]W)_S*7X[O1^)(^^%8>/CQV8Z(A?^,<\[O;>ZGN_]UI! M^<.>^,+^WY)OS++=^=E^^8N?%:%?^8]?+YO_^;.\+)%/^G'^%*[O^)P?^:Q/ MR"W8U"9"WHN/^5>1^\N]^[*1Z&%M\+>/QE]H:\2@[IS1^Z5O%+_*;]8D?WYA3#"I+$4A"\Z$\3T8;^+FV[A^)HT)OWF*S0R-"JBJPB*4VEZM$>2Z!C M39H-FU;M6K9MW;Z%&U>N6Y5B#J)-JHELPHPB-R&=Z[&OP\$/.P8FMM=G8I., M`S^&'%GR9,J5+?NT!S8A,10H8FCDK"+5-J6,EMI%.+0S#G]_O4HEJ!3%_PIM ME&`/C0$*A>BN(N/`LHVZ-*48VN#`+BC[J%6L'&,?GZW1*@H<#VWO[LWQ%1,4 M=B%&9]Y5)7+?P+L;G%Y=I"9&<#YS]FQQ6>?B'56:/E]P^FJ$\#\;]&^;^>+C M"):EEF."*^?^&;`^I-(#<+?1,&)"L0T22 M@S1-CK+G/X3Z:BV6!9?!RBN)4/K'F&E.]"?%C6S#*C,9EVJNHP\UPI&9(8]2 M2J(C1I3JE2`A6E!96R*U?J-NV5V6.I[*NO5Q-:L-,F:R4H6%I] M\_5&(SOC+]5)QR6W7'//E2S+A88":[I6.>7U15YC7.8_9/4CT1Y&!NK276I7 M?9=!>W_%%BUZ_\-54V`1CM>P/(6S=:]Z/_WUV6059M8@=KOUBV,8J90UH8TQ MJD(\*COFUF#7KHV108PIS`]=F6>FN6:;0X)(8;,@8NVP@H9JY-I.]9OW+WM` MO+8@8FX8=NEM?V;*2X[_KXV38K*6'C:YOR;&B->0_0%$8(N&?I:E96#`H[>J MG5W52?7`SICGLE$6.M[I7+2NYQ*W?.CDEO_!&LF5J6SYZ[`UCOIFQ1=GO'%( MYT/M'BX6)@W3$QD,&MJ&/>V8YZZS`II"3B]?9J^Z_CG::I'@J*Y3/A_Z*]7P M7N^7B3T3%*^C:;UZ6:76YX7#KM1%%Y1CL>=NN>Y/HUQHX@4!MU>5I/]^7>NI M7:.]1-(M=+Q[[[\'?RW5XDO.MA2D.`J?4/CC+`7S$:9J/9CF<[*Y+(6UB+U M^3OI.K#@XQ1W0(008V2%,T$"%UA4HZGQ:296].E-E_@B0"3Y#S`+5%IG;F0^ M__01A#.YB4[[WJ>;BFRP`[CX'%`C!8P0B#ZH&Q!A\!_[6Q;QPK=# M'O;0AXQ[GH;\\;2D^"PH0T3/Y'ZX1"8VT8E/C$D0,X27(@(F*'H"$/>@N$4N M=M&+0'Q3ACA3I[R0YXC7,>$7U;A&-K;1C6^$8QSE.$X/7(9 M8.EE1,*"2VT$4.R&IG2:)D69J`"F$3JF"V^%_2Q/),B[ MN$JD2XV-D?*4%CW/?2RXG\O>1.*57M;U=*B84Q2PFFM$Z/;7B_:0Y"BFT5NY M)`^EJ/NN-8,"8&$-6)96;1A6^>O1I23NOJCKC*8^:,#9\$$JL#C.P#I3H_J! MYL-$JLVR;.C9#")HA3=<7PYQ2,9[E-2_-^YBKL(+E`%I9CP@ZO&#?:)C#"5M M/RRI_[%@M[B[FL03QT]^(B*[*.4+,;D_.W:B:J_Y5RAWV62(@(?E)8XDJS?),ULB^>>/N+G( M@;ISHL,W%.VBYRI*9@@5:2+I5N(YEC>A=%Q(=2B98#$U?,XDJ!4B&U$KVM3C M,H8T\DHT2"_$R=?\[*L?@UV:R/HMUD49K*^<$UN;Q+FG!O;,)(A!_>AN@E.`G MN2'H'.J-^T?ICFL.G^VPU<$[@]U6Z+FE_9W;Y9#%=,LWL_\;JNVL)/F!W38? M*:T=,YA59][]@:`_'3JATEP[V!>76>GNY5(G*2B6U;);4+?14N4HFRLMTD:9 MV/2FX;4TOSWJBLM_6M2E($WE1;E=T+Y$0A;)]':F8=+*;MZWF"Z/I70E5,G+ M.=,*S;SDX4'YT#G7N9V_7*B+*JK/9&XD^RE]@#O5B\O[<[M"W&E+0X7Y>EBT M:HRWO9"\D46NG^`I< M^VZ.W:Y1*XMQY7?<8HM9T2*K6QD/\KZ#BXR8-9KF*:0PP1_^WV4EBWKQZ7G9 M#FVD@E>]VV7_J/U$AZ,,H[N,T%K_<.X$C&V5/05C'RO2SOY;L@0SO9&.Q MK2=@T6)^>B&_3/4:&KV#`[S!8S6P@''^LL>-Q?$WJZGBXS9IXA_\8-S<>N9C MN%V]-[WK9S]_#$E0):G%/;?LGAJB3&_OP">NRYL7PUJNY%L;GCJ_`"0VC4DN MQHL6`I.^;`E`R?.:`+P^C^&5!?R9!OR]KCF%"20\ZSE`Y3*A`A2II!D>!'PL M!B&NUNLMN3&BT(D]^J/!RU@I`*$QN0H/=J.2T!B;[?&_]Z*(::B0XA%`UQQ+BLL/)VR'#>A MQ/48L6TX(`\#I0R#.%$DGQ7;,&8SQ0^S#1%;H>F0*4=4`>.@CA5+OOFQ146, M,?6X1/U@OE$QWB4QWFDQWJTQWO$QWS41W@, M-/F3K^R8L+FX/X\R/&HI2%C9QX2$1YQJ"(:TCDWB)'5\B4QK"/^*5,B+[$9_ MG+HXG(M>VPF/5`B0Q,B1#*T""8Z\8P3B((V$(T4$*9)SZXP!JK;K<*U:V8[S M^`ZL"(_^(8\"(2A'RZ'A`"'R>39VBS:+BQ]_BY!J#)`&T8:ZNZE'2F6DQ-AHA.^P$ME$AU#N;0D69)8(+F/&SJTVZ6M=,Q`LIB, M03U@22G+F[O56XW+E!KGHTR1`*D0',C(5"L$;!ML42]I6;7]8['GT1;3])N! M2#R\>\S9A$R`R1CT2QF2*)S\+!P^D&DT M]RN1Z",<:Q).W51.Z@R_ERD_VM3./$*>DTE!L`H!ZW)!2$L2J"E.2P\X2&Q+N08YRE-QP*\&VP>/^+HO.#30%YVC[R`/`(JWTLH1#JN1!D(*&]+1A'@X@WC+B>`.*QD/ M,Y)$#?J.:&2A1E0!4Y!%`JFPC=H(A>H@4K2]&;*]@H"A#,**#7,A&[K$ZH'1 M,16M@+0,)`*)_VS,"33%""4BTS>5,S5-%RR3TYLH1Y&$TSSMKY(3(Z4L(XCD M"1E-(STEU$(UU$-%U$15U$5EU$9UU$>%U$CU'A5B.YD8M(/DL66ZIZK8LY\8 M2)O02$_%5$E]+?Y9QD4RU>\YLV>I1@HY"G=\E'+,B7$,"UE-CJ?00)K82!%C;6K>ZR]CD@`.7O+N@-+;\#+CR.,EX>QN&;42BI(^GA$E@ZM@,>JAQ M!5:\";-MO)D3!`3A1"VET"@+:[]&L=6P?#D?03MCXIRDXTO0^#FNHQC8@+KB MD+J1LI/I6B&GB\H@^2Z0\;CEP#K!I"FG5;H:24SW65K+@Y&Z[#B`S!8PB8XQ MJ:O0E4"D0?G5:9*8P"FLJ4;02*>*HGH5I(L=7)%#QE M13`D*4W,`QU["13*\D#*2SY60T'1L]S"N$SG:-S,$Q4''$!_M4\UW#W,W,7\ M6RNQ=,]DH3ST*DT*I5S2QM-UOU> MSBS.DR#!LKP1R+M>U4H,J+?WZ5%X"3]B30 M`@Y!NGDL#4Q0T^,\$.2IZO5.#H3>K-#>7,,P3B&P!5:OY#S=^4I=PZG@NY#@ MTKRMZ9E/Y'$-#5Y!J/E?^74(%TT-:&UA1[$RT,W`.RD:@.HN#@E.+%S0:-F> M-R0+-<2^*K275/CA^?J_KCE#([0\3YF>*2S=UVN8!VV.V`EB,1PB#`U?#A[? M'@0/#K5B\9!B41&>_T]$P]LD46=9F216'2!V0Q?N"3;#B[^AXQG>D-]T5N4S ME<=]8D=1(7#)Q"R]Q&'LQ1!Z4EKDBF-L,9C*Q>.(1%6$*-XKH:CYQ4:N.5W\ MO$)T*&H(1J*S/486H5FLQ!;:#2=U'U+FMD2$FOSH44]Z,1G5C"-EBB2M4BS= MT"P=Y?@P9#F>U1+BBB#CMIC,VW*175_Q-[F&YWB69V$- MY,X`U#4=U9-`-*#@5D#;YX\(M'F^*U4FQ4H%'X?E-H/N$(P:5%'"8Y#8U?\Y M%K5@%>@ZNI:_!)QG;:)[D:SB.A=FK4FUL&9U`E=>$[61KN@V*I:!@!&D_:'] M$^"94:W7J39DRP^A%#>E%-B.\">JC`V6K#>D5#>$L[!XK?RZ4F& M%>3*@9,26MG_\&F)!::DCMB4WJ+C:X3^?>AQP<-*D@V%;A35J@NP"YHP$1+9 M.,M$R6@*`;IXA0HUT4LFL=O;L-$T&9*B8Q;$934\>;I'"Y6P/).1JVOZ,42Y M)K:RU;VVY;D!+F:M!I\$Q:BOGI3QP)AF_6@RRIG1M,WSHSQK\9FY29G:#=]1 MBUQ>T#)9)G7U.'4^U">==T^E&PG2I7!+=[_'W*A-FO.Q\G!1K"^SSX9 M0],^\73.^B3.%;X+Y*@^\T4<]J5B`7E?O;3.SHQNX\DL]&7NVV;FI_;J)F(, M/"2IR/80,J*GX8)/]V0\%ESO7$VO$YYMHVG//M3/U(Z[L2)C^FSM^K9N\<0L MUB%M4)'@[O9N*&(,R64B&#$B8C47A@Z@-$90`GY"\M[BK5EC+W;CT_[>N8D6 M'?Q5RD&>W>/BU[;.YZ$&#]5N+"QC#C_P*$,^+"KG\,D9U"FM8HCF0HK2B6UE MX;"@>R,G2;;2+GU$#IH*+\4.44YD,I:*#J+&_WAECVWRHQ"A3(9DF+$2&D7R M)O4[;[ME4]9)4'QR\WYQ_\5)IKSSTQ^:CK;DCH8&(FXN\SCOQCJ5\SJ?O7.V M\SS7\SWG\S[W\S\']$"/LT_UB8#65:N,'\LF])(P=$$?TU#2$L#X#K)N%$;C M"8J>"9A;0$TG,!JV[(K\=$?/IF"2B&2ZZ-^.E%2C]))`Z9`8FGX6HU!W-5D7 M=4Q"5\=XGI7.<4<9MDZ_-Q?QC^E*R<^XIZI&Z(6[T)(='U3M#!NP#ZS6L'P* MJ(#=6!F)V:0\*':#=H&3CW5CCX3;R85CC9.=27A[-H8B\UJWJXYB3=3ZZ,QY M&::3"*:;6+3^!\;&6K[>3,1]=2>8KJ_L.?T&[+-]:ZL`.IABD;Z<]VS?2[X^ M6O^+2,SHL+O`UEK2B-N`OW=H$3EU5[.^?>(%-F:X:[Z-9%#0]KRXL17.[6[B M95#-Q>_-/$W'@\KL4^U&XL'LD\VX6>(RW+W17,X`4F>.[R]Q>9[O\9GQ6?4,L;^"S%4-3,#UYN`1M-W4X,"6_QPPO"[Y9MY(WXBM MMQON6"JOC_H+UGDAG&*[*^&?;VZV3_L^PC6C:O4SW5W`.2@+IQ7//WL.%=\6 MM^\6]_OJM7JOR?`5]'S%OZ[-IQ;#;T/\"ON+EOB=OQ/_T=]@C8_CRO>RORFL MH"\RJ1I$4(ZJ$?,P3A1R)`_S%QMS6);)-D>R-B?F,;=E*E]R*^6*T$#E$:KG MO3C%#Z/$841RIA@05J[RW=#D942-Y_\@3TY5W[\Q84[TY+9'-G5P^==_T+I3 MRM___P>(?P('$BQH\"#"A`H7,FSH,*$_2B@F-GIH\2+&C!HW;'+91,A4EXG^=\]057M[._J[M.U>$\0955NVJ;LEPFB-G7MSSPN'?P7OT!PB\=?+$ M;F]\:YGC^HM7V:=TCS0^2_SS$8J%/I#Z2?A9I9EAFXQ7$#.H-.>/*@H)6)UH MP7'4F54&DM>0/8P0>"%(]QP(57K&Q(696(Q@Y=\_Q(0V(B4FHH!BBBL>%I&+ M*/:UV$$J/G8='"AP%Z,*J6P#VHXQKB"D89K1>&)!CJ'UCU@^%G85(Y249B22 M1(H6Y?^/.D(V7T1%0JF9BD=&IF*0/!)GU@J1]<48E!*AD-V`L2SY(D)>LB@E M?`KU)D)Y::D-@F`OZR:156*F@38_$*?9";/]H>9TF@?[W8UY\0KDH MGI.MR42;IIW%&)567CIC'*^>8[J*)Y2R#LJA58!0".V$6%TY%9$HM'D5<:+&8D^I[L%F)U:29D<, M=&:9F`(LY7ZKVUTI_CH0NJ9J"-@RV4GGCQS;4*.)5_NZUFBW[MI#IZ!PC8EO M99.5&AUJK<7UKU>8Y7MFNDQP!?`_Q2#&;2P"Q[5OOPN;IK#_/WE@6M%^RSS< M';L&(RQ0O<):O*W!.$L)[H@J[Y=BQHU0#++)+F.Z\\N?LCR60,5(H1S%,'][ M[<5L:6:TMSS'Z=5?4/H,L,,3UEUE M+%SCFE;I/UV+6ZE89J-MX=H_0ROBM-1V)%Y5(8ZH),?VU0EEY`I+CAQA^]EG MGSW7GFQ9YRP&S`2*/YL%X^2:*TP0YUOJ1?E>IR_G5>A;?[ZK_,%+?.V)F]+"WG%T!-D MM$'7-R^^I6\W:*E6W(=?<>:00YLWZ;F:SS+']>,X?E9^U)GM06D4 M[R&1_)J%K_91RS<;4IQ'"#B::]$O>XWA4_;N484#&BA[+9N7:38(K"UIPD:O M@EWOF%4AM:$O.@I+SU7FUS_6G1"%EB)AND38*&V]1X&S,B&S,!,\U`5K=2NT M8'1T*!`8EA"%]LG>,E"GP0..S4),E"'RC"BHV&2(,'^I8/^0^(^S?>>*3ES= M87@31;F$,8P=)%"]Z+=&A'3-4NQJD!E_-L>#I*=)GDHC7A2#-CC.SXJHX]!D MM$(?"%IDBA/D(`NS."(XX(!$XM/;$='7%\_M#3%:,]P%-[87":WPC#WD'*[& M-D,_\H]VJ?]$'M^ZTPABS(M^H22(A(3X0E2=IX@]3)L8.XE+>*E2DJ9,'W+. M@TE9^O!@SVNE\@AU`P,2XP8-`N/[HADG&*G&F2A$8C4-N$1>VO!GP`2?#R5H MGEK1"T_>K%[_U'F>\5&0$I7:D.G',D)P<0Q4B/WX$+C*$@X M\=D-G9(CQI94`4SQK7`+[+#22#F:*(1J2ESS2I,8754YH1 MM8IJLR=21SK&K9B*90O-9O*>(RB$%C6JEU.JH'C:-7.ZT4Z:N9[_A91:QX&L M-2+S@^H3^Z?6XO1QB5_:D%M'>!TEG75+:17KASQ#T()BQ&-3221W=*HB=DGD M2Y%ZFJU\!(L>D7`B;2H3'R1+V:-E936)--99Z(2/4/Q/19`9[?_:69G%3E9, MLZ)J7\Y%$8*@EE8Q$DUL+?/9;;#66F?2%C5(2ZO:PHE(A5B=8U#D)$YA5K.N M[8YE1W:6A[&VL;R5K'6GJL+=WA84/)P5=;'[W`*.2)QH0M:.JCM>)Y6F+^%E MK&M%A,N)^$='PDGOG(:T(IKQ*;G+F:U'P_I=_D:(OO_U5)Q\!%FV?NRQRNE5 MC)3C7T8.EK!E.0M5+(5L_A"`&HQ MC&.,DR@!6,8VOO%35`1"'/.XQS[^,9"#+.0A$[G(1CXRDI.LY"4SN^42.^^+H-;_G"MM65BAM2X?:6+$6;9J0]&.--0AT[*&1D2Z88%:,B MW0F(_WO6[ZI=/O_[)V/?^9L07AH`0Q1,/#-M2.+:[2_T3'EVVZ,)ZF-^<(FI;GK=7RVYU6/3:M\* M)`9M?KM`T_-Y_BF>+RV%NNK)"I#S19M3C:?&UU=05K0G9-\)Y_2*&8CW?7E] MY[,_QL^WFX39+#'IO6_ZI>3U/QU](B4MZ?9-1D:>%25!)=-4?3Y&?Z ME:3[X`GT/Z],V'L$G_L17ZC=7Y_XTS?)2HH8(#)!R3S!7M_EWS^)%#!)'^:E MC?O]AZ%I'P=NWP$12-GQTTE]6.&-2/&-8%)HE6EP%4/=E4@]DJ5U!Q55:U([)/`5[H1=\.9:"$0=K M;58B`=B$$8JV9!:[;!8-3425O&%D75:-$81\]8D?+E8L&!=R&1A?A):;8!CN M341S3)A]Z=1`#.*G^&%WP9Q`6*)VH8XAH@FD8"*$H8DI2(EBX5>;3!AQ>:$7 M&@Z60=>O:!R)F9-$O(PLFAB'K2`K[B(O"@4:/H2O@=@O&D0PAABI%6,O)J,R MRH0$.02IK5@S]AKV@1B-;>`R7B,VOH0]3./X<",)'A+O9:,XCB,YEJ,YGB,Z MIJ,ZKB,[MJ,[7@:\X?_`I,7+3)!A0F#;K-C`G)7%K+VC/Q;4&CD&8X2CA461 M0.[0GGFC4?`.*1U:I7&&H_$-HCU:0P"5<73A/V;D2Q#009E*?2DDAVS/.M&C MJ#'&,S*%V[#.1_%$KCU$\KR:2_8C2""C1M9D3"2;0%!#^Y4&34(+3N+#F1B3 MQ*28&F):OCW.4VE*IRB*4JI6PY&;3P'<)4:B_6C@8LQ(N9A;"BP+G(2))MJA MF)3)4\X)DCQ+KS#U4C+F;D'H[U4,<#"R;5,8-+<30VEUOU<143-9!;;6F[_ MYDF\VAB.G>)(SF0,)*J(76`1Q:E-"5;0RN2)4>D%T^8M7O4!GEN*#@#*(,H@ M"E8TPMR5H*[Y%(QLWMR9CN]PIG$:A^=4U/@AV[7(3MA]W^EMX*?EW@MJ41ZU M4`IQ$W42I!F-U!,IH+`$6O!M6W-<7W8*7^H)&$@>)WLZQ##^`R>V)02])P%- M''22GY58ADA*8,!AYSL5DU3=TOSIWR'VWQC]GW>B3/'E@32LP"F0TWA:!7]J M(.[Q)CFU94.VIX9JQ##:U.QHV'OB9`@NIU(H1FEL3Q/6'O7`%H$8EIH*JS<#8UU(=(1,@3!-RX8NJ5!+*54IA_^2&'NEM-H9_\(8]@@?U MR(JHE0YH)H572@F70-9YQ>%SN==OM>%[K&*"I0"6[HPB[F&Z99PCEHG0;<6- ME.ER%<>5$@>8@FD=FM8V@"F2YJE#Z)%6/,PMQF5%$`EWC";KP*6>'BJBRL1[ M]IJ14L6B.DBC)JJD3FI'1*,TAIBE.LAZ4BJG=BJ'IAI!$M8V-D2H>JJIGBJJ MIJJJKBJKMJJKONI38-E:_41=,`4^WD3BT*-,U"JL3FIG1`DGJ6&&,8Y/3%I3 M2`Q%T@31&&NO-BM*,`X0[MBQP@$W1>I*]&12P*1-T`^V.JNW?D07`<;U3.E2 MH)Y<[,J4@$HE]4CEF9L*R?\;J*`(6O)7D1@*HJ`KH$A;"G$/=K%+'+06$*%* MBTB;6#8BP+G;5*IFE5Q+M^'KIV@*6EY:R)"*"1ZBC&1.O*90:CFEP9;FMT'B MQ&[+AB3+PI&E77YK.IJ'Q=!E5.#EY&"-NP!5YVA#+6[#LUEFUH1+Q)0,U"'= M(/GET0#F`>4<8[969=PLW8CK0GNZ[1E\;RFXK[9=UY@YL!= M7+S_9VSVK5G`^R;J!9D'EJ(/)9 M%;[@T#$!2ZHIU>&BYX<680V%:O#@+N16W'6N7\'I;<6:$_S%5:#NV.S&KFDR M:5H9[R'-+NGRA)-8JX?-X6RMX6%10K7^)S3YG?HUX$CZ)U4-*`5:"/GF[C@E MD\DUZ.NVG@/"[U0]K_SF9>;^'^0JVONZYOHJ;]^5E>R>1;#>T@#.4#CQ4UHI M6@;>4O:^8^)T*U*H8$=VE?.:C&)2ZQCIQI`F59'>4/TFGP:WJ-N%546,58[& M`,U"A]:$\.T`Z8S>9DEM<*\1%8L>U>:,,!#RT$117PV:_^T]CK`,JW`I#15, M;>$(3[`[2EX3;0;X@E>7%MH*T"Q:>"5W2*)XG99P"2PFFI9WAE9O`"&;;$B:JD7IU8="AAL,2*]ZLYJDO&`J5<(_ MX"D7&YHE4F(BZ88J?K$34_!9(1B,->E06#(NCEA'1C(G`QDF!\4GD]@Q,N/52DIF[(KOS(LQ[(LSS(MU[(MWS(NY[(N[S))R.IIXJJ;-<6M MID0HQP2O3L@^\K*G[5>(+5.O),HO)\6@&25.,"OY160T?P2CN80ULY$U5@O3 M4CFMTT*,ULJ-\:`=QM@+QQ@64U^'6$.-*G7+U32UN9CUP`2U11"KQ3T0L8;) MIJ[=REW_S^..C?+V+N?.\-\NGF:+J^#A;^'NILF@^C3C-'6O'YL^4WMU%VVK8]FDWD3D1AG!GT&<[MD5DJH8E3C.> MEZ-BVO%R\-ZRD!@.GR;5T`75;CH1+^'N+D]Q-G8C+[,([PMY=]V,-W7/-CK+ M$>XNS/)I#_;-KA[AKBR&C4'D40(Q[R&BMT9IMW([Q)\V]ZXY4GR\U&%YL/E] M$H":+SHM<`KG+TN=;VW[+^$*5,I(0\,\^(6JK_[>+_]^\%&U)82O-T"Y+]WF MTS[%[_U&\'RMU/OF&<",+2[Y+T"5%8-#4^1^M28#!7 M$2$*4S=APS`9KW!U9BV,5J$2WG"2&R%@[?5000H,@_"59Y`17WF(G_!1T9"3 MM^[):+F(!QR2ZY:"1R'^E+E>@Q0M&A53P91,Z7,S&H=SO$A0S*!_=O+-'(I MIEQSVG&"(9B=ZM2FP_&=ZGJ@(\0KDAB6-?NL4#.A0T4QTRJ10\2(%46U+WM0 M;SM+7KM15'LW]X2W[O,\[O=>[O=\[ON?[ M+OHRG1ES,F>K%LG9;>2J7I!(,.NJOB>\3DRSO86S48P[1N!;ID'$N8W'-C>& MPRN\QL.:^+*:Z$&+/<7O&5=2__S-!;KL56Y>CV/>?/QC^W$.U15,\-Y/4">`%'..T6!O9&KWK_ M4&)8*?I$:,`Y'P9!7P5FH1!;G^EW/N^+69N/D8ZC#'\>L)BX>(8&\4BQ[XLO M?XE3*)SYDP7)?O/9B3VUIE--/W\;/X_W/O?S$;-L,A1).47%()GO:!/#7C#] MJ!%_>9EKSOGW(%8B;\;TN@6F:%\MKP7R-Q,#>O?W_W1D!4#$V/;O'S$4*6!1 M0B'0'YR#4E+$,HC0(4--*#"B:$30'D8Q!/&%PHB#8$F#*_@X+)8\F7)ERY1)U>^G'ESY\^A M1Y<^G7IUZ]>Q9]>^G7OMBQD/QE*]3$Q#W)G)NS7?G7U[]^_A#UZ6T]_%\Y[G MBR8=GW]_____R\^DKD*S!ZC0B+D/P`49;-#!XP1,:RT)T>)I(6TT800.@=2J M$*N%6CHIE98Z/%`H3=CR)XY8&F+DHM(^M/^($4HX9,)#@T`DB*L1_RDQJ'NJ M:$FH%86BQ$6R)%3PP269;-+)Q2(4"HZ/_,ECF_K8VJ]#%`BL\DH4>W1BFWN: M$.\>0X2Z9"`OL?Q1S!,1NB@B>U8(\2.UCJQ3*"O;O$=,,LU$TQ\YKN033()4 M%`].%N6,Q1X"GXQ4TDDIY2O*ESZJ*B.2_!2R3:K`.S#1'IF`4=.:2K+GJD3[ M?+/3H#X]U<,AS2RU)%F!^I36$S=ZM=)?@0V6TBC5VBB]'X-TZ=!CV^IH*5*1 MI`K&H%1MR9]-&.W5U62598M9:L.C,--I$3U4*&QY#5-(8=EMUUW^HB1&3P'] M`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`*:\'A84?C))B>V3!I#M0SK*S>NM(2F1\I-)S,X:8>^?<8AJI2-UXR MR1])YIB;"245E.#4.\$4%E^"M%=`(R+8:@8SD65T:)_\&"Y]YD_Q]`V9+27H M334SQX@&I1A$(TA/^^?_'#ZZ[YXE`6HK?5K1B^1D+.JCFA//-B8;Z4E?&"E$ M+^G&$JS$P">H8LK5UG8BC.AI;2+]AS$\Y9"M@?)V3?'=3G`:U\OH2G];"J"- M`F9-A"9'5W;5U+/L>DNY#I:PBN'F7JKIT!PB5IN%=>QC\5*XO!P..I+%"V4A MFUG-[J5QEC+?*C\;%VANEK2E->UI49M:U:Z6M:W]#=7RRIDQNI:VOF$@\RK( M-N^NC(M[R24[Y:(SO0:AZ9PF*!8'\@$/850@B^J*HBT1KT, M_]%(&RSK($]4@$'N#G@S-TN/#>4F/.@(DJ9@!,2_ZA79LJXXK4YA9)$;>R2H\Q*8Q9AAX+2HR[;0%D>0'6L$6O^%8_)> M-Y?::DDF'6.[FCP23#3%<#@314FUS+C%33:,6;T)8/&.-ZD"*YG MP3Y&:G&/Z4YU4B675#H4&W77(28[F2-T&O.GT"Q0G?"YS8V^"Q1="9E*2O@X@GR5(X&[8^'V^,^D M.DU+"2VECX[YDRUM6=`Q+5OCYO<<]5EN=&=;G6OF]WM=O>[X1UO>1_7-E0%VY'GG>_.W#;7'!,# M[0*&8&D-)YZ+YD@-/>::XB)FX?HN;'+I7!WI4<]ZTLT)9GO#:DN:,$6R7(UV M"0-RA^,TO-O9J>]&G28`"M=YQ:I@?=Y+(?KLEYI6B4I\NY2A#6%H1AO\KY1B MGEL+745$"@PPB7Z>VZ*/_*8&7C,//?XW/^M0W+)9QJR+)`80-\]1)',CB1&* MQ"*RTVDCODB)O]YA/6U=9@K_:]E!4RR4\V[XPR:S8M69'K\7HUK,Q4G_3 MQ'6Q&M%B%C):5#E4=B)YF*$,M23]"Z,E6]+QP'QZWI\'9>QPDW]_;RAOU.C3 M8A7>RV$^#S@!_\N.&VM:CV]6N*!5&C7KJ_7FFCWFI?GFB$N'F^R;.D5S@RE+ MFGWUE;2GQ\U9,^.NQHY./6A<@@HX M&.C8D`TLC")'RJIVL*B6-.6J!B)M/J30X*K7B`V(M$8FFLTLW@9N#G`;-G#_ MM,]&_ZJ-.N@*-_Q(L$1P!6D+N^)"Y%@P!E'+LN`"XV3P!E.KL^ABM'"P!WWP M!X$P"(5P"(FP"(UP4H8B!K2!?!B#D?:"CP9CMA(#"NE""H_P7=+C=VA/FCQ) M+5XH,!J.+B`([\"0T>QB#.M"F9S&#`\C#*\P.3*)7_#-!F$(PIA0,&`0+JCP MR=BP+O;0+=A'_"PC#]]PFW+B?VC()/KP<^K#WF3NJRZ$$G#.;#2HOV(A>+3! M(;H"#5U"(0R0ON(@(:)%2F`/*U:`1S`I@79DKTX(Z.P+43P1ZTCQ65XN0U[1 MAN+F'NSL3JCOX&!:',J$PJS-#21?!@A8FFZ,PT84Z\ M;HO`KNWPY>W.Z^W4A.ZH\>Z*,3CF*`4'<)0TQ5A"2?',A*202E MY)+^J=5(YL@F+Z@@Z;,ZR?#ZAH^,#.&*[U4NR>."ZB(EI#1&\JXN[Q\5;K%, M4A!AB!BZ@IB$2/G.C&9.(U'"\)!$LO4FDLS,IBQN#YET)IC>`KHNAB=[":9. MQ,Q",B)K3T&@*_8>(YA,KRI'D25[8[AB:1&O*R.\DC>6"ZDF)OD6#]%PTI)@ M``\02BD-:=#^J="@"C?*SV)D"?O_8+&?G`\H.\UWYI+Q2F_0/.XE])+Z(N;X MS@,OM5(WABNB8!)V9JM:;&JC&H/]L@@MLP568NU^;&4,02W6/*Q?*BG_:L@N MZ0_5+&EECL;P)H\316W2X-'+0,WC>D;^ZH\T9S.`YF\Q9VDIWP?P^`\0<`12 MPNJI#,FJWD0"YP:(K#'88&]M"I!Y.@12-E#9MJJK9@46V\8"D6(L2I%"9JW8 MN',@%C"V=$L#.W`#PZK80I`WE#!!'?1!(31")71"*=0]9N=I2M`R=&=U/H-# M*_1#+T-`_WXH+/%P)4'T1%<)*.+%$36#$%'T19>#(0_D9$((V?"+YHP-*%J1 M&&N4ZC#22&XQ1KY$@SCH1G@1*WP1%]OQ:(`T6NX&1J$4+^;H4BBA/)I1BS)H=I4F&O4H>'*!-U4445+E@I7F:2GO"%8NS)HUJGX";F&M_G8I)O MF`:-55W)517-I9!F5'DUD:K/8R9S_8!I(WA&-4G3_JRQ=4#5R__F#&<@B5A3 M1C7C#M5L*E9#M5=[M4U@"R-FK3BC2@+?*EIN"R)@H0/#5?)V:#DI(D>,4P*A M4RJXQES#JA88"FT\%82*&$#[TY2]?4\)+<$#F3'+SN/ M!U]K0Q*32APQ]D%$%+`BXR+'TB1,-#;R8RIA10YKB'PL;GN(`WUV;S'ZE3`$ MJ:AB=D'XQ_^HX<=`J,J.EC8<<\<04G1IWT-;-2$5&%"1O@2(?%1U_/0_ M,PF'6F+J4&^(..R(NF@CE,@=42@AS28\U''K\''PME$LI`U-S215RXASL4US MJ>=@FA%OWP/\&`$;C0E&8JR;`'(I@TL@[2AE9BY%_G,V",F01?&G+P5H1XC8:23/<]^J:]F`U%%;%Z]\[](\=T5;;95HEF$M]ZF?_G1YF5+>G4$HW"F63F*GV#3<6LIU(Y5 M,UN-0&KS=80O_I*72$J)C:I5@_D.I$CB>7EO6"59QPDUZ6D5A%EXODD16=+D6>I@GDX>3J6`;"H M9\6*@VC)T#!PN8E]4R[^9H`EJ86&]XGQ>3^)N&K!ZW74<8!,CD4YPD!]PVMS MK15CA.?@X`4VMDOE"^D\I`!ET4>B*"$0(A0=0O9^KKY&D4=_SA0%S$87*>;8 MQ@!G&?8PT1:STJ)QU"4.ADA:44542%PY*:;92@DAID:)D6#9%->NC`$3MSKJ MPP_Z5LZB9W$!L7&=<4NZY"Q1;)(Z:M1CJIBNZ<M,+(@-)4\0ZEI&Z($X5TK2R)G_UV@3WEH\0$PDG.PFGTR45!]6S"?9Z_]IOAQE6K^,C3>DX M:,D1P7>'$"VR80DB5_1@HF^UOUM7O?NUT>55 M#:Y@:9M0)ZV%['F/_SIXG=\Y^%BX(%Q8*#0JHV+3%*4*6@O5-4&MXI2P2OTR M&%E<5G?3U';S5J155CN3";".,&?8M(>&P=%LQX&89+J[P2.\IM#OA@G6KS6\ M/HYX56[W.:3<=Z[BY(RQBL/UBL=JF/<]S*Q*P.S/"NCK$WKX"%.K\<'<"7'FB*%0@$]L&=XRN7J6@EO:\EN)< MC/_5?/-JVH9BUH::J#51;J!Y22)9EA\$D2TYTUMLTSG=02KYDTO9V3QYU`\Y M9Y=9U145SV`]UF5]UFF]UFW]UC/"+W!]UWF]UWU]UET]V(5]V(F]V%V+:O^H M1*L68[P/HW79V'_=2JR*EKGO>+*^T]EA99_7)T.-'73`=?F_"S5E@H9`! MR="H@<]1<$,XJ(MP@.#'Y$^XI2I6@(.^Z:$!R6G_J``5!ET3E-#IKX02"`3B M$]X+FUD\OIZ.S_ZAJY+.A<;'!Z*1)63FXHM#U#Y$YD3P_UY9:/$I..@JTCF0 M[!Y#Z'@KEB+P,00%YE[RUWT;PC[@$KXJ5.#RR;/F-\3=LSYO&AGD@6:/3\8@ MVI=<$(R:R1WM?Z3TR=UIDA@MO_MP\J\)$U$B%0*AN`6(9"C'WF,38]B_AOX('!8KQIPE%HX3V4.#X M1TSBOXHX[L6"F"+6/X<@_V,51(%R($E-(14RW.9P(9,5TT0JK"@F83/'*(,*,$TLJ):AUHT5_<%8@ M5(@VK=JU;-NZ?0LWKMRY=.O:O8LWK]Z]?/OZ_0LXL.#!A-:I&PZ,TR?3C$SS?EO)V5B+9-^ MY1S;:,++9P5:[>RT$=2!27$7G`SYLV[>3%&8+0P]NO3IU*M;OXX]N_;M?XV= MQ7@QMT][$S,R`J20;$A_Z#D^WG:/R\(F1XE3EJEB&^V/NG/'T*9)?KOYY!5# MVO]0LEY$.9%G(((VR606,0**]9M.E(1762P"'13??")!-)YP!AU(5&Z6V8?9 M,B5"])\F9A4488+C,=)?9^\Y=5YI*"+D#R??<0=DD$(.26211AZ)Y%\@/A>; M*NE1@E)X%3&I&`H"DH6"#5`2)`I*L`$5%%H%O2#5@BAA=E*)]]"G%`J0"92" M%`1"V912<;*V$!<5K>BC6L2@*9469=[3)9Z@13G@G;"UR:%44^7$XH]IBC1F MF19&69&;9QW:`QSC6;F:F],X&F:F*)689*JJKLIJJZZ^"BN0MJ7JCY-JK?F@ M=KB^->MT(*:$8:S"#DMLL<8>BVQUO1HI84ULV3-A=F3_+=K6LM$M@Z$]P2;+ M;;?>?@MNN.*.2VZYYIZ+;KKJKLMNN^Z^"V^\\LY+;[WVWHMOOOKNRV^__OZ+ MK#]QV'2H:^\N8V93OZ)DU:XC4:OO?FQ)G!;%1%H\%\9):@QPQQY;)S%$Y6W+ M+K9YRD00P9<@M.>#Q$!<+WD93DR4S#,+*3/'<.D\9,ZH?@QTT(/9P\C`&T$F M<*[K:IL0-;VYQK1.1C-6(;UD5?T6:%@'>?6X70L-=MB`L9?T2$AKLO6Y(JME MCVO$_%:V2U7\6*Y`*!`U:4\IK>?I0*:&!!0.<-J4T5*%&^Q6WK%Y*N!)84`Y M$9AW4RI5&)Y.!"]#>E0TMCVB[>X\3=#^]Q)9,8R:$S6@2.056<\U M`V!(TFODU7[VO"C\/7/'!=KS3$"J28NM.S?J0=LWPIE`*K1/FE'-]R<035IQ MY/R/+`*8GX*$1&+>RP^(J("*%TGF)>^K7OH`B)#\T2]X\!E?[B[X+YF5K2"0 M0M[2$.>//'PG:LE#R]K2!:*#X*1BU.M/1AZBBNYQSRC]*XB(H@67%=ZD*8UA M#E?BMR/9'`2(8-',0VH$'*X,YR&4:!3\%)26%&ZEA2U)3`]W!*/A87"+]UH8 MP\1R)O\MGJMM=/,.6MYF0@^><(Q8T8I`MO7#_G#$(S+LBOU(Y9.3P*QP=5)* ML*RH$1]2L3Y%K!_@M$+$E_"O+#\"I(B,*+DC+H4B;4S.(),8R!WU!&9<[*2] MXD:U=Y$1+SM]R(*9[)9"&# MDTA$WG&(^--DIJC$R^`LT3;&66!8XEA%'OK2-CSSI#7?!4J(<#)=%+P);&1& MPA*F$EWNT91Z/H(>'/VA1C&188YH"$4&R<=A67,0>_P#P:_PQ#SK/-$O][,A M0Q*R>7U:R_\"!!\FY&<_(%K0$TM43DLRHI\?>B!"]:F5#M'_\YHO M$]H-)<]!8V2^^!,+F@M+6LJC5"94$16<(HP_89/=5.B<4`V13ATH3*!3*S!4E,RA1E.>)LO+R^8*KKINQ*UBN@]>_PI8=]EC MK&]!6&"[=2A$O:5P?#VL8Q\+V[W#47,V)!C.?4JDKA MN2G=#C?%5V9D!:GP'8WP=#Q8;+4HC(##?Z#4$A`=TBQQ2^R$3H(AJR+35#B` M"".:2!K\$@P.[RWP?-/CJ=C%`19;ZJO"-%'?@Z"74:09&%G>NR@PO;:[)"ZQ MD+X+D8N,-X3UFP@UIGO&I#)!..%CTSUP>TK?A02M.F'<-NPA(P,:;1GB16U" M4*R;M1&91R)D<346R8OM MF`+-3>Y[/#(R,49LXCC+V3K?1=EX1WKAU%8WBD;CH`E_A]T2:C,WJD,:'*QB MLO'&QFBC[/\FGB_2Z#W_A+4G'&77G-SGZEK:R&4;=)NBM,I%5]0J25M;-[O) MXSFK>M74J?-(TNPDP_XYM2K=(=XL1>B%2%K4N4$?YLX&FZ39S!^;$,DR(.-H MB!U[=KONIDB!G>L-5G?9O>:UIV5=E`JU+->Q*;:I*?T[O;)ZW.06C*N=DI.Z MWC/4&R5+@3U8$3M&;M>=_MW:>L=MC-Q@%)LJMMF8'<'PW)/:@=:U[ZR";R?; M.].($>_"1[T;@0/BA*!Y-\2[S9]YG^4DN"RWQS]NEW.#1L83J7.H,8(T52Q[ M@[@=B;P-'D5*+,CA7;D0S!4#-W_[^;<)+3GE9(Q,9T^WXC#'-*7_JNONHL-A M0?^=\3^0C.@A&HWBW@8TI44(\JQKG2Z_^LV-F[.HC(@N(CG%4IQ"@H]0*#8C M:8:2Z/I&E-3U!)G_,&-"ULNRO=DD4XOZ6ZZ`T@BYS_TL;%?S"@[4QY-,*+&H MXKOM:GXW*;1$[/JQDBGN1F%SDAVE6^^\YUD%RG:%7CJ*/MGG3X_Z(HU^7:N' MSEWOWMO4RW[VI;6R\M"EW]L3)K&3I+WO?P_\X`M_^,0OOO&/C_SD*Q][PX^]#1B2U?"EZ=YR_?L<45X(1%S81P_OXX;%_0'1KC047]? MV$\=]V__L-M6B(H(IHET=YQ='M&)'$B3_TX_H3)B1"_:M3/1=WV[)A@&Z!?8 MYWH(.']S!4IL-DX.""],TW]K$4[KLF%W%T8WI0T>9GM9E#3FM4&N!4LJT%YR M(6!3)A(9H8+?L6&'$CL,!D4<5FHV."=7MG$HV&,D-3QF1S`35F'D15_V-3VW M8X)3!WX6`F*PQ%X$&($?TU^:X`99&%R=L2,-IO1B+FGA!<3.,'DAW\K*!XK:![+)MXN,_]N9O MHC9L54=JQ89M)P4SIO(;!$=I.H=KW$A*T*:+W$9L&5=T@EB._W9S]@>/Q9AN M$+-&VT9U&@*/SKA)T(@[TG@VY5$>^\>%M":#8,A6<&!Q'C)K&,<8^]9O](AQ MZA:`%!(7ZL@CW^B1&Y5P;*AQ\BB.]7AT`:<3Z`&2PDASUA9N$A=M$EEOXQ@+ M%*AP)[E#$&F0^<*)ZV@2E.9!(36*+B$?.I&))2-UA)-R3B:2-I0>*8G_<5)9 M9U_GIB=I)744#8&M-# M)7;G%!&B*7CG>/^0=HJ5?GKG%"I`#6K71[_R'$%%>)CG=E.D89:'FDJ($H6@ M:3_5'"#U5B^U*70"4;*9.HTY>9>94XIWFFGF*0>QF7WTEQ\#>#_8=+19@`WC M*!7"@,?)%ZTGG=5IG?-"G=>IG=N)>[;'G=\)GN'):F!%GN5IGN>)GNFIGNNI MGGK!GN\)G_$IG_`IGO5IG_>)G_FIG_O)GZHB_UIBPB;BD1)^62Z=UH21\3/' M\BN0DIJ^A6N%@3%L%WY.$3N;8YC844V#H3,V!:&EB$1JT4P,>1T^LZ)]83,;"E'ED:`>*BY.LQM9 M591[92]$XV&"2('BT@S3,T3/95#4UQG0CDHL*>( M-A4&HZD]\3H6D3F0ZO^9DE,B@M>!8HHLV#9Z_E"B\;([3,@:G?B)%RHLA[$G ML/!B*(!`AV=1_,5(_X`]NM%*D[=C M`>1,:L($`_047&FMWW%0W#I`VIJ3=`BM"910Q]I`Q30_KE1@"-97Q^H\Q2JL MDUBMU]H2[QIWVXJL%:2KKKHJ+#9.C@%GZ:)!4X-W@QD;:.@MAT&I+5<^:MD8 M.P0S4M26S*$:*\$:CH1NM:(C1[0>"&9#J:$81G0;4NI(2U2Q-M1067H[T#10 M;K096"I%.@1+:/:"FQ%#+G1)+SMC;4FPQ4*9O'9&!"HN7B01:)2%E@9C;\K_ M(YX2'I$4'*1DG!M12;/SH!R;LJLA20@G3:IC$72T'#=[2(^"LC*ALK_E+#O4 M2X\$MI'$6XZQM*MZ`;%ID"9;N7X2I(O+*H-%$:0& M;PDK?AXF.%%)%D_",4\!:KRO@F=SR7EFZE%])A4U.*G>XHB;\EQ6)24;7"5% MA@*=$E:RB51]154)`RC,N2OF92=R`BE]4UZ1AR?Q47^Q45`6UCDK_(-715I: M550SI2E(92K,*:DM)6,;'%,Z-3LV15,Q1<2&AB@^!5\1C,7DLJ5$(J?5XE>D MMWE9F\5C'%=;'"3A];:\\L77DBW,2\9OC$&,I2IO)!=R;!U6)<9PK,=[S,=$ J,I]_#,B!G)[N*)K,B+S,B-[,B/#,F1+,F33,F5O%T!`0`[ ` end GRAPHIC 11 inb004b.gif begin 644 inb004b.gif M1TE&.#EA"P-$`?<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRI6-0OGT,A^=4_BM7M0;D&_ M60,+'DRX,$)[*.8J2P&WH:;$"OW)V78/!>.V<%1LLVF/;FVNXM.G3 MJ)7B%4/07NB%_C21/GC/"5Q_FSS3=-N8)K'7(T'-=B@\M?'CR)//O'?Y(+&N M-S;_4X9B1:IM_H@Q`@6Y(.*N./YM_[K--87TQRJTE;^%.(:IZM?C4F*\5;/` MYRJH2?>'-KQ`?Y1T9=]`_E@2%H",/`>81I"9V^0.*7:7(9K([%=YH^?L=EU3Y:22>?D ML]!&:]BDSO;%XU8H!EG(*BJPJV"#&8ZK=GO49C M5QIJ%>:KU19XX+9SY(NFJ%=^.R.+J@@$(KWAL4M0KD'^RS"^6GY[3Y@&N1MQ MOL4U#->Y018<)(^"EJ5OC_1N&*^T**>L,E7P))H0B,UEB"*G$!2C>8Z4]A<0AZ9U<93M0/T)K95N*:*$(C]$SCLM;7./]659M^>;VI[)+:PS/ M7,M`K15:?`D:J)G:*DNGV3.V.A!B+M]31;>V&0D0]$3`^C%-F#QRFBD*3%-0N$ M6%G+L.A/P3I[FR_:(6LU.4%5`QRDP-/=X(QT'`<)B)2B"\2P>.<%+%V&X\J' M`^E-1!D[N(UMWOE_L&?N#]JI_P?Z/Z<;[OWWX,L$8I9:<2'0,M$Q>"7Y\!P2 MV]6X.[ZVF6,EC'OW9Y6%I<$+#KKJA)3ARS*NQH2R@&5LM=(1[=A"L_A=;U]J MZ\T]F!`:6Z4I3^1;1J#\AQL(*BU5?^C60'2V#3O=9V<=>Q_UV)(_`E5-A;C) M4P'3=*<,#B=\.,RA#CU2F1K]ISQ\8`P^_U`!G2)9QA9]%[VCBA5\!Q,X^AEVXJ-2$ID$I0`MH,=:+3(>DTPUEFG`X* M;K`H#(7Q/UZLUUF2M,-.>O*3H&Q)/U;AN"V$\I2H3*4JKT(KS7%RE;",I2QG MB1.\T.N&M,RE+G?)RU[Z\I?`#*8PATG,8AKSF,A,IC(M$D@!12DBJC))AMR6 ME)MI))K+S*92-)@B6?WC;X/AIE:\^9]_?5-&RR`?3]`'R!4\4RS<>>5'_,&E M*KWS,\#12'U$N/^3T6CSGR+)'O?(."NQ546@<(L2,4@5I#\4Y#<]808*NS<1 MMI6D="O)&`_I!!2-`O2C&NF=JY*FN7Q.1:1:(NDW&4'2>'#2HSA9!@XP!`=& MS(A^&B%*RR2SX38TL-ZE5,]@A/>3M-7GOU8 MXHW="5)_!J*)J<[+!FC1S#X+XJ(PE0A"!`H0`.NTU?]P!P>_`E".UH0F!JD1 M16<=TE@$ER'542)!7CD?>/@)TL(^Y'GEC-(]`$'8IR!68]H;F83B&*0J\$2B MCBJAK&Z&'NGX;X+$"M:II&:;*JU/2US24@AC,\BD%:HQ6",05S0SJ;#_=!:R MA2KA;-EC+&2%ZK:XNE/S!/(KF\'*+;8U%:JV]B3GY0$['`0%:VJKI6N]Q4N\ M`F!M(96H?<+C!MEX+M\0V=TUU;$:7W`L*AE97GC.9 M%QE))[#A<:L@#W/@M>!@M(/AT7%F[56*9I=8X?%E>.(B4;D^MB_6Z->IPWL> MQZA(6(O9#F(3/(D,2`,1J/#P*SX4'FVS:_.?EN86E\]R])PQ*]KY#!HU$DE7Q$>N<-H, M9F1-1(BD7OXFU"S*MY'&(F\'0' MXGFZ=9X.LNH*=@^ZWJ:NE3MV8X;',!4[`16D_EV,)Z?C0EO;=)3U\'\R9Q4> M-YA`0$Z1.EF=DV4HD;F53-9`0#&N4;+M9NQ4GY;8IZR\%/=H//U@BN*WFF\: MRJ+U4QJ)\F(/^X"6AI4>=)O&/1#,/OK=2V/7!!O50DQIBE M?0F0"@P9"R<*?5QCS'KHHGK.KC1'B]]JY%Z7.JL)P8([*]!&@'SP';X\)XU) MK#ME4UYHQ*J(-/<(X54,ST32C.SPCK8L*&M^V$17-!6BM#Q"'DWXSH?DNXTM MDDFE`OJ+P'2'(Y((J"FB.);X8[@,B;GG9Z\1(1NDE8&QO42X#4HY[__O@#[__ M^,=/_I?<.Z([(RC( M!Q)G82BP,1G(51*"XC(3,2>WX#._)Q)?\Q$3%X$Y@6;WEQR+-3:C5QK](&UN MLBJLP0Q(!Q27-E#VQQ'^H'ZTH6H*:`S+MWXL>!+*D((5L8*AAQ/$$(,92!CX MP#O_AQK248.R0R*7D(,U@5ECHRB%``<[0TC"5U9,,TF.@Q9)-7?N=!\38E0& M0R\W$!N,X(39('9LD5=?*&4$L2BI$#TR@C,R1(6`,UM,A3#MM5-LIPEA2%61 M,E)"ITX3!(>B$H;T(B*SA5-1Q!U#IR648`C<$1IS_V>`CH86):@M+X(*5`(' M],$$QH8T?>@J<,"(0V)+/<,5_E$IH"A`/M2#RC%GRD&"IF-6Y]43;J8)>8=W M),(CR]!TK;05Q((LQ>$/FL)J#$,M\Q8D1V@SD]-9(Y.+@&0J^^1M]T!*S7(Q M"?A`QV)K?X&+35%X9TL="1WI%@JIB0H)B89&&+BIY7M\5),$(.$FC;C<3DET3 M9#_I:?*VDB86"SQY92"'9+?PD.2'39($^;V%RQ6<"02:+!W/J7X.T/94%7V9JV1 M5?N6FR9I7B*CDF@26W(66'CQA74U'C+E*J;V-JA6DTO9,"6G:`;S;WRF<:$R MG5K_8FIU$XO+8`.Y]A=P@`-3&4'!:9-!UIO<$XX6(VCCP9.A`G))PQN_Z0\. M]6Y)UH&K21@#Y"0<$UO,Z1-NMC!E2`E(]U_385:JL$G_`':\>$%.9Q<$64+T MAHRW\8L.VH]L\WADXCBD-"-AT3J29284"G:.1@D),SOK10GZ^&H9,Q8E-G#* M8A\MNB\BXU&(8Q#QYC#&DZ%.UW2NP@1A`78`$B&'619F9(UYH9`MAF+'Y2;W M%F"^-J"H@6:MUY5H,QT6)J`U`2E[*!"(6)-AU1MF:A_?D2T'(T;T$C>9-(E+ MI'0^I2QKJH4I<'<34@ND.!#XD$FE.%M2D"A_=V9;9S.[_S6%635W#)BG2;I6 M%^=VGO&F6AA8W&%D"*>>EG&HMX!&=A@F:<=)F-J%EIISA?`M^`&HJ?H_?8H> M4`626R>J@6=$@\>E@G%AD)@:\V)?D-)^V?=^#9%Z%[$]*4&L%4.:NMJLSGJ# MFL<0G%<1%L<2$"BMT?JLVKJM!N%[$"&/%$$=^I>LA1@9BZ*:W)JNZKJNLQ1I M[OJN\!JO\CJO]%JO]AJO%G&O^KJO_-JO^LJN`!NP`CNP!%NP!GNPPM2.I0%. M"JLENTDRT1&81A%(S))$2(@1,A,2B5I&#+@0Q-"Q'X$HZ&IZPL>Q[U1?(TL2 M*+M[((L3*TNP<).R3O&;,6LZ=/]'G0]%94/Q=]*!K),ILUG$=AZ1'6JW4#QH MM#RD&&H'$HJS&(2%M%JAM!=;$DUK'KM7LC11M5/[K+*7%??0*MIFK/^`#YQ$ MA$G1#)O:,0J!31=!(V1J$=A%$X!A$FP;>R%($W7+%'E+L)0G&+%8<^P%*9RJ M%6MY%,VP5ZRQ/2YR-4S4*H'S=E)7=VLD6&$0($D"(O_('3V5BD8$=30"`XC2 M&Y@KE6A1N5`W0G27(4V8&'-W".WQ'EW7AH&C(322(RBPNN82:?]W,%&6NDSD M=EVB5F+05$_T=#Y0N[VQN)V;JYN'%LT!(-5!4[?+%8P;:9<1.*:;HG:GN=LP MNDQ40 M^FVKQB%9E[]!\4AP`PN@\[&2`B7KB+YM<@/3P`2UP@0W%QKB;DC9Z?: MTEU.&"L/*'FKPBB4`<%GT;$+J+U!M\%-QH`TH@+9P`0!F!EPD0JABRKXDGB; M@;;=$2QAL<(MO#.(P9XH'(DXL!5/Z(0-;!<)[#Z[W&83$L:4<5Q8_YR!TRH8C78T M*M6WWS2)6VFX@D<^]5-"2BI)NH$8!N5_1Q5%-"(&9U&6"U.\T;&A:04CO`@B M[G/'I[S#)U+*=,-0KDS$=><^U,!3FCR/.:6%/WH9B'$(N#S*_OA*B#13E0$< MU*$H5FM$8D!K2_P,W46J<`$2&IC0EL9&]+,Y]0(N,S)"]@8HWP6X[(K MZ`Q(MNP5Q2PX2PQ&WRPZ[QS-O(PDB)1/H$S.B&))\ZR]Q.R$H;RUW0?`5>%M M_2NVCL-8IWFVF1:H8Q-IK-&(!`$B;F,/*?`*$"R]V<(,[NS"MIDC8?*'*#*[ M76$(HTS&?W(9'DW,(!T7HB58P[O1Y_]T`_>0"K_+5URA3M3L*+(\T]'QPW@Q M@).2S3!"(QA,T3ILLSC@4B5L1"E)*G](+Z3<-`;A4U@D6*T"(DA'T>=,TTK- M4&Z+R\7R@`)=UC(-R&X,Q%'$U?]S"!+999#,2?=@2FXUV#R!>4R=I)0%SJBK1&?A`^,\*Y!;U8.G MSC1]'U(MT*CK/J$;RSW"V;7,%K$[#"\?WD2@TLC,;>*V0,EWB[,+J0<(B M:^!IG,)G>2(39&0T8@AWS3W$3.#>]!R,X%!+_=4!R`F-]<,@4L2)\H%H>KM_ M$,^GO=)XC`(E/LC?>`H9,`+KL89 M/M,HI.+M`@I%3L=00DB5YL]1=>`.(,2[[/>-K=N6GK=:+K156HHI3/9M0 MH7!M'M&0,;NS(3<$;7//@:2@`[U971G;;'5MDA8!0LS-L'4FO:AW_UH(3=,/ MHJ!TLO5%/9("?("^!Q,#ARZTE?Z]D<87U:A6"5/H;*=FVS`O#)S37C%&-TN^ M/2!E3'<\U7$*@_4?P_4=,"+J\U*6?+X\C4ZW0'M8$D\2E8)R%2\?;@X1*9;Q M$7_QE'/G&]'Q#(]>'7XT#%?1'Q\9C^'8%/]1@34Q@2=A\P^!@12HB>F-$3C/ M$31_$CJ?\C3&#*GPS/Y0#0F![A@Q/"%AF33!]"0A]0RQ@W$]2!A M]41/:"ZU4"3B,7]8@IG^4"'"<^.KAK>A":#(NVA3T?=1.2*K+"]IV?B+;$@(P?58C_A(M/%FB%%YDX(-/TZ*%?,>7! M0G'0B5,HEGF(B.-"ZC9R(.OA*HM(T75G^%_?2W%UW_X@C?BXCC>TBV11PYLE MC7QRS.:.8^^2:?0N^YVK[(?'%=8TALS_TM!G0 MG\'H;RKJ3RY0^OCBFT54]S"J)'C/V*'_O5CPM`2PF4K.&I"<=*>S7_4 M+%($=1*G3I[^9OZ[-X>COU$W'X8(_D2T,4+TG]F%?O7KY]_?X%'%CP8,*%#1]&G%CQ8L:- M'3MFAO`>$S'^5/U;AD(S"AP4-1'T>,\)WJEQ$,(4X[&BRWMRK'KL)T>R_VND M<%)WS+SYAL@8'$6_+DB5(2C6M&'+;GAQ=$=XNRT7S*T9Q^3;'3\7[&B28M7HG%]2'MS<-VWRD^47_,VC\):" M`[3KOBOHNI>T.W`YX5Y:#I[-4-A-/Z2,8^X&COJ!PR7R@$JM/O84Q$Z[^-Z[ M!1[Q.'3IQ`"I>RQ&&6>DL48;;\0Q1QUU9$8]%6#)")[J@OLIM#](0PJNAV!" MH;J0$%0MC@V7JPT%^9;YKR`5@Z,R.&,0>K++CC9QZR*EIIKI'M"$_.@>.*P, MCAC0_MGD%G_D1.K,.PE:QH>][,EIPRH^`HLB4?\>2L\>1`]-:-%8V/R(R2$! MW.PAWK"CDLS[F@QN4(_66PJ4U/;,;4,@9,2=LR0?38 MVDZD20LM"-"N&@WNT%H3DB\D?ZAT$P58=V2V66<-NZ?29Z=M+%K-+*7V67@L M?2O$SEX"Q-9(F\"6PQO2\TC"%HE#R@GS%BQ/0&5%VHVB/S#3\$+S_$F5W0!5 MVP1,[L0$Y8:FH/NVGW![G3>Y8!FZ3K25DLV74#APR&XV;'.ETU)B#)8JX-7& MC&4][!;6$LZ_EA&O-;0"9@[.UK"U9RZ''9;XO(=Q=I"MG)>IUY][6=[OW9'0 MTL1#V3QSR61PQ?7GX@__1T;U41708G=DE^5=-ENOOP8[;+''#KO'J3J\#Z&# M@.I:&5DI4F5+HR3+"+.G3A,S0824T>J6?NH2Z:("_S$;)@^9X.EA8*'TJ%\S M\8+)TL@-BN5O+=>=T_$\T3IX+Z!+PO7CI58IU!]&`41;\9`,K3PFRI&J>YF- MQV/B\!6LJC,ENPL2_272*>DL*:S-''Y,.W\2GFV6X-K&38(*K_V^VU6#PT\$ MHV9MKLG7+O1S=(%E/6KKJ0QS0\#AZ9IL]==GOWWWW<=I7NP`!Y33@MX2;ZJW MF.<0+BE28$@HI'._G,#B3?GK"#,T4PC:W$,4FJF72#13G?KE!%O$@`L?"GA` M_[R\104:5,$KWE2Q@AC#//5+S3T$2*&.X.\?'M1@"D2(@MXT9$++BEI.^`#` M!&GF:B^DH0>!(PJI8/!J&-20$6^!PN"L\%N`J>!"@*@":CAQ*O'[X63@\AH, MRI"#0)05#',R0_'DIA!4DI#*_A'%V3%I+B]YDP4[PL3E62F'*?B?59"X#25J M\8UO28$!:8B4%4;P?8=$9"(5N4A&-C)L_JC&5+C@2$K&B"I(JF0F-;E)3G;2 MDY\T##&J`XK9@=*4']M*7 MOP1F,(4Y3&(6TYC'1"9?)K1,9C;3F<^$9C2E.4UG)O^&FM?$9C:UB:8(4 MH01G,!DC2=6HB^8AAA3_DM!2.D89O\K10P?*T+Q(])T79:>OWK7+/C'L5[Z2 MBC]0QKOT49)O4GQ.7^R1I<1DAJ6/:8A">0?1OA"#IHU!W_UD6J.5OG"G'K'I M0W+Z0AYBU*CH_)`OX?'$ERP-.TXUR$9)VYDS5&KGJ1L#A4R5J\EFK-&W?&6H7+9!#:MB2R`Q\$?T8.(# M-\F*+/VPJW"SP00_@60A,-'0=^YQI()(="=E8:^;:*H0FL!EO3@@#7]3MH)I MP$%6`IF+3^(R%J6@MR#X>`MZPFI=`AO8NCB(&EUK@S$F`#C#!4X-=U$PG!00 MB"?5Y2^$&S9AEBPX&Z.Y!R`&BEP:O[*MN[0'7=MZR;QTU#I<760S./(6&`". M0^9%_]M;L@2HK]I00Y/Y80*M-)FW7?$DY44*$]Y($0/CMQ%>C:FE&M(5!1Z" MRH32Q*^\.IE\=:L]77:3F;6,T(8)>,U,T)!+32+6A`Q20I-21G'-#8U>J:=(]7`8LDS;C$KYA*S-, MO8H(WU90SXH!O@%^+YY5J[)D;8:W=F1Q@J3HU5>[5ZA3MG"2R/L*X(YZ4]51 M-%"ZHBXL`PK#<)A>FV0H:PFUMR.EWC/#;G`/,$DQPLJVBJ@U8V;%3MKR6_AF75UQCF2QBC#IL/VEM!L ME1SFX$"Z$"5)LQ[K+,6"2Q:SY\:Y*:>[2^:62')0[-UATC!40@#NQR3Q:V_>9M M,8UOH_YT4O%/SM??_HY1T8P#,]7[L]*6FT&U_A/``=0D'SN,EB!`56H.Y@C` M!'3`!WP?2.FJEX+`"K1`;]JF#-3`#8PF:^+`#P3!#;S`$23!$C3!$T3!%%3! M%63!%G3!%X3!&)3!&:3!&K3!&\3!'-3!'>3!'O3!'P3"(!3"(23"(HR16CN$ MR`B,J/F\3;$!S:N6-VG`PV"2VJ-`Q6!"'6$1OMA"V$@=(P1#(004T'@H/LL+ MG/@\?]B(_VBY*<;PA[LP"S-$JS6$0D5BNL%0DS#40R+DD"'I*T$@GV``7V4`4W^:J-=(I>^9PH>8WR M@1!V.PJK1)![T#A":94S\0ACP14?RRI<+)+TJ`_KB9Z99$L2A(>;^XC6>HUD MN8T&09)!#)C\2Y!Z(A=[*`33V)8J.4J).1',@#^2O!F?$1.\%)BKG*-;TIH& MHJ^I2!62'$22=)J\:*W3J`)VRYK3$8ZA8L=`9$=ZR@LM.LJV5,W^PQX!D&(7=Y*O_))F=55D=W"R=GW#*VJ2(GJ3-I0"> M[]'*O%,-1K'**M$P+J/%5M&\U=&4^KJ!2S2>MZH3'V,]Z]K&U31/;1,XR`&^+L,D?$7_IA,O?`>7"F8#2&=K($9U/D/=N08=L1/D9",*RG/\S11 M&EO%BKFC';H%?$`_%NHB6SB@-BF]DVH=YE$-[VP/WWC1`!0WS0`--]([WQ(+ M4@2LT6N$2HPA&1VDK#"^A3@I6`BHG]P?DO`@J_J1*;V)"=F8%?V5^.$)#(H! M5)0*(@K&V^$;_PVI1)2@/W]8H?:*LQ.5TSG])$,+K"V@TSS5T[52!F0KQ#T% MU$`%I]$:,4$UU$-%U$15U$5EU$9UU$>%U$B5U$FE5(SZ/Q^*R<<84"X$KBE\ MI7XX"M@(U4HEU42*S3[K2D1BAAJ*KDQE#)@`Q[V`27QBEJ'*%@ZYN3'[TU+E M5:\)JOM)#68P)$0"%?+4D6/)U*=L%F4HT1LY5<7IU6A5GWM@A*]=4:3/28@5T(:W*(JCJ(F5Z-/:,+NO,,Z#61VHT)ZZ>$-5/!-^O,F1 M[;,K@[1M6#?K\"WB%%F>\`G0D`CE20F8/!OFJ1G):#"/C,."*!P86YKO6B.4 M8A2F2,J*M5H=,;J9;:^W0J3>0BEV62.''9P!%9',T@W>4,B#PP^]`%""N+1Y M#%#M8!SX#-N60P\%*5O_T(L'28@A2:H%I%JJC$JFH8A/K(]AO=K$C9&<>I`% M%)>-5<8?@XZ?A,CYP@L)A`Z6RE@H29:76A52X=@[&17CM%;]FW*PDQ(G8DG M\W`:A:&7X!B:?-F:QUR6G'&8X[V9N#TX,;'+J*T\`XFMA!DI=1''8L$042MB-G72;X%"%[9&,P8$> MVRD+_6P3CFQ*_BT5H&B1KP0.G=03X&E@7A%@V($.[Z*$I9N>"HW@+Y2;HP!5 MA!!>1G$>PI'#^55APHC-DM5=1+(A.>HKT/"C",8B\*`_"<*^S>`A%2*^T(BC M0YBL+-NBC@LD#ZH%*90LN)@AZ$U8X,`?'+8??+`BZLFMEM,AS%)"["A%*6`[ M&AI2*4JCU%SA,D8K_^>R(4_]P6?UB]\TXS=6W'3C"UN%XSJVVH;T"[[12#OF MXS[VXS\&Y$`6Y$$FY$+6)."--$[:U!H1B"L47+C:$3:^2:`LC+,R9%C275J5 M/O5P9([R$(]4/Z$B8[)95;=(Y!RA8\>`LA2>D3_,"Y;S#+BT$5SUKH8SC%2^ MY%=R&KE\3,P"!7C[)9/)/DO93,D:9?Q]NS%T%F:ED47&$6(`LNU$%5:&J5'U M$M_]"&;.95JR!XU\UAN#9F#JYM+`2FS19O?1UBR+/#`&UZN!53N!@WRM5[W" M#N`*F@(!1@4"8P\26.J)-=F#`XD4/NJ+,G*UCG>EJX;E"+Z)+*HH6!1Q/O\@ MNJK"%;/389((2JV.2T5_W>.7D%=$B0.(O0U^00N?@;YZ46@=EI4/V5=$B>=B MY&=JWN:Q(LG2*!>@NP?4VZ5.J[3YP!;+?1^.U02;D*^EH=6U:4@W(8EU"]I" M:4C<_%D,)EK!Y<^#U*YXJ\FF_@E^S.84*I"BUBVCE2+^2@L`2=K7^$3C\0JA M/6NZL(NE4%GOZEGFE)6C99V2/"NDFQ5\BNH]FUF>>&J>&-J-F&GW&=!O=C=6 MP6:=ZY(;0VR9IA:O]:ZQ9(_>U!ETD9BRS96VO8_4_)"MB4RKL)"M*=M`#*Q# M].G4[EN?[K3GNNO@@!G-=FVCS*>SG2.QO96GN`W_F!&.K;&0N-)8\LC8+*1; MO2WL"-2QQ-XYCN$EO71MX+ZB3@:;8FV3VKJD.RP=:[6'7<&3SSV5UB5GQUR< M"%FU"-F51@20"95-VY5'B/30U?&HE4CK:5[=O``IU%&9%_Z(T'7OVQV5J14Z MJ&"JVGW=S-D&U!W=J3RVXVX?KO3*R=X7W>0YC>,QUP6)Q786!/7"<]&T98`! M/P".N,6;`P=?Y'40$I$@EDHET%Y0JR`:`EW>A4'QEY`G5((##B]II$&/RI0/ M_TPE#U6<&.YDCF\'>R_Y$DB;B_%E?YU(00CQ>CMG>F)%N!I^6 MWWZ/F_:N&<\E+M\YOB62_RSWFOR-%<6>B@TV734_+]?A'N118)V,G=D)B34= M[PT1+\3Q&S@O\(IRT!"61S8G3NE\"`^F;[6^8$2WG,`Q6116#0;^W*,H87D\ ME*"-RY4^"O"T$PK^7#GWC3K7 MGA\1BR2V#SKJ(C(:,AIRTP'*"WUF(*L`)$$2#S9B&/L98H'#U'W]G["N+242 M4X3-XE@`I(<`I+]KTU+<(8(+O@@:X],$KI*+Z.4!(".RA?W9O5CW8H2(8@]J MGB?NN!`:H6V@8F`?];'IM+^2C[^:DYR^7U4J3'_W5S4">$_R!VH0)C8^)=:[ M!_]@SG=NCMS`".=?REG!.&=.+_JD M_WFA5_JFY\"CA_JHE_IW@[AK\K%QI/UOU"Q7`I001E+!0P/*Q#&ODXK9K^VDC5OG"[3NK" M)1PT33LF_=!PT_:D9K#7?_A-AA8"A4P`*%XL:V?\10'$SX3R'#6`^7H8`!*L6MA_\$JI!X#PZ*0B`; M:=2$4.-"BR@._;O'D!$H%0G]@93ICQ)#,2X9=OQ'T2+&APM12/19\6+&A_V8 MW+"#`@=-AH?LH8BAL27#K#T_AASY4""*H$M1A,%9E&M/BABYBD1!C5RPI0&63Y43)(J44V2C?ZU&Q;'^@WFXO;WYXLVU4 M4\!2A3)%+'@J;E%;?1K.C6E,O-]CNC3&-OTL=\\?#G'T"GZ,?70#=1?%\A&` M]\AQRSU5:!13+/;(U-\-2\&GD7@?&J5"-DP`.%%=_W@8"S'PB8<"%:C,YX]) MVF@B4S]PR/1/,]HXN&!_/6&HX38?>/E!)16>*)`MU`TXD:+94EF`&"J1]+]:U$8T\Y[MBC ME+!;58GSSW3-@%BE=O8>8B@I*F`((`A/ABG MIW"1:*)Z3^789G.@1'HCA4QTU&)&L,J7D28PRE@D?AQ:NEJFD$J:$965'EID MHN<9>RRRW)T$HG17]1.'=622ERRUU1+G3QX)B4D=M-9ZBUPSK1UD2'-PX!`@ M$Q(=9AU58S)6JU4?[:@116*\J:A+;]T(&!/G+C5;M%,^*'[ MZ;S%M7N52SX8+3/-ZX;HT,TI,\WON6,OO%+#$L?\4-9&IZVTU$L=O1!K"2]F M--)MK\MRP_(J^BW@@0-WSV_-/7=:LR`24[3@C9MG#'-^E>TXY4[F^!3;3,3E MG7T:"83#DRET>1)7[C*#MI=S4=S@6JGWM[J*FF=8/:RF(R!!VOL M413QN,N8U#)&84`AP!=YQQXL,4@A``$B'1WM#YRYP28#M(66X)`T.OF>FQ*D M$/A0)$+:O$<3)`)"[\"C$5JBB8A85Y0$@BU%3")4J)I3HQN!;76>@I`VN#G/ MC=C31`G-I]]BDA2J[!!*-!(1^DH()8&F60:LYLG/"L7F/PVUT(XP(60+;]55%CV5%4;("3F36C M?[&+"^Q04C:V:,Y>HI#*-AFB-:.D@`\AY,QB^(=9,M'P(R^HC&^K5L_N."2I5+G&%7U2U8&!MF/X:0'(-&8[&9GF]G<-3\> MQ"QPO<@7XZZ.*P!SR0I.$4"'^*,)&8&-5:@BD[N6C2^8NT'\IZHOOK'CEC%CXX""7#C^,9`]?(^JQ?`FS=RBAXFQ@FF(N*[P**`] M=ASD&^L8204,#ARGK.5J6?,XRQ#BEL,LYL95J(?^$$7UAM+B"E/DRAR^W&#' M[.*H,&3-P%&SG/.LYSWSN<]^_C.@`RWH01.ZT(8^-*(3K>A%,[K1CGXTI",M MZ4E3NM*(1O`2JV+C9.4(S-7JM((F5)QA.:M;V.&*#0CV:3AXNEHTV6&YBO;J M:AT*,ZP.'*B/5>LASMK2OOXUGR7&M@W?`];7>=&&`^>W:S'AD#?)I''\<8FH M>G?+Q;Z.,@&W;/]M&[L\VW98]&HU8+;-7%^Z:QR M7D?>8EYW=L+DAG3^9#.1 MM7JJ&"$P4Z06M`\\W-R7"8>\I:G MSNU;;]CWP6-_:OT'XQLSK(O>XNFWF%5+.._Y%\&'2%GTSE(8<2-8U*HCSI\U M,>P\K)\*17J_^QCV>LUX3TUC]IZ*?%1O?X_0`QS&FF!)ZVGU4O8GA1CWQ52S M=*_Z#.VH\H&:?O7QWTPT"ZEA"^ZQ1+O1WBX]BYG,R.GUWN=EB[207.<-2#F5 M'P(ZR`TU8,@\7:%DQ#T@H!QHG>*5H`D2Q\%1!Q-@BLN`Q6")1]'8!LY-Q&8%5M"!H&G(_YL+8HX]D,X,"I/%L4:5_<,H M#$X3!M/%44<.@@C@K9L,3D83,LOQQ%<3=N%W))$3^D,6-L?B4,?A?,?C$:'3 M+=/4Q07H?(3�?A-$<.%J$=.DL:EN%,4,+3B.%,X%L1PF!+5.'AD.%=:59+ M`.$?/F*YR%/B]"!LO.`:,@L/RN&#`.'@^:"*Y.!2N-L)EJ(ISD51]%Y[^(3& MW9ZST)7JU$7II$KF<9YC=`LS':!/G`2-C$D1UE-SH)E/G(B$`,N1P<.)V)M2 MT)O]U1`P-H:];<+]9![`"4103!ZIE=EI"./MV=OMS9`FU0:!`-/M^<,F),4& M=AEUG*-;-<229:"HH+2SQ9XA',RD/'WD&,;D0[`C%W[A M6-Q1P$!%L[36,*U;00I%#TQA,#;>,J$94OJ#-B')9A0',BI%%A)E3:I(M7E. M>*#E5Q8B>7@E(:K((C9A%"[-71ZD@O@D)>JD1,2E-R'B3:Q));[E@S@F*.+_ MI,>,I&=Z9O`IA0U^!$NDX.0Q!BB<1#^LPC)T2K>`W@!E(#4NH`TB7SOF"(,4 M(Y*L((@(8Q_Z#6D"'P@R`;DPB9MT"S(R1XZ(9`&R8P_N6FN>G$W&5Q:JBK:H M@CYBXQY*8'"TIHJ8&C$`(7:ZHC3N)GF8XS2ZXZ>4ID?X&$6.VGZTD$U(X_I] M11V=R,;01!WNH?KQYUMD9W_.Q.T97JN01/#UA_00&6XFGZW1TZ3T!WOB'DDD MYP8V"&N@YX+J9COJ9@A.1+=])HB*FU\]S#T4!6S4S6%@F,4QA&20'1]@!#Z< MSA$=!D'@A(K2V5*YQG+]#>1H!-8EQ"6F@$.<*%WR_T2TD-??,`,-R@Z+#`3? MU2C0@41G8<1"I(#=_4:M%!;6>58*)-1BK!AB"(W(2<'(&437'<8-&$35.$G2 MR(0=081,$.D_X`,JQ)EQ!.G7_14UR"C<#<6.')9#5*F7FD:*;L.6AL6@DD9( M?.%.5,QE"!](``R.0@=LO,50',V83I)5&!ZN%):X0.FY^$,H.&*(EJJI#E&% M_MC2<-BJM@07G"JN<26LSBJM`EH1`MFU<9C`&<:'UFI?)8ZO!JNPAAD(Y=.' M&82=U16=^=RPGH?Q-2NT1JNT3BNU[AED72NV9JNV;BNW=JNW=FMY?*NXCBNY MEJNX5BNZIJNZKBN[MJN[OO\KO,:KO,XKO2+:,HQ)B&'-[]UKI6&::,K%GHWH MH]@H"1[+6(@DDA2(>53I=!`#@#'&)A3LPO)6E9(@P]:,BA9'8#PLLN@2Y6#2 MICEL]8!LO9J@/0C0;E%J6!2&,B"LHOG#J_8AT&",E.49CBG6B1;>6A1X'09]@`')J7B6TAMR2+> M$B*.#7'EKCY:N$P$0M@#$`*KGC4#WYU$S@;5)QJ+L`V.K/:5(R&'63J.'`&' M'%G2J)E+G@4A4A1R(BGS5#-AQ7JV90F,+5E7$% M1C'_A(B8Z;((1!C,8V.$Y_B$!?5IVL\5SE!`(0K8@!WDT],^UN?R!HV@;D4X M!3V]1%E=C@-*A0M^B$#`@!TL5>K"!>M"%!P`KZGDA1B`%7,DX)^)"K:+QJ_,9Y.->Y"VDF\@.F:7P70X)C#_PIBSUS0SV@X6(2HE(F2Q9 M7,GYRX`HK&%@!'A$E1,ER730SU\URF^T'G1HL,A.#!6D@DVH"IFT*!S,1KB0 MTBP%!\`'#`6NY2BRLR[+%P]_`S%()Q)+Q42*5TIF4_Q!-.->C\$P'AU'6 MB(R"!#%"Z&>C>`G@9->MW.#.ZA M^0,I3(8-$M.>.8E!P("/G8I=7)//74U%-H1Q:H3O0(_J>&3K#$S5%#&Z-(+S M\)8$'96!D&@)^0X(U8WPC$;&K";(E!&;%/(AA["72$SMM*WU2)4KM0D(I0D* MA$^<"$0S98HB1T_0VHU5H#)JSH_PKD0_8"?^\`8#T3&$+@7[A/&CE9[7SEL. M662D05.F?6^>I5A4"-#RZ,S>.(R;R0>G-%%D`1*^A!`ID0[H\E=._$S=FA+: M,"U%C%$K>0?P+!'H#,_GE.C8>/\SU&V..\=2":W,OS#9RV".'H6S:=P#"9V$ M-0O$C@V2/A.6S:F1*O4S!TE9+4W44["SP@Q/)267SARL+S_:&&LAXIXE&A?: M,S*&AOD9FUH,Q"A*YYQ-:3&%EC"'U**R^/RQ/K6TT'K$*T6/_D`'*&M/FXSS M;@((*@>4]:#1^A1"5#E()IL8*S-0@`&(L-E155D44BLREJ2T47P43R>=3654 MF\`&D;40G%0UJE#N[]"=CA0"[GT(1"L,3%]%U5;THLEO3I9:_4J:/8R).M)( M//)9C[9&`67<=Z@+"L#"7#Z2D"Y-UFQ22X2>:V7/O=S'9HGLYP1(S$JD%A=; M`=]`R'G_$0?/C#CSEM^,\-I`2@HOLKY$\&4/]6A0-E-0WR["YR5CS5*034['%PI%Z1$#A/80&6!5FD) M&$R:5$.N5 M5^M<>YG+EKF:KWD8FZN;OSF<Y[F>[SF?][F?_SF@![J@ M#SJA%[JA'SJB)[JB+SJC-[JC/SJD1[JD3SJE5[JE7SJF9[JF;SJG=[JG.Y._ M^IUW?PF0-TZN6^J M_SJ[Q>R66WF5L3-UC."DC;"^G6QK>$<4.A,\H(*(.+E'E_J?922P9[NWC.U# M%B"R>\[1-1H\,`*TR"!F3(BWCWK@'/]O==3@Y=2?_<26C"QR'$ MVZ&$Q/5&UFFWE!VBVM7[5>S+WZM"C#1@]:?C['15_< M$@KF6@6?XU$'$69+.V+@:0#@7^3O1S)!(Y0W=>2!+M::YZD(_:F([4V+E'A& M\VUU!D$?RA=COM:GZ)7U\75YPP_]=O`K.%K<>7X[I$%3$8JY0!W"T>NO,:7@ M*/I#-9P=J1JNUR$B&3)E2>Q37`3T(FZYHMKIU@>F@GRAT(S]D5TA&JH[T<>] MT(S";6^6XWY'S3+:M54'E5]<8F:B,<'>5[!'8#'#D6%[6QJDO"DP,,W>1MRA M-28%5[BG2`+_*'6JT@(?D_;.]X5^I$/*/>@7AS%_!Q!:9)$W&I0SA!^\^E24 M_L0#3DKV!A3:?6!I_5"&82(V9+3L9!36,G5^,X1PDA3\HO:15Q^(/2/7G_L9#QW(VD8%FY0M9?O(Y1&IJ MRRHD8`N-_S!*YV';9QT+YVF49X`VAG6JB"HPY*W6IT\@($!H.O3OGI-;_Q`F M5+B084.'#R%&E#B18D6+%S%FU+B18T>/'T&&%#F2Y$)[8A#:&P@*)3R4".'A M*#F39D-_<0X20[GL)BY74:-"B,10J0[&"_P^*%-K@ MH("*4)/1%=ND'D5XKRE"?UE3\$EQ"Q\SHS)3&AT8=6K5%+:R;EW8=>JVLU;5 M;L.'ZBU"J2I@44)Q8YM0QX\A1Y8\F7)ERY=%VC-J5$7C?UWA&D:*F?1#?Y:6 M^@.%PH="T*5AQY8]FW9MV[=QY]:]FW=OW[^!!Q<^G'AQX\>1)U>^G'ESY\^A M1Y<^G7IUZ]>Q9]>^G7MW[]_!AQ<_GGQY\^?1IU>_GGU[]^_AQY<_GWY]^_?Q MY]>_GW]__[Q5VVRIV,X:D"1_*!F-HGZ<:*Q`H1X,Z9XY/*,LPO\P%&^90S1C MS36M$N++J%@VY,ZEA$Y+33'&%+KIH!-)L_]'K^D"5%"B>YA0X2"A5"KI'C@Z MDPP>&S,L$KQE<+B'BW_Z8:*GEF[X)YX=^Y'C(%#FP@Z>*!,B9BU_!/H'E-#$ M5&%`G6)DL3K5B(R(P0II(L;`D2:$TS%EVC12S^SL:0T?S^"!JLY__+D$SGM" MDQ,[1!6ZAQ'4[MG*Q91@B:-"/#&3T4$X&.DJJ'^*TLHO4`J!0]"L$C5JJZ)4 M2,4S'%$@$Z$J8SFK$4\="G5551MCU55"-;D5A4\9^@L%'9F4X\QC?T5(UTVM MHA(.0[J::QE5LU&6R6FK)13(6'!$EDDF%DNHGZR.M?.O%`;L)XY7LC*D452Y M8@0.QI[]!QY5F8S_8ZESCQWPK$Z'36BU5G?<4^'>5,L2)L9D-"M8A4!1\)XJ ML)O8K#]N(I'%AID$Q%T#[_G#3LGL8;&KM>SYRC"4?F1D-9?]&:4Q3?YM\!YE M^Y&WT,;ZL?FS.55;:^5;6CY9&9CA..3-G6/IF5!#"06%934;PEG?SHH^2.J? M7R8(CD8FA8?K@\$-$LQ:K;XE0#/O41LG)ALD-(^JD0)Y&9=1G-OL;?I1[*M[ MUC)+:)R["O)I;:FIN.HO4?MG[YNCAU8A5(Z3%^Z\MC<7.G&9UJK.$FRS M(J]N4(2,\0O2((?^IQFWYS:K]LHB!A:I@AKCO<4P)=^LW+[!A>/3:S?C_])< M?S_;O>Y&GU_(11R)G=CWAK;LW(]L?JI,Q!JQ%>+/\Z!"(1&45!*\2=^+B"%-#U MHPE$P]+#-K:M&TPJ+DC94B9;)(I::0U\8VE"PC09P$X""WY$7`8D=X:^3CFQ4@)+>54IH-?6$28?H0,L%,:NQ< MFV1>\\PB2GO`3F,3.R),8GA'<9;F?@@Y8U+J=KTJH?)_UJ%?BZZ)$,>92UMF MN:1E"(DW@H!1&9)21>S$AA1FO`@J*9(:!P/Z$U2VT6TG!&-4_"E&@\H+H7)\ MZ$*:I#XFN*R*!QV28?QYEM8<46LD'5`58V?2?TCE*TU:2CRZ9SRQP*F1($V=#02C1P;D>C_-DK(9%`6[5WF)#>G<2Y5,D?LD067LC06)D56*;+. MZE"4NL\HD).$NMUD1'0(5L%K,87DS#8,V=.R;.M84DA!*D1A%.7MJXX4.Y9= MR`K)WYT58"F00JM"(5=G626O?C$5G!+YPX-MXQYQ'5[5SDH0=\+S%O@J'T7H21+E+;<9RUV0I MX&Y7._GDB**ND\>.8$JNN'QO''YJ`FE'`)62,?;"D64QJ@V\+T2@*1+R'VL*]#@$H1\/9MH<)QL90O*A+R,F?. M6>;//1::4X5X9L_@<916"2(3J][9,EY^LVM%)4]FH9E@_Q637!N#/+TF*Q7D MHNBX'FO;PKCH7(98S4M*?6KBI;JNL!*L]-`R(+H^UO]=9`T*K"AH+QO&"R M%[YXI6F_7!-@31[8L2^-,#^'!\EJ`I,?6IN0-_:88U^=)RC$!Y38;)-SB^M> MYI[L%R\AK8\ZI!`E'>1(L\"ACX1ST-W2R&)BD$X3B&%5V@0>,$%_QN(:5QL< MHJKB2?%[+`]%4%\(ASZ(_S%QVZAX:B(W.4+]4>:YDB03:A5SEZUL&TG[1^.0 M\O+/6*7G-"-F#BL.BXL+^D'*$/G<^'WRP14.@C,/.K"U"+6U<>6'5I7YT7RN M%,U1>=W6(<8/)\0(R=&L*#S_!D_KK&H6JGFKKJ59AKC@S+PF!:6=I53(,TF8 M[=3X9+@R`5VD'.0O7FYO\3OJ&"_G<)!>EC.,PV;S-YGT4\(+3]%1A+JDQF9! M949/AZ%-"23%[,TI=G!`JD]\SE[?^'V^"&L/`QHE\C?XG0BO-;6<- M),#V1(HQ?[F4DDX1]ME4?_MC%Y,NZP5X+N9DF,JO3W\`\XV%W`F+&&U6,$8A M^J]JN&^(]`^8C(I0CLY!@&G]RF@IY"]TZ&\@[H_\B"7.L@^@]F\I"G!_]&F. MM@_Y_\8CN:2OD&QD`KTC0`[)60P$4XBA]B[C7#XEA.Y%Q/9E(%P/UG#@F>Z) MG@9O(-@K9,8B+SS#'VH(FLZ'?9:04)(P3)H05C8MC)#%O$II?80++L`LDMIH M*4@.FQR(;H@HRMI,;2:F[[#H#*L(#1-/\K#H">P/IQ0' MYPAB\/+&&%2$J'+(>V:*B&+00:H!07P1!?<)&3LP!',HC?]8Q2]B"^0A21QZU@* MZ])BX&!NP1\A"7E`JU?NBB*-\"(+,2.![=<\$B$'*YQ@RTR*`MQ6,BO$Q1]W MBQ_/D3M$+4O*[2"0Q]?$0Y7F:2.-##[\`:F8Q!(/Y)_&XM,P0L1JXKH`1"P) M@BQ-XZN>\BWA4LZ"(BM'PKU`Y?C_)@*]A$(3+,TV[)(8\/+O)#$N";,PI4@Q=&-,T'-,P*;,R+?,R@T-X-',S.;,S/?,S03,T1;,S.6(T M3?,T43,U3Q,S6;,U7?,U83,V97,V:;,V;?,V<3,W=7,W+6P4N+)9]",JTY$B MQ&PR_`[[Z&4CSB4PT:G.4(S-*F(Y=4,Z>9,X.F0K84/W+,Z M?<-%1B'@"$0MYH0(?Y$GCI40AK$9M!2 M-FI43!IAF+JG1.^A$*:+-*ZO(4)%35C*551#9GJ2+CKKQG0H*T@'09S4=-"% M;U!$,9J,+(S"[1A4,:227$)#$QQRUQR/2PWDY'XR5S`M'%_(6V+AV&XLBT`. M5Q#DV8"D#:UT-<9T,T0.+1S/$A*C)U,L1!PRL]X4>1C#3EC*_1"->!MPPC0[1:4$A@!.&L#_8811OP!$,SR,N[..6/I'N[S'N3E M$36!7=[)7'1&6Z;A!V?%9/X'R,6\CO% MCUB5E5G9I^7.AY)2HYO8)8#^)D!L%79D=>PJM3)P1`9A@\SH1NW^ABL>"S)P M9$9HHRNXY"^"0A0`IT@S13^+A9ADRBPX,<_Z!A19"U#)\03',2E`;T#NS*I` M<+@H+C5$\60)0E)(KU$N2KPB!`*MR*M`$70FA6=Q8@$'I1U3XF-`3&4W;S-: MMD4T+XAP(I]8;`''94,#=B\)EIS8L>!H#!@E0S4<%H\VEJ6VR&4I52C,1D6A M"V67Z(!F-BY,"V0(D"VQ"73"$/,^T+W_0E25-$%>\@]DEK%N_T][G).ZNNAC M^#*8W(=O_Y"7W,=<#_-T,\?Q)**)(^;)-"(UG8LBM1Y M6P_^K#=G?=9KGB<)NV]6R*5K+8AF',=HSX]T^J%Z@=?6:B=0M2! M?%"!?F0@AC-T_Q-(LO"NFMIG1_SN+.2%Y'!$H.[5`O^0A)?P@Z"M(?`-:%0! MAAEO?W/8`A50AW5I)=*E`T,7@I;K+(CJIB@T2%;X)UHXF<:M]8)HEHRX?KCP M>BSXG/P7/,6@9J:!UV0C%.Z5'3<-"0.W)$Z"B[UX-L@X0V>4>_`H>8X0+0)C M,`JC*"RKL[:TK7[H*4PBWNP8*SK+2^-T._O"+*J-:!#3([WT)<*B$<`6AK0T MD4Y2!OGB5*A;EC*+@"YH'(W,D$-=MA4D=>J MD==%+0Y"*A@#;.7S)^V8LR2EMT`UBVM"?G9W00\9192R,>C*(R$CD?]4M-&, M(KI(DFBTZXZB3RAV5#>H-RG`DAH'TY>MHV;&%CQ.43?C;B^EMF"SI-!,`]&X M>9T)$UB7F;X@4VK=F9WIN9[M6<%4,Y_U>9]!LS3Y^9\!FI_O>:`)NJ`-6L(" M.J$5.C3]>:$=^J$WXZ`E>J(INJ(M^J(Q.J,U>J,YNJ,]^J-!.J1%>J1)NJ1- M^J11.J55>J59NJ5=^J5A.J;9^>1NUT"IXT+"8T1%(@`A9&YPFJ8 MSU(5U+ED&D/`!&:8P%WUP\HP`JH=(\?*V"-FN'2%CB&NFB&PK"&H6KJD+8TA M`UHEHJO#*)@UPJR3VIIKYYK_`YTK`JYK0HO_:@*H:P*EM-IC`6DH9I:N+P.O M'Z+/%D*N14*PUWHW5$-V;0LN%AM)>:5+'OO2_K'M)8Q(6U M%TY8-EO=)(O6T$5VA6U\K**RTU*&M1WQ160D.W42F1>E!9 M3GNS)WM:5H,LBQLKW]2`#6;2/`O<(BVV<6WA".:R"Z:QM\744("B&'4;)O6P M<\.VL,:;AX:_P\_?PN9'%E*C&Z@?ZPM%%L)>JX;]4*OG0*H()2MFFC1?297 M8AYWB_A\^$:C\,;%TIKK?J@36>T'DJ13"1D=EN*'\ZJX;O:.`$4]=TJI"4]O M4P31>5[%^6P/?]R15E`]69<->(8K2L)0U9'5:Q1O$`WJ)>`0S-?\4 M<2Q@W9X<)H":B]+]7!2=@#"2)YAV6&SZ$LYM@QA#SCWDORA_(W9S,O=\1<",]B?Y&(XG::!LH MOD+G"N'-HJ_+UX8V7K0N-*5(_>+=D6UW!+`COJX<:0/9"'/SYNA.H4UP M%J!LJYRU?3*VT'8D,&+_`+ZV#*-N4._2F`Q3@LT%:%(`W7+SAN&B=W\C3]Y@ M``]:<93R''WQF$.I6%BCR(S@5P_!28$TI@[==E;_TCB7?$GVF'=[T&\+MVZ9 MPFD(MW!N24_J`3'AAF_LV^PHX'Z7$E>4`']3>E#SYN*3"(7+[C[0&$^4AECK MEVU_W4?PD0C('C\U@*G+P@EDJ@EO)ST/N3"`&`05E-YP?UB-T+KH'R-"\DG` M%0KW!XH"O7&E_`E4/F85C+&`V_?HM&$>US?3*/C=K7'A',9\-QX6;>)\A[^H MYHD4MQ%SS!%%YJD:0[2?S$(5O'\5)\GXQJ6EM%$7QU'[DVI<7BJFF$8_AY%0 MA%\=#%U5D M]*>I\<%[3/CJ)(88EEX5M0[;.(PXJ+_#B5/9#^)7JQ]' MWHN"\,O9M?]1MJQ1+VM[@!'Z"[47AUCA&2?R]0A69..,OQTC1*T:Q7#<*8(2 M1Q'X'^84M+431(Y".<+OX?_]W6LZ+&3)OBOWW4V^]SWT-S;:]XA:+)MM\QYB M!_^-AI@4\6$6TWOM?1<:6,ZAT$ALO)F'8`I\=(<:++TE)!EF?66HX&D&:G1< M;"K!$QMEA.+Q'6(>]L3B-*'OU)Y,F,=F%9))*+LED MDTX^"6644J+ESU%SJ<*6/U@RQ-647GX)9IABCDEFF6:>B6:::J[)9D&OO>45 M6Z#H1HQN;-Z)9YYZ[LEGGW[^"6B@=$46GUO*H.!#6PCN]96@CCX*::223DII MI99>BFFFFF[*::>>?@IJJ**.2FJIIIZ*:JJJKLIJJZZ^"FNLLLY*:ZVVWHIK MKKKNRFNOOOX*;+#"#DMLL<8>BVRRRB[+;+/./@MMM-(B3DMMM=9>BVVVVF[+ 8;;?>?@MNN.*.2VZYYIZ+;KKJKMML0``[ ` end GRAPHIC 12 inb005.gif begin 644 inb005.gif M1TE&.#EA?P*?`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRI<7<,=[3%;$38A8Q6*[D"-+GMRPF5N]_E01-AR3F-K-(?4N%$VYM.G3 MD$D39N17C,#5E&),8X("QT#$M0N695V[[-A__BBA2!'K-1S>KO]]11%CV^K6 M`XFA6)'J\3_ESLW(6C_W",NKSY\U55:R)NKSEA[_[R.-=$](LF%:)([IU'VAZ(99<02KB@".) M[5U&8H][+4@:B$@FJ:1,(KYHHXD["K1,E`2!YH^+;)TBHR:N_?CD9PB*AAN5 M4U89YI!&#DEFFM8MZ>:;<*Y%(GXUTJB<;<`!K(X&)8P5JCAF5_2Z21! M]OQ%T#)X^@.(E\JQN6>>D0K99IR89JKI0TUB%B839S%3'&*A%NX5%G+1@[0CM M<*82:^^]^.:K[[[\]NOOOP`'+/#`!!=L\,$()ZSPP@PW[/##$$E/C?M]$:$<7@;;8W&`8MPR2W7''@W\^;C MLF3%\0IM.W(-V\G%VA:DG4^W[79&N)T6?/NP?6-U\C`\;_LE]_L?'W M[MSTO2T7)G$0DTRW9*WN*H3OA7'.66 M_.+HXI#CG+M'_W9P:@7)Z^9PN&:/H'F!6NOFQ[.5_-K7,U_E)L41HS.5TK?O MLZ/.DM=NM'73&QVSZ:H[G+7398N#UHO)G[,,LQR:O:=1<$";^Q;8N*+YQ#(, MC"#C'+@3RDGP@B`2BP8WR,$.>O"#(`RA"$=(PA*:$0BQ*`*5\C"%KKPA3", MH0QG2,,:VK!M)&,1NP1RCR:(K(1Q2W\RE1X]=\="(J5,H=MC[-+X%$26+)!2>J0A M)YF4"$WJ1HN4HU,LF4A(7K)VE`SE4(P1ET$RDCN95`HII05(31:I4**,Y4_P MJ:PG?C,IS[WR?_/?OKSGP#M5]TZ]C&+]+$D!ST4]1R24)=PC2(+5<@VDPF1 M&3&&:B&Q:$`C0SG$O*PBA*EB1V)FD)!2%%@570]%77+&7?D0HH51R!FU`9V, M/LB(&R'I1DM3M-Y=Q!_H"\G0#@+4E1Z)H4&ER5%K!LJ#P*6H(EEJ1H:Z4\H0 M1GXWTX^N4'4U^ED-:Z$JMDHX;6ZM6Q%NZDI`/7'+*A623P5.J`00AXX*15+!Q8CWN.[23+JV@CP5K]T5 M$,XLNLH2):NXS/V.&;OK&,/1E%Z(X:ULH/M2YYH4:-3M6X!K:Q7(:1(SJ^.2 M)EF'OLY=V`FG$$MV8)4[.4KWE0K]#ZYJ"2'TX0YG*V9DJY0C8BP6Y,7:A-ZA M2HHE)AP35O8=;U!QO"?"9*>@H`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`V8E[&<77Q-UP&IE*:)(*5XQ@FB%[M!V$VZ'\@2#'>A1"YM6^G)E'9]>L@PP1%^?$-R%!1L@:AR'#S!A< MQM4RAX,KT8=N_;-'BX@9\I$0:&APWF-[P$$)VE,@\6:)V%-RV)@8T^",GO-4 M),>(QT@Q\R(CG>5V<#=Y796".7=LP^%VZ38OI4>0ID)S;3%`^J,"@$=Y;>47 M8>$YX`(*@;<@^<,=_3=%1'=XA8<;6&60^VA?:=<('HDT8F=Y]3@ZF@<3F7$; M3:01*YF2^123+@%%3P2*1/_S>3*Y3Z.'$_6C=AC1DSLYE$19E$9YE$B9E$IY M1WKG?E/1E*('D4!9;L37$+AW$QK%>M#2?!MA;'1',UY)$EO9?:%A:U/#@F8I MEK:(*#@9$>(7$F^9%'')>E<""Z.@#77D$7XH)1KI="11EW>9E]3GE\N@6'XY M$O6%$%2%$8LI5&TY%(W9>N(C;1`$$@[D;+IX$I.Y#95Y$I<9@S2I$4S&@`!D M-H&50)&W(G-U6&O%$/O76;%%5FJE@/]A@#-C7#/8-9.U30Y8@;'U5=%">",F M6.'R6*U%F[$%F[H9G!D84-K1=QD5.X21"F+W3'])5M")$CVE"=3)3:&9$><& M8.3_X6#)I5E!N#A&F-&,>UH8H$F-Y:(>/@8>0@FHK*FK"4X9`HD`J^F4DVAOD]Z*:%(>W M4H=511@9FA%%0V2NY)F:\*.6&3M5II,?$:*]%CEE1HF%9F!^YN&LG:A!>68P)1X]%U:*QN*59__H=M6@=ACIJ8>HH M-V**JOB+7[)LP^B<=TE^$+JA-G)92FJ9G?J8<0JJC+JG%=&G]C:.NY@KI>)P MA\J>`E<6+0>F6[JB"`)Y&T=BWTA4\SARVD,>UP.H*;>+&Q>LXP4KLKI1?*%W MTY"6IQI;FJ`VAV[&JOEQ&O M8>>0Y$)U/>A/)V*J%#%XY2B%%EL2$YL2%NN?A#>5!M.2//22,H6M1@F57(&R M-F23ZO*8JKJ42_F3+EM<,%NS-O_K$?:4L_0T3SK;LSE[LT`;M+OCLT1+0CQ; MM$AK0D*[M$S;M$[[M%`;2RJK%5.;LN.:$Y@A?)99E1?!?B*1E5&@&KI?G-)$7%[?$QPIR-%L;2W56B+MP`%F'C)H'+K=%W$ M*DUDHE]K-8$)N#DEN#KC/(7+HR*1F/+'MPL1F<6GN!5AN1CAM1VAN5>VF9WI M$1%J1@_21I52$J"+N3")JF<$"V/4KN`I([(9+:6)4::%FERSFOG:KO63F[I[ M/^SBF\=&FLA9CLAQFRCU4!=H'9B%?Q#8@!(8&Q3)+JZU.K!E'`RXD(>53L^I MNC63I[K_AF+7R0C9Z9G@NSB2"Y?_&I]N09Y[8YX`BI[7I9Z>ZGR1(R`JE9Y( MHUW]*9[M.Y_$(6$%YJ+F!8,0DE_J1H2#4Y[7LBL$ZH-.%L`(+&'H*%_>.TD. M>L$R$SN=M"C1M!88JL%!R<&2)"4?K)>M)*(U!J@B9J+JUX>(6(WM!X;ZV:AO MN(M/)6I$,HJ5>>G?1\F>/X8DVC*:-:FE0"L9'8L9D^J14]*J% MB*5K>L+D9*=2K'WG*SK]Y9FC\*9YG)."-*=]_+9G[&M!`ZB__]8NL[H0FFA& ML!9LA0J,A^R+.#Q>.KP\CYRBXJ9R?ZHAWI9IX58HF@JRYJ1W-$6Y%86JHO%P MVEFJ*3&Z:^;*U(?%A9*.VN2JS?K"A+IO^P%O\!AP-J(9RGK+6MJK-:*-3.BJ M3I1]Y=ARYK@7Z,C,%G*LHLQR])@CP9Q.S[JMTOJI7.1,>Y$<<\L1W=XQ;G,4NBOV["NZ;2Q(%R=UU2CAR,2&JV9(XDX*2(6 M=OLT+]MZ58L5*\U.*1VU-2N4,#W3*?^9M#;=015QTSH-0C3=TSY],#L=U#D= MU$0M%C]]U$B=U$J]U$R],>7+TD]-M5?;U.>1MEEAU8'AME<)MK*;O8VE@X0XNSX"5L+)(\;) M6@.B+%I56..QO6QMF=A9UD'1O3GA16\KP/L+JQ"&+<45?>;5A(I]V$X5PER1P5CI%Q$+$JQZ)#AV`'*B"VMS>"LM4B]XV80^IC<*_+`:$=)8`>+49'<>/C`M;14G7N(JON(%4]0V?;0N+M0L M/N,TSA0QGK1#?>,[7>,\WN,^_N-`'N1"/N1$7N1&?N1(GN1*ON1,3A0!`0`[ ` end GRAPHIC 13 inb006.gif begin 644 inb006.gif M1TE&.#EA50)C`?<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO-OW!:02VK-FS:'GZHX0BAC9`)<6B(#OQ'A,4.`CZT]1VVTE[ M*`+'\(O1+EZ]?`>G7,5%,T!YI>XKM=M)NAC52('F,\$59=_45Y-]``/HEX'445MB58?P):!@* M*VQC3PK)?7;;!= M(-(6BXN\T4C:C1+F:.&23%Y%XUPE!H9"&+Z=-UYF`FT8F!:UX6>;D%A"IF5Z M0B)DUWA(6CD@CZJ%V:9Q8^HXT)DVXBAGDWCFN=1>'=[CQ'9A*CE=E9+].6>7 M98)):&A^;N=E0FE&>!YS(`DHXJ55?M;H0I'B2*F>H(:J$V[2&!]= M/A[Z):*U!?_ZHV9E(O1@H1)*IQQ9;O+:YEBM*G3KIM2):NRQ.&'YCST=\NF7 M/6'`$9D]VMU&J+/+DJXE&&K+\]NN2/ZH\&:Y]>+V'`H@SFL=@#_2E`$O##Z.@W3(F$L:@ M>VPA#*&4FG6G&(V?9@08E#8&%BV[?#F<\9#H[3LRR2.:![*_--M]=9<=^WU MUV"'+?;89)=M]MEHIZWVVOT)9G%BCM::);E(C2RCQ]O)_2C;?//_>P\7@U*& M[G\')[=LX4G]'7B^K5$&F,:'0][WY*!20QB2U!4[G:[1&6Z4Y77F>IRNFF_N M.>6HZ_F@I.:67GI2M[*NJNNM6>%'2MV? MI(ZT%V]4\LJK:7KOSA]O?6/^<$*8[*C6_KI1V6_'_?#D7V]^8\483BSGS2^5 M/D'KA^B][^?77]8R=%EVKK[4]Y\4_@+1W_X:1SS_V>^`7WE28*J%MSF5AU4/ M1(H")?8V\T0)@H%I&@(WR,$.>O"#(`RA"$=(PA*:\(0H3*$*5\C"%O9$2C", MH0QG2,,:VO"&.+SA0W+(PQ[Z\([F&;D?&*+<0!Y(BJM0P0U7%0,-.C(O4TP1IU!V&/'!)] M8-B(0]I')9TIX-O_/ZD71F9Q"W,8LV$H\9J23_DPG3))XD25*9(YI-&-S&PA>\%D1AT%48V>1A,45>A+GN@HB4AQ(I]LZ<9,VI&7 MBF2D*+'I1SZJD)">#J?6XF5'?*I2FUQ1/`,98VNDY+B*O4R,3"T(@SZVQ8(8 MQ@]]06C)JGJN!7[+;2.;#\F>>@K$A560AT-!@B@8P(IEZ2Y8U>A4:7FP/@`T MK6!4&1TYUE83E55C@9S./8HU&E*I`X MBQUHN"AFT**&!(UJ5%@;W3/:ICEE:`=#U&[_Y:6? M<>SG9+JJ@FGL1SCP(6I75^!;_H#,+IN%SQQ3TZ$UDK2UI$T/;.-X+K>@E`JG MB($T7,F$@1U2N+IU+6^+*Z$JK1:9Q/VM::O[+4C*UKGZV874.;% M`6!P@-PD:8RZR^6L9T_"Q[3^D63OP2PA#1EJ/O#L7NZA($PN.Q7X/)R,-MY<]"`/97A8,"[YTC#X?MF-F M7>S3#C/PP@;I<+/`Y9="L@QA*P9J?,+%8Y36.)&MO#%;:XOB(J=TP"!I)&01 M%TFY4-*2D6S;AN@Q`]IY81;THL_C M7CMC>4#V+)DG96M*=E$Z87*"+8;;.Z13;XS"APYQ4'VKL28S^$O=(9F6)0!7@5G6.*)5?>_";HN?"MC<%.USS,J/%_\8*B-RL\ MQ`4/[<%?"44Y+Q7BF?^-^*3C3'%P9TF6*RBK?CED[I+)6\#I_@B#@@G#:&7P M'LTDF0*5R01F'A,Q;NMJC08ZA0QJ<3!`9XN\(OO5OHPL!5*X#WE`]'0/!0;K M6C>,%NYBT63VM>F)G.M:P`ZSH>O3,#9XY]9CT76"2?;K68=/U.^:5K:7_3YU M'QG:0A'3_K2F_[TJ$^]ZHVWSM4/!;1E@3TCOQX+8\C4JG?1H.MS\0P9%PF M8^^"RIK27B5Z>RN2#Y\L..#H\T';?5#6,PIMR.'VE>I,](UIP'?+$H$O`1B_01U#LPW)8W_< MPRPWR'VKH7LL03$A,TN[92U_1(0QN%(VMA)THCN$TD50-E1/N$^O]2M,V(0M@4;:0#\E@20;>"?>IW/5IX8BH3EM>!O:,RJ:H%'V M<&D%^%;?D2F$8H8W81EHR($Y16'A8B[D488108C5_V>(/F@X!3@AZY83+A9` M^A4NS$(-TY`!O*()%"8C.O5_;C$*INA[0\4^JK@L MB@%`R\*(^R1UA\$@+[`?OK5%CQ0QIRB**M%%NF@1+X,J.$88PD<2R)@2&X(J M;!$N$U1\QN@SLO<5VYB-WOB-X!B.XCB.Y%B.YGB.Z)B.ZKB.[&A".PA26[B( M[6@^,'@4[Y@0[-5_*%/4*$WAG$TAH&--E%*)"%`,P%_K8<1"GEZ MCV,XJ`$_Z`<')E@4$=E]M"4=;W@3N#&#)*&(ZQ>(J\(1(FEZFO.0_W"`';DG M/Q@@OM%_R8@2M[1.:D=U8?]6(#K)!!"X(53%5H>B'V,&8DFWJ_343,RDSVA.3J8(Y,Y13,A0"OX0R)EK`F6_52KX`IV`2"^]J8"=^5;Z M2#?RJ(3G<0,?Z%/4,IN3TB/VV5/Y.43PYYO%0RH#48E/\3WKU)`T48F3.9^& MD(=^,7`>2BSPLE3ZZ2OT0B@%UAIR4BLS]BQBX*&280CU$BWY@UB:2%Q0XBV! MHHE3!)U5MBQ48IZ>]3WKAHLJZ9(_U2"'8YGKUS##YS8,]1Z!-DQ@YS!. MZEP;LB]R`5@M0S"*%1@WD#+'<8=4^8LQH$5#QF4MPU.71(PL4U7P=7K3>$&K M`4,&>11U.G<.5(QFTT[\N'N9&:B$6JB&>JB(FJB*NJB,_]JHCOJHD%IZ]QBI M931T9PB)E+H1]6B83PHY`#D4G\H=<#-0&49\Z_D2]9A/0IJI#EE^HBH:&P:K M'UJ1%XD3BI-^0<8_7+@X*MB#,D&>)[6JK/H8]$,=.BH=!&RP4\Z?H;7`FJ M9#0^_<%%PF.K?\*I0E(KA)B82'F8K08:HM%;,<*"N8"+L9:N@/ MHF`'@+6RF`0]10&S$6N(T'.<]/]:7DNX+-I)F*H)FF,1-(%I)2RJ&L`JG2?; M$.CI+N?2+$I+#+P4/O9HIOWA*=PAM4FUK#!!+*&X%P3ZH0LJH)]!FO9)(.2B MH+_!GT>+C_13)LC!MIQ#H4,!M_^F.7"+H3/!MOG95@KFHOB)65!7KV7;)D26 M+9[(I&E;/M8R+=8V+4=CI,*Z$HY;$(.35/E3HX:[4,F4,E@$25)[,<.8I:)5 M.%0:I\VY15MZN`I1IQ_%J:L99WAZL`?YNA_50)!WK44GBZB++(#:%;N;NUIC M-+`[%<#KN\1;O,9[O,B;O,J[O,S;O,YK-G;[O*JD0`:UC])KJZ8JJA+7%,F7 M?"=)$[C_^AQ'(T#19Q-'*C*/*XJ]*ARZZA09N3&89(1A":,CLF'$T9L+J2HF MJ;^%*JW/BKN8YSNE`Z+I^WM,X(8IH!]0^H!323#C(I3.BAX<6(?PZA2O$X*/6,#&QQLH�OB)BVN<%ER9-$ M>RH8$HQ4VY:%`Y?AQI&]9;`M^"VV.1]Q*1!SR8X4"Y8H+,!ORS(LS!$H*%$E M"K:^@9H`JIGQE;.))Q,W)5.G!Q]R;\U M@;8XV*^F9*+D"8/6Z;.$"2O4Z:QD6+Y(IQU&*YWDB3-&&ZB=_Y(D47PS;XQ, M,'2YEWHW'JHL\S)$,"@W\_(HM6*3^2G&!CHP_'DF#KJ8=+R.P1(_P_G(B-'( MFFJR2XNS=[PJ+9HM67P>\VE,\=+'VS)(?!O(B[DLU4(MTH`FZE&X,^I_*?J) M_-B*D[O*IY/" MOPA#>7&Z!'-;?>'.2GR[4C6J3[&G=BJJKGR]_-S/_OS/`!W0`CW0!%W0!GW0 M:C.I"Y&J"/U!#$))"IT0S]C0(#'1B8P5S\BZ.1%1Y]L0#%T1':V,^VR.0C@= MVA?,PNNELKK16.L0'PU3T_P8,4VI??\H$/D'L53A+06DTSB1)K:WB,-(:=EJ M,/%K=DIGC6[%(%8I,QX\&U+I2.BQU"V]J")(@NTJ%1@(4.NJ$UW4)P-[+GF1 M/BYREG7LS+",$!U[V",]CEI(*P=\%5+(*RX+P)`K5X'8*N29)C#8 M'8(MAJO9SMB9V:"MV.,YVHTMCFWLGL)K)_[0M'D*$V]HR7D@#5Y-6((-H*&< M-Y'MAPZZG[T=;@WZM6),TXKEPG9=-XFX'&YKV2DQVYER"?)D7<,\=NT,H`5( M+9Q8N,O\'3__"BTH6KBF;:*U#-ZI'8YC:8L1?-XW4XL1`K(`1\)K_N$@'N(BSGF0\:#1.^)@8ZDZIPD^!]D.?KVIJLGV M7"+)G8"WW)^D"EQ\9:LW'D#":N)?&Q(A#=+L;4[O*U&0\\RH(1M`SFW M:I&2$2)*>[.*/=/NQ!M,;H4L_+W2UY[3,SW4<=-%KG-RJ#G-FG_W4`7RC1*; MDL').G9"%KLC1.: MB^*4/(M]GNVU-6+(J$V7ZMF&U*KH3(KJ$EKQ8 MP)ZS)>*`56PI-YR"!$\THWS`O\T;IVS%L\(=^!M__*[*\8KMU?,Z%*KK`-\E M?1M`P]Q;\M(FG6'Q)ZI::YF*PSP>V:T"V_]M(\=,\^6-QE-.\^--R]^-\V;( M[P,$G","Z[/8\;43N9+1[3*8N>=<.,[EB^6!I0@N0UR7U&3ZSMJ+`F@:C`(7 MX%BOI06>=MD\]8>AX/&GNB2SI[2[C,\30:L;0;4[,)..%44DLQX9GX9*X5JA M]VF1L39"]!%QX84J^%U!^([A94J*XHJ_^(S?^([_^)`?^9+/CR<^^=9#O6T- M^`W]J:&:TX=WT1Y)":2Q+MMSOYJ?BP1]JZ*?)>BW^E81Y:]UTJ?_?O2+RT0L MH"OAY?S=TRY3XRDQQ6W_4\6#PJ]ZN;U^.0VFCL2WGY?*S-;_C-/ZMQ4.6^N#"&4O M?"WC2;+:(BP`N^QTF4Q!4YK_;/<`<8_+/X(%#1Y$F%#A0H8-'3X4>/`>$S$/ M+5Z\.+&BP64I8OF#TXB@/THB23:ZYV1;P7M-8BGTIPG%BFT34>`@:!-GRI4% M08K,R>0F1J)%C1Y%FE3I4J9-G3Z%&I6A/TX]?5:5FM4I5:L%E\7HJM5H3+`^ M-8$].3+DOY\3@?YK^?)@3(_V5/34R)*B6X-I#>85&UCP8,*%#1]&W+"87(.+ M$S]NS-B@/9R0'4ZL_(_87;9KV9;\W"@FS7_VM+A$:(^T:FD;EXFY)_=U_TS. M]L3\S"E[HV7>O7W_!AY@\XX"6SI?Y":/6A-JV+MXX=K/O,TNW?QY]?_T'L[#GWKXZS_98" M<*9M[&$ON@$79+!!!Q^$,$())Z2P0@LOQ#!##3?DL$,//P0Q1!%')+%$$T]$ M,4455V2Q11=?A#%&&6>DL48;;\3Q(/9VY+%''W\$,D@AAQ3R(B*/1#)))8/, ML4DGGX0R2BFGI+)**Z_$$DM_1@D+Q2V[S#),,:M$T+RH=%IH(H_@$FI-EE`3 MJTPWGT(3H0*+JZZLTO($D\%E?MPM(7]4&N[^@HJ$RQBYH0*4:22\?*8QN_#NI(KI@J M^JHG!"F%2E5677W*GUAGS6VD35Z*"*2=!B*IU`:14_,EVQ@B)M"^-.'UJ6J- M(B:&7!-"T-%LF=I64ZC"?56J@N+65T4X)TKWX-F_DS`J.3-ZE8N92XU)C^J M`ZK;;2KVJ>%#-1%CZ*S_*&/HM=06I;I"D>R6; MCM9SNJY![0/IY*I;#3Q8X'`T[+97*-Q-^,H"7'"]T^8/A2 M_PGJ;QL"5!I=J'"*&$CC)A/YSP07.$#[\PG^,.@3 M2@A(@RT4(0D/ECX<@`^%KW,3"".7%/%@3RF`\4I9TN(/4=@!4LX33!.S`D6) M9$PB`_D+&+7&A#E-!"TZ4Z!:W(9$5(%DC1P$"AS-0II:*="-GC(C$KWCL\OA M)%PX[`SKV!2Y/,H+@N<;F`K)=\@4HH0)G!G-2CJ"BJ'PK)#Y`LF:L,,(37"F M5EKDH8$THTB=75*3-XO@'1-R2-+01I+=T1GX]A0Y_`V2C:#LB^E".3Z=N5)Y M)\/(EK3AM*B`3'E2A)H_CJ49EF$Q,,(D)E2,Z15K4+E,/(R``Z7^Y,?L`-)O=;G=YMN1I)3AJ$\.Q(-[)3WPA3^7M2=&0WGM4[HD\LV!/\95(R:1Q)#ZUB2N]02I9_E&C/ M#EA&&!H2E8CTW@HWZM%X`N^@A"PK)MLZRL!=$79-)8T=2QG74SJRF5JMUUE; M28DY`>VK"+6J+>65TKE8T(3_YN.E_PC[/*+80SNCD`8PD0*=G/D1+93X7C-Y M>J[+9I:R1^$L0N[A1:\41R3-40Z%M,?"!TY0%?-$4&3/@UL#\:0T#53);R5Y M.V;$`GZJ\*W!ZE6_"E+*@W_23BF#JYKMM,<0M`6;(WUHVT4*5J`3_-/"H+L2 M9FR.)N-=;BP**;CG$O?*ZPC?(M5KO.CBZX(SY" MJ$"9&1U>R*A>H=A`46A;HDUWI"SN08A=_!US83,4[W?>^]ZZN>C*&[MN<\V;,NO],C6^";SNWF>[, MN!A[N9(5W.'B1I#/\H;H.!*V[?,`QS^%#$\3.TR[=ZZ+>N5<,A_*?+U5U51_Z*"V: MPTK/!;!?A_NJ]7VYE=XD['<$272MGO;CD@^]S'A%?A$>=\)7:=T^FH]0"LV6 M/-3<0&V&?->B=6@ORSG,A<=\YC6_>]*='?>I5OWK6 MM][UKX=][&4_>]JOR#TTB4UA(BW_;[G8VTX>-]?$?2\IWRM:4:GI6O&W4N^! M8P30NF=^UVLOH@*ZN>V#*9?)VPV33V^?O@'?B/*38J\EZE.@S2>*P*7O?(02 M1OW3;U%XNU)TI:"00P^+(#WLKC_TPZA: MQ4EZJZV"Q<3:I$YZ)?]*NE+\KC-4*K9:1DMT$`Z:GBF$'?+A((@:*#V\EKW[ MF);*/ZKS1C/L0B`+&ZXKLGT2C>[C+WK*18Z:&8QBG;7"NE],.5U$JVQD#X-R M1ZN01]&H-.QP*!X).HYH*5Z,I9/B)^^2'/23QN7`#CZ:&$T4G?]K9,=0Y,*B M2TC(DI6I.[MQA#E59$<>LK!BO+X]Z<>4TI^QD@NEPL>\JL>73*3[2CBWZD>] MD$-CQ,'"DBB\:L8%>L:SXB,/>L@'$0\]68;*@!_Y6Z%P^COC8DBURY117*#X MBJ&%DD!`TLBK$X/Y8K"R**[D8AD"Z\@K`K"36A.QK*Z=,`2RQ$?YZL6H4CNF MY"^P-*\/:C^RA*/VLDN)LDJI_+X\&BBQQ,N;*TK[:)M$T[(H%)7G\[(ZVXC9 MBCR723-2$19M*(^WX9/)+(O)ZQI$X[$E2SH41)W603*D:3/+8YT4BT'PP#(> M8[,J3.[O3.[P3/\!1/?,,-O8"PHH@+C."+ M2V0"DP"JQHJ.6V$3]ZRF]YR21UL1_+R2].P050J*:$R*V6H(FSC/X"!0]"@9 M_YP.V!`*^LR9_FL2.;%.BW@^%2PC./E/ARP*">VISU2M%?L+$+T3_1#%P(@M MPRC/H"A0]<30A8BM%%V.$S7/AH#1$%40&:T27VF5P1M09J&$19'/;YF[!3TF M'K4('046ITB6'_T4>7*3W&,+HKH/?P"$Z'DF35C18`$-J1SG5&!IP&$&S%8G!@2D$P% MB4N-GRV%#VO)U$B5"11[*.( MIO<9TV""&JFIJ9PY&@K3A'%5$!";4BZ)"12C*5.%377"%:D3B8E@5O.(B_*, MB'^`4S5B&]%I&&_"3*"@OYUZ"9:JN7YM1?><5T5EF()E#^[)*9I:GO]ZP17T MJ3B(?:^%K=:$EYGW>MVU)X57<=>19Z?6;W*48X#7>G_`+8G7>.JD1:.I< M&L6FOEBFS;A3QE"FI1*>GV&5T5*T]!5=!"7=]T17^X@TXG';_U54SKI>K`T) M-.4BK"U3>5&N98`!/,#`6&C3LH7=9(V7?%';V'VMMFU1OH".\'W=]:1>BJ_4,QV78$(70%?&I[:CAHS@J$C=VPT]^:!IA=V)UH4;+`KXZL."[VQ#^# MC2^U8^.LVC\IX9:$$U^RAS!@WI.]WC>V"VJ@!AEJX106U;)=#2WPXAFQK'XQ M+6ERK5'Y'@'1*9(`XZDI+0UU"-A24\]R,TU0Y9Q@+4?[CB=M5H4R$/A`'X]# M&T2^L@@T#PRBC\:R,O=-CSP<6-M1#V]Q'72$C_J`#_6P,J0S*110CRN*Y=ZK M)^[P#O-89@Y2U:_)90MRO/`HCXJLCAO`YFK>H8941EBJCF/&RUK&YGCNY6LV MDV7^Y1K9,&TAL>S*T)9XL"9^B'R&GGU^%WX=H@;\F"*^$<*%";$=3_^Q MT$^)GLKEF&A,6;63!4"@C>C\V#06^6A4^R@(J\2.-NF31NF45NF57DYF<^E> MT[67ENDE8>E8F^F;5I*8QNF=!I*:]NF?!NJ@%NJA)NH/J=!^?A/)".@(.6J] M@!21&5$0@1L>J>'=$SM3#IJ*YKWM6R7@BS?AHS>N9@IJ1+[;$;^QCCX.*\`L M2FNM\5$@E=@)Y$E<*;\!65)GF5BO>%);D5(/@180G9:%R+ZRP$-3D M(%2\>.40$="6Z;^%2XP#A.UX.G!*WRZD(M66IY`'%3C&AP[ M_QX<2140(?S/V5E4_$Z!#BPR`_%N";1N"P1P$IFM.]3#IH)![&87._0N*D2B1<3"B.Q#;M0^!28[Z^N@,41% MY=V`[CIW*W7D1JAS*L;BF8`*)VPT1Z39QA)==.49)^L[ M)4T%2:XLQW1"QW3T\^C4FY2\QG**1X74J$'?='OY<19XO@A,7]RBIIA0Q4]F3AJO7/&.4'X7FS:.5U+0T],5T3 ME^YVN_3CLDK&$@^V7$IXYLDY>&BRLU+LR#$FOE#FP#+P_XR.] M9$?\&2^@4NC,M[G'J0`\M6/"\K9[$*6JC_^SLR[/:FZSN`JJ_! M%+S?*)#]$:2ECIT@8WP'27Q^#B2?J3"K^'40.3'Z9I/Z(312.;3IKDTQ`#3' M9`_1M[+7G#+)X,P#0H$9<\/&.W3.?.?.C,U\JCQ!:Q[_ZBA"K`$SC.,3U71/ M/FG-7?-Y4>S%CN^S8^%/"/.TYP8&;_]X?_^#\UGJ;_GE:V^L=_]I#__>?_ M_O?__P>(?P('$BQH\"#"A`H7,FSH\"'$B!(G4JQH\2+&C!HWU:3F'_+L"J.ZR_/-G^4&I4,/+APQYMU M!Q)+O&SLO\=;1=-,NB*E/:\]NG5CWW^#" M*]I3H6UDL]X?_<7969SD>^53ZSW M^))'D1CDS?<0):M0SMMD?*12E5]W/_P_@!%!)<9(,<&V376A:9(*3M:)!]IR MB!6X7'?D804595V=)E!7]0:=LDA<*&G.&$@FI6B975B[3A=-J) MI[G(5DA1[1<6C@05Y8=45GUU(V@\UM?5?DDQLI9J-9ZBE)*4L"@C"HQ$E2*5 M*?ZX7_^.6@G91X/BX>2A9K!0\M:*3:[H%5!(8J4DDP,1&2"=+AT84U=-KL!( M8TZ%!2%(=U+(GF(7(D80<`(E^M*(+HHQHF+^'1B6?&+BT-.1D]%VE%J4V7.4 M5;^AF5BGFQ:T5T\XT(>76J>%%8,VF@Q5ZJ>*ZA0JJDP<%98*TS#!&*4*?A76 M"KYB%58CF*84*EA3M8H@EYSIE*I:[CW+[(%0I4#%*3%(8U1/*5*J+5"YCL6K ML21)YBF@=;HK5U0.) MA\OH%*QW4IY6K762^0M5PP_[9[&\__3DK*RPP(&EI3+"*BO_>%):]W%*+).+ MK+**;HRRS,DRL2',-ZO+,$D.QW+34?<1]6MD(5,R5%A6;NASGB&MY2%8UM+L M,LTY>TCQNUF7))(V%7*UR4[$U!?PH03=N_5@7F\4GH4[RTO:0'`SVJ:.&:ZU M9B,0FUTL$U=']557.E6+-\2!\\5;5XP4I&:XU[AFEQG79!S<5 M6G/184B>P78UPCN_&;'MHQ/JJAT:($]%'Q.D^$XI65UZ6QHN5:O&/;(VBR/J MW_=84IV"R)L!;3+D?#TK%%#GQ](Y_^S"EKOYZ[6')CZ);`GM,=&T9:;3+:DN MK)/1I?I&':D-17Y1LQG4.$2)".:N@A&Q!ZQ&(8W;;`T.B7D.5(+&&`YIHF,; MP>!Q-D@HC"P/49YI5S'8$T.9E&=H+>(2,^;G'K/(R2@WJ<\]FD>;TP01.F/# MH0[%H(HBTH:"N8(5_\JW#:N>R*)+,@(!MR(Q.:I"B`DQAJ MTJ2207JD*%-"%@FCY4C53!)/.H)0#7GD'_CYR"<]6,NE"J$ZRMRC$'=3C283 M`[]2GO(I.OY"4X_ZAX(IX(26^V%EF!2D%3>9R"M2P,E[X.>BJ20E!;_#O6.BDR4T`PD.AF" MDG1R9)UY82<\XRD7TZU0GO:\)SYCLHP_YK.?_@Q)%/\IT($2M*`&/6A"7,1! MA#*TH0Y]*$0C*M&)4K2B%KTH1N6YIHURM*,>_2A(0RK2D:+@(20]*4I3JM*- M9K2E+GTI3&,JTYG2M*8VO2E. GRAPHIC 14 inb007.gif begin 644 inb007.gif M1TE&.#EA_`&Q`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRI.[D"/7W5O0[&"7@-FJO:Q1;MRWDD.+UDJ9H%I& M@6-LQV;H+T88,7D-@T'Q>+936#UQG$8!8Z_<%"C4/T/[/)M M!&GS#3Z\;&#?L:1;#_M[M/?O4$L/_W3L5KCQLIMB^8NC/OWZN69COQ9SSPGT MOYK0$E.AK;>*;?8L9EE9E"PFES]R0$?-?7^Y%X=Y_P6HUW$!PN+@A/]("-Z& M'"(E'H&&K>79;+"%U0AM)@Y4WVKVK2B09W+!^-9F99V%G'ZU15>B8#*JQQYP MK^S8R'O`/=;AD4CN].&--X[HXHOV&;3BE%%F^%N,H!UHXU]K<:D9'"LP^&21 M1;Z&EENO5$GBF:`EZ>:;-2U)XV8C`D96879F.!B5+-ZG%H6J]4@CDY;YHXI` MQ3"69V&":A)H<)K<.:2CJ[4)YZ68IE0<=MIUPC M8)V*:IB'\?^7VC:>'@=J+)[RUUNJ*IH:JS:STO8"$RM,8VJI*`P;9J;,-NOL ML]!&*^VTU%9K[;789JOMMMQVZ^VWX(8K[KCDEFONN>BFJ^ZZ[+;K;E'V^`;+ M*`Q^-")$8'5'HK[O]MOL@90V5)A$:O';4%_-G?K>F/XV#*>+_M#+4&83W1N1 M/;+9YPS> M8;`Z"`LESRWSWZ#^^`PT?4S05^5K@3+!B,_55=:;;,O(AK/.6(]F5K%">K;9 M@*B:R.>3(Q*C1=>6%K3,LE5W*EO6<$N&,'Z%J.DU>X...?;2;9K_;7?:IB68 MX<;YQ6TX9'?#$JF>9F:H&MB+GMCBY/?!Z`2PDEILF\+LW5-%O8>'OE5?UYUY M+(K+_E,KLL0%MFJKVXT*'6VMRTZ0:XW2/D;\7KU7P-MT& MNO',5Q4?JO__[\]^___P`,H``'2,`"&O"`"$Q+8$+&!(/93&VY M4R!V>L6O!U*0>`DT7EY4QYR%J0EV->/5339(C`YVKDH@_,L)EY=!YKE(8_BY MC`5K%D'A10F&'$O80'!8N!9.SW/0L>"'_V8H$"+F!(@Z5-W;9BC$M_FP>1@K MHM6<:$0CXB2*S9DB#6NFQ2I%YQF`0 M#V5HQAK:)(X[)-Q@9CC'-QIO&6?RR\(^5T8([@20LQ%DYPA91%<-DH5^A)NG MN#.7U_`K7KS"I!UE,LD)ZFZ')KM@)$=)RE*:\I2H3*4J5\G*5K(+?;",9?@< M(LM:VI)[KLRE+G?)RU[Z\I?`#*8PATG,8AKSF,A,IC*7R_R5)"8 M#H:F)RG.VXJC,'U6[EB="HM!;[<<4(B0=D%%P3Y%6A!BC),A2#2-)G"`1141 MLHDB<6I$%U(8>1:D/J;(9".\.ALG\$&$_`1:.3,D&&(L"S"D,HL8:!0C1DH- M!:B!GEKF>A9_&"NC3+725A%25=[4$(OV6%9+-Z(AB-",K#7K034:]]@]VF"R M3*AG2&X5U-\`9EF8#*7J$!-.2L0`6*D+[7E>`UBFWN,5@%,(&%G(#,7_&72V M`YGD4SGRVM@J9)J0;2-E@+O'+I)D;FN2JU;Q0ZIX.;%40QT/'$ZK">@Y5T>M M%>GP%FL0/$KIA%&*T^SM`OE5^PP*D1B2X14II MI_8THQ^5I"_.^4V\4M"'\SB'.9ADSCU2<2RP?+G-5BJ%SF.Q&_G+8`XS2FY)9EC2LLQH1I^8GY+F-L^R_R%NCO.;UTSG.G=$SG@6RYGS MS&<4V/G/@`ZTH`=-Z$(;^M"(3K2B%\WH1COZT4ZV\E(D/17G\*>C,8F/K99Z MXQ0])*3Y@L\"C83ACK"3(^GTKU(9Y&.4>(HL9MER2TJX#-7LQT^'>N9#!]J0 M%$;'+Q94:*\4?)%=#S8B^ZW2!DV#T&,S5LA_P31,;GV0D"+SI?@";)/'9%.1 M8'LC+(7UU*+C8`^3Q->@3(%PPM3JW`J55N\FB*>F(.01KWL;[3XQOFTWR0DK M<[G93D@_H\/(KA+[(@`'MWM[M=.I-CFK:'6W"J2A`F.)H;%UG<9;HBI?X_0W M5Q2WN(;@2F.?^I4).?\F9F,=$M+X/!>+E27)RC.26.A\R!^78-"?7'T>M<0; MX+SK[VC9XJG>.;?`JNM.T&OSV9*3"NG0[*VSV8B0M>D\C;/1R\&K#-NI/T2W M1A)O;?$I](]D[A"/J#$Y4#KX6'S/3IW@?@\UE&=_;;,H:FS;D?GWS2)`^7IC-W=G'7 M]8D2_&EMNPK"?LGMUBE2X=4[1,*@JRI*MV02YT![QN1,[SW\8*H5`Q64\<8] MCW.D;WW7&)I$?KUH>3=\5W627Z5>IVA="FVVHK7=3%D[HBG]$.Z_Q/N7TC[_ MI!_2Y>MYBM/C3[_ZU\_^]?=9SGM^/_S;3__ZVW]=\G=S_//?YOO[__\`&(`" M.(`$6(`&>(`(F(`*N(`,V(`.^(`0&($2V##W0`5VL&,5<7@LY%:09!*:9B\D MTRGHMT[^%F4AR!(D7!1%EO4-FNX(6L8P7RJ4X(6,7`I"&ZDY8&Y5H,= M6!(#)Q+@9Q1#R!0TQ8(544(_B((VF!$T"!+6YH0[6!)1J!)5F!&G1A%_=TXA MU!U<^!=8)WU3N!%D94E&`D\F,5%(.'QO,TG,X8;0,7/;%$1%Q2NTP39K14XQ M8%1BL#J](,8=)U7:K_\:&>FA4-Q,6[/:(+B:) M>B@-CX@JCA08J3"&V#=OT(94;*5N8`(LHM5O^P8]A+B'O`*'U5:'N4.*JA@2 MQJ:%/R)L"!-L>L$I#55L)`51;9%99;%"TI5R3M@=2#@?&E)7E9(=A+11XW%? M/H<:;U51\\&,7@@TC-`;>>4GE,!7ET%R035Q%9-WFAW!A$O8X48GN>, M?Y*-Z.A9ZS@T?V4=<76/-#9=P+*/<]4E;/6.EZ&-%>/G<>/96)7IL&-]X4<`3DD$6F+P6@1P<4PVZ8F6.92(>D1W38X,60= M?+=9RCAY<+%T/S881<=P4O^UC]357.E%DS5"7=256MJ3.YZ7=+M#=^(&E`!F M$%KECI\75&PA=#YY=DN)=)Y'E=3X7_>E6C>S&$X90HW07W!'(4,I=X_!65;) MCE.IE:ESD^'DC^QH?:&4=R"QAMV'D;-A5T'X(GJ9'NNT6Q9A<(VT1F5U5LB( M<-`#=&CAD]#U4VWG1%?)EG'(*XR)E3MY'^+WE$9)3F&ID$H9E_+FE?"XD6P' M()2)E,AQF2324SKYC_VHFMK7E%/(F&/)5L\%<,IU):'G>5,)E]S$-"R$E4+I M1'0)$C,7<`5153[W@(#F!,13\2>5=B>=#XC"0" MF>S_&&NNB1P"`@C<"1]P&90!%B;()9&/IWFZ88^?B7Z\PWSD2'GJ`0?GF9Y< MPIZK:1W7"*!4*6#X-6"<^83AR7D==W&-YYZIEW;U!1=I^72;YUF2F9?/N';D M&9=JD5\$%GJ#UW43,4;C$89%Q$VX=3LO21%2]V1:)UQ48UR#EUG%`61'F2.[ M=SJ\ERIR^&XP!E2T02K8YQR?F(AY:'U#I6_"1X@H<*2*F%[3B`+T=ASZYGNI M,J1T2'R^$6.(:*5`VJ5`E2^B MNJ-S^F)BFDGQ=GR#5UXE^ESB-1XY-Q"#VD8PRET7ICUWPJ)'@^E&_#15'J&$ MT9.9,?%P--%Z)9H[J#=>1<1@JL=8H[=X&N%5C\0R/N)U&8$\+:BJ6&.I+W&2 M.9%\)L5(SS>3TW>KX^&79#A]Z[0G#?082X82*XH1&C@]N;*$WU&$"1%]%W.8 M!^.J$Q@:&N:B:C*MYW*L6EBHV-JMWOJMU\)_:;9_XEIFX'JN[U.NY@IGZCJN MZ`H1[7I+Y!JOLO2N]GJO^)JO^KJO_-JO_OJO`!NP`CNP!%NP!GNP")NP"KNP %21(0`#L_ ` end GRAPHIC 15 inb008.gif begin 644 inb008.gif M1TE&.#EA@@&8`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRI:Q(KK%*'5.4^O"O9(;ZNQ'[ZB]-XI55&(Z*O;T8EFT<1F=3JGT;=>RTBU\QX5K0'EM[ MS",/C?RU4774=''A9AU4\"W6&7U/25:@5,L@J&!Y M'-94(`KJY:95&(/]U2!N6FDEAH1J,=:B;YHEN)Z*+![TU%X:3D&EIZ-F M)99)IGI<)I2A-`B*EN2;)OGS&&J<53A5B3L.YF"5C5W9!(SIV=FEBPA]UZ1X MG(W9HV8^-AJBFP,Y=RB=G\%IZ4E2VM/>DE?9$P8<:=GCVJ+SC6K/BE:F"HM\ MHMJEB:FH5O]:T'B%'184,2MHLTEGE.P%(FIF&@?K6?35VM>ER!:ERH?MS:<5 M<+:A`-]`!2+X[%W2KIHM'"BH<(I6HQIW+;?31IKB6V(Q5R"D,67UJT#+C-B? M-E6EX)NT$SY+D+OOIGO5NLD&S)*4?JDB\$3^&'SPPB6=&-0RS3+L$,2O26PQ M1T:]>_'&''?L\<<@ARSRR"27;/+)**>L\LHLM^SRRS#'+//,%+F+GK\">=FB MK!_;W!7..1,:-,\TQWP/%\"R92QX^)I;+LA')UW:7L\U+5!63Q8?, M=Y'&=0BGK_[Z[+?O MOOD8O2___/37K_[X^.>O__[\]^___P`,H``'2,`"&O"`"$R@`A?(P`8Z\($0 MC*`$)TC!"EKP@AC,H`8WR,$.>O"#(`RA"$=(PA*:\(0H3*$*5\A"C%"N(((J MCS]&43',S;"&(-M-BB)&DQ=V"2KL(HJ[_[(V$Y_-JBK3@\JQ=&:2(=:.)$8L M2+P&A)O_(!&'&2'<7=`#Q2`R)(:JZV)(!$C M&1,!DF7$6ACT4(IAI1:8.&S:`C2\K&.--YAC2$09?K M1&)(1"H2)(PD7*0DHZF?)0IR%PG36N"5HME41073@%`LLC*]/_TF.(9)D19R M8RW>-$$Y6OG)%&]SH@\!4D=BH.%.OA,ITH'G6*`,"5J$^1)B.BM<5/%#+COG M18GPZV:)HMB/PF:,KGP%/^QQSWZRN9\L`8@)`HI!*D%T&FW*1W*)1`PQN(@3 MO@U$BT5ZR)/8DT+1$Q0C#I*`/.>HC4C3!PTB-BHV:D$K"^+2S MBEXM5WH*4JR`)9=6-6B4JA%+-5DBN7LF%#<*2J9(1'K&Q7T)0]&AQ!1.NI'P M@-19S9+0/6#!&6;(RD]]0P.!SID8:*43"E)48P:=5I;D!#8EQ`X4-*JA!A84FSHK1YC%! M+BR*"U7.ZAJ'H;0L;GEJ/FL".QC*CFW.O*I'`CO&P::DL`B1$WB:195"'!:. M%*%8:4#4RX&=$AF<@4O$V!@!WRMIZE"V:583X*\<`(,9_QZ M"_5.(M^5U-\^70D`E$-1__[$B:Y,A[:#L]0T`F2P9VG>^Z M9(@9,RQOK%.NXSK;D9YT9[3_\"ELK)8<)E2W_Q$%=M!3LK//J<"!$=SJ3IO/ M5J^TQ::6W6$69I+',LAM&36-33*'\D;-H6*&*P'MB&:+(06)SFF-KCF/7>2C MYB%!14`1$EJ/HC=E34_MCZY"SEW/:9W%Q1.>_\RAEC]7J=2-1V)YPZ>"B#$M MEL9QU8#HI)CSVJNC#J?%8?')-GD&)>00BMA;JIA&;XH;^*+,T+0.7G!QC3A= M$X2-HK"#CJ,;T7O$XBYBZ&:D>GVDO'(K7/*E3(,:M,O:Q,C9GYERX?R8,Z.B MJ"],S=RL\1:V^@II88RN*EUTU1AJH6?F( M0L^^:Z!$'>2__C#$)O_#-L&9[66$(VYU<@-$7K4Z2%#!XII*[X5QLC_/\ M3+,J=F=K1)6HHYHFY$UQ!; MO=XNMT!4($#J,%NVR1JVFF:4C53>FS,3L\QY`*/>?K>],+S_"F=Z M5V7`_'I`!LO,\",CI`$E'+,'/_S+8Z^ZB"=/^0KL9?;B@'OZ:;=FV(OKBRX*W>?Q$-&D MF!&F)R"+FB.EE]F2IU(7@BWCR-8[V/)SEK9=W9.=V:2G1J)\$<4K)/FQ/[[_ MUO(&27NB=4A=EOQJR._-*G@S_7##\D8(IVX[S5D[H1Q$-"/6 M@GM]=B=:L4=:L74N`TK$1!6ID$MAD6@7DTRU%8'TT@C>)FDIDFE`E&.QT&:_ M`FL]$FKGYGMP!F5J-Q@:1RU[$3&U0EDHV">N!GPD`SD7%"G8Z!T8R:5A*$M%Z M,^-$.5&*-R8]F!@]*0&3+/\QDY[FA[(7"[PG:6C"6@DQ?)X&D!XC1W)`@_P5 M?7G$@KSC.(M81W\R1DFY$DWY.,V'93JH%M5W7!'Q:K+C5D?D)H3W,IIR2-L0 M3S:1="TW?&@#-\4'1;EB22M!E`)1?KD3+I"DC'%D5-C8)[1T%;LT&_*WCPER MDCTD@6L6+M24@0USF$JI$4EE1@VH"0]H/8?X$9/BE`*)5-E45UK#8SB,AFBUAF@9Q@Y.5@VZ'BAZQF<;V-W%Y-40U?E5AE!\1ACT(+S#E M-[%T+BGA:RUA*S#DB5_8/&;8EZ^AA[,H%TFE#;GYAUGEE2@QB`<1&-3T;=JW M%-GHR1.Y*$6!F%"9J9EIDIIY`HYSM4J[^9)PUEC.V!+O*%DPISJKV$3S22_U MN5*7MB_.-8J:09NU*31%MPVKDR6OM0+3H(8N@UO%58_V&9Q"^!E\U(PW25S& MY1*0)6,QXEQ(]YP?@3PI12Z54BVNHE[52#/]A1/2$6"YT7O+\WK:J8$0J!+4 MLR[LF&SA)(\AE)*L(98Z(:0PP8\C*1($&6$0EJ1.^J10.A,=.:54"CT06:58 MFI%1NJ4,DZ5>:I$:^:5BRCY<6J9F>J9HFJ9JNJ9LVJ9N^J9P&J=R.J=T6J=V ,>J=XFJ=Z"J4!`0`[ ` end GRAPHIC 16 inb009.gif begin 644 inb009.gif M1TE&.#EAQ`'0`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIVA0(%#H#]-4;?]U+HUAEB,9+O^^QJVJ=NW([^*^7>/B5J']AI%?)H"ZT1_ M5/U1TDML[K*[/;_JS0AX+1S"AA'#G4S9HE6_C1\26PSQ,D5\9S?? M M;8J9Y[;7E]I[^_AI5/_?E!Y8*NK'5E79K_9=:(YZ-%B`* M?=D#(8#>$23A/Q2&*-^))RZSE5XJ;G7<516*$6*+6RWW7H9.:`.C7"2Z>)R% M!=4E1HE`[I0?C!I6J%>2-/9FD)!$KH;BE+81`^$RT0WDF5PS9JGD6DCF".,_ MA9'HY9?KX=`>FA?BZ-Z2L&')T&%KFDCEG6YE!F8L)0:VHVHS4@>(=SCJN.![ M?;)ID#TX))FD3T=BE:1W3`J*$*..PH;GIDP)MEA[=>G%S()PS.5A@(N%^L^H MA(9IZ';8J?\ZJJ(B;H)5F7)^QPFJ9**0&Z6PR>I70?[82J9A9W*J;%&`$;/5 MA]MM%1US'/KE+'9DS>5L"K`\J`U4.+187[3H]8K":BWVY95R7E$RKDW.GBM0 MBX7`MBTL4&$K;79;J5NADT^]N^S`G8[94S.Z*8LPP0P7/*Q./!(<<<,4&\66 MOQ5GK/'&''?L\<<@ARSRR"27;/+)**>L\LHLM^SRRS#'3'):Z[8E71,/WX/S MLC377)_..>\L\]`HWW7>:+#=;_?_#1*64;:M MY=[*RAEXW77[K;A3]P7.M^#+,BC6X7LGOOCE$QDC5MZ+(4[XIIHO/;=>GC^- M^>D.+9-JL)J6/K#JZ;%>6N6?HV[[I='EA6N6KBMK3^Z0F0GYX[<7;U"3O[(K M'6_R[K8BITU^.*+SS1O7O/'89Z_]]MQW[_WWX%?FX_CDEV_^^>BGK_[Z[)-O M4?OPQR___.B';__]^.>O__[\]^___P`,H``'2,`"&O"`"$R@`A?(P`8Z\($C M\\M4%-#2\AGJK;I`8#,[)@C"9`6U2-!B(N]V@0;OTR MW4E26)">S8LX;!'81!N$;+*:18.5OC MRT:CC0DNK":).QN)TA;'TG21)'2T8Q+C0C@]=JTXPYK4$S62QH'$JSMP.`_O M@H."'[H&A^8!"^^@XJO9.`-?YJ+F_8$QS5-BI3OR91!1?:5 M=<)DEI(CB';V615-6+0D&+U/=L)%G2*A,5G14E=!]WC0A#EMI83VIF%F MZ1ZII,1R_@10ELI41%J]#$P%.M-_;A-LW[153M&:2IZ>A3[TK)@$:RFEF+@1 M=D&:HNQ0,E>3YK)V>,VK1*WJ%;6:94MNE1H267A8B':5BD'TYR^_Y"P(W=16 MD&6"97?:U8R.['<2G(;0:&*YWRV-,\6P%K).`MI1B%:&(/V<:;>SFM3_'DMX MC`&+CPX;G!1(H2_W"HZ^8@A6#OU6"AS"5UO(4BU^:9!>]O(5'Z;I(G4Y:P73 MY5:^-N2BNFZ,1MY]B?4PA*#H38-YG)G>2<#+DO$Z)@;(@R9Z:_93D_E#%5*D M*"]Y([5#P(E]S,"7>TIW(2*G;Z2)#C46*\TLC;'`*<122U.4"7H!;R"D(+98%D:I+L]B9C7J M`<4"B=S11H,`-_!SYF%J*T:L:)CK4+&E,>E7*MGN3L65_E<$3-;5I7Z3%NUR7O8IYB MTXD-4<*S)O!_1%4@)_^'3\E-/IN47SL]?+*48+8Z+*VP2.9NI2:AC`7Q6IE[ MXEQ5M_0L1(P;\+)/K9KW*7#>62#9'&L"#^R\HCR9DDM=ZIJ6LK!8NFU0DVA) M3!"56;FIU:^6,K,_O*G>YOUG4RWS1F7GH*J6)_:D%_.\8K]W3Y,]=:@[>TRS M[7'@J=X4@0]^\#7>[>;V94K?ZU7>,XX)*VN*Y()E!7]& M00\XZ:]X@;V3!3EYMGHE3E^%7DV,IWQ;KD4-R+M29N/%9G'0&]_H`?PH[M6] M>Y%7;QY[__O@]YO_ MK3UIRRY_F%CF%.]`/4S"#=>N+GUASMQ\1/C"OY\)*A4N:N`/VXDX:S5U45_$ M`A;UEQ*+Y1,:US+Y9#K+H%+O00Q=@55>\4?PL8#'XR_>`8'S0D08T0RG,"[& M8`I-]F5^%1-4IA-6QC+VP`B1YDQULC>,![+ MH85'J$J+1AQ*-"B5HPE^L"(-!R0I:!N`@3B:D`K/DX;)<88VUH';H(%T$0MI MI"$I5":ATDWM842O=H.E,6SG\2$T-"O/=$S%=BJL_R8BPT8ZFF`J*A4F`<(M MP;$?\5=L011LAMB(QU:"):,Y(N0$C$`B*B!4536!OW<4I+@WHW&*J:9SFE`O MLCA4%H$PM39!_;1M;11RCO55V68B[?9?D@5N9*51]O90"V*)6'@H"K5V'N=M M*V4G*--C=5,GE%`(^L8V,1@?V`B#D-0(5&05J."$!<@0"",7GW9;!.$T2$5^ MG25Q3.(E)G(9"?B.S<5PR6AP-=0=.^*,-Y5N=C<:'R*%*5;"R8Z;\)< MX[*&M)%!#3E9W@&15$4KN3@Y*J!F[N@8-.=B>J=J/U!`A<$!S M(]ES+&0I.A>0\T:2B"6)'?]GD()2C0KI?'T49\.2@F'3BDE1BB1Y1>3(5AMA M6S/G&G=Q2)Y!#-VA"M5(C\$2=JORV;!>4^S>I('9]"%9JY'2:7G>97T+5RQ M>HCIF91&4:3D+H-)9S\FD?&Q):RI'XN',0J&BW#A;D_U?!]D/\W7,;_)*?DX M0RAV8[RI/=,'5)/8,,XB@"!QFX-4?>$WG=19G=9YG=B9G=JYG=S9G=ZI0$WB M(B/_.!/GEQ*>HD#\UWC]MRS\IV`<6!&PDR2SU1+#^8YQR6/WV3(-B!G+&5,5 MLY\QXE49L3"3@E\N`9N.E)\_@:!N0TUM09C\R0CNPFAB*"X4!V@?FJ$YYDHY5(57*%996"Y@V(7H06A/^&ZI^3)? M`8?-(Y7;8&T#LZ.`:19`BA&/,GXR%4V@6!S*=AK066NX9EF?)Q;(EJ0[@VS= MY!FIADS*Y$F1&*#:Y":"F(D)LHF"5B!*)6P!XFO45*6+$XLDLDQ>6#%PNJ4> MZA$56B1BE5C;H:+Y58SH-QT)B&T=@Y%E(U.\H_OB.`-F,-0F4 MB%6J9W606B*IEX-+!.:C%,,YNYJC$-&I[4)S*V4U\G*37?HE(4(H+7F30+F6 MK#HO,CE*L&IVWQ1T!4EO.XFK;\I6S$@Q.O4*8'.<$2&L7!>,CN)UL",8;H_=5K)1W[&HW&4AG-Z660\>6;LDJW'IEFM"73V$JE[HI M7Z&7;;<=.'@1-!(=IM=XQV6988$/MD<=I)=DLQ8:CWDMI%F8O1(#H+"$O'%Y MB_E"FDDNG+D5]>*9H`>:UB*:*O]`FK"''J=9LIMJ7V2Z/'!&,;3I/.]Y$[XD M2\=YM-\),TIK$R)IG.NYM"XCG8D!%0O[+T4KM5HK/O33M5[[M2AP$F`[MF3K M(UM[MFB;MFJ[MFS;MF[[MG`;MW([MZ=#D75(0SUCMY,J%'K[8C47>JQ`0 MBJ\?<9YOU'X0G!!/MA%:4;X=@6,'49]D%K&[H;LA@<(??!`AK!'&D)%/)6<& M,;_2L7X:G!(X_,)E1&:N5%D>*<2[5U=&\[3F@AV/]&AXH=A)Z:B-?RDS7A"B_$HE/_VJFEO6EMU47 MR2$>@HP56%IJC8IJ4CI-+"R]Q)1M4K,\X[D6NR*@&CQB-O6H8A*KX\NOB&)O MY':X9.7)LUI-RUANQ[AVQENL;8QMR3)RH8K!K?1#\9@>216[^,:6K]*]0.:` M+()M_8@V+;5PCMK,05+,6B)GJ'HCAN4>M)K!`+R',<>#^L@93X<0BLC!=#%: M(GG*R`S(6>62S&0I,`G-,I4HSAK/XKS.]0K/VDR(R@JJNZQU8BDIZDJ.!7UC M_G9.5S25O'I?_2JER/R`_KK-SKIUF>54:#>P"T*6$%M56TTD<__^I6\FS%>31F:PG33/+%3H=7,9E76'1 MLIA90]65>8RG8'!6L2V;0;EQ7:%'LM=RLKEA'-"RLSZ,,DV;U?NSU5R]8<7V MU6(]UF1=UF9]UFB=UFJ]UIRJPR5*2FW#FD&Q3RW%=E MS28XR5P:L*C_.!M\V`2#"&Q2@6LW'8IU+!ZP&MZ43&SQ9]X;TB$JK#A49H&Q M%FE"8Y1K'Z*Z@TD"QS:L:B10@KN-2-1O:\:MG88TN4=(5'2<)KN3!B".J M^,^F2CK&(FE.3JBV`JT4CCD@3A='\TQ57#;?^N-'$>1?_B1G3KYCCN0M`94' M?I5XC*:,-:\_5RCVNHHD/2;4X.98_L[PVE6V_PT45#;H M!L'HL@JP1U[@(#69P(6QPQ6T^>MXR-5Z/=TH*0NR/1H5)ZL"G0=O[DF9)3OJ M\K7%0#W!,B-R\Z5[^8N(\T6TB:3=2T$IM8Y-Y_68\0NT1X3K;'W"'_6_#8': M0M'E`V'L"X'L:FVZ"'G<,"SM0@'MMTKM=SSL>('M<\+M/.;M"4'82UNVY%[N M7?L^YI[NZAZV4KON[O[N6W$1\#[O7JOM]G[O^)[OV6-!2F2,>!*>C+<7DEY` M)G3!*H'$/=(6+B9__0L1!=\2"%_7"@9)F"ZQ736?BY*\ENQ@6^1$#<\11Z8G M2":H>!A;3*0-VDL2(6_9#V@CAN'J"D&@8/]CH#`<7JL,08&T#A;?I+E56R^P9'D[WQ% M.-5-SXJ!W7CJ05I*'E7*WE7L8/.$M+`5X(#GW4'/!#!?PO9D@?\/LC2XR]Y8Q"M(PW_7$^<4,D7=(&*"/P1ZDY3?2K#MR^1#45QZ^P32,M^PW46CN(1\DWZ&X([A.A_,7)5,T_ M+`YWZ*0_$1/+2I'-+[*47IF"FT#L51.YAR#N];XCGQ+C?_"Q?AV]WCQ19!SA MW[;\?C"+O\%<[Q)#K^^Y!?U40L``\4_@0((%#1Y$F%#A0H8-'3Z$&%'B1(H5 M+5[$F%'C1HX=/7X$&5+D2)(B49Q$F5+E2I8M7;Z$&5.FS(LS;=[$F=-F29X] M??X$&E3H4*)%C1Y%FM2B3J9-G3Y=^E3J5*=*K5[%FE7K5JY=O7X%&U;L6+)E GS9Y%FU;M6K9MW;Z%&U?N7+IU[=[%FU?O7KY]_?X%'%CP8,`!`0`[ ` end GRAPHIC 17 inb010.gif begin 644 inb010.gif M1TE&.#EA@@&J`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRI<[)M(-BQ*%:T]4JW[DMB.`022Y&V(%B^ M".V557B/B=R"RV)L`WM8H6"[D"-G7);W7^'!?C?U-4@,<\*U># MG26K7@V1\C^P*N861I'7G^9_Q,0J_K=,][;9E5_#$=M8].[+N5'L!LMHN-@7 M3.+^-AR:M77)O=6'G9>[S5-DIU M_W7(E6O+N,>;&`09^$]I@+&W#(D$C689A"WN1A"*%IZ'886/>:CCA[514IEK MKP$"GC\^5IA@64#Z`PAO#W+H(H5%(GCA>0(M`P,>'.ZH)55X"50:B0+R!]YH M1K(79EJ%@4E=C*&1*:6-5+Y&"8M;UBG56\JUE1M?I:%`XIZP4()""E(`EIMB M?=+9YZ";X3DAD8,6&DMR91TZ%W]V9JKI2/ZHLNFGH&Z48ZBDENI0;L&9JNJJ MK+;JZJNPQO\JZZRTUFKKK5LE!]]P,HX$&I&GW81GKU0-FR6N'MG3V#V&F%18 M<3X10R=6TB)K4I?^;'@2:$%5JY6WUOK*5H[`#:1K=XQ0TFNY1#(2%IW^."=7 MF7"XZZ=`LS%XU[3X1A?M;P"L,C'"JX1(DK;;^I'>> M>$W`$A:T%:,;%I_NJ:B"-IKP]1:?\\)1*<0K'8Q>=_G-1QZSKUW25L<8ZG0P MSA?+'%ZS_MC\"Q*+B^8$'A,3&M MUBS;=##82G?]==)%EWC;B`?1R/2*)4+-9%N_WF8F6RJ&G5+6_'K_R:AET;$( M]T]C]WWBW[,);GC:KZV=Y))$%KATG%56IN3=;;E8=XTQTQT=L2R!>T\LC\LI M^6:E(6GYDCN)?L?JIAOIM^H4LLYXXWV=.7>%3)^).>!JKJ"-W5!W/).WX.GN MYL]5YL=$69BVSJ)MKSS_#Z;+T\R;\]#W5W2^@R4*9:2$:C>C6'\."@NOI$DX MJ72`"AH#R7`%>Q*>8^TFOISDPQ**OGZ[ET[PYYO]08I0*?`?``\GP-OMI%-& MXX(#)R@5<*6&@AAL2KS&8K\,>O"#(`RA"$=(PA*:\(0H3*$*5\C"JRP*=!3I MD^7"`D-G1<!1J.)]&2G?E1`I204M/6/OG(4KYQ(?:X)(4R M::%-AM)/K.2D*"M42FV<,BP%$I0J+;?))BX,)=P:WX1<";!#$N5""%H+_5!V M,XN=YBUY21+E2K(,:%$(02&:9M=B8P\8V(%1A2&G.?F"GY-U32X.TH8UW:FL M;>#'(MW,DI'"^?^Q<6ZCG.=<)!/4:0=V)K*?C(SG//M9SWNJ))G[/,P],6:A MM2%R/='$F]S(9I`T:7./'PE1EB@)+&BBR0DDP^A)M3&Y]=@HHZ=(&N;0^!"1 M&H2DE/C.2U>ZTQ>QM#YP4NF+8NJT2OYJF\Z"$4E55DFNX>XH)GT1S*3*MH50 MAJ1('4DLS>@BL'BRI]($*THU,R6AKN44_)II5A^R58-T51-?-2M*Q3H\H+I4 MKFCU2_'6*JZYO)5$.:/14XT2U:.&L71MPP&WDGD_.,BQ$?4\4F'G*M>ZEO4U M,(6=6D&ZD'@]-K+JF6Q*,;M2L@:5M$/5[%XY^Y%DVB-DIXW7Z09[1$[_W.P\ MN1&>W'1G$`-5:W`IZ0V+[B%!V4I5M'0U[5U1NY9I6`]3F[V(T;5*&L]`E$?455%$&2185"J0&AH!!LB5^>&,BO[#P*F%"J M(4A>2#`4N`=0&_.EA#06%P$39QN'`H7ZPC*RX>!@?_)5C*4LPE^$_7?!!1:4 M6!(88`W#3SD*YK!_M>%@"*M/?@B>[TD6--SH%.=0)";?^V39H4"V\,8M\2J. M=\SC'EL$+D`.LI"'3.0B&_G(188(DI?,Y"8[&_G+8`ZSF,=,YC*;^F6QM#5G.5-%AFZAH6S( M,Q`\BP2(O67J%C=LQBR:I7HCU/"K8MJ(:M3^(]E5TN]0I+DA&[-$C7K!C#T8@:#6 MHK3:QX8(M.=V(FZG!=NX&:]$J+T-:WMDW$\Z$<3L$6F26`VK0BT()?6:KA@X M=Y6V[&0SE_9+`?*NF)`L*D,^26>8./%RW=[U*1L>$JM!O#].E#@C*$[I7OWQ MCRB!VT>=W:*^O65>"_]%YT#_Z=_?D.7TE"!\ MQ[J"TKIUP0Y);H),EE"&@:>`X"FF(Z"-'#PNF1:-WMU?^\B`) M?+8+`G*3@-%H$&ICT$]O%@6IUJS^*I-RSSO[9,ZF[6XQ-5]10N^R_5GWZHX( MZYTZH\XG$?A?](P_GDZAJ)_$'BQZS&^G%W'H>RE89GHNYYB;)]G;E?;?;^/_ MU2$"_6Q-@\\O<:;:1>7)49P_T56,_F"J[LPMMO_]%9>_O/5M_(YH#;9;`SY- M(Q8-YG':86(B)CP>AD#OLP)\H#[LDQLJ8`HGUGV:9SX,L2#!YQ'VY3WKMQ$: M&%)P(2+[-&DA$8(@\7]Z08-U!BHZ1A,6M(%OQD*0 M@H$]&(1".(1$6(1&>(1(F(1*R%8+]!8RHA^0!BM06"7'-!1^YFB/=A17V(0H MEA*U)G>_Y6F/LFH\N"."53M(H43`\H6B=FOPYQ-JF%-QN%Q=@A+PMFR#U&RR M@VXM2"I&5&Q&P8>-<(=SL6U!-Q2"*(@GLAR'^'R(_^)W^<9YL()T>I84&;>( M-R,DC4@4&0_&&/)%T)>=S0*>*/<&*K/A:MP6* M%S%U,Q2)_4)$H;)^ESAM;?@R)Z*+1B%WMK9I'T@2@8=O)">)I]B(]U`%=7<3 M3L1WDF>+-=&)E5%AP8498<=U9M1[SVA&M884XCA\Q)<4XHAWI(>-,:1_TY>% M;K%>J[)^Q0"+JW@;UC>,Z0A5%G5(.1AR(WA;`7A#2&*"K2*``E@4'3B`+=>/ M0]&0#7DXKK:$%GF1&)F1&KF1'-F1'OF1(!F2(CF2)-D4CN:$>^:!FU@J4XB% M5@A`+IF,0+&%JW2!D[1B%C)?RUQ;Y!((?7DI%)BYCDVY$OLH?4U$?2K9F%NB=O4W M%`:RFY@ADT$!D!85FZ8'%X?!B@LICZLB@!/)B9.F-<6!G#TAD0B9;B7YG>`9 MGN+_.9[D69[F>9[HF9[J"4(G68F6@7Y4J&(6Z6>0XG>E213TV866EFFVAANB M>(9!LI%%R1Y=PI2'*10#BEO7U1>Y>1)0.4A2&7&`B)%W*`V,V!_,&105>J'% M-Y:/6(O.AI(=Z2"?*#&I"1,D6I:HV1)U.8K$>)0:N2*TV%2O<:!!)`8SFC,- MJA*XZ**NJ99*V#'(6'VA^4#<,:2H4Z0K$S&%?;9`KE2*N,<1ET$DY%1O^^A6-TF$I"+$, M-`8;S_H2[/:"*A%9`L&5Y/5M[?:L'U@F&?6*5)6OV@!NK^8]4-D?41FO%9$; MGC$;(>,L]$=RZ!4\XDG=7.3M)HP*I;?=RLY%S.'^R*W9J$XW'M;RGHO\@>M-: M>8_'>&8;LI6R&ZE1LI3G>!^[DH)K&=+HLBA11FY8=NW31`+E:;SX$]DR6BS1 M1HZ3L[V%?$ETN"<%CJH'G#-HNF5;:&GZA:D'(\C$M+PA%^[:%WOQ"EQPM?3# M"("0BG&*G_=7JU*G"0VB/_J7+,7+NA#Y:)YU(K&11_8Z1JJFBA'T"A,%O!$)#*J5JZU6D:<./,$4#&::>L&7 M2JD8O,%P@:D7,*6>L(HG,(BW,(N_,(P',,R/,,T7,,B $%!``.S\_ ` end GRAPHIC 18 inb011.gif begin 644 inb011.gif M1TE&.#EA[@%Y`?<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIJM[-O__,79_0R%:U1J.#^CYJFQII$VV.=9_S[ M@>[ARZ/^>E)]\*L+R7E7PQ3$.7/Y>P]]V& M'";%F6?S?1:69<;=-]D]3IS"E7`"37:B$ZV)%1YM,Q9'6F,+HB@-:F#==1^* M,;XX#1.P=6CDD49QEAJ/FO`V8(GP>87B*446Y.*/,`ZX3)4,<@FE9#FFR*23 M4F;I8YG;!.9.2_]ASX(TDMF@BEJ<4YP\@7[X88VIZ`K),H'V&*VQN)&[%;.-I="'UO9B.NZ[+;K[KOPQBOO MO/36:^^]^.:K[[[\]NOOOP`'+/#`!!=L,$Z7*I2P<]QMQ6>,)>":#5`__AYMB)6>R)=U3C/;CPOR)U<&V.8F&U M)*F413:29;6;I,0>.;)$LI$:BDE,T.0`.)ZUR)1*`>62TC0^H3E/+JTDI2?G M&*+K#6B*KX1*+=N62UNZ;997W)WE;HE*7#9%F+;#T:>&^4M@0E%N#$KF*?UH MS*5`DYFYQ*8SW>@9:?$RE].$2C?9]AGV>;.O2C,3NC2$=JQHR0]*0HY2)(5\K2EKKTI3"-J4QG2M.: MVO2F.,VI3G?*TY[Z]*=`#:I0ATK4HAKUJ!4!C<,,$D^DZJ20>BSGWYBJ%=0( MBSN6_`E4!PFXJFKHD"R;JEP8F9(JBLQ*\?%C1TKFU(U$B#DIF M%(BTR5L'(M?K9/):F:QKD?R!5Y4P<4],W6!(=-96C3`Q:)>81BLSU+%8YBF: M`KD@4!X[659^1I:P_.PV7K8VS995$Y-S(5PT^"FG_4H[0^O:6JS'7)66Q^A,)&9VL0LG;P*39>0#GD15&R-:*>0WL%.?MN- MR'EM]UT,AA>\`NGF57VR7U"E-[T!_I985U*\'SH'NLSSVYJ:-R4NX3>_._N4 M+7V+3H(4EZ#DM"M/<-NV#Y/3OR`6+$H0>TIC?:T\$":4"@?3NT!=&,,-X6S] M)%L_]MP3<`\C;2=QHF/1_9A7],0GBX6\XK!X,S$1@RX$YY(:&F/)@A&\'8[U M:TJ#&I1X+JO2.%7I6N_K5L(ZUK&=-ZUK;^M:XSK6N=\WK MH4K4M"497J^MZ"BQ$(.2>YFHP@!(Z&%K#RQ<8NM"&&L183L[B853:XO,-1KL MP%9KQ%+!=JZUFO%0PCHRG)S3\.*LD\$B#E@K&XN2MAQO;\>UV!%WFIB@[&MK M9AF3"^=Y+"29#.6'ROX`K9&;$"'KVJUT'XNN98@!EV)@C7"0PQ2[8V$/%1`< M0]B5KF04[N](X?U%[(L:A8*XXTSL63!9S\+1G^;;V-3=M[3WO@?I MQH-/_.(;__C(3[[RE\_\E/Q:V]4VVT*`CV/0Q'[T'@8]I&-#5J)87V*U[1C_ M(,.ZQ^[3!._'AC[*FYEPYZJ_1,C^=!7?,@U&NIQ7]B<2F0G;[)S,GTED[41C/XQ!#056HV@R*P$$I(I$H,$@-,MGA%$8'T]'X%5EKO MYQ)#QU3<%E;BIB(+-F5D/()7A& M<8.[`U9,-5P]J%PT`7`<8S-X@W!R$"%IH81-@T],Z%F%!%V(TPA3N%U@4Q!6 M9QM.\C?M%3?-L2SQ=UCL55YO$G'&Q2-AX7)UY_8(@9(%`/(5\@V@/MWE3-Q6`%H'(KU@",1D[/3@!JQ M@`>AEG/$@1HRB\P(@DB!2X!QBA]8',#VE9J@AJYEA6-Y.N>F-!#5:"_(9^@& M+:E5;DLC'K+U-35LPA%LP`"[1Y1T9H\ MB#)^8D\LESY68GC9A#2JX)YIE&]OR2,TV1D*%I'M.%S*I)*<&*'DJ1+$L`)4 M8B6V"9_R"2MW,S)[Y3UIEWT*V5S^^4=3$*)`$H.,2*#&M72-$8/[J3Z@"$6B MB$0F5C*J:%[)DT69K-*5^AWA4`V7E05\&\B=:RJ5^_Q*#F!>F6L*-92HQ M^@-!W,F*<:*&66$]FM@H1CH4QD2G!3&/.;H2<,8T#D8MV!(+J\J@L\L_>K<7&0+@0L?):KM#HL+_2'U8)U4920 MKL.&_>%HY":A/5&1X61I^V:LF5:M&>I]JH!_)FE'(L:6X^I&,B1$1Y52[-JN M)M6N\#I2YSJO]%JO]GJO^)JO^GH2*"E5$?E]@#A6<0-H@-,P;SEZ0KFOIGH? MO>E7<4H:+L.#ZUB`WTH3D]&P%ZLN''A9(I!JAN(FB4"BF0)H>=$CX7+$5GYM-IZ=2Q$;6/[$UEYN9J` M@424D=Y:N:9[NJB+1?&ZNF6D$:S[NF*4NK([N[1;N[9[N^JD*^I*$JXUE`]J M4_VJ="R2L-;D5;R3W7 ML4*[M1[_89:4P8LKE;($88%O\;))V9.==1"!BUDG^Q>K%9BJ6FX`VYA@T[LP MA`(W4!J.HX+X.X:\4X+D$6]^$SMHLXZ:N14O,'[W"P?608,>ZT8]^QCSL2.O MF9I-86+7DHI`RQ*GZ7!L*QN,L"`-$IS)B2`O4(J7`R0Y]!DF;&>*PP2$)"@6W%RJ`'LRV2<'!W6K)!)@2>;PIXQ_NP)/')HC.*_I`*THC* MKQ0&K#X6/GP$M+)1" M+M08`ZF37"&=!&W/QR)ZH*E.H-N0*^(KG'N(<5-IH?N0Q*.1N$)]N'LP(CW2 M!#-\'P6[*OU%[[K2+KTB)AW3,CW3-/]=TS9]TSB=TSJ]TSS=TS[]TT`=U$(] MU$1=U$9]U(61;E_E9$UADQ31(^!T$$X=1[OSO`RS*PG;A4#!/+)!24KU,PN6 M55H-$G@G=GPA&$:"E!41O1/!U@#S,EGYN!?8.7:%O0BE.S:R#,@VO=Y[UR.Q M=;9Q()%Q8Y<1N1%AKA"!V/SROLKXDU/"MYFE5HJ-$XR=J1R3LNK[T<5,2;(Q M!:O1&M:Q;J5Q&EA%'.QF+,X";P(L@X:I-/;F.=)7H/$F.*P1F5[3G4%T:6CC M/JRE'`>RE.A#OV3\-Z*=P/A&F2@(OOA"(O$DFCFKP:1XQX9U2Z3)K:MT(\_M M@[RRQR)!G$__T[_ZH;(AUQO:0K*T>8,6-SB/$T$"0C<"/,`YW-#V M08DHO#$5])L,]\)J+67C=T&XB<(=YX02IQN(HC?/J67^4C.GN#2P(<4%NKXT ML3#?R3=J.\H2;I\4;A%(.,!B<"=G5\9ZX9Y]\4JHHSJ'5R4*.N$02TPA"L;. M(Z:G$X,O8]>".LT,0N*I<8<#RN#]PKQ-)8AKAJ%7RQ/U"8?M1+4!9<='[A&) M^#]?C">+7.+>&7EC'&&1G'1C_9.H6I88ED M0]CX(N0/GK;&=24?3$<3,EUGLYP;A$(J#8/YZ27M7:7HZ9M_W<@4QK+ M"`UDRZBI6-C6J*+CE*-`R/GVL:FPSS' M.E&?0?.EI,O+&?CG%E'6>:$I@[K-MP-!KD1Q.Z2XNGYEE(>%>RK5V'Q=EXY! M)2NIQTZ6@5[F+CHJORX64T:->+XO#AZ/Q4XU[ES2,_%.FL"I7^6X`['M#^X1 MRK&LS/)GMEIOU@U#7RCL*/!ZHXO0M2K1Q<%Z?;9M)Y30OP*L.*0>NXD"-A#1 M!)F\XK&J`P%LKEJKR@H7]"Y$M[=G<I)S,L1DWT3+_\/\^0[H1WN$.45]3^6?C.)+/DM:1V^:V*_06^KO1]N#VV<'Y+#,\O-E1@_8: MPG4SPDQ0PN8QQ#-,."L\WW)HA29\>"H8,)7I48@5(1(3LXQIQ)[; MIA;E*K:DOZ@2>?H$*I1HU:->%XX5R=4>BA0)%3+)B/TC#'BWH):$G;ON[JJ9$@ZO_O)(,RW[^&K5CJU?QYY=^W;N M$"%/+$ML;BHX#\L2'UR0666%3IZRM;B\_31#$);UUI7[_'+GTOB M#;,OIS`U:!2`/;5TOW')^M8CD`;>RN`PUWTTVG?=2XQ1PRQ63&-]8;7',Y'L M800AZ2S-\-20@SN8FJ>F.MFSE,.D=[LN.:2$$1Q!FC;'>'M&`3.OZ%0AE:=N MUFE()`O4>2F-Z@1NVJ;_PZ"D+X_4O%!DH.\UB,:EXYCQRJPE8@2.G)!^VL:D MNN;+(CB:!JG'H@_^F%"/%P2D(IQN!,G$4[D:*)5L2W)J;TWZUB^D>Z14L:Q[ MFOBQ[=)NS$BXY"J_$4D3/02Q;R9*EBI('`56X4>=^[I(X"`Y&5\?J&GA'*>,<T^5JJ-T>/Y3+Z#/JP;D3]/=@8G1"ZB,/7 M48VV)T;VXUHHGG&T_N"A6^P0/">D(A7Z#P`%8CX14XL=+F?9GISO_P))H4HG,OA!(B7 M`NX%=15JRPMU:+YM:.6!A[I;<@:(HGQ![%,:S.&S+"C!_SUH*PA248&8<\"W MF#`H%KNA3E;HG2P!QSO"V0G]9`B;M^!O0*?0S7Y.B*[+X"8I`YF";@"WG/*U MAC1;2B,1R5BS(W('>B89'VWL\Y"$9;!*R&)02/B3E]W$['(LFDH?Y^,^>&6% MD_;21EO\QA\(&41"YJ%0&]?8H)Y0CDZ#RY##_N*N::$R:0];@8@$E!8.<1$J M;K.E;Y:W'T(64CL17`L%I^A$3T5K(/S#8*B\@Z)EGO]M*Q1,48'X(@4\^8A& M?6K(PJS4-C%M(U"S01/6@L8F&7T3%`T9DX_,]+1"N.=+8_E2VQ1W(33&"4GW M?&5KE,;-6'#KG;_C)SO+Q)<^0,F8+;K;0+HUM"1RBVZ4R2S6P/HI(8-8LT MINV,;>OT;=!2H;]SH8U*(BJ7?^(#-W.=JV=+>QN.F$,CJXQ-DE1Z9XUN)$_- M^5=,1AM)><4FJ+1==J@;Q&(5)>*',R&N51!FUM`,9^$4>51HO!M>Y70"8M]] MT3V-S6U63@PYY$U.=K3;W"5^])8B!D\S($;10'XH.=-@RB.@V\_QVG:UW+T` M*`44_QY^5IP0"!7#(CB.,>Y(G4E2POV),*E?EB0Z&V7!QZ(*TF\F":5%JIW:`C6,0.TA"<<8&A*:SXL. MVN=27.-#.,=F70P2I@MS:!1`*^75"&*U)P\M&",FV-0\9'-2,1R:**ZF(,Q4 M6;$Q345D8Z?3NOFT'A&DQ0Z-VB!\]&5/3NW7O>BL->7I(Y:1\TM6_J8R=1Q. MK8WS&0T)!-QW?,Z6Q$V=#II:VL$-*K(XIF_X*7*Y_\8>QO_T"E-_3S<[M0T0 M=679+EU2EY?3@[.U,YEMGWS27:/TMAPAOI.$SXS,KC(/1<14$4V=#& MC0NACL=BE/5^2\/7X^BDEG9.-J_@4YIM*ISG!9O_J*85LP.CA0%TG/_\4T"O MO&IZV,#)D(6=\X*W@WI!:^0G,)FKQ]X4,)ITE%`ZR0A(0B(2;^MT MISQEZRHY`>@YI]4M,GV3ZTRI]%(O@LXD#WI.3$RRAZ.\.#FQ,FH'X MQ#=>J%4IZ0`E/WG*5][RE\>\Y6V2>]*='?>I5OWK6 MM][UKX=][&4_>]K7WO:WQWWN=;__>][WWO>_!W[PA3]\XA?_J]C"=V'$PM>4 M`#75K]V.LU8"6!=)?Z=WU592\HY8<(W%(^+\DLBVGUCG-V:EUEVS.%EB4XI\ MJ+&B3;ZA1KM3?G7%N+P5F#6[,MM2)6P9ZE@7I6&R-$$PN4&PQ:$C->L=LT&[I2E!`AH2P2`O&;PVN'F:%S`C M!0L#.+`:4+JC'_0<-:,((CR(A6**[MK!LPFO(TQ"*H1".ED!!-.7WZ(-O:FP MR4(5P-$$_\&I#I&PE`U#PWA%B[1 M&DH<$LS0'3@C,3>9L\82GM.Q"$IL,158GD.R%EH,">DI'_NZGE/)'B?8GD;\ M&?U2HB[SN>H:00YAH#Y3H)(3-&)[#]*0GT)0-%E".4!$KHG8H/E1-_A1'_E9 M(%42B#"CH0'91#X+"BBBBODIM+!H-#;K(Z_(QF_<)`<*E@FLY;>NJLV;"+]\Q1TM#,W MA+Z9%+J;9(R"G`\SLHR-DD>[*!=_BY]G3`@-U`N95(V)O,9C0Z,0ZX_L`4JE ME,I66J5RV\16FB$:>SLZBLIP9"-QVZ,M:C6.3,JP!+E!JL7[6S0**K@/W,>G M@"0%M(Q!JR2YY$DZ_$,'*25_((]@4K<+.3D50\IK0Z5ANH^7PT?#;!`M(KEM M),#QF)"^Q$JTO*3+++LI",E6VL4%J1BLV24$F;BSA+709"#]F*1BL<=B M!,@J*D!-<29-@";Q&;6@(QCF,XR8;*?_L/.9'5&HLQL2.H31&K71&\71'-71'>71'O71'P72(!72(272 M(C72(T72)%52NO*H`QR5.:&^['#!FE"6^-NK9:'2W6*,*"46L0B_1?LF?QCVB: MBSCH`[V\P$Q]%`T4"0[\"@\$N`O$#B.!TA3T.J,Y,+IDG.;XPA/4"5B5&OWJ M&8C,R8:X@2VC!)S1)P5CCB"DB.V"N%@]FO!ZNOG:&2Y401RAFB94)ZU1U@71 M5;#AK\%XB"P$KW-)FTUD&_RB+QM<5`%EL_,3HE0X0[]1G#G4E,`9G)%XPW>E M+.V(E@)D1#4I1#F8Q?L;&AUK-3N41"#3PT?0)>' M9$:*.9!#8\FJ198PBB0CPD&Y0$@UPDR/?",;FB/-10NV!;9&24D@DHK)?=D+ M*=.YS,>F:(ANT4C:<9#::Q(ZD];[_FCT->F/+I^W*GSPWH63&.#JN MK+7*H62=H+#<46.-]SLCW-A(6!O']E`N=@NCU3#>0LNCXRC+M_TCZJ6QX*7; M;FG-DHBHO`0XFJ.4NFRN"8Q+@,..?=V*J*BEEV7-0F!-U$BDX0T/D1-,RB5, MZL+:LHQ,RA4XBP/)."0ERAQ@D5PESGTE#%%.SZ&ED5,67)*YL^S4C4/=KHE@ MR>A?6(D6GYJ_HGA=V;PF"HV49Y*PO,A-G=/=ZPBD`4H?LCNGYX3.,#%/L*O# M=1+.[B3.M$LU]?0D\&R3ZZ01S\BGOBBGYX01==J2\(R![XPG&9DGAJBGW$DZ M,CK05.NG,`:HZ5RZ_ZPS*)<=8C)1FOR$/E8YBCP3FO[,-9I)KT>2UWDE4(DP MT!?E$@#=M.RXT$7A4Z8*T9L:9)L@5:(B49APU*HZY)MJ9$IMW:.249E0T:S* MJ5P!O4[VY$_>O$\6Y5'6O"4UY5-&Y516Y55FY59VY5>&Y5B6Y5FFY5JVY5O& MY5S6Y5WFY5XVEC2U$B?5UD*>B>7[N97(Y!QEO@8;O^[+1,!;K("4T&1.#(WP MOGR]1TQ*/Q&46)0/W8[RMWD/PUM5-2"/M=BX?TCP$JF"69`A7'QAPCE M+6(NC`AR,SBUY]XCF6.NOT5:56[N*<\HKL-"KG^Q0)U:9)E8#V)`HPCMKO\& M,R!H)0SRTM7\(J!NG5([BZ1G-9+<.?6RPXA-=KP;7;Q3"4QN;, M=8R9LTV#4`4/V@DK2XX=(YT[G$3CH5D^M!&2=F]:0B MJ=T*S9<0I:G`==VJ1A&JA@BYWDO%2)G_@P55.,E&L5Z#;%S5M0LG.`51.>O4 M18MHQCJ^%-L\3HR9Z9&PN+<%`6!SXU[RG4K# M1MX89I#E!=[4\-^VAM$095-Q-C@&=4R+X3?_9%_7NUZ,F1'-EOOJT0ZY"-'@ M5#KM#GZ?PX1,Q]G?$F[,'0U1)XO-G:--_^DY0@4JW6SA%T&3]:P/HZLTN0&O MWPSBL7-9,BEB'#"ZQ$W.)`F*'6Y.D9%LZ"XTPKN0-DQ03\DH8>1CV-&S_)[O M7TGDEUAH7Q8M82[1?7:525X);Z8K4H;P"&^(4);P"O?D8;EDEZ!F`P?P[+#P$>]D"B?Q$[^\$%?Q%6?Q%G?Q%X?Q&)?Q&:?Q&K?Q&\?Q'-?Q'>?Q 6'O?Q'P?R(!?R(2?R(C?R(T>5@```.S\_ ` end GRAPHIC 19 inb012.gif begin 644 inb012.gif M1TE&.#EA5P*)`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J7//JWA6,Q8C#\XC6H^CNSQ7I-8"RUCUOF8\6(Q"C5K_ND/E&?0 MB%/G9';KGS+0]V!I0D'YI;W-LVMO?*QB,T+>OG42.R30'@H:W!LU@,'G=5CE?ZF!DB%PEL6X8G>;W-)/')AM/^`HD(M M,JIPBSW.]0-'>,K%1UX_I/''(">]^I^(&F)Z6Z;K@H MD=[9>N"F>/X##["DFEH>FX4%6&)DWR)9I(R+Q48B1"BL,\'/&I3#O MPC$%F"5CC4Q<7)@#XXD$%LY;M%XBQA MI?>HVW.2'&H&'[Q'/CKS?9`)Y*BL2NL"CL[V3S!A:24FH+!J)I#T&#ENUZC5I_$_I'38BN-_@JM*Y="03C!F^UVYC MNS^CO+VCZ?WMS9>(9@I$C(W7JR#%AIB*K%_4,W8WFR&F-:*8L1!NB=^&MLQF MX/7(91]+]HC^6I#W8JJ@S6RC-V@#$XJ"D+'4A((7`'!;-NF,9W0D,D7=9S;: MVY`V9)0"/J1@>PZD"?4&N+$;K(]I(FM/AQJ$@P^V;T4H*M"0I+"E&AVL@]*+ MH0S9Y(]J`(D+,\RA#K&SC`PM(WH[#*(0__5"/0L-\8A(3*(2E\C$)CKQB5", MHA2G2,4J3L4XRVE>2$8C$<6(L$@`Q!A1UK(3I54TA1H;`8C-KT2R0BA@4+ MX1G.SU[V]RJY9V6ALQGE6JIS339I/)P\9YJT^4#01D4MD), M,_:8:)'BU=;$P<&#(%W:NIR`P&:2\A['2]ID'`78V]W(;."3E5FY"AAQ+>]P MYHH,[;@45<+!(S[M4FMHXS59WGE5;&L67I`U85%712=/_-B)R M_1@8+O^QN=U!+R>@(.1]M`B\?$5.8&4#ZK_R4)#A?9:R?;F'(6IT5!*.<#$9 M+-2HZ2>%6A+-\D'I\Z].U:<[[$S2>L+.FM,MQF M-TQ3>X0B4!!5Y'T\1[+KDVR69:18@,[E]^+MDBLO3MD MJSG,%GFVMH?]L6OSNBFLW<8RC,56/&=Y&8[.R3VJ`%!VH^9:6],//ULR[X[N MTX<H/]9!G<:1N[BQ%O"*5\Y99)MCYVJ6"7V($[-!1*@:4_; MW,WHSJW^@0]'HCQ%*]=1G'7*\YM7)^;6$_FW*4,O^D'L$1FFN^;> MO/IAU$V^%'_D`45>;[>_\]T3LVL.->UF!JBY@[:5]*.U2(=X+CFX\(+DM4.^ MN5[$S8YVN#<MN8YL@PLZ),4AO;&^';-D1/TDSG@/MP>G(Y^`>7",N!4TX")<@JU]/ MZT^O;-V')/C6&CZU]7R08P<=2+YW).^+7QK*`+KTQPX]4L0N73[2F^W@UPG_ M]PU1ZG1#/G$(_3Y+*-DA0Z1:_2F*_,6M=7DK9>X?H=B6V/M!?D3#'^2=!G\= ML7_]%Q_JUW?GMW4OTP]YA'_NH7+M%X"8,G+EAW?:5Q37LQAC]F:^H4T@XX'" MP1C0KLH/W(6@7&(52.(546(5&1F18"&02D85< MZ&)!UH5@&(:>\85B6(8U9H5HF(9JN(9LV(9N^(9P&(=RB&X-2!37LW@B`1S- M=7]SV(PB)G&@0@-8982`'J0!/@#(EN51-Z]4DB.(<2H(M-0)>_84RM1,I&D<0 MU(4?AU"+*"-?](2J-YG=B)R%4D8R97 M]M`#HR`--G"-($,,.(`BQ!`+]C!=F"%7K"4-/F!^_G`)*%(G5$<9'@=M'@=- M0Z78/@&".Z78/8Z8,R,&.[X&/S]B) M3G5.0Y)>BSRD)#8,,NP M&7U4:LAE5EX'44P'B+M3.Q.9?46B8I(H.O>ACD!2=:5!;]&XE0D#@4Z53<0! M#^Z(,YI@E>JV&?;P>T:#`HQ`"2^$9\UVFFGX7'YQ#Y6HG7[H M#W7_N!?,$XC@V89IM!=IQ*([08$991`@)R)9 M)J$784@#P8<',4`AB.1D4:;-A*T,PVWD)H,P:44!0=A9J9/Z30;0:6Q8*4QH74-=4X#TU)> MBG#B9X+IB:/A`VT0Q5O\&1'Q<`H.M%L(`4D?02@/035'_XJH`I$*]Z,VY1FD M":J6=%1W7^%4@T@1G8&'["<0S6"B:1.H%Y%7TR"BH"JJXL->H:I9KOBB%'$M MS8"J+:%%):FH<$.J,P&`?H(0?GD(..EU&G$IQ,`BF5-'"M4B^3H3E;=\+'>/0"%L,Q5QAUE"R#*N%S%[C^$8]W=7DP,9^$0BMT(V M5L(GFN`8PK):Z`$Q!@H<3NDJ*?^+4.B1B'*:$([*2"?*/0AA:'Y$LJ,R=%>7 M7T)B'X92/X8P)9B&EYK2+"B+(CM[L5]4$0SU'C*2>)"JJL(J$EX#KEU+'?!@ M`]6`(\`ZMH['<"$14#AAH9^7(9^:&(Z6B`61H[.!',:P*,Z2$;S'(+%P?U65 MK*:C.DI")+67.#1E(8.+-/YR"Y;DB2GC6#Q7?PD1KO?AL:Z#KKF$IXVK@CI" M.8/+4HNC3/UB,Z!;%/?P"I(D$; M=+W;FI*(J=7!NK2:$J.P-4G7';>[$ZDWIYX8;VII.YIH$;/+6RD@H#%[&=XQ M&H\Q-GS_DCQGY58ELR!&8R1Y18-U1'(]T9[!`Q]L=1LGM<2Z2A/6$1L^51%S:1")RW.4P76` M![;QL:RH>K!$]:>^BUP6^Q'6@0_UE9TG(:1/Z9"6.K$]D7HY_S=YCI:\QR*< MN2<19?8<_2#"N%E`RK$-!6)?"D5!?"`KX"-"`F1Y!01`WK@B_$-`O3$D%J2P MBJ)`+V?!C1$R4B-=U)4EU^$K*R!@B_$"RC%!0JA46:6MW?5=C49+)<3)L#P4 M2CA_#5&"H&8A%1*+^Z0O2S@2\.L05>>)BH2O2 M6FHEUFQ*%?'81_=1IXZ#ID"QIWS4+BC)!#?"L<^QIQ@QJ(4JU+M#U`^!J\^\ MNP]!O#;-UP>!21G126]EJ1DMV$CQ,X7=/!P,K+U:$PA(4D M#=E<(DD5KP[_PLVE%"&R_:RTS1)]C)(9YK#(A[B)+5'V"FKG+(EZSLUO=(Z:YXB,;<%T5N8;6G[7!(L;1!I5-TQ)09,7L%4 MX4RM<=J&5[9G:S2D<2N<[9*9R],/-"-[BT5'GA!_*]>"&UN$VZWTA[A9YC*' MT+BB2QZ1"[N3B[J6&]POHES)6DPC8S.-RZZ-8CE$JS!_?KAZWKDH_XGFEH<: M<:[GI.M2MFU2;).Z+3&I%-5(>>?E`_&Z,?%S0(+IETPD2AC.4I&!OAEUDOBP M/3%[7J_58HY(TWKN^XWB4N;HV-'Z^\Y&^T`>^ MDE(>_;M/P5PHB:?@O!XWD+6]NX[LW1LO7D,U^\N]OJ[FGA(RDJ+K?K4E%NVV M4"/`5?,N!=R^RC'F&V'"%%6_TO&J0"(*[BX2E0U-\DY\+]D5CWFKVY'!JFT3 M,SC:CJI=LUPD&>;"SAP1,QXQ1[S#7/P//PP]03QF<5[$F5OQ<9#$ MXBD03(SGT\TE5H52F&4S'C,Q(._Q)_4Z\_^N//]"'B\O+P1!Q>6Y\8-R?YM# M.8_3(5^L/&'\1IY3/$I,\O>.$8<\GL5Q+[H5L!TR\"GAZ4]/$''Y-EG/%??` M-(4L,:<"%'*\PXM9$+`N$(Y,O>X-$21M)9:LA+Z\)9OL+*P,R@TBR@W";KUL MRDIU`ZG<0+N>,JU,]^02R]WA*Z!A7JE<(`140K.QRQ\47S$`S!8U<(NQRZ0<]P="+GH_S-Q3S-+!S@)Y>?!^ M9JVQSET=@^#]#R9L'$=I'`1J%4IBB&?VV][LO,<W96&RR7?R%#SQ`-$O^< M%/T@TM/_D`*=%`3_G?U4:(;@CP(3$?Y$1H;D?_XZYA#HO_Z+X?WN__[P'__R M/_]*5/U2T;M(X9])MF`<$Q&*0?H`\4_@0((%#1Y$F%#A0H8-'3Z$&%'B1(H# ME:%`<:CB,HP:"]Z#DR(605"-_OF#@S%C18>@,)ILJ&FEP9(".8JTB7$D2X7$ M.O+D">_&07\R=X+$^8_C3*!-%_ISF10E"A7;"O9C@A,J"AP$1UD%RBP6RAO; M[L$\J(HHJ*I.W;Z%&U?N7(7W8MR+)7:B/TNQ^C6Y19"O7R=@09K$!]88V+GV M;DR[52RP0I0^$![^=V_5/WA=[_W9UJ^P7+MX]=)5"`^%Y8+^*'45.%CT_S;9 M@%&[C3>26-E_S":WCG/KWARS./P%%^C[;3\X,18N@VU0DXK?MZU?QYZ]*;P8 MS:I'O%>X7YR=`AV?!.6Q69J-.10"'*@S@31I9)E#BM(('@R;(HLQSC"Z MSR<45M#&):[0:VM"&6>D,3MB5"@0(JAPN&?$95@C1J.SE-&O'T.L4R:%[PX: MCH\7/VJ$R/;44@I(C^*Z,4<#?VS-"5-6L\G*'7NL<:+/P/*'B2O-@TT9,>XQ M+CA_J%RN.<;N41.>%&#!LRM[4&B$K5N*HJY,0_\/1;0B/;5TB+D$">I/(`#_ M2>4?]I)C%"Y[DDJ(&1NJP7--2BV%R<+[[&EKTKG@P;%&H0I:QH95\#0ITO_N MM&86_XLE$0X>,OIP8Q`BLXG):&*45=KK[WVGE?D MR'2A>&`!Q3E(/0HRGL"DC"T5$^F*YQ7;$@KVOS7-_0==@5BUZB(4E*1+6VYI MY)(@$05R4RER-?HV7&P3\B!Z,82GD>-NB1*FC39,T&TU,1Q=C^P`XO51%Z]5:"Q98?*\&\$'7+^U"[@]P`8[J:]^"@<^(GW-AF@ICS@2,B3Z M+O7N.A>C2T@U0$_4KZ:E$OQ3>;I4A#X[[[OR>.J?!$)J)^GO=G'?6]8WF@F3 ML.(TE-^(3U;S!#A`YN$%+@:T%N,FTH_5:0>!B&(@`24X00I6<&'$D0B%O&&*D1B$I6X1"8VT8E/E(L1I0A$B4S1BBX GRAPHIC 20 inb013.gif begin 644 inb013.gif M1TE&.#EA$@+5`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRI]*<)A5NW8B*R18'UX=RZ,/V!HMO1'YP4 M9A'V^RM6K>'#B#$2\_KOWJJ'][!:Q;LP\K_),"UC[AMV;-G$H$.+3D@LKD1- MDN%05HCZLNJ7;%,'YDAV]D&PMD?KWJUV<>/`?E&HV/8/;"H4@=NB\#%9V7*! M5E$P%JB<^57G/HHW.1XK^O3@I@7>_XO!3/HR%*:##]=^JVW`;RX&UE[%>MRF(E1]U;JF0&V\()N@4,0`F%Q!)>"$:5Y&R5L@.K'-/7-LTX^=7RK976=NKBG95IK85U!T M;L7R96U^F17HG(EB]J66E%8*5&D$V1-@8TPTHJ%M/;YV(5E7XB?JJ9Y^1BI! M]]AI$*FMWO_IQ"V:.MKIHF6%FAJ&X37FJD"X::>HJF7%.E"PP5JJ[+(W^3;0 M/:_5YB9!6@V*5;7^Q%$JF=>RV8"RU6T@*Z(9M>;?:/ MCB"2^RRQL?3#A*,;VBM>M"TR*_#`+6&*GR8Q;`-/A9-"UYJN;%4(CYH/H_KI M987.*YDF.,PW7:OI\BD'CX5N0V5C37B9ZTPYC_8,9C"-@P.%UUV!$6-PM12\X&" MTW+*)V+2ES$82UN-P/.<>C0RN((V#-JG=8!52^C6=-!-V'%;P[7_U61T-C#A M='!)!_<"'.L1K?CBC#?N^..01R[YY)17;OGEF&>N^>:<=^[YYZ"'+OKHI)=N M^NFHIZ[ZZJRW[GI3T[XN^^P3T8="&*,\S9%?4$9TWH[`,M$[[<2#'NY\33ID MSX$+Q6Z7(4YBOG+[E?ABH= M%UE'(O@?4*$^C)6P#)@@KI%(03Q(%'TI31*_4Y4'*_ MFTV1XE>EX0PF7AW*5KXF)`:UQ:@*G$H8/*`T0;T="G%B60;T_@&*[SWPA8XC M7-@2]:5Q=0<.9D$37_"D)S[ER1]!6PRB_Y`3OH$0`P<*,PT#8'Y&K4 M9;3%JCRIRXY!;.-LB@B=W(WG,J)`WQD'J:6+@6R-'>O9/9C@%29A+%X9FUAQ MLABKBY6/.#P[A,T.`H^X^".0]P`A(4>IK#3NA2]CTX\4EB80!G7L:@1BQ%YB M<9Z.'0V)`MP;*P5B.[)!:U-J$R0IATFI9-WD9<1,)K/X*),_*O.9Q432MJ!) MS6I:\YHO>8LVM\G-;GKSF^`,ISC'2MKSGK13FX&"M_]/@2P#:_X$:(+.LZG&$&8@"GS60?$)S7M`#Q3V05$HB7.> M"OF30EARZ#\@1"-05H&B]`.DHD3)4&52`UAVPA]Q-E&8?Q+$I0K"!W%X^,=/ M!B:AC?E;($M*S2`MK)6F^>E`3J8E?\C!9&-V@EVVFKE]E!'DTX7OK+3=W25=K_*NB4 M6[-5[VQGT44.K[7`#:YPATO%"E"X!&8>`CS(Z`8 M;]%86I!F3/.]P_RL0?R1AX2,8B`'KDCY'&+?RUQ"=R39GNX<`^!G&A7"4T6( M1ANC1I%\ECCX4XE7#Q79"B?36002PTZA)39[\+4NP6&$)8ZD`FUHRW8"/4\, M@O,M)@@4:G$BAJ+@D#1]A?0>!KPPCLF$`EC$H41TT1?6C(8"0[!TR9?AGHFA MVB)]8>62.A)+?B^#0#+/M%,;U=D6-N$'6WBV_\,LC)<5A+E@@_)V7SQZ, MUO=->H69SBH\J-!2%R;6'CTXL#U^;*Z;:27A3::5'2<9.0Z=#XQO(F)G!&'AX!:=W94N',7NLCVZ4"MUQZTN3M@P_ M^`PU([ZK98&F(K.$6"!C)@:VO9?LR_`7149T[+";:+2Z,",PAW528'@8I?M, M[Q_W%H_5M`P=DOI3,A^:Y-/T(AE1,,**VW`Q=%RU1([=QQ\@+,9][#&XA)NK M&"UMGX!=<]]Y7X]#A?])]Q2\PHSW.5I&J+A%*&,^9K5U[!Z+12!JC^U>U"Y# M#.X]EA.HH2=K+XP:&5XDPF_!##^$X1\ZGY%O*MJ8ZOU<%A'3_K2F_[TJ$^]ZE?/^M:[_O6PC[WL9T_[VMO^]KC/O>YWS_O>^_[WP`^^ M$=/_.(;__C(3[[RE\_\YCO_^="//N5"])$:46N*";F8>`+F$N_U1=L.T^__ M&L4_&LHWKDN@8;MIC)R\CJ`M)&PT53\/8I6"UA_"+(F_^T$UY@$3@_RA<30E MQQ($-2;V4#AP$G04#2P38;)1RT@C07,Q>Y]888TR#WD@I^_S@8A+A(P`,L``07!'&'R<,V9`$+RG$#-K,7PZ$V-P`6K&A; M`V([8$<5_1`'J2"&7'%4E74L<+82V9(*`\@2$]-_FA`CA=4J7D,V$Q$/=Q(@ M_G!24<(C<81#%O)_:[1I-+(AG'92T3$LP#$A3;(,;S,G6-,:RO`W_;>&E+`I M^?9$ID4C]D(E$7=W^H)$]Q`@DV)^1O,@D#8G2*0C_F:/L*".EW%4C()#]0=E M4\-Q-(*&T'AA7$&1A,&\<@C5^$7?!<8S>"1-Z0BV-@=P)B%:'&$-R&"!U@0 M=947VG@3F?>`<@=B-I`O0?\S$30((=IP@9"8)E7T+`9W++E2,GFS*\_2&>&R M*%-$+T[R2CV7*]$2%C\997#PAQ^(?9BR5/]`<)ND*3(W12SB*`F8*J"B+574 M+OR2+R,S+]"('Q^R`DR%R"W!GX208-J5R%C*8=XXT5^@0.[.!OTHBO',D4:M"A7^4:M=`-! M]RD[""0?^'+8QY_B!G`WP`FE$J`IPYQYEI5D>0,:E):AJ#(W`T!].1@2JBV' MM'TWQ"Y!`U%N""3[V9XN^5M285_V-9DU`5D%P97B,8PK886Q8#`W,6:'Q32' MD&\'JI-C0@SKF!V6X80!>1G4H%+A0@W5(!`:)R@*)55()";449"^]!J7L2$0 MPI^:(*1843)`M(1-,%/M9Q4-9#3GF!U>9ED#L:6-L9>E^3>6``MKQ"];Y"6Y M4F!@!*=RJ@F,H0IB`H63@IH>.J?4P:5#.'940876N14V_V$,VH-OT&@9,+%J M]R`AX*D2-,DH<6"/)HE_#/$?O>.B(F)1Z:50N84C?%!C<`(]4A,+SC&)&N(U MP,,WVH,D8[(]#H,""0.)+R`X/&(B`G0XB3.(NOHTJVD0D`@\9+%*PQH<$DJK MD)@"4K`"MQ`W;0$#L&@+>Q$AXCD=R2H%.V)D`>(W+$0AVZH]W#,7]I%>SEH< M1%TS9.3(6&-'/8Y M5WA^OK@YQF03(N@9ESH1/S=4_"I]E2*(-5&J"Q$=8",2RA%`&ENR)GNR%$%= M*KNRVQ1=+/NRU(6R,LMZ,%NSTO\%$C:;L^LTLSS;LS[[LT`;M$FQ@=_WG@C[ M*A`:$65F$1U('>/5#ZR%'^BI$2RS.ZTAM7+E?39A?HS3L%RQM`[1#WG@J=EG MBL6!H1_Q?B!1A"*9$/57&%IQ=PVQ@D:(."#2?R[9/FM:L=TSM1BAM7N+$%*H MKP)+%-OI$@R8L2B1::$E4+0J;+[33_[@AIRIN`A!M",1L:]2H`3[HO,:M@6Z M$!<;$B0X$A.[$*7[$N63@M0&%+44$X=EG:W[$K=&=1>U6"WX4I]K$$"(2]4H MN'QK(8S*@=PW8#DII=W#:1C1N?@!C-7'C20QN)<+O9E1A;&`#\$;$X?+$I1Z M)P^+$O[_H+QZ-50`I9[0X;P/L8;[.;D"Q'6?2"US^*^&R4%K6B![)`>IP$%:08CZ,HGY-A@!`L&%0;_$`8G^(FP6)F>U'%ZJZ1*(JT]2G^ M2Q^@N,$C/"&"CA&#;D*$#GF([RP:=0XXYU`8_`=([[1,7W:!\CM(1,8!^F^8^S M`5/#&;[$(8Z!=#P+1H]YHP()"5OWD#C.\I`3LGA@HW]#8E/A_V+'_R".'8DX M?PQ%5F,O0&HA#Q8H8Z8)A6"WC?*V4/@/9LR1#>*.80.]DD/EF600DLUE80\[E&8&>?4I2:7?PE3KE4F8`/I/,G-N:4Z1]H_M&F[1))],/[J5#W]8^=-F@ M^")KY\;+Q6)P)(J54P*5*/.A(G(W/Y,2\<`'NXL31/P2B-G/)?'-\^)8H%<< M;>DD`BT0E4FF)]6;))2D@SH9T]*/%;PO<[0-QRJ<^`+1X'*\ M8=I*\;*IMNDD$(@O[:N%@]HP[2(@0?]C>2)MIW"D*%Z2)Q9"P))2%E(Z+31I M>895T9LIFL&IE)L:TN]BA@M'P"=AG=2;RF^YF-_9RGCCR@7AJ+,&$>HIBP@] M&[GL*[=*9"8Z+X`!S"@C(!RJ*B_'1?[IH3N(EPGW+_*&AEM4LHM!!1P51GU,9ECC-*7C8T_()U'>&E\T,U_\I ME4MG$$Y)$C*XHI9;$__,$C1JHZIKT(Z55M#!UT`5$>9;R6O$I80JM9ZD"@LS MD;=`#3`#NBA'RII;9=,K+YIOA!"0TD;%WA)/OD#[_- M(Z#0,?2UW#+_#=3N4AA%>-,&*JB7`5'ST1TP$PK:S2[@S9KI0G"9$E':0@W% MUEX7R2^%D=SL`85Z42'+@]T"P=X[E\`QPEUJZ#&*D`9"`X`JYV`[!54Z.$*$7,2C*LQ+%9=A]^HR<3$C@[HN&& MPP3#>C3MQUBY(6OEB@*/&>.K2HDA!8DP+B!M80-V(!R>J*L(71AS`0-'K@*V MT!9"2'"0^$KOBF[FB@).CN1^D^3+K#0ID*IW4L@;G##6&L,21B`)LX-W6%OT0^=X]KTWP;PM,80N*><9T6Z!OJ3`_$%A^&U MBW,//[P2Q@D1A@X432NQ6>NW(L&C+A%NRX#@LF=]XG/C/Z'B,^&Q`R;?(D%@ M=XY;I0U[:6X7>"JTLBYY.EOKZ(2SMI[KXC3KO%YANO[K[/01P#[L+=OKQG[L MR)[LB8'*^('J68&P@_OJ^\?+1UL0WPV>_]$#%2X1G[P1W4X=Z+/MB^G@)P&V M].?L*0&&H'&'C,%B?9D1=W&YLRL7=GLPLLD6)62O&'7LW.X%91,R5^,X2I^3I,4%0+96("F9_"NN2#L[LTWP1R,L0 MG5X2(0]&'UB\;NO80+'2E4'Q2!@#UFD,Y/\N$K4;4G1(-D2-$O@S#;=`MSA! M8>U8=3WTZ`K1#*B0BI1K(9AN%U9Z*.A;$<[\L4\/$E&_N1GL$(!.$Z#^J0>_ MZ3B@HG[.$D%"F-O6O$3_$?A#HSQ!=+YR"R,VRQ$1#]H@W9<1=-XQ/Q5IJVJG MY&2GY/$A4$C*R?7.6Q5L/]"!P?ND0+Q`QA_AF[K9R(FHZH8Q19Q M`0J(=;6I("%HES#TB'*]S"0*,SP`<8_)C6WV4L2ZUR36OW_,%C*$R>6/S@J M7L%!H2*6/17;^LFYU:\)+(P'X:FXY4]3(Y5AX*0@B<(D2G]Q%A*[P9"A/SG; M(DYIQ:>H7\P_VB) MB2U-=)TX][T4M_JJ]5?MW^K$CH*SOXC MD"QX9OMM*_JVL@?!`O&ZAP\''Z1PK&:T4F:YQ_"ZL#A#4A'-"=\8JHO!G+BR M)R/5*$&!+['$8FB9P!+RC<;B4(CKGCE&%$VAY]Z3R$8;/;.+1!^A"NVDA>XQ M:CB)'/HQH24EZL>)\7;+S6E0YEU#,$V4++K1@- M;=2L>V`!A=)*&;U'4QUYQ(LPB%"HKB8>XWMO#M8HP<'4]WKC+#'G8E1ON\14ISRH>D`W(A?[S+C5=?&2*F!U6,]$W9XU*Z[3TXEHKMQW^4 MB0J>&T:1;-II;:7(AV.)2O9-58L%5EQ>4?`/,U9-U7&\JHQK]Y]FGYTVUG.[ MX@W432%"*!9B!RYP09T49HCA;2=$.,_7;B%&TX@)]`>0K@X63!3)<$H,E)S@ M84D3334)+!5[+NLG#EC\X=>8B:XMKK.5KQ(+GH/ZL>^?4%+29&26^O.)NQ[1 M)?.A12%BPJYE+@M3IH_@M9D.$ MZ8O'%IHO%LQ;R:CV3-)_EJ8+B>+0OW+DW0W(E?Y=0C!@7- M_6$"3>54D&(%;5C$45\T8^]HI_,8RA`%+2K2!B,4BGQ])Q9M8&(%G$%!X08[ M,MIF]AI@!53]& MJ+<>>^T52P$?`C@^;?#/([7KS>I@0#W=\:^`RT%!9VZ7NP.B27N^NX$!$^., M__01)$.E>E_Y>C>ZV$5P='FQ"D-21"H5+D8]W$O="8L'L1/*I80R*8CL:ABQ M98B.AP@:TP[OT@^-"=$K_!)-$8VXQ,$XCHE@808-NQ+%)][#B4_$(A8U<<6! MW<-^VLKB5^XQ(";V<&%D#&,:L2BXLGA1C6^$XPG]P8D8;LH?>0A743(BL#3R M+XTJ68X4XSC(B\V1CV'!&R$5N4A&-M*1CX1D)"4Y24I6TI*79!0$-;E)3G;2 MDY\$92A%V^$9SSE.4]ZUM.>]\1G/O6Y3W[VTY__ M!&A`!3I0@A;4H`=%:$(5NE"&-M2A#X5H1"4Z48I6U*(7Q6A&-;I1CG;4HQ\% M:4A%.E*2EM2D)QT=C"XVI+&LKDUS8>-8PH32O,3CD.VT8C:7L9A#,*..7%D= M&BN%%"[JA!@(,=I651J8&V:I8@@J5/*TWJ4\OBK6;`8A,WQ6(_^((9KHG&:2]=XLJF M`0M12'6)>LU<8B@S4X&L%:W_L^J+88<#6:;*"4!QY4J^$*99N;;QN^D3#>D1)0)9C*02\HK:,:^XM$$%"@I1&^>.")#,[>Q96I8* MR1ZV4-[CPW!W(@J\RC$.Y%WD'+6"LGL4D626%9&"#:9E%D5[E'*IC`EYR"HKQ?68974<0ZQ<3%7Y3MB^TH6R7)M`M8 MMM()KD1S+<["6#.$WE6Z;J%H)C7"T%D",UDNA5]"7HA.#TO53W>8VJ6NV$HP M#-@-SYJ7QNYJ%13!0HZ073:XXL;[7@&1=K.>TFJ4LMEM2;62J77M/6+Y^ M4]..ENFQQ",6-A6Q(NEHN7]P^HZB'IT5K4CA%>/Q9C&M-H_)H@RGWK$OO*4, M-83SCV+@9S.0M4=I3$4-3C-$$]49XZ5###6C96UJU6GTV>8\L]][B\;2R.E7 M?SRCGJ`E!]/,!A@.+@7H-RI.L>:YG+@IAUK)W=F(#0)4'.BG\;$P8S'!`R`? M5)"\Q?`E=@?;@ M-1R@RQP%\I,QQ+E20D$R\4PZ;.%9<:NY)RZWS4N\>IMPBZ!Z:S-;4N]<3N>9 MVI.R%.UO;ZABH@YWNM?=[G?'.SV;N?=C]I+O?\]EW@4_>,(K$O"'QZ7?$;_X J519>G8R'?#(5'WG*+\?QE\=\YC6_>]&`."``[ ` end GRAPHIC 21 inb001b.gif begin 644 inb001b.gif M1TE&.#EA6`+F`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J7//JW/'D"-+GDRYLN7+F#-KWLRYL^?/H$.+'DVZM.G3 MJ%.K7LVZM>O7L''ZTX0"A9AEM5=LFXTBQK:#_N`T`BY\XKTFL=SZHS3DSI[[.`)BO_G/CPE M%+JWUVY>7GWZIK/]MTQ^](WR&T3S%63/>`8%%Y]:";:T8$(31K3<@V**(/X*(''DU/F6/"CX61^**$D57T&P,)OED6\MUB1*7 M")$IT8QMH?B//>F9R:)Y/,(ID#WFS28G02@V25Z.<]XIDYILTJ>)='8>E"<< MMAFT#)S$B)'GA^?QJ528@G;8S(C8)4KBD_;45IL8RS%"FV^\19DIG*5BR%V' MQ*!`9:?IG?^Z*2K=T=C;;YUZ"J>L>#*!WX'!H:"=/3'@=INFQ!IKK(O"6G<< M+/=)NNIN<(AZJZT='D=K([QB.R)]]VEW(724I``+;5%.6VIZTSZ+*(RI.IG< ML]'.Z:FF6BF)HT"-1LJOG/ZH.O./L+P;GAP[T[PO?2GK&=[*FM0Y*(\J:(.HHQD?:AMVCC+Y-#%4+O?K MS>S1I_,_U.Q6KKS^$-UDL&TFS3/19(]()C'YS?B1S>V)%3&3'GVS&>U'/-:--TA23ZNM^FT*6\+Z7`,Y>[IXWHB29!G8)' M[(GSZM[=\6LV._/1F>X^)Y]V(X?B]D%RO^2)3V8_[Y<#M8JJS%8F/W[SQ/.+ M[W7AQ[\^I3SBJZ6]U8GOX?KZW^V[YUGQ1QX.]+B(E:\V#UH&E0I(N8$PXUP= M.IIZ""03`1)P=.?!8'@&6!!C?*M^S3H2!$<$0*;,)@P"FU(A,!4DB87/5Z[# M&_J&HR:,T9!\X,*!TKAT*1*UD'(Z_/A!V-&02C*CW?WXZ*/JCBD)O4/=;R+(OM!`:[Y3DQ12+R7BNS M]<63-:P8T)EA*;,H2OK#'EL?",8(24Q)EDICX&:R32OM#]]P<]H+*)FY$"WIKIY$Y!1\0<@'!BV MX<&Q-[:[5R-:5?^=5DW.5+[Z3Z9>P`0*>BT%4B"0/PHIL8#R)H:(0FC4T&6] M3&'/5^`AXFYH8ZU&X$:''*6-1P'Z*T'A)Y](]%J4^!F+5D4MHE*8:.#LR:R* M86RF[D,!0:G4*ATBJF(]/:@4$.HJE*;(5P0E:@SRN0*4YK-]6&D5`IV5G>3@ MIA&=0B)W8)0K_M2J/]$SV%9I(M40YDX[5PUK<\I:G5S!Z*I9)>&G(E<;V77% M']20&!=X@E>]DJ:OU]FK6>Y13X@0=BJ'I4ABZU+`=/*DL>,<#63%])7E4<2R M4<&L1#1+EU*]+R>>9:=G0AN;TIKV,/=*K6I7R]K6NO:UL(UM;2HBV]K_VO:V MN%WM:7?+V][Z]BNY#:YPAYM:VA+WN,B5[6^7R]SF.O>YT(VN=*=+W>I:][K8 MS:YVM\O=[GKWN^`-KWC'2][RFO>\Z$VO>M?+WO:Z][WPC:]\YTO?^MKWOOC- MKW[WR]_^^O>_``ZP@`=,X`(;^,`(3K""%\S@!COXP1".L(0G3.$*6_C"&,ZP MAC?,X0Y[^,,@#K&(1TSB$IOXQ"A.L8I7S.(6N_C%,(ZQC&=,XQK;^,8XSK&. M=\SC'OOXQT`.LI"'3.0B&_G(2$ZRDI?,Y"8[^_G+8`ZSF,=,YC*;^E*6_K2F,ZTIC?- MZ4Y[^M.@#K6H1TWJ4IOZU*A.M:I7S>I6N_K5L(ZUK&=-ZUK;^M:XSK6N=\WK M7OOZU\"6;O)@82"IA'$KT-M(LD5R-RNYL+`/27:P;""\C1S[V0F^VR:C^1;< M0<3;(!F71\1=$G)O"0X8FA-E3X;NL,ULV>%N]T+`';EU7X3>OU63/XI=%S<] MQ-\A@3=&!/X1@2\;X(;"(<$#+L4MQ='A]JX(PG\[&PSQJEOGJ4VV?%5$&%8I MA,FRS;(V]0I?>4?CX/\#G$\#AQTJ+;$)*J>KKEP8<_M(#UT"]16:MVZ**G19W.,Q,RN]Q(IR9BG1F=8Q^JJ>FG--&?VF M-7HYM"K6+IC7ZZ8N?Q+/H:9V^,X3;DW5$7TN`Z3R5#]]@3)RZUQ6'ZF/<\T\)P..5G<6AZ&V/_ MW[Q//]&/G6I9\Y';L%_,4-J>V[%9CNNJ]SSG=4E]X=0FMI<8R_ZGZ$EAI#[Z M$S*[,4]I]$73`T!J!$;51G^^]UG(!$2=E"/BLTQ#I#WV)X%/8CX-13S&@T/Y MIX%9-",<>$X'"#,?:!WJ!"+^UT0`R#-E)",(."A(\G+?%W3? MHC]/R((_-$7?0BE/>$0C\H1G=$-0V(6U%!SNA"EHU$E(5(;Z`RZN@X98ESMJ MN(3+UQQ&I#DX:():"$179$8TB$1W4X7?QV[Y$3Q8_T0_?QB%W?-#0EAM+I)Z MIC4C>B)*O10YI+(R,L-*QC1+W^,]>BA,N/*),&.#UW*"A'A*+TB(+X**Y9=* MQ7-,[-8WL\A9P*,*I+A,VZ9MYA%)\F,R_X!+@C*,FM1,[C:*0X**(FB,R/B+ M>!B0P!E`Y!6G?YEX`9F((YF(19F(9Y MF(B9F(JYF(S9F([YF)`9F9(YF919F99YF9B9F9JYF9S9F9[YF:`9FJ(YFJ19 LFJ9YFJB9FJJYFJS9FJ[YFK`9F[(YF[19F[9YF[B9F[JYF[S9F[ZI&@$!`#L_ ` end GRAPHIC 22 inb003b.gif begin 644 inb003b.gif M1TE&.#EA!0.P`/<``````(````"``("`````@(``@`"`@("`@,#`P/\```#_ M`/__````__\`_P#______P`````````````````````````````````````` M```````````````````````````````````````````````````````````` M````,P``9@``F0``S```_P`S```S,P`S9@`SF0`SS``S_P!F``!F,P!F9@!F MF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,,P#,9@#,F0#,S`#,_P#_ M``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`S#,`_S,S`#,S,S,S9C,S MF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9,S.99C.9F3.9S#.9_S/, M`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_S#/__V8``&8`,V8`9F8` MF68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F,V9F9F9FF69FS&9F_V:9 M`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,S&;,_V;_`&;_,V;_9F;_ MF6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS,YDS9IDSF9DSS)DS_YEF M`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9S)F9_YG,`)G,,YG,9IG, MF9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`,\P`9LP`F/($.*'$FRI,F3*%.J7,FRIO8,.*'4NVK-FS:-.J7//JW/'D"-+GDRYLN7+F#-KWLRYL^?/H$.+'DVZM.G3 MJ%.K7LVZM>O7L&/+GDV[MNW;N'/KWLV[M^_?P(,+'TZ\N/'CR),K7\Z\N?/G MT*-+GTZ]NO7KV+-KW\Z]N_?OX,.+_Q]/OKSY\^C3JU_/OKW[]_#CRY]/O[[] M^_CSZ]_/O[___P`&*."`!!9HX($()JC@@@PVZ."#$$8HX8045FCAA1AFJ.&& M'';HX8<@ABCBB"26:.*)**:HXHHLMNCBBS#&*..,--9HXXTXYJCCCCSVZ../ M0`8IY)!$%FGDD4@FJ>223#;IY)-01BGEE%16:>656&:IY99<=NGEEV"&*>:8 M9)9IYIEHIJGFFFRVZ>:;<,8IYYQTUFGGG7CFJ>>>?/;IYY^`!BKHH(06:NBA MB":JZ**,-NKHHY!&*NFDE%9JZ:689JKIIIQVZNFGH(8JZJBDEFKJJ:BFJNJJ MK+;JZJNPQO\JZZRTUFKKK;CFJNNNO/;JZZ_`!BOLL,06:^RQR":K[++,-NOL ML]!&*^VTU%9K[;789JMMB/8.Q"Y%]Q+4+0K\UHO1O/X.]&Z\N))K;KTV&/,;PS3>HF`NN8Q\?;:W5;_["MQ>4\TV'';C7;'(,<__RP@E8&O- M+]8R4_)WX/NJ_<\R9F^S==93KY"*Q(R/_4_B#)<]-N;RPL$(WE5?GG;$@G/M M-^"A3ZW"Y*5GG7C%!&D>PS:HDP96'3 M'R-Z][\`-M!Q$"S7XO:&0K&!D'8HE`,0_^,'L,61+H:BFR$'`?@U$$X#A25[ M(?Z`AC+\Z7`9L$/7_5IXN1XVHHC+.*+QTH4R&SJ0=%J,@PU_F#_?I2R-4PR: M"N400'_!D8LJU$3;4#!`)A3PB=W;XQFWP<4NRDN(?2)@Y;"V2*X5A%P#'-H8 MV[6,V75/#&V,&;OZIHG0/8^)!QM:)N45ZRC8W$P;P" MY[5ZN1)CGMS9+3MYRG2YLI6#0\$-4KE)]*5O<#CXI2052#E+XK*7VHB>*M7U MS-TI39GM@B0%S15+;-:/FE0DIB3GI;%>TFZ9U_MD'&.'OC8*#`[E3&4L,]D[ M=&T/F>9T)[EHB?^GF0DL#GWPY.($JJ\FP`)>.\O7+C&92DV2L7J=-)Y!U2A. M:IIP@C*S9D5]!SLDMM*9O)0G03L'0_I-\Y+V6N9"S8G-97C2G(73F$L)XLU) M#F2E&]7F2JT)-&_>8Z+;'"A-+7FTH2D-IC\]:%#9M;/K)75YNWLD)4!I+Z#" M4J#TC)<]L5I1=\9T:72*H-96,(T-7LX0/]6J(89Z/XQY4!6:R-K5XA;%AM:3 MC/2ZG%E52;TZ,E,@5UNE*;N:!Y.9LUMQ$^(IS7H/M*[U'TUS)V+E53*O>5`4 M3*`KV2K:+?VIH*QJY>QC;9;6LW96=$=TJ\PPF]C-AG(:HY5?9BE+-I[_QN*T M(JMD6XG)6+0R07]BO-=1-ZK;Y74UKC)3Q>Z*NTY[C99_-P67<0_6VZPJ$+1G MS64##X@-2HL"-+9\D1!VV?[?5P@0&7@CY86,;B59V( M!_=&)J178Q@V[S'%:Z^T-2)R?`#QYGRL7BF<>&PP7D&2]\;D_I:4PH3#,'_5 M&XL@-Z[`7U/!?;EFW@*'&,-8-ITF5MFJF$G$4!^C8-]!_*$*>\%O6_MQ MIA!B>-*[>*Y/V4K:D*EUK2$PWF^@%\WH1COZT9".M*0G3>E*6_K2F,ZTIC?- 4Z4Y[^M.@#K6H1TWJ4IM:2@$!`#L_ ` end EX-101.PRE 23 inbp-20110930_pre.xml EX-101.LAB 24 inbp-20110930_lab.xml Condensed Consolidated Statements of Operations (Unaudited) Condensed Consolidated Statements of Operations (Unaudited) [Abstract] Sales, net Cost of sales Gross profit Selling and administrative expenses Operating income Other expense, net (primarily interest expense) Income (loss) from continuing operations before income taxes Income tax expense, net Net income (loss) from continuing operations (Loss) income from discontinued operations Net income (loss) Basic and diluted net income (loss) per common share: Basic and diluted net income (loss) per common share: [Abstract] Continuing operations (in Dollars per share) Discontinued operations (in Dollars per share) Basic and diluted net income (loss) per common share (in Dollars per share) Weighted average common shares outstanding (in Shares) Condensed Consolidated Balance Sheets (Unaudited) Condensed Consolidated Balance Sheets (Unaudited) [Abstract] Assets Assets [Abstract] Current Assets: Current Assets: [Abstract] Cash Accounts receivable, net Inventories Investment in iBio, Inc., restricted Other current assets Assets held for sale Total current assets Property and equipment, net Security deposits and other assets Total Assets Liabilities and Stockholders' Deficiency: Liabilities and Stockholders' Deficiency: [Abstract] Current Liabilities: Current Liabilities: [Abstract] Notes Payable Accounts payable Convertible note payable - CD Financial LLC, net Accrued expenses and other current liabilities Notes Payable, CD Financial LLC Liabilities held for sale Total current liabilities Stockholders' Deficiency: Stockholders' Deficiency: [Abstract] Common Stock, $0.002 par value; 50,000,000 shares authorized; 20,965,074 and 20,915,074 shares issued at September 30, 2011 and June 30, 2011, 20,930,174 and 20,880,174 shares outstanding at September 30, 2011 and June 30, 2011 Additional paid-in capital Accumulated deficit Less: Treasury stock, at cost, 34,900 shares Total Stockholders' Deficiency Total Liabilities and Stockholders' Deficiency Common Stock, par value (in Dollars per share) Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Treasury stock, shares Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) [Abstract] Balance, July 1, 2011 Balance, July 1, 2011 (in Shares) Issuance of Common Stock in connection with Convertible Note Issuance of Common Stock in connection with Convertible Note (in Shares) Stock based compensation Net income Balance, September 30, 2011 Balance, September 30, 2011 (in Shares) Condensed Consolidated Statements of Cash Flows (Unaudited) Condensed Consolidated Statements of Cash Flows (Unaudited) [Abstract] Cash flows provided by operating activities: Cash flows provided by operating activities: [Abstract] Net income (loss) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments to reconcile net income (loss) to net cash provided by operating activities: [Abstract] Loss (income) from discontinued operations Depreciation and amortization Accretion of financing instruments Financing costs in for stock issued in connection with Convertible Note Payable Change in fair value of derivative liabilities Gain on sale of fixed assets Compensation expense for consulting services Compensation expense for employee stock options Changes in assets and liabilities: Changes in assets and liabilities: [Abstract] Decrease (increase) in: Decrease (increase) in: [Abstract] Accounts receivable Inventories Other current assets Security deposits and other assets (Decrease) increase in: (Decrease) increase in: [Abstract] Accounts payable Accrued expenses and other liabilities Net cash provided by (used in) operating activities - continuing operations Net cash provided from operating activities - discontinued operations Net cash provided by operating activities Cash flows used in investing activities: Cash flows used in investing activities: [Abstract] Purchase of property and equipment Proceeds from sale of property and equipment Net cash used in investing activities - continuing operations Net cash used in investing activities - discontinued operations Net cash used in investing activities Cash flows from financing activities: Cash flows from financing activities: [Abstract] Proceeds from notes payable Payments under capital lease obligations Net cash (used in) provided by financing activities - continuing operations Net cash provided by financing activities - discontinued operations Net cash (used in) provided by financing activities Net increase in cash Increase in cash, discontinued operations Cash at beginning of period, continuing operations Cash at end of period, continuing operations Note 1 - Principles of Consolidation and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Note 2 - Liquidity and Going Concern Liquidity Disclosure [Policy Text Block] Note 3 - Assets and Liabilities Held for Sale and Discontinued Operations Disclosure of Long Lived Assets Held-for-sale [Table Text Block] Note 4 - Inventories Inventory Disclosure [Text Block] Note 5 - Property and Equipment, net Property, Plant and Equipment Disclosure [Text Block] Note 6 - Debt Debt Disclosure [Text Block] Note 7 - Significant Risks and Uncertainties Concentration Risk Disclosure [Text Block] Note 8 - Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Note 9 - Related Party Transactions Related Party Transactions Disclosure [Text Block] Retained Earnings, Appropriated [Member] Common Stock [Member] Scenario, Unspecified [Domain] Treasury Stock [Member] Statement, Scenario [Axis] Additional Paid-in Capital [Member] Statement, Equity Components [Axis] Document and Entity Information [Abstract] Assets, Current Entity Common Stock, Shares Outstanding Repayments of Long-term Capital Lease Obligations Cash and Cash Equivalents, Period Increase (Decrease) Payments to Acquire Property, Plant, and Equipment Income Taxes Paid, Net Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Entity Central Index Key Earnings Per Share, Basic Liabilities, Current Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Operating Activities Document Period End Date Income (Loss) from Continuing Operations, Per Diluted Share Increase (Decrease) in Accounts Payable Amendment Flag Net Cash Provided by (Used in) Financing Activities Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share Document Type Assets Amendment Description Increase (Decrease) in Other Current Assets Shares, Issued Income (Loss) from Continuing Operations Attributable to Parent Document Fiscal Period Focus Current Fiscal Year End Date Liabilities and Equity Stock Issued During Period, Value, Conversion of Convertible Securities Operating Income (Loss) Gross Profit Entity Voluntary Filers Treasury Stock, Value Entity Public Float Entity Filer Category Document Fiscal Year Focus Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Stockholders' Equity Attributable to Parent Entity Well-known Seasoned Issuer Net Cash Provided by (Used in) Operating Activities, Continuing Operations Increase (Decrease) in Security Deposits Entity Registrant Name Increase (Decrease) in Inventories Entity Current Reporting Status Statement [Table] Statement [Line Items] EX-101.DEF 25 inbp-20110930_def.xml EX-101.CAL 26 inbp-20110930_cal.xml EX-101.SCH 27 inbp-20110930.xsd 001 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Note 2 - Liquidity and Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note 3 - Assets and Liabilities Held for Sale and Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note 4 - Inventories link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note 5 - Property and Equipment, net link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Note 6 - Debt link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Note 7 - Significant Risks and Uncertainties link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Note 8 - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note 9 - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.INS 28 inbp-20110930.xml 0001016504 2011-07-01 2011-09-30 0001016504 2010-07-01 2010-09-30 0001016504 2011-09-30 0001016504 2011-06-30 0001016504 us-gaap:CommonStockMember 2011-06-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2011-06-30 0001016504 us-gaap:RetainedEarningsAppropriatedMember 2011-06-30 0001016504 us-gaap:TreasuryStockMember 2011-06-30 0001016504 us-gaap:CommonStockMember 2011-07-01 2011-09-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2011-07-01 2011-09-30 0001016504 us-gaap:RetainedEarningsAppropriatedMember 2011-07-01 2011-09-30 0001016504 us-gaap:CommonStockMember 2011-09-30 0001016504 us-gaap:AdditionalPaidInCapitalMember 2011-09-30 0001016504 us-gaap:RetainedEarningsAppropriatedMember 2011-09-30 0001016504 us-gaap:TreasuryStockMember 2011-09-30 0001016504 2010-06-30 0001016504 2010-09-30 0001016504 2011-11-15 iso4217:USD iso4217:USD xbrli:shares xbrli:shares 8047000 6439000 6618000 5481000 1429000 958000 689000 910000 740000 48000 -145000 -448000 595000 -400000 -7000 595000 -407000 -232000 406000 363000 -1000 0.03 -0.02 -0.01 0.02 0.02 0.00 20936813 20625981 563000 563000 1960000 1205000 4509000 5367000 823000 823000 163000 173000 3680000 3722000 11698000 11853000 1519000 1598000 192000 199000 13409000 13650000 7805000 7805000 4578000 5152000 4500000 4500000 730000 921000 300000 300000 2818000 2667000 20731000 21345000 42000 42000 0.002 0.002 50000000 50000000 20965074 20915074 20930174 20880174 44553000 44543000 -51818000 -52181000 99000 99000 34900 34900 -7322000 -7695000 13409000 13650000 20915074 42000 44543000 -52181000 34900 -99000 50000 4000 4000 6000 6000 363000 20965074 42000 44553000 -51818000 34900 -99000 232000 -406000 90000 85000 319000 4000 5000 -10000 -6000 -2000 -30000 49000 5000 158000 -755000 -135000 858000 1044000 8000 -70000 -3000 -625000 -1350000 -116000 67000 49000 -271000 168000 757000 217000 486000 1000 145000 2000 30000 1000 -115000 1000 -115000 40000 11000 11000 -11000 29000 -11000 29000 207000 400000 -207000 -494000 478000 384000 INTEGRATED BIOPHARMA INC 10-Q --06-30 20965074 false 0001016504 Yes No Smaller Reporting Company No 2012 Q1 2011-09-30 <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 1. Principles of Consolidation and Basis of Presentation</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Basis of Presentation of Interim Financial Statements</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying condensed financial statements for the interim periods are unaudited and include the accounts of the Company. The interim condensed financial statements have been prepared in conformity with Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and therefore do not include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011 (“Form 10-K”), as filed with the SEC. The June 30, 2011 balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The results of operations for the three months ended September 30, 2011 are not necessarily indicative of the results for the full fiscal year ending June 30, 2012 or for any other period.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These condensed consolidated financial statements reflect the classification as discontinued operations of our branded proprietary nutraceutical business which is operated by AgroLabs, Inc. (“AgroLabs”), a wholly owned subsidiary of the Company, which distributes for sale through major mass market, grocery, drug and vitamin retailers, healthful nutritional products under the following brands: Naturally Noni, Naturally Pomegranate, Pomegranate with ACAI and Reservatrol, Coconut Water, Naturally Aloe, Aloe Pure, Naturally Thai Mangosteen, Peaceful Sleep, Green Envy, 1st Choice Multi-Vitamin, ACAI Extra, ACAI Immune, ACAI Cleanse, and other products which are being introduced into the market.  These are referred to as our branded proprietary nutraceutical business and/or products. (See Note 3. Discontinued Operations).</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nature of Operations</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products.  The Company’s customers are located primarily in the United States. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in 1995. The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company’s nutraceutical business includes: InB:Manhattan Drug Company, Inc. (“Manhattan Drug”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and The Vitamin Factory, which sells private label Manhattan Drug products, as well as our AgroLabs products, through the Internet.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company also distributes fine natural chemicals through its wholly-owned subsidiary IHT Health Products, Inc. and is a distributor of certain raw materials for DSM Nutritional Products, Inc.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant Accounting Policies</font> </div><br/><div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There have been no material changes during fiscal year 2012 in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Investment in iBio, Inc. - Restricted.</font> The Company accounts for its investment in iBio, Inc. (“iBio”) on the cost basis as it retained approximately 6% of its interest in iBio (1,266,706 shares of common stock) (the “iBio Stock”) at the time of the spin-off of this subsidiary in August 2008.  The Company reviews its investment in iBio for impairment and records a loss when there is deemed to be an impairment of the investment.  There was no impairment charge recorded in the three months ended September 30, 2011 and 2010.  Pursuant to the Forbearance Agreement with respect to the Notes Payable, proceeds from any sales of the iBio Stock will be used to repay a portion of the outstanding principal of the Notes Payable. (See Note 2. Liquidity and Going Concern and Note 6. Debt).</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental Statement of Cash Flows</font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="6" valign="bottom" width="28%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="6" valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental disclosures of cash flow information:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid during the periods for:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest - continuing operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest - discontinued operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income taxes</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Earnings Per Share</font>. Basic earnings per common share amounts are based on the weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible preferred stock, subject to anti-dilution limitations using the treasury stock method.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock options and warrants to purchase or otherwise obtain shares of common stock were not included in the fully diluted computation for earnings per share as their exercise prices were greater than the market price of the common shares as of September 30 2011 and 2010.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 2. Liquidity and Going Concern</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company’s condensed consolidated financial statements have been prepared assuming that it will continue as a going concern. The Company has cumulative historical net losses and cash outflows from operations.  For the fiscal year ended June 30, 2011, the Company had cash provided from operating activities of $390.  As of September 30, 2011, the Company had cash of $931 (inclusive of cash of $368 included in assets from discontinued operations) and a working capital deficit of $9,033, which is primarily attributable to the Notes Payable in the outstanding principal amount of $7,805, which matured on November 15, 2009 and are currently in default (See Note 6. Debt), the Convertible Note Payable in the outstanding principal amount of $4,500, which matured on February 21, 2011, which are secured by pledges of substantially all the Company’s assets (See Note 6. Debt).  These factors raise substantial doubt as to the Company’s ability to continue as a going concern.  The accompanying condensed consolidated financial statements do not include any adjustments that might result from these uncertainties.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has defaulted on all of its outstanding debt instruments in the aggregate amount of $12,605 (see Note 6. Debt) by failing to repay them on their respective scheduled maturity dates. The Notes Payable and Convertible Note Payable are secured by pledges of substantially all of the Company’s assets.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company defaulted on the $7,805 outstanding principal amount of its Notes Payable, issued by the Company under that certain Securities Purchase Agreement, dated as of February 21, 2008, by failing to repay the Notes Payable on the scheduled maturity date of November 15, 2009.  The Company’s failure to repay the Notes Payable on the scheduled maturity date constituted an Event of Default under the Notes Payable and triggered the right of the holders of the Notes Payable (the “Note Payable Holders”) to give the Company a notice (an “Acceleration Notice”) to accelerate the payment of all unpaid principal and accrued and unpaid interest (including interest accruing at the default rate).  The Notes Payable are secured by a pledge of substantially all of the Company’s assets.  As of November 21, 2011, the Company has not repaid the Notes Payable or the default interest accrued on the Notes Payable.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 4, 2011, the Company and the Collateral Agent for the holders of the Notes Payable, entered into a Forbearance Agreement extending, among other things, the due date until December 31, 2011. (See Note 6. Debt).</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company defaulted on the $4,500 million outstanding principal amount of its Convertible Note Payable, issued by the Company under that certain Securities Purchase Agreement, dated as of February 21, 2008, by failing to repay the Convertible Note Payable on the scheduled maturity date of February 21, 2011.  The Company’s failure to repay the Convertible Note Payable on the scheduled maturity date constituted an Event of Default under the Convertible Note Payable and triggered the right of the holder of the Convertible Note Payable to give the Company a notice (“CD Acceleration Notice”) to accelerate the payment of all unpaid principal and accrued and unpaid interest (including interest accruing at the default rate, if any).  The Convertible Note Payable is secured by a pledge of substantially all of the Company’s assets, which pledge is subordinated to the security interest held by the Note Payable Holders.  As of November 21, 2011, the Company has not repaid the Convertible Note Payable or the default interest on the Convertible Note Payable.  The holder of the Convertible Note Payable, CD Financial, LLC (“CD Financial”) is a significant shareholder of the Company and has not made any payment demands on the Company with respect to the Convertible Note Payable, nor has it converted the Convertible Note Payable into common shares of the Company.  In March 2009, the Company and CD Financial entered into an oral agreement to suspend the cash interest payments on the Convertible Note Payable until the Company returned to positive cash flows in its operations.  In this oral agreement, CD Financial agreed not to give any default notices or increase interest rates due to such default (the default interest rate as defined in the Convertible Note Payable is 18%).  In connection with the Company entering into a Forbearance Agreement with respect to the Notes Payable (See Note 6), CD Financial has agreed to not receive any principal payments until all of the Company’s obligations to the Note Payable Holders have been repaid, including any interest payments at the default interest rate.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There can be no assurance that the Company will be able to repay, restructure or amend the Notes Payable by December 31, 2011 or the Convertible Note Payable prior to receipt by the Company of a CD Acceleration Notice from CD Financial.  In the interim, the Company has continued to make timely interest payments to the Note Payable Holders at the non default rate of 8% per annum and is exploring its strategic alternatives, which may include business divestitures, developing business and sales strategies to increase operating income, the sale of some or all of the Company’s assets or operating subsidiaries and/or capital restructuring plans.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If the Notes Payable are not repaid by December 31, 2011, and as a result of the events of default that arose based upon the Company’s failure to pay each of the Notes Payable at maturity, the Note Payable Holders have the right to give the Company an Acceleration Notice. As a result of the event of default that arose based upon the Company’s failure to repay the Convertible Note Payable at maturity, CD Financial has the right to give the Company a CD Acceleration Notice.  Each acceleration notice would (i) accelerate the payment of all unpaid principal and accrued and unpaid interest (including default interest (if any); with respect to the Notes Payable, only default interest arising subsequent to December 31, 2011, (if any)) and (ii) require the Company to pay an amount equal to the sum of all of the respective amounts described in the preceding clause (i) in same day funds on the payment date specified in such notice. If the Company is unable to raise additional capital, sell certain assets or successfully refinance the full outstanding amount of the Notes Payable and the Convertible Note Payable upon acceptable terms, it would have a material adverse effect on the Company, including the possible foreclosure by the holders of the Notes Payable and/or the Convertible Note Payable of all or some of the Company’s assets, which would impact the Company’s ability to continue as a going concern.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 3. Assets and Liabilities Held for Sale and Discontinued Operations</font> </div><br/><div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is seeking to sell the net assets of AgroLabs.  Accordingly, the Company classified the business assets and liabilities and the results of operations of its branded proprietary nutraceutical business as discontinued operations.  The operations of AgroLabs for the current and prior periods and the associated results of operations, financial position and cash flows are separately reported as discontinued operations for all periods presented.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The net assets classified as discontinued operations were comprised of the following:</font> </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets of discontinued operations held for sale:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">369</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">162</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable, net</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">152</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">199</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventories</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,882</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,029</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">114</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed assets, net</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangible assets, net</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,103</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,127</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px; TEXT-INDENT: 18pt"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total assets of discontinued operations held for sale</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,681</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,722</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liabilities</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current liabilities of discontinued operations:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; TEXT-INDENT: 9pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and other current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,818</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,667</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; TEXT-INDENT: 18pt"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total current liabilities of discontinued operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,818</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,667</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net assets of discontinued operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,055</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company’s net sales, gross profit (loss) and results of operations classified as discontinued operations were as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="90%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="6" valign="bottom" width="28%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="6" valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Sales, net</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,829</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,646</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross profit</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,324</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">958</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Loss) income from discontinued operations, net</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">406</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> </table><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 4. Inventories</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inventories are stated at the lower of cost or market using the first-in, first-out method and consist of the following as of:</font> </div><br/><table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="66%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="66%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="66%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,031</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,560</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="66%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Work-in-process</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,114</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,058</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished goods</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,364</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,749</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,509</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,367</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> </table><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.5pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 5. Property and Equipment, net</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.5pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and equipment, net consists of the following as of:</font> </div><br/><table cellpadding="0" cellspacing="0" width="85%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="66%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="66%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="15%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="66%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Land and building</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="66%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,122</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,122</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="66%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Machinery and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,697</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,696</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transportation equipment</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">68</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">68</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="66%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,137</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,136</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="66%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: Accumulated depreciation</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">         and amortization</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,618</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,538</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,519</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,598</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Depreciation and amortization expense was $80 and $75 for the three months ended September 30, 2011 and 2010, respectively.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 6. Debt</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes Payable</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 21, 2008, the Company entered into a Securities Purchase Agreement with Imperium Master Fund, LTD. and three other parties (collectively “Imperium”), which Securities Purchase Agreement was amended on October 14, 2008 (as so amended, the “SPA”), pursuant to which the Company issued, and Imperium purchased from the Company, an aggregate $7,000 in principal of senior secured notes (“Notes Payable”). The Notes Payable matured on November 15, 2009 and bear interest at the rate of 8.0%.  Interest is payable monthly.  As of September 30, and June 30, 2011, accrued interest of $47 for each period is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">An additional premium of $805 was granted due to the amendment noted above.  The additional premium is subject to interest payments commencing October 1, 2011.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Notes Payable are secured by a pledge of substantially all of the Company’s assets.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 4, 2011, the Company and the Collateral Agent for the Note Payable Holders, entered into a Forbearance Agreement (the “Forbearance Agreement”).  The Forbearance Agreement provides that the Collateral Agent shall forbear from exercising rights and remedies arising from the occurrence of Specified Defaults (as defined in the Forbearance Agreement), including the Company’s failure to repay the Notes Payable which are due and payable. The Forbearance Agreement will terminate on the earlier to occur of (i) December 31, 2011, (ii) the date the Company fails to comply with the covenants, conditions and agreements contained in the Forbearance Agreement, (iii) the date of the occurrence of any Event of Default, other than the Specified Defaults (as defined in the Forbearance Agreement), under the SPA, the Notes Payable, the Certificate of Designation (as defined in the SPA), the Registration Rights Agreement (as defined in the SPA), the Subsidiary Guaranty, dated as of February 21,  2008, by and among the Company, certain of its subsidiaries and the Collateral Agent, the Security Agreement, dated as of February 21,  2008 (the “Security Agreement”), by and among the Company, certain of its subsidiaries and the Collateral Agent and all other agreements, documents and other instruments entered into by the Company or any of its subsidiaries in connection with the SPA (collectively, the “Transaction Documents”), or (iv) the date the amended Notes Payable are paid in cash and all other obligations under the Transaction Documents are satisfied.  Additionally, under the Forbearance Agreement, among other things:</font> </div><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 54pt"> <div> </div> </td> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Collateral Agent may cause to be sold by the Company, shares of common stock of iBio, pledged by the Company to the holders of the Notes Payable pursuant to the Security Agreement as soon as commercially reasonable and apply the net proceeds from such sale first, against unpaid principal obligations under the Notes Payable and second, to any remaining obligations under the Transaction Documents.  As of November 21, 2011, there have been no such sales.</font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 54pt"> <div> </div> </td> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Company shall not, prior to the payment in full of all obligations owed to the amended Note Payable Holders under the Transaction Documents, make any (a) principal payments in respect of the $4,500 outstanding principal amount of the Convertible Note Payable which matured on February 21, 2011 (the “CD Financial Debt”), (b) past due rental or lease payments under the Company’s lease obligations to Vitamin Realty Associates, L.L.C. (“Vitamin Realty”) ($686 as of September 30, 2011), or (c) any rental or lease payments, including any past due rental or lease payments, in respect of any other personal or real property leased or rented by the Company or any of its subsidiaries from E. Gerald Kay or any family member of E. Gerald Kay; provided, that, so long as no Event of Default (other than the Specified Defaults) exists and is continuing, the Company shall be permitted to make interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt and make current rental or lease payments under the Company’s lease obligations to Vitamin Realty.  If an Event of Default (other than the Specified Defaults) exists and is continuing, the Company shall not be permitted to make any interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt or make any current rental or lease payments under the Company’s lease obligations to Vitamin Realty. Any breach by the Company of (a) (b) or (c) shall constitute an Event of Default under, and shall trigger a termination of, the Forbearance Agreement.</font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-1" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 54pt"> <div> </div> </td> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the Company fails to repay all of obligations under the Transaction Documents prior to December 31, 2011, then on December 31, 2011, the Company shall pay to the Collateral Agent, for the ratable benefit of the Note Payable Holders, a fee equal to $1,000, which shall be in addition to all other fees and expenses payable by the Company to the Collateral Agent and the Note Payable Holders under the Transaction Documents.</font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-2" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 54pt"> <div> </div> </td> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Company has absolutely, unconditionally and irrevocably released, on behalf of itself and its subsidiaries, and its and their respective successors, assigns and other legal representatives, the Collateral Agent, the Note Payable Holders, and various other Releasees (as defined in the Forbearance Agreement) from all Claims (as defined in the Forbearance Agreement) arising at any time on or prior to the date of the Forbearance Agreement, in connection with the Transaction Documents, on the terms and conditions set forth in the Forbearance Agreement.</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the period from October 4 to November 21, 2011, the Company and the Collateral Agent continue to discuss the options available to the Company to repay the Notes Payable by the extended due date under the Forbearance Agreement among other strategic options, including retaining an investment banker as contemplated under the Forbearance Agreement to assist the Company in selling its propriety nutraceutical business, to repay the Notes Payable under agreeable terms.  When and if it is determined that the Company will not be able to satisfy the payment requirements under the Forbearance Agreement, the Company will recognize the forbearance fee of $1,000.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Convertible Note Payable – CD Financial, LLC</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 21, 2008, the Company entered into a Securities Purchase Agreement (the “CD SPA”) with CD Financial, a significant shareholder of the Company, pursuant to which the Company issued and CD Financial purchased from the Company, a Convertible Senior Secured Note in the principal amount of $4,500 (the “Convertible Note Payable”).  The Convertible Note Payable matured on February 21, 2011 and bears interest at the rate of 9.5%.  Interest is payable monthly.  The Convertible Note Payable is secured by a pledge of substantially all of the Company’s assets.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2009, the Company and CD Financial entered into an oral agreement to suspend the cash interest payments on the Convertible Note Payable until the Company returned to positive cash flows in its operations.  In this oral agreement, CD Financial agreed not to give any default notices or increase interest rates due to such default (the default interest rate as defined in the Convertible Note Payable is 18%).  The Company resumed interest payments on the Convertible Note Payable in August of 2009.  In March 2010, CD Financial orally agreed to defer the interest owed for April 2010, in the amount of $36, until the Company returned to positive cash flows to assist the Company in meeting its short term cash flow requirements.  The Company has made timely monthly interest payments, beginning with the May 2010 monthly interest obligation.  As of November 21, 2011, the Company is in default under the Convertible Note Payable for the nonpayment of the principal balance due on February 21, 2011.  In connection with the Company entering into the Forbearance Agreement with respect to the Notes Payable (See Note 6. Debt – Notes Payable), CD Financial has agreed to not receive any principal payments until all of the Company’s obligations to the Note Payable Holders have been repaid.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of September 30 and June 30, 2011, accrued interest of $253 with respect to the Convertible Note Payable for each period is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets, including interest in arrears of $217 in each period.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Convertible Note Payable may be converted, at any time and at the holder’s option, into shares of the Company’s common stock under the terms and conditions set forth in the CD SPA.  The conversion price is a formula that bases the conversion price on the greater of (i) 90% of the average Volume Weighted Average Price (the "VWAP") market price of the Company’s common stock for 20 trading days immediately preceding the conversion date and (ii) $2.00, subject to adjustment in the event of a stock dividend, stock split or combination, reclassification or similar event and upon certain issuances below the conversion price.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Also, in accordance with the CD SPA, the Company will issue and deliver to CD Financial, for no additional consideration, 50,000 shares of common stock, on a quarterly basis in arrears, until the Convertible Note Payable has been repaid in full, after which the Company's obligations to issue shares of common stock will no longer be applicable.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Debt discount of $324 in the three months ended September 30, 2010 was recorded in interest expense in condensed consolidated statement of operations.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes Payable, CD Financial LLC</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 24, 2009, Manhattan Drug, a wholly owned subsidiary of the Company, entered into a $300 promissory note (the “CD Note”) with CD Financial.  The CD Note matured on November 24, 2010 and bears interest at the rate of 5%, which interest is payable quarterly.  Interest is accrued monthly and is payable upon maturity.  As of September 30, 2011, the Company is in default under the CD Note as a result of the Company’s failure to repay the CD Note on its scheduled maturity date.  Interest is paid quarterly.  The CD Note is expected to remain outstanding until the Company satisfies the Company’s obligations under the Notes Payable. (See Note 6. Debt – Notes Payable).</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 29, 2010, Manhattan Drug entered into a second promissory note in the amount of $40 (the “CD $40 Note”) with CD Financial.  The CD $40 Note matured on October 29, 2010 and bore interest at the rate of 5%.  Manhattan Drug repaid the CD $40 Note on October 29, 2010.  Interest was accrued monthly and was paid on maturity.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The weighted average interest rate paid on the Company’s outstanding debt was 8.49% and 8.48% in the three months ended September 30, 2011 and 2010, respectively.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 7. Significant Risks and Uncertainties</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -4.3pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">(a) Major Customers.</font> For the three months ended September 30, 2011, approximately 80% of total net sales were derived from one customer as compared to approximately 87% of total net sales derived from two customers in the three months ended September 30, 2010.<font style="DISPLAY: inline; FONT-SIZE: 10pt"> </font> Accounts receivable as of September 30, 2011 from this customer represented approximately 39% of total accounts receivable. The loss of this customer would have an adverse affect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -4.3pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(b) Other Business Risks.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">Approximately 56% the Company’s employees, located in its New Jersey facility, are covered by a union contract. The contract was renewed in August 2010</font> for an additional one year term and was extended in August 2011 to December 31, 2011.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -4.3pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 8. Commitments and Contingencies</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(a) Leases</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Related Party Leases.</font> Warehouse and office facilities are leased from Vitamin Realty, which is 90% owned by the Chairman of the Company’s Board of Directors, a director and majority shareholder and certain of his family members. The lease provides for minimum annual rental payment of $324 through May 31, 2015 plus increases in real estate taxes and building operating expenses. On July 1, 2004, the Company leased an additional 24,810 square feet of warehouse space on a month-to month basis.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Rent expense for the three months ended September 30, 2011 and 2010 on these leases were $184 and $202, respectively, and are included in cost of sales in the accompanying Condensed Consolidated Statements of Operations. As of September 30, 2011 and June 30, 2011, the Company had an outstanding obligation of $715 and $738, respectively, included in accounts payable in the accompanying Condensed Consolidated Balance Sheet.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Other Lease Commitments.</font> The Company has entered into certain non-cancelable operating lease agreements expiring up through May 31, 2015, related to office and warehouse space, equipment and vehicles.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.5pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The minimum rental commitment for long-term non-cancelable leases is as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="12%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Related Party</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="12%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lease</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lease</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commitment</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commitment</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr> <td valign="bottom" width="12%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td colspan="2" valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="12%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012, remaining</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">243</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="12%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">324</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">339</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="12%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">324</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">337</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: white;"> <td align="left" valign="bottom" width="12%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">297</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">297</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="12%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,188</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total rent expense, including real estate taxes and maintenance charges, was approximately $276 and $294 for the three months ended September 30, 2011 and 2010, respectively. Rent expense is included in cost of sales, selling and administrative expenses and income (loss) from discontinued operations in the accompanying Condensed Consolidated Statements of Operations.  The Company has a remaining lease commitment of $170 ($139 remaining in the fiscal year ending June 30, 2012) in relating to operations classified as discontinued.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 27pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(b) Legal Proceedings.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is subject, from time to time, to claims by third parties under various legal theories.  The defense of such claims, or any adverse outcome of any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.  The Company believes that there are no significant legal matters pending that would have a material effect on the Company’s liquidity, financial condition or cash flows.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 9. Related Party Transactions</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has a verbal consulting agreement with Eugene Kay, a former employee of the Company and a brother of E. Gerald Kay, the Company’s Chief Executive Officer, Chairman of the Board, President, and majority shareholder. This agreement is on a month-to-month basis and provides for payment by the Company of a fee in the amount of approximately $1.3 per month. The total consulting expense recorded in connection with this verbal agreement was approximately $4 in each of the three months ended September 30, 2011 and 2010.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See Note 6. Debt. for related party securities transactions.</font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See Note 8(a). Leases for related party lease transactions.</font> </div><br/> XML 29 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 30 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 3 - Assets and Liabilities Held for Sale and Discontinued Operations
3 Months Ended
Sep. 30, 2011
Disclosure of Long Lived Assets Held-for-sale [Table Text Block]
Note 3. Assets and Liabilities Held for Sale and Discontinued Operations

The Company is seeking to sell the net assets of AgroLabs.  Accordingly, the Company classified the business assets and liabilities and the results of operations of its branded proprietary nutraceutical business as discontinued operations.  The operations of AgroLabs for the current and prior periods and the associated results of operations, financial position and cash flows are separately reported as discontinued operations for all periods presented.

The net assets classified as discontinued operations were comprised of the following:

September 30,

June 30,

2011

2011

Assets

Assets of discontinued operations held for sale:

Cash
$ 369 $ 162

Accounts receivable, net
152 199

Inventories
1,882 2,029

Other current assets
90 114

Fixed assets, net
63 68

Intangible assets, net
1,103 1,127

Other assets
22 23

Total assets of discontinued operations held for sale
$ 3,681 $ 3,722

Liabilities

Current liabilities of discontinued operations:

Accounts payable and other current liabilities
$ 2,818 $ 2,667

Total current liabilities of discontinued operations
2,818 2,667

Net assets of discontinued operations
$ 863 $ 1,055

The Company’s net sales, gross profit (loss) and results of operations classified as discontinued operations were as follows:

Three months ended

September 30,

2011

2010

Sales, net
$ 2,829 $ 4,646

Gross profit
$ 1,324 $ 958

(Loss) income from discontinued operations, net
$ (232 ) $ 406

X
- Definition
Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 33, 47

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

+ Details
Name: us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
EXCEL 31 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V9#$V-3=C,%\W-#8Q7S1A,C5?8F4Y,E]A-F$P M93'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M5]A;F1?1V]I;F=?0V]N/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K5]4#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H M965T&-E;"!84"!O M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\V9#$V-3=C,%\W-#8Q7S1A,C5?8F4Y,E]A-F$P93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!);F9O2!);F9O2!296=I'0^,3`M43QS<&%N/CPO'0^+2TP-BTS,#QS<&%N M/CPO'0^9F%L2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,#`P,3`Q-C4P-#QS<&%N/CPO'0^665S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^3F\\2!&:6QE3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4VAA"!E>'!E;G-E+"!N970\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#$V-3=C M,%\W-#8Q7S1A,C5?8F4Y,E]A-F$P93'0O:'1M;#L@8VAA2!D97!O'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6%B M;&4@+2!#1"!&:6YA;F-I86P@3$Q#+"!N970\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PP,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!S=&]C M:RP@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`Q+"`R,#$Q("AI;B!3:&%R97,I(&%T M($IU;BX@,S`L(#(P,3$\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XY,#QS<&%N/CPO6%B;&4\+W1D/@T* M("`@("`@("`\=&0@8VQA&5D M(&%S'!E;G-E(&9O65E('-T;V-K(&]P=&EO;G,\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA2`H=7-E M9"!I;BD@;W!E2!O<&5R M871I;F<@86-T:79I=&EE'0^)FYB'0^)FYB'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA2!F:6YA;F-I;F<@86-T:79I=&EE7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@("`-"B`@("`@(#QF;VYT M('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY.;W1E#0H@("`-"B`@("`@(#$N(%!R M:6YC:7!L97,@;V8@0V]N3X-"B`@(`T*("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6EN9R!C;VYD96YS960@9FEN86YC:6%L('-T871E;65N=',@9F]R M('1H92!I;G1E2!W:71H(%)U;&4@,3`M,#$@;V8@4F5G=6QA=&EO;B!3+5@@;V8- M"B`-"B`@("`@('1H92!396-U&-H86YG92!#;VUM:7-S M:6]N("@F(S@R,C`[4T5#)B,X,C(Q.RD-"B`@(`T*("`@("`@86YD('1H97)E M9F]R92!D;R!N;W0@:6YC;'5D92!I;F9O2!W:71H#0H@(`T*("`@("`@86-C;W5N=&EN9R!P2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2!O9@T*("`@#0H@("`@("!N;W)M86P@65A65A2!O M=VYE9`T*("`-"B`@("`@("`@2!O9B!T:&4@0V]M<&%N>2P@ M=VAI8V@@9&ES=')I8G5T97,@9F]R('-A;&4-"B`@#0H@("`@("`@('1H2!!;&]E+"!!;&]E(%!U2!4:&%I($UA;F=O M2P@,7-T($-H;VEC92!-=6QT:2U6:71A;6EN+"!!0T%)#0H@(`T*("`@("`@ M("!%>'1R82P@04-!22!);6UU;F4L($%#04D@0VQE86YS92P@86YD(&]T:&5R M('!R;V1U8W1S('=H:6-H#0H@(`T*("`@("`@("!A2!N=71R86-E=71I8V%L#0H@#0H@("`@("`@(&)U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@("`-"B`@("`@(#QF;VYT('-T M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD)SY.871U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/@T*("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE28C.#(R,3LI+"!I2!W87,-"B`@#0H@("`@("!P2!W87,-"B`@("`@#0H@("`@("!R M96EN8V]R<&]R871E9"!I;B!I=',@8W5R2!C;VYT:6YU97,@=&\@ M9&\@8G5S:6YE3X-"B`@(`T*("`@("`@/&9O;G0@3L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@(`T*("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A M28C.#(Q-SMS M('-I9VYI9FEC86YT(&%C8V]U;G1I;F<@<&]L:6-I97,@=&\-"B`@#0H@("`@ M("`@('1H;W-E('!R979I;W5S;'D@9&ES8VQO65A3X-"B`@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&EM871E;'D@-B4@;V8@:71S(&EN M=&5R97-T(&EN(&E":6\-"B`@(`T*("`@("`@*#$L,C8V+#2!R979I97=S(&ET6%B;&4N("A3964@3F]T92`R+B!,:7%U:61I='D@86YD#0H@ M("`@(`T*("`@("`@1V]I;F<@0V]N8V5R;B!A;F0@3F]T92`V+B!$96)T*2X\ M+V9O;G0^#0H@(`T*("`@(#PO9&EV/CQB3X-"B`@(`T* M("`@("`@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&-O;'-P86X],T0V('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(X)3X-"B`@ M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D"<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$S)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R<'@@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@ M/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)3X-"B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87-H#0H@("`@ M#0H@("`@("`@("`@("`@("`@<&%I9"!D=7)I;F<@=&AE('!E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@ M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ-C$\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0 M041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L M:6=N/3-$"<^#0H@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD M/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,#(\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64-"B`-"B`@("`@("`@("`@("`@ M("!T87AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD M/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS/"]F;VYT/@T*("`-"B`@("`@("`@("`@ M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/@T*("`@(`T*("`@("`@/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q! M63H@:6YL:6YE.R!&3TY4+5=%24=(5#H@8F]L9"<^16%R;FEN9W,-"B`@(`T* M("`@("`@4&5R(%-H87)E/"]F;VYT/BX@0F%S:6,@96%R;FEN9W,@<&5R(&-O M;6UO;B!S:&%R92!A;6]U;G1S(&%R90T*("`@(`T*("`@("`@8F%S960@;VX@ M=&AE('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,- M"B`@("`@#0H@("`@("!O=71S=&%N9&EN9RX@1&EL=71E9"!E87)N:6YG6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE2!D:6QU=&5D#0H@ M#0H@("`@("!C;VUP=71A=&EO;B!F;W(@96%R;FEN9W,@<&5R('-H87)E(&%S M('1H96ER(&5X97)C:7-E('!R:6-E3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#$V-3=C,%\W-#8Q7S1A,C5?8F4Y M,E]A-F$P93'0O:'1M;#L@8VAA M2!A;F0@1V]I;F<@0V]N8V5R;CQB M6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*(`T*("`@("`@/&9O M;G0@28C.#(Q-SMS(&-O;F1E;G-E M9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',-"B`@#0H@("`@ M("`@(&AA=F4@8F5E;B!P65A2!H860@ M8V%S:`T*(`T*("`@("`@("!P2!H860@ M8V%S:"!O9B`F;F)S<#LD.3,Q#0H@("`@(`T*("`@("`@("`H:6YC;'5S:79E M(&]F(&-A2!P;&5D9V5S(&]F#0H@(`T*("`@("`@("!S=6)S=&%N=&EA;&QY(&%L;"!T M:&4@0V]M<&%N>28C.#(Q-SMS(&%S2!T;R!C;VYT:6YU92!A6EN9R!C;VYD96YS960@8V]N2!A9&IU2!A;&P@;V8@=&AE#0H@("`@(`T*("`@("`@0V]M<&%N>28C.#(Q-SMS M(&%S3X-"B`@(`T*("`@("`@/&9O;G0@2!T:&4@3F]T M97,@4&%Y86)L92!O;B!T:&4-"B`-"B`@("`@('-C:&5D=6QE9"!M871U2!D871E(&]F($YO=F5M8F5R(#$U+"`R,#`Y+B8C,38P.R8C,38P.U1H90T* M("`@("`-"B`@("`@($-O;7!A;GDF(S@R,3<[6%B;&4@ M2&]L9&5R2!A;&P@;V8@=&AE M#0H@("`-"B`@("`@($-O;7!A;GDF(S@R,3<[3X-"B`@(`T*("`@("`@/&9O;G0@2!A;F0@=&AE($-O;&QA=&5R86P@06=E;G0@9F]R('1H90T*("`@ M#0H@("`@("!H;VQD97)S(&]F('1H92!.;W1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY4:&4-"B`@(`T*("`@("`@0V]M<&%N>2!D969A=6QT960@;VX@=&AE("9N M8G-P.R0T+#4P,"!M:6QL:6]N(&]U='-T86YD:6YG('!R:6YC:7!A;`T*("`@ M#0H@("`@("!A;6]U;G0@;V8@:71S($-O;G9E6%B;&4@;VX@=&AE('-C:&5D=6QE9"!M871U2!D871E(&]F($9E M8G)U87)Y(#(Q+`T*(`T*("`@("`@,C`Q,2XF(S$V,#LF(S$V,#M4:&4@0V]M M<&%N>28C.#(Q-SMS(&9A:6QU6%B;&4@;VX@=&AE('-C:&5D=6QE9"!M871U M2!D871E#0H@(`T*("`@("`@8V]N6%B;&4@86YD('1R:6=G97)E9"!T:&4@6UE;G0@;V8@86QL('5N<&%I M9"!P6%B;&4@:7,@2!A M#0H@#0H@("`@("!P;&5D9V4@;V8@2!A;&P@;V8@=&AE M($-O;7!A;GDF(S@R,3<[2!I;G1E6%B;&4@2&]L9&5R M6%B;&4@;W(-"B`@("`@#0H@("`@("!T:&4@9&5F875L="!I M;G1E2!A M;F0@:&%S(&YO="!M861E(&%N>0T*(`T*("`@("`@<&%Y;65N="!D96UA;F1S M(&]N('1H92!#;VUP86YY('=I=&@@6%B;&4L(&YO2XF M(S$V,#LF(S$V,#M);B!-87)C:"`R,#`Y+"!T:&4@0V]M<&%N>2!A;F0@0T0- M"B`@(`T*("`@("`@1FEN86YC:6%L(&5N=&5R960@:6YT;R!A;B!O2!E;G1E6%B;&4@2&]L9&5R2!I;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&5R M90T*("`@("`-"B`@("`@(&-A;B!B92!N;R!A2!W:6QL(&)E(&%B;&4@=&\@'!L;W)I;F<@ M:71S('-T2!I;F-L=61E M#0H@("`@(`T*("`@("`@8G5S:6YE6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE2!$96-E M;6)E2!A;B!!8V-E;&5R M871I;VX@3F]T:6-E+B!!2P@0T0@1FEN86YC M:6%L#0H@(`T*("`@("`@:&%S('1H92!R:6=H="!T;R!G:79E('1H92!#;VUP M86YY(&$@0T0@06-C96QE6UE;G0@;V8@86QL('5N<&%I M9"!P2!D969A=6QT(&EN=&5R97-T#0H@("`-"B`@("`@(&%R M:7-I;F<@2DI(&%N9"`H:6DI#0H@#0H@("`@("!R97%U:7)E('1H92!#;VUP86YY('1O M('!A>2!A;B!A;6]U;G0@97%U86P@=&\@=&AE('-U;2!O9B!A;&P-"B`@#0H@ M("`@("!O9B!T:&4@6%B;&4@86YD('1H92!#;VYV97)T:6)L90T*(`T*("`@("`@3F]T92!0 M87EA8FQE('5P;VX@86-C97!T86)L92!T97)M2!T:&4@:&]L9&5R28C.#(Q-SMS(&%B:6QI='D@=&\@8V]N=&EN=64@ M87,@82!G;VEN9PT*("`-"B`@("`@(&-O;F-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@("`-"B`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^3F]T90T*("`@#0H@("`@("`S+B!!3L@3$E.12U( M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@(`T* M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE2!C;&%S2!R97!O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY397!T96UB97(-"B`@("`-"B`@("`@("`@("`@("`@("`S,"P\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@ M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R<'@@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@ M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S M)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^07-S971S#0H@("`@(`T*("`@("`@("`@("`@ M("`@(&]F(&1I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY#87-H/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T* M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-CD\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!8V-O=6YT6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M.3D\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0G/@T*("`@(`T*("`@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR+#`R.3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^ M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0G/@T*("`@(`T* M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&:7AE9`T*("`@("`- M"B`@("`@("`@("`@("`@("!A6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0G/@T*("`@(`T*("`@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/ M=&AE<@T*("`@("`-"B`@("`@("`@("`@("`@("!A6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR,CPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X- M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT#L@5$585"U) M3D1%3E0Z(#$X<'0G/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^5&]T86P-"B`@("`-"B`@("`@ M("`@("`@("`@("!A"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@ M(`T*("`@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^3&EA8FEL:71I97,\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@ M("`@("`@(#QT6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!8V-O=6YT6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@("`@ M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@ M(#QT"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$"<^#0H@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@ M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#`U-3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0V('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(X)3X-"B`@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$S)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@ M("`@("`@(#QT"<^ M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$S)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@ M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^ M#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$S)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^4V%L97,L#0H@("`@(`T*("`@("`@("`@("`@("`@ M(&YE=#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N M/3-$"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@(`T* M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T* M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,C,R/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'1087)T7S9D,38U-V,P7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*(`T* M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY397!T96UB97(- M"B`@("`-"B`@("`@("`@("`@("`@("`S,"P\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^ M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$U)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R<'@@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D M:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"B`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#$Q-#PO9F]N=#X-"B`-"B`@ M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ+#,V-#PO9F]N=#X-"B`-"B`@("`@("`@ M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4 M;W1A;#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N M/3-$"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@(#PO='(^#0H@(`T*("`@("`@("`\+W1A8FQE/CQB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#$V-3=C,%\W-#8Q M7S1A,C5?8F4Y,E]A-F$P93'0O M:'1M;#L@8VAA2P@4&QA;G0@86YD($5Q=6EP;65N="!$:7-C;&]S=7)E(%M4 M97AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`M,C(N-7!T)R!A;&EG M;CTS1&IU2!A;F0@17%U:7!M M96YT+"!N970\+V9O;G0^#0H@("`@(`T*("`@(#PO9&EV/CQB6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"B`@ M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY*=6YE#0H@("`@#0H@("`@("`@ M("`@("`@("`@,S`L/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@(#PO9&EV M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,86YD#0H@("`@#0H@("`@("`@ M("`@("`@("`@86YD(&)U:6QD:6YG/"]F;VYT/@T*("`-"B`@("`@("`@("`@ M("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^ M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,30E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#(U,#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,30E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ+#(U,#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT0T*("`@(`T*("`@("`@("`@("`@("`@ M(&%N9"!E<75I<&UE;G0\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D M:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M(#PO='(^#0H@(`T*("`@("`@("`@(#QT"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C8X/"]F;VYT/CPO9F]N=#X- M"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXW+#$S-CPO9F]N=#X-"B`-"B`@("`@("`@ M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U!!1$1)3DF%T M:6]N/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@ M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH-2PU,S@\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D"<^#0H@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE'!E;G-E('=A2X\+V9O;G0^#0H@("`-"B`@ M("`\+V1I=CX\8G(O/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY.;W1E6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X-"B`@#0H@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;@T*("`@(`T*("`@ M("`@("!&96)R=6%R>2`R,2P@,C`P."P@=&AE($-O;7!A;GD@96YT97)E9"!I M;G1O(&$@4V5C=7)I=&EE2P@86X@86=G6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@("`-"B`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;@T*("`-"B`@("`@ M(&%D9&ET:6]N86P@<')E;6EU;2!O9B`F;F)S<#LD.#`U('=A3X-"B`@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;@T*("`- M"B`@("`@($]C=&]B97(@-"P@,C`Q,2P@=&AE($-O;7!A;GD@86YD('1H92!# M;VQL871E&5R8VES:6YG(')I9VAT6%B;&4N(%1H90T*("`@(`T*("`@("`@1F]R M8F5A2!%=F5N="!O9B!$969A=6QT M+"!O=&AE6%B;&4L M('1H92!#97)T:69I8V%T92!O9B!$97-I9VYA=&EO;B`H87,-"B`@("`@#0H@ M("`@("!D969I;F5D(&EN('1H92!34$$I+"!T:&4@4F5G:7-T2`R,2PF(S$V,#LF(S$V,#LR,#`X+"!B M>2!A;F0@86UO;F<@=&AE($-O;7!A;GDL#0H@("`@(`T*("`@("`@8V5R=&%I M;B!O9B!I=',@2!!9W)E96UE;G0L(&1A=&5D M(&%S(&]F($9E8G)U87)Y(#(Q+"8C,38P.R8C,38P.S(P,#@-"B`@("`@#0H@ M("`@("`H=&AE("8C.#(R,#M396-U2!!9W)E96UE;G0F(S@R,C$[*2P@ M8GD@86YD(&%M;VYG('1H90T*(`T*("`@("`@0V]M<&%N>2P@8V5R=&%I;B!O M9B!I=',@2P@=&AE("8C.#(R,#M46%B;&4-"B`@#0H@("`@("!A6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,2D\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX- M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D/@T* M(`T*("`@("`@("`@("`@/&1I=B!A;&EG;CTS1&IU6QE/3-$)U=) M1%1(.B`U-'!T)SX-"B`-"B`@("`@("`@("`@(#QD:78^#0H@("`@#0H@("`@ M("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX-"B`-"B`@("`@ M("`@("`@(#QD:78@2`H82D-"B`@(`T*("`@("`@("`@("`@ M("!P6UE;G1S('5N9&5R('1H92!#;VUP M86YY)B,X,C$W.W,@;&5A2!!6UE;G1S+`T*("`-"B`@("`@("`@("`@("`@:6YC;'5D:6YG(&%N>2!P M87-T(&1U92!R96YT86P@;W(@;&5A2!O9B!I=',@2!O3L@<')O=FED960L('1H870L('-O(&QO;F<@87,@;F\@179E;G0@;V8@ M1&5F875L=`T*(`T*("`@("`@("`@("`@("`H;W1H97(@=&AA;B!T:&4@4W!E M8VEF:65D($1E9F%U;'1S*2!E>&ES=',@86YD(&ES#0H@("`@#0H@("`@("`@ M("`@("`@(&-O;G1I;G5I;F2XF(S$V M,#LF(S$V,#M)9B!A;B!%=F5N="!O9B!$969A=6QT("AO=&AE6UE;G1S("AO;B!A('!R92UD M969A=6QT+"!N;VXM86-C96QE6UE;G1S('5N9&5R('1H92!#;VUP86YY)B,X,C$W.W,-"B`@ M("`-"B`@("`@("`@("`@("`@;&5A6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,RD\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D/@T*(`T*("`@ M("`@("`@("`@/&1I=B!A;&EG;CTS1&IU2!T;PT*(`T*("`@ M("`@("`@("`@("!T:&4@0V]L;&%T97)A;"!!9V5N="P@9F]R('1H92!R871A M8FQE(&)E;F5F:70@;V8@=&AE#0H@(`T*("`@("`@("`@("`@("!.;W1E(%!A M>6%B;&4@2&]L9&5R6%B;&4@8GD@=&AE($-O;7!A;GD@=&\@=&AE($-O;&QA=&5R M86P@06=E;G0@86YD#0H@("`@(`T*("`@("`@("`@("`@("!T:&4@3F]T92!0 M87EA8FQE($AO;&1E6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@3X-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY4:&4-"B`-"B`@("`@("`@("`@("`@0V]M<&%N M>2!H87,@86)S;VQU=&5L>2P@=6YC;VYD:71I;VYA;&QY(&%N9`T*("`@#0H@ M("`@("`@("`@("`@(&ER6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X- M"B`-"B`@("`@("`@/&9O;G0@2!T;R!R97!A>2!T:&4@3F]T97,@4&%Y86)L92!B>2!T M:&4-"B`@#0H@("`@("`@(&5X=&5N9&5D(&1U92!D871E('5N9&5R('1H92!& M;W)B96%R86YC92!!9W)E96UE;G0@86UO;F<-"B`@("`-"B`@("`@("`@;W1H M97(@6%B;&4@=6YD97(@86=R965A8FQE#0H@#0H@("`@ M("`@('1EF4@=&AE#0H@#0H@("`@("`@(&9O2P@82!#;VYV97)T:6)L92!396YI;W(@4V5C=7)E9`T* M("`@("`-"B`@("`@("`@3F]T92!I;B!T:&4@<')I;F-I<&%L(&%M;W5N="!O M9B`F;F)S<#LD-"PU,#`@*'1H90T*("`-"B`@("`@("`@)B,X,C(P.T-O;G9E M6%B;&4@;6]N=&AL>2XF(S$V M,#LF(S$V,#M4:&4@0V]N=F5R=&EB;&4@3F]T92!087EA8FQE(&ES#0H@#0H@ M("`@("`@('-E8W5R960@8GD@82!P;&5D9V4@;V8@2!A M;&P@;V8@=&AE#0H@#0H@("`@("`@($-O;7!A;GDF(S@R,3<[6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T* M("`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY);@T*("`-"B`@("`@($UA2!D969A=6QT#0H@#0H@("`@("!N M;W1I8V5S(&]R(&EN8W)E87-E(&EN=&5R97-T(')A=&5S(&1U92!T;R!S=6-H M(&1E9F%U;'0@*'1H90T*(`T*("`@("`@9&5F875L="!I;G1E6UE;G1S(&]N('1H92!#;VYV M97)T:6)L92!.;W1E(%!A>6%B;&4@:6X@075G=7-T(&]F#0H@("`@(`T*("`@ M("`@,C`P.2XF(S$V,#LF(S$V,#M);B!-87)C:"`R,#$P+"!#1"!&:6YA;F-I M86P@;W)A;&QY(&%G2!R971U2!H87,@;6%D92!T:6UE;'D@;6]N=&AL>0T*("`@("`-"B`@("`@ M(&EN=&5R97-T('!A>6UE;G1S+"!B96=I;FYI;F<@=VET:"!T:&4@36%Y(#(P M,3`@;6]N=&AL>0T*(`T*("`@("`@:6YT97)E2!I6%B;&4@9F]R#0H@(`T*("`@("`@=&AE(&YO;G!A>6UE M;G0@;V8@=&AE('!R:6YC:7!A;"!B86QA;F-E(&1U92!O;B!&96)R=6%R>2`R M,2P-"B`-"B`@("`@(#(P,3$N)B,Q-C`[)B,Q-C`[26X@8V]N;F5C=&EO;B!W M:71H('1H92!#;VUP86YY(&5N=&5R:6YG(&EN=&\-"B`-"B`@("`@('1H92!& M;W)B96%R86YC92!!9W)E96UE;G0@=VET:"!R97-P96-T('1O('1H92!.;W1E M6%B;&4I+"!#1"!&:6YA;F-I86P@:&%S#0H@("`@#0H@("`@ M("!A9W)E960@=&\@;F]T(')E8V5I=F4@86YY('!R:6YC:7!A;"!P87EM96YT M6%B M;&4@9F]R(&5A8V@-"B`@#0H@("`@("`@('!E6%B;&4@;6%Y(&)E(&-O;G9E7,-"B`@#0H@("`@("!I;6UE M9&EA=&5L>2!P6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;'-O M+`T*("`@("`-"B`@("`@(&EN(&%C8V]R9&%N8V4@=VET:"!T:&4@0T0@4U!! M+"!T:&4@0V]M<&%N>2!W:6QL(&ES6%B;&4@:&%S M(&)E96X@2=S(&]B;&EG871I;VYS('1O(&ES6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/@T*("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE3X-"B`@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY/;@T*("`-"B`@("`@($YO=F5M8F5R(#(T+"`R,#`Y+"!-86YH M871T86X@1')U9RP@82!W:&]L;'D@;W=N960@0T*("`-"B`@ M("`@(&]F('1H92!#;VUP86YY+"!E;G1E6%B;&4-"B`@("`-"B`@("`@ M('%U87)T97)L>2XF(S$V,#LF(S$V,#M);G1E2!T:&4@0T0@3F]T92!O;B!I=',- M"B`-"B`@("`@('-C:&5D=6QE9"!M871U2!D871E+B8C,38P.R8C,38P M.TEN=&5R97-T(&ES('!A:60-"B`@#0H@("`@("!Q=6%R=&5R;'DN)B,Q-C`[ M)B,Q-C`[5&AE($-$($YO=&4@:7,@97AP96-T960@=&\@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;@T*("`-"B`@("`@ M($IU;'D@,CDL(#(P,3`L($UA;FAA='1A;B!$2!A;F0-"B`-"B`@("`@('=A6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4-"B`@(`T*("`@("`@=V5I9VAT960@879E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@(`T*("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@($%C8V]U;G1S(')E8V5I=F%B;&4@87,@;V8@4V5P=&5M8F5R(#,P M+"`R,#$Q(&9R;VT@=&AI2`S.24@;V8@=&]T86P@86-C;W5N=',-"B`@(`T* M("`@("`@28C.#(Q-SMS(&]P97)A=&EO;G,N($UA:F]R(&-U6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z("TT+C-P="<@86QI9VX],T1J=7-T:69Y/@T*(`T*("`@ M("`@/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SXH8BD-"B`@("`@ M#0H@("`@("!/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T)SY!<'!R M;WAI;6%T96QY(#4V)0T*("`-"B`@("`@('1H92!#;VUP86YY)B,X,C$W.W,@ M96UP;&]Y965S+"!L;V-A=&5D(&EN(&ET'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"B`@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U7 M14E'2%0Z(&)O;&0G/E)E;&%T960-"B`@#0H@("`@("!087)T>2!,96%S97,N M/"]F;VYT/B!787)E:&]U2!T:&4-"B`@("`@#0H@("`@("!#:&%I28C.#(Q-SMS($)O87)D(&]F($1I6UE;G0-"B`@(`T*("`@("`@;V8@)FYB2`S,2P@,C`Q-2!P;'5S(&EN8W)E87-E&5S(&%N9"!B=6EL9&EN9R!O<&5R871I;F<@97AP96YS M97,N($]N($IU;'D@,2P@,C`P-"P@=&AE#0H@#0H@("`@("!#;VUP86YY(&QE M87-E9"!A;B!A9&1I=&EO;F%L(#(T+#@Q,"!S<75A6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T* M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE2P@86YD#0H@("`@(`T*("`@("`@87)E(&EN M8VQU9&5D(&EN(&-O6EN9R!# M;VYD96YS960-"B`-"B`@("`@($-O;G-O;&ED871E9"!3=&%T96UE;G1S(&]F M($]P97)A=&EO;G,N($%S(&]F(%-E<'1E;6)E2!H860@86X@ M;W5T3X- M"B`@(`T*("`@("`@/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+5=%24=(5#H@8F]L9"<^3W1H97(-"B`@("`@#0H@("`@ M("!,96%S92!#;VUM:71M96YT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z("TR,BXU<'0G(&%L:6=N M/3-$:G5S=&EF>3X-"B`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$S)3X-"B`@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,96%S93PO9F]N=#X-"B`@ M(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,96%S93PO9F]N=#X-"B`@ M(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VUM:71M M96YT/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@ M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^#0H@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^ M#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$S)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@ M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXS,C0\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR.3<\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^#0H@(`T*("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=& M3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^5&]T86P\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\ M+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$"<^#0H@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF;F)S<#LD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#$X.#PO9F]N=#X-"B`- M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ+#(U,#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T* M("`@(`T*("`@("`@/&9O;G0@'!E;G-E+"!I;F-L=61I;F<@ M2`F;F)S<#LD,C2!H87,@82!R96UA:6YI;F<@;&5A6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!A M9'9E28C.#(Q-SMS#0H@("`@(`T*("`@("`@;&EQ=6ED:71Y+"!F M:6YA;F-I86P@8V]N9&ET:6]N(&%N9"!C87-H(&9L;W=S+B8C,38P.R8C,38P M.U1H90T*(`T*("`@("`@0V]M<&%N>2!B96QI979E28C.#(Q-SMS(&QI<75I9&ET>2P@9FEN M86YC:6%L(&-O;F1I=&EO;B!O3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#$V-3=C,%\W-#8Q7S1A,C5?8F4Y M,E]A-F$P93'0O:'1M;#L@8VAA M'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*(`T* M("`@("`@/&9O;G0@2!46QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE2P@80T*("`-"B`@("`@(&9O2!A;F0@82!B28C.#(Q-SMS($-H:65F($5X M96-U=&EV92!/9F9I8V5R+"!#:&%I'!E;G-E#0H@("`@(`T*("`@("`@ M2!S96-U6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$:G5S=&EF>3X-"B`@("`-"B`@("`@("`@/&9O;G0@ XML 32 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 2 - Liquidity and Going Concern
3 Months Ended
Sep. 30, 2011
Liquidity Disclosure [Policy Text Block]
Note 2. Liquidity and Going Concern

The Company’s condensed consolidated financial statements have been prepared assuming that it will continue as a going concern. The Company has cumulative historical net losses and cash outflows from operations.  For the fiscal year ended June 30, 2011, the Company had cash provided from operating activities of $390.  As of September 30, 2011, the Company had cash of $931 (inclusive of cash of $368 included in assets from discontinued operations) and a working capital deficit of $9,033, which is primarily attributable to the Notes Payable in the outstanding principal amount of $7,805, which matured on November 15, 2009 and are currently in default (See Note 6. Debt), the Convertible Note Payable in the outstanding principal amount of $4,500, which matured on February 21, 2011, which are secured by pledges of substantially all the Company’s assets (See Note 6. Debt).  These factors raise substantial doubt as to the Company’s ability to continue as a going concern.  The accompanying condensed consolidated financial statements do not include any adjustments that might result from these uncertainties.

The Company has defaulted on all of its outstanding debt instruments in the aggregate amount of $12,605 (see Note 6. Debt) by failing to repay them on their respective scheduled maturity dates. The Notes Payable and Convertible Note Payable are secured by pledges of substantially all of the Company’s assets.

The Company defaulted on the $7,805 outstanding principal amount of its Notes Payable, issued by the Company under that certain Securities Purchase Agreement, dated as of February 21, 2008, by failing to repay the Notes Payable on the scheduled maturity date of November 15, 2009.  The Company’s failure to repay the Notes Payable on the scheduled maturity date constituted an Event of Default under the Notes Payable and triggered the right of the holders of the Notes Payable (the “Note Payable Holders”) to give the Company a notice (an “Acceleration Notice”) to accelerate the payment of all unpaid principal and accrued and unpaid interest (including interest accruing at the default rate).  The Notes Payable are secured by a pledge of substantially all of the Company’s assets.  As of November 21, 2011, the Company has not repaid the Notes Payable or the default interest accrued on the Notes Payable.

On October 4, 2011, the Company and the Collateral Agent for the holders of the Notes Payable, entered into a Forbearance Agreement extending, among other things, the due date until December 31, 2011. (See Note 6. Debt).

The Company defaulted on the $4,500 million outstanding principal amount of its Convertible Note Payable, issued by the Company under that certain Securities Purchase Agreement, dated as of February 21, 2008, by failing to repay the Convertible Note Payable on the scheduled maturity date of February 21, 2011.  The Company’s failure to repay the Convertible Note Payable on the scheduled maturity date constituted an Event of Default under the Convertible Note Payable and triggered the right of the holder of the Convertible Note Payable to give the Company a notice (“CD Acceleration Notice”) to accelerate the payment of all unpaid principal and accrued and unpaid interest (including interest accruing at the default rate, if any).  The Convertible Note Payable is secured by a pledge of substantially all of the Company’s assets, which pledge is subordinated to the security interest held by the Note Payable Holders.  As of November 21, 2011, the Company has not repaid the Convertible Note Payable or the default interest on the Convertible Note Payable.  The holder of the Convertible Note Payable, CD Financial, LLC (“CD Financial”) is a significant shareholder of the Company and has not made any payment demands on the Company with respect to the Convertible Note Payable, nor has it converted the Convertible Note Payable into common shares of the Company.  In March 2009, the Company and CD Financial entered into an oral agreement to suspend the cash interest payments on the Convertible Note Payable until the Company returned to positive cash flows in its operations.  In this oral agreement, CD Financial agreed not to give any default notices or increase interest rates due to such default (the default interest rate as defined in the Convertible Note Payable is 18%).  In connection with the Company entering into a Forbearance Agreement with respect to the Notes Payable (See Note 6), CD Financial has agreed to not receive any principal payments until all of the Company’s obligations to the Note Payable Holders have been repaid, including any interest payments at the default interest rate.

There can be no assurance that the Company will be able to repay, restructure or amend the Notes Payable by December 31, 2011 or the Convertible Note Payable prior to receipt by the Company of a CD Acceleration Notice from CD Financial.  In the interim, the Company has continued to make timely interest payments to the Note Payable Holders at the non default rate of 8% per annum and is exploring its strategic alternatives, which may include business divestitures, developing business and sales strategies to increase operating income, the sale of some or all of the Company’s assets or operating subsidiaries and/or capital restructuring plans.

If the Notes Payable are not repaid by December 31, 2011, and as a result of the events of default that arose based upon the Company’s failure to pay each of the Notes Payable at maturity, the Note Payable Holders have the right to give the Company an Acceleration Notice. As a result of the event of default that arose based upon the Company’s failure to repay the Convertible Note Payable at maturity, CD Financial has the right to give the Company a CD Acceleration Notice.  Each acceleration notice would (i) accelerate the payment of all unpaid principal and accrued and unpaid interest (including default interest (if any); with respect to the Notes Payable, only default interest arising subsequent to December 31, 2011, (if any)) and (ii) require the Company to pay an amount equal to the sum of all of the respective amounts described in the preceding clause (i) in same day funds on the payment date specified in such notice. If the Company is unable to raise additional capital, sell certain assets or successfully refinance the full outstanding amount of the Notes Payable and the Convertible Note Payable upon acceptable terms, it would have a material adverse effect on the Company, including the possible foreclosure by the holders of the Notes Payable and/or the Convertible Note Payable of all or some of the Company’s assets, which would impact the Company’s ability to continue as a going concern.

X
- Definition
Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.
+ Details
Name: us-gaap_LiquidityDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 33 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data
3 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sales, net $ 8,047 $ 6,439
Cost of sales 6,618 5,481
Gross profit 1,429 958
Selling and administrative expenses 689 910
Operating income 740 48
Other expense, net (primarily interest expense) (145) (448)
Income (loss) from continuing operations before income taxes 595 (400)
Income tax expense, net 7
Net income (loss) from continuing operations 595 (407)
(Loss) income from discontinued operations (232) 406
Net income (loss) $ 363 $ (1)
Basic and diluted net income (loss) per common share:
Continuing operations (in Dollars per share) $ 0.03 $ (0.02)
Discontinued operations (in Dollars per share) $ (0.01) $ 0.02
Basic and diluted net income (loss) per common share (in Dollars per share) $ 0.02 $ 0.00
Weighted average common shares outstanding (in Shares) 20,936,813 20,625,981
X
- Details
Name: inbp_BasicAndDilutedNetIncomeLossPerCommonShareAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Definition
Total costs related to goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 2

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details
Name: us-gaap_CostOfGoodsSold
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

+ Details
Name: us-gaap_EarningsPerShareBasic
Namespace Prefix: us-gaap
Data Type: num:perShareItemType
Balance Type: na
Period Type: duration
X
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details
Name: us-gaap_GrossProfit
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
This element represents the income or loss from continuing operations attributable to the parent which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4613673-111683

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.13)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details
Name: us-gaap_IncomeLossFromContinuingOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 10

+ Details
Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 11, 12, 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details
Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
Namespace Prefix: us-gaap
Data Type: num:perShareItemType
Balance Type: na
Period Type: duration
X
- Definition
This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 47

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.14)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 15

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

+ Details
Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The amount of net income or loss derived from discontinued operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section E

-Paragraph Question 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details
Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
Namespace Prefix: us-gaap
Data Type: num:perShareItemType
Balance Type: na
Period Type: duration
X
- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 27

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details
Name: us-gaap_IncomeTaxesPaidNet
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details
Name: us-gaap_NetIncomeLoss
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ Details
Name: us-gaap_OperatingIncomeLoss
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details
Name: us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 1

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details
Name: us-gaap_SalesRevenueGoodsNet
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 4

-Paragraph 5A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311

+ Details
Name: us-gaap_SellingGeneralAndAdministrativeExpense
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details
Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: duration
XML 34 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
3 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows provided by operating activities:
Net income (loss) $ 363 $ (1)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss (income) from discontinued operations 232 (406)
Depreciation and amortization 90 85
Accretion of financing instruments 319
Financing costs in for stock issued in connection with Convertible Note Payable 4 5
Change in fair value of derivative liabilities (10) (6)
Gain on sale of fixed assets (2) (30)
Compensation expense for consulting services 49
Compensation expense for employee stock options 5 158
Decrease (increase) in:
Accounts receivable (755) (135)
Inventories 858 1,044
Other current assets 8 (70)
Security deposits and other assets (3)
(Decrease) increase in:
Accounts payable (625) (1,350)
Accrued expenses and other liabilities (116) 67
Net cash provided by (used in) operating activities - continuing operations 49 (271)
Net cash provided from operating activities - discontinued operations 168 757
Net cash provided by operating activities 217 486
Cash flows used in investing activities:
Purchase of property and equipment (1) (145)
Proceeds from sale of property and equipment 2 30
Net cash used in investing activities - continuing operations 1 (115)
Net cash used in investing activities - discontinued operations
Net cash used in investing activities 1 (115)
Cash flows from financing activities:
Proceeds from notes payable 40
Payments under capital lease obligations (11) (11)
Net cash (used in) provided by financing activities - continuing operations (11) 29
Net cash provided by financing activities - discontinued operations
Net cash (used in) provided by financing activities (11) 29
Net increase in cash 207 400
Increase in cash, discontinued operations (207) (494)
Cash at beginning of period, continuing operations 563 478
Cash at end of period, continuing operations $ 563 $ 384
X
- Details
Name: inbp_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByOperatingActivitiesAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_CashFlowsFromFinancingActivitiesAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_CashFlowsProvidedByOperatingActivitiesAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_CashFlowsUsedInInvestingActivitiesAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_DecreaseIncreaseInAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_DecreaseIncreaseInAbstract0
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Definition
Direct costs (e.g., legal and accounting fees) associated with issuing stock that is deducted from additional paid in capital. Also includes any direct costs associated with stock issues under a shelf registration.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Technical Practice Aid (TPA)

-Number 4110

-Paragraph 1, 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details
Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The component of interest expense representing the noncash expenses charged against earnings in the period to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include Noncash Interest Expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_AmortizationOfFinancingCostsAndDiscounts
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details
Name: us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details
Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: na
Period Type: duration
X
- Definition
This element represents cash provided by or used in the financing activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in financing activities reflect only cash flows attributable to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details
Name: us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
This element represents cash provided by or used in the investing activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in investing activities reflect only cash flows attributable to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details
Name: us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
This element represents cash provided by or used in the operating activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in operating activities reflect only cash flows attributable to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details
Name: us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details
Name: us-gaap_DepreciationAndAmortization
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
This element represents the overall income (loss) from a disposal group apportioned to the parent that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(2)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details
Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_IncreaseDecreaseInAccountsPayable
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).
+ Details
Name: us-gaap_IncreaseDecreaseInDerivativeLiabilities
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_IncreaseDecreaseInInventories
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The increase (decrease) during the reporting period in other expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_IncreaseDecreaseInOtherAccruedLiabilities
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.
+ Details
Name: us-gaap_IncreaseDecreaseInOtherCurrentAssets
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_IncreaseDecreaseInReceivables
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The increase (decrease) during the reporting period in security deposits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_IncreaseDecreaseInSecurityDeposits
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
the increase (decrease) in cash associated with the entity's discontinued operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInDiscontinuedOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The net cash inflow or outflow from financing activity for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInFinancingActivities
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The net cash from (used in) the entity's financing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in financing activities. Such reporting would necessitate the entity to use the Net Cash provided by or used in Discontinued Operations, Total element provided in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The net cash inflow or outflow from investing activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInInvestingActivities
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The net cash from (used in) the entity's investing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in investing activities. Such reporting would necessitate the entity to use the Net Cash provided by or used in Discontinued Operations, Total element provided in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-Footnote 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInOperatingActivities
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: na
Period Type: duration
X
- Definition
The net cash from (used in) the entity's continuing operations. This element specifically EXCLUDES the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in operating activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-Footnote 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details
Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: na
Period Type: duration
X
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details
Name: us-gaap_NetIncomeLoss
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
Other expenses or losses included in net income that result in no cash outflows or inflows in the period and are not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_OtherNoncashExpense
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details
Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details
Name: us-gaap_ProceedsFromNotesPayable
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 16

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details
Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

+ Details
Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph A240

-Subparagraph i

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_StockOptionPlanExpense
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
XML 35 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 36 R7.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 1 - Principles of Consolidation and Basis of Presentation
3 Months Ended
Sep. 30, 2011
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note 1. Principles of Consolidation and Basis of Presentation

Basis of Presentation of Interim Financial Statements

The accompanying condensed financial statements for the interim periods are unaudited and include the accounts of the Company. The interim condensed financial statements have been prepared in conformity with Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and therefore do not include information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. However, all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented have been included. These condensed financial statements should be read in conjunction with the financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011 (“Form 10-K”), as filed with the SEC. The June 30, 2011 balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The results of operations for the three months ended September 30, 2011 are not necessarily indicative of the results for the full fiscal year ending June 30, 2012 or for any other period.

These condensed consolidated financial statements reflect the classification as discontinued operations of our branded proprietary nutraceutical business which is operated by AgroLabs, Inc. (“AgroLabs”), a wholly owned subsidiary of the Company, which distributes for sale through major mass market, grocery, drug and vitamin retailers, healthful nutritional products under the following brands: Naturally Noni, Naturally Pomegranate, Pomegranate with ACAI and Reservatrol, Coconut Water, Naturally Aloe, Aloe Pure, Naturally Thai Mangosteen, Peaceful Sleep, Green Envy, 1st Choice Multi-Vitamin, ACAI Extra, ACAI Immune, ACAI Cleanse, and other products which are being introduced into the market.  These are referred to as our branded proprietary nutraceutical business and/or products. (See Note 3. Discontinued Operations).

Nature of Operations

Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products.  The Company’s customers are located primarily in the United States. The Company was previously known as Integrated Health Technologies, Inc. and, prior to that, as Chem International, Inc. The Company was reincorporated in its current form in Delaware in 1995. The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors.

The Company’s nutraceutical business includes: InB:Manhattan Drug Company, Inc. (“Manhattan Drug”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and The Vitamin Factory, which sells private label Manhattan Drug products, as well as our AgroLabs products, through the Internet.

The Company also distributes fine natural chemicals through its wholly-owned subsidiary IHT Health Products, Inc. and is a distributor of certain raw materials for DSM Nutritional Products, Inc.

Significant Accounting Policies

There have been no material changes during fiscal year 2012 in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.

Investment in iBio, Inc. - Restricted. The Company accounts for its investment in iBio, Inc. (“iBio”) on the cost basis as it retained approximately 6% of its interest in iBio (1,266,706 shares of common stock) (the “iBio Stock”) at the time of the spin-off of this subsidiary in August 2008.  The Company reviews its investment in iBio for impairment and records a loss when there is deemed to be an impairment of the investment.  There was no impairment charge recorded in the three months ended September 30, 2011 and 2010.  Pursuant to the Forbearance Agreement with respect to the Notes Payable, proceeds from any sales of the iBio Stock will be used to repay a portion of the outstanding principal of the Notes Payable. (See Note 2. Liquidity and Going Concern and Note 6. Debt).

Supplemental Statement of Cash Flows

Three months ended

September 30,

2011

2010

Supplemental disclosures of cash flow information:

Cash paid during the periods for:

Interest - continuing operations
$ 161 $ 161

Interest - discontinued operations
$ 102 $ 102

Income taxes
$ - $ 3

Earnings Per Share. Basic earnings per common share amounts are based on the weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible preferred stock, subject to anti-dilution limitations using the treasury stock method.

Stock options and warrants to purchase or otherwise obtain shares of common stock were not included in the fully diluted computation for earnings per share as their exercise prices were greater than the market price of the common shares as of September 30 2011 and 2010.

X
- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

+ Details
Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 37 R3.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands
Sep. 30, 2011
Jun. 30, 2011
Current Assets:
Cash $ 563 $ 563
Accounts receivable, net 1,960 1,205
Inventories 4,509 5,367
Investment in iBio, Inc., restricted 823 823
Other current assets 163 173
Assets held for sale 3,680 3,722
Total current assets 11,698 11,853
Property and equipment, net 1,519 1,598
Security deposits and other assets 192 199
Total Assets 13,409 13,650
Current Liabilities:
Notes Payable 7,805 7,805
Accounts payable 4,578 5,152
Convertible note payable - CD Financial LLC, net 4,500 4,500
Accrued expenses and other current liabilities 730 921
Notes Payable, CD Financial LLC 300 300
Liabilities held for sale 2,818 2,667
Total current liabilities 20,731 21,345
Common Stock, $0.002 par value; 50,000,000 shares authorized; 20,965,074 and 20,915,074 shares issued at September 30, 2011 and June 30, 2011, 20,930,174 and 20,880,174 shares outstanding at September 30, 2011 and June 30, 2011 42 42
Additional paid-in capital 44,553 44,543
Accumulated deficit (51,818) (52,181)
Less: Treasury stock, at cost, 34,900 shares (99) (99)
Total Stockholders' Deficiency (7,322) (7,695)
Total Liabilities and Stockholders' Deficiency $ 13,409 $ 13,650
X
- Details
Name: inbp_CurrentAssetsAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_CurrentLiabilitiesAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
X
- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_AccountsPayableCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_AccountsReceivableNetCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_AdditionalPaidInCapital
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 12

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Topic 210

-SubTopic 10

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

-Section S99

-Name Accounting Standards Codification

-Publisher FASB

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_Assets
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Section 45

-SubTopic 10

-Topic 210

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

-Publisher FASB

-Name Accounting Standards Codification

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details
Name: us-gaap_AssetsCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Current assets (normally turning over within one year or one business cycle if longer) that are held for sale apart from normal operations and anticipated to be sold within one year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

+ Details
Name: us-gaap_AssetsHeldForSaleCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details
Name: us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_CommonStockValue
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_ConvertibleNotesPayableCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_DepositsAssetsNoncurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details
Name: us-gaap_InventoryNet
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 25

+ Details
Name: us-gaap_LiabilitiesAndStockholdersEquity
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_LiabilitiesCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Liability (such as a mortgage) related to a disposal group that is held for sale and anticipated to be sold in less than one year. The liability is expected to be discharged as part of the plan of sale for the asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

+ Details
Name: us-gaap_LiabilitiesOfAssetsHeldForSale
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_NotesPayableCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a)(5))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

-Subparagraph 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details
Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 3

-Section A

-Paragraph 7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6911-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e7018-107765

+ Details
Name: us-gaap_OtherAccruedLiabilitiesCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_OtherAssetsCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details
Name: us-gaap_PropertyPlantAndEquipmentNet
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_RestrictedCashAndInvestmentsCurrent
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
X
- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details
Name: us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details
Name: us-gaap_StockholdersEquity
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Technical Bulletin (FTB)

-Number 85-6

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

+ Details
Name: us-gaap_TreasuryStockValue
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: instant
XML 38 R1.htm IDEA: XBRL DOCUMENT v2.3.0.15
Document And Entity Information
3 Months Ended
Sep. 30, 2011
Nov. 15, 2011
Document and Entity Information [Abstract]
Entity Registrant Name INTEGRATED BIOPHARMA INC
Document Type 10-Q
Current Fiscal Year End Date --06-30
Entity Common Stock, Shares Outstanding 20,965,074
Amendment Flag false
Entity Central Index Key 0001016504
Entity Current Reporting Status Yes
Entity Voluntary Filers No
Entity Filer Category Smaller Reporting Company
Entity Well-known Seasoned Issuer No
Document Period End Date Sep. 30, 2011
Document Fiscal Year Focus 2012
Document Fiscal Period Focus Q1
X
- Definition
If the value is true, then the document as an amendment to previously-filed/accepted document.
+ Details
Name: dei_AmendmentFlag
Namespace Prefix: dei
Data Type: xbrli:booleanItemType
Balance Type: na
Period Type: duration
X
- Definition
End date of current fiscal year in the format --MM-DD.
+ Details
Name: dei_CurrentFiscalYearEndDate
Namespace Prefix: dei
Data Type: xbrli:gMonthDayItemType
Balance Type: na
Period Type: duration
X
- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ Details
Name: dei_DocumentFiscalPeriodFocus
Namespace Prefix: dei
Data Type: dei:fiscalPeriodItemType
Balance Type: na
Period Type: duration
X
- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ Details
Name: dei_DocumentFiscalYearFocus
Namespace Prefix: dei
Data Type: xbrli:gYearItemType
Balance Type: na
Period Type: duration
X
- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ Details
Name: dei_DocumentPeriodEndDate
Namespace Prefix: dei
Data Type: xbrli:dateItemType
Balance Type: na
Period Type: duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, and Other.
+ Details
Name: dei_DocumentType
Namespace Prefix: dei
Data Type: dei:submissionTypeItemType
Balance Type: na
Period Type: duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details
Name: dei_EntityCentralIndexKey
Namespace Prefix: dei
Data Type: dei:centralIndexKeyItemType
Balance Type: na
Period Type: duration
X
- Definition
Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument
+ Details
Name: dei_EntityCommonStockSharesOutstanding
Namespace Prefix: dei
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: instant
X
- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ Details
Name: dei_EntityCurrentReportingStatus
Namespace Prefix: dei
Data Type: dei:yesNoItemType
Balance Type: na
Period Type: duration
X
- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ Details
Name: dei_EntityFilerCategory
Namespace Prefix: dei
Data Type: dei:filerCategoryItemType
Balance Type: na
Period Type: duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details
Name: dei_EntityRegistrantName
Namespace Prefix: dei
Data Type: xbrli:normalizedStringItemType
Balance Type: na
Period Type: duration
X
- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ Details
Name: dei_EntityVoluntaryFilers
Namespace Prefix: dei
Data Type: dei:yesNoItemType
Balance Type: na
Period Type: duration
X
- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ Details
Name: dei_EntityWellKnownSeasonedIssuer
Namespace Prefix: dei
Data Type: dei:yesNoItemType
Balance Type: na
Period Type: duration
X
- Details
Name: inbp_DocumentAndEntityInformationAbstract
Namespace Prefix: inbp
Data Type: xbrli:stringItemType
Balance Type: na
Period Type: duration
XML 39 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)
Sep. 30, 2011
Jun. 30, 2011
Common Stock, par value (in Dollars per share) $ 0.002 $ 0.002
Common Stock, shares authorized 50,000,000 50,000,000
Common Stock, shares issued 20,965,074 20,915,074
Common Stock, shares outstanding 20,930,174 20,880,174
Treasury stock, shares 34,900 34,900
X
- Definition
Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: us-gaap
Data Type: num:perShareItemType
Balance Type: na
Period Type: instant
X
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_CommonStockSharesAuthorized
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: instant
X
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_CommonStockSharesIssued
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: instant
X
- Definition
Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details
Name: us-gaap_CommonStockSharesOutstanding
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: instant
X
- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_TreasuryStockShares
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: instant
XML 40 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 6 - Debt
3 Months Ended
Sep. 30, 2011
Debt Disclosure [Text Block]
Note 6. Debt

Notes Payable

On February 21, 2008, the Company entered into a Securities Purchase Agreement with Imperium Master Fund, LTD. and three other parties (collectively “Imperium”), which Securities Purchase Agreement was amended on October 14, 2008 (as so amended, the “SPA”), pursuant to which the Company issued, and Imperium purchased from the Company, an aggregate $7,000 in principal of senior secured notes (“Notes Payable”). The Notes Payable matured on November 15, 2009 and bear interest at the rate of 8.0%.  Interest is payable monthly.  As of September 30, and June 30, 2011, accrued interest of $47 for each period is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

An additional premium of $805 was granted due to the amendment noted above.  The additional premium is subject to interest payments commencing October 1, 2011.

The Notes Payable are secured by a pledge of substantially all of the Company’s assets.

On October 4, 2011, the Company and the Collateral Agent for the Note Payable Holders, entered into a Forbearance Agreement (the “Forbearance Agreement”).  The Forbearance Agreement provides that the Collateral Agent shall forbear from exercising rights and remedies arising from the occurrence of Specified Defaults (as defined in the Forbearance Agreement), including the Company’s failure to repay the Notes Payable which are due and payable. The Forbearance Agreement will terminate on the earlier to occur of (i) December 31, 2011, (ii) the date the Company fails to comply with the covenants, conditions and agreements contained in the Forbearance Agreement, (iii) the date of the occurrence of any Event of Default, other than the Specified Defaults (as defined in the Forbearance Agreement), under the SPA, the Notes Payable, the Certificate of Designation (as defined in the SPA), the Registration Rights Agreement (as defined in the SPA), the Subsidiary Guaranty, dated as of February 21,  2008, by and among the Company, certain of its subsidiaries and the Collateral Agent, the Security Agreement, dated as of February 21,  2008 (the “Security Agreement”), by and among the Company, certain of its subsidiaries and the Collateral Agent and all other agreements, documents and other instruments entered into by the Company or any of its subsidiaries in connection with the SPA (collectively, the “Transaction Documents”), or (iv) the date the amended Notes Payable are paid in cash and all other obligations under the Transaction Documents are satisfied.  Additionally, under the Forbearance Agreement, among other things:

(1)

The Collateral Agent may cause to be sold by the Company, shares of common stock of iBio, pledged by the Company to the holders of the Notes Payable pursuant to the Security Agreement as soon as commercially reasonable and apply the net proceeds from such sale first, against unpaid principal obligations under the Notes Payable and second, to any remaining obligations under the Transaction Documents.  As of November 21, 2011, there have been no such sales.

(2)

The Company shall not, prior to the payment in full of all obligations owed to the amended Note Payable Holders under the Transaction Documents, make any (a) principal payments in respect of the $4,500 outstanding principal amount of the Convertible Note Payable which matured on February 21, 2011 (the “CD Financial Debt”), (b) past due rental or lease payments under the Company’s lease obligations to Vitamin Realty Associates, L.L.C. (“Vitamin Realty”) ($686 as of September 30, 2011), or (c) any rental or lease payments, including any past due rental or lease payments, in respect of any other personal or real property leased or rented by the Company or any of its subsidiaries from E. Gerald Kay or any family member of E. Gerald Kay; provided, that, so long as no Event of Default (other than the Specified Defaults) exists and is continuing, the Company shall be permitted to make interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt and make current rental or lease payments under the Company’s lease obligations to Vitamin Realty.  If an Event of Default (other than the Specified Defaults) exists and is continuing, the Company shall not be permitted to make any interest payments (on a pre-default, non-accelerated basis) in respect of the CD Financial Debt or make any current rental or lease payments under the Company’s lease obligations to Vitamin Realty. Any breach by the Company of (a) (b) or (c) shall constitute an Event of Default under, and shall trigger a termination of, the Forbearance Agreement.

(3)

If the Company fails to repay all of obligations under the Transaction Documents prior to December 31, 2011, then on December 31, 2011, the Company shall pay to the Collateral Agent, for the ratable benefit of the Note Payable Holders, a fee equal to $1,000, which shall be in addition to all other fees and expenses payable by the Company to the Collateral Agent and the Note Payable Holders under the Transaction Documents.

(4)

The Company has absolutely, unconditionally and irrevocably released, on behalf of itself and its subsidiaries, and its and their respective successors, assigns and other legal representatives, the Collateral Agent, the Note Payable Holders, and various other Releasees (as defined in the Forbearance Agreement) from all Claims (as defined in the Forbearance Agreement) arising at any time on or prior to the date of the Forbearance Agreement, in connection with the Transaction Documents, on the terms and conditions set forth in the Forbearance Agreement.

During the period from October 4 to November 21, 2011, the Company and the Collateral Agent continue to discuss the options available to the Company to repay the Notes Payable by the extended due date under the Forbearance Agreement among other strategic options, including retaining an investment banker as contemplated under the Forbearance Agreement to assist the Company in selling its propriety nutraceutical business, to repay the Notes Payable under agreeable terms. When and if it is determined that the Company will not be able to satisfy the payment requirements under the Forbearance Agreement, the Company will recognize the forbearance fee of $1,000.

Convertible Note Payable – CD Financial, LLC

On February 21, 2008, the Company entered into a Securities Purchase Agreement (the “CD SPA”) with CD Financial, a significant shareholder of the Company, pursuant to which the Company issued and CD Financial purchased from the Company, a Convertible Senior Secured Note in the principal amount of $4,500 (the “Convertible Note Payable”).  The Convertible Note Payable matured on February 21, 2011 and bears interest at the rate of 9.5%.  Interest is payable monthly.  The Convertible Note Payable is secured by a pledge of substantially all of the Company’s assets.

In March 2009, the Company and CD Financial entered into an oral agreement to suspend the cash interest payments on the Convertible Note Payable until the Company returned to positive cash flows in its operations.  In this oral agreement, CD Financial agreed not to give any default notices or increase interest rates due to such default (the default interest rate as defined in the Convertible Note Payable is 18%).  The Company resumed interest payments on the Convertible Note Payable in August of 2009.  In March 2010, CD Financial orally agreed to defer the interest owed for April 2010, in the amount of $36, until the Company returned to positive cash flows to assist the Company in meeting its short term cash flow requirements.  The Company has made timely monthly interest payments, beginning with the May 2010 monthly interest obligation.  As of November 21, 2011, the Company is in default under the Convertible Note Payable for the nonpayment of the principal balance due on February 21, 2011.  In connection with the Company entering into the Forbearance Agreement with respect to the Notes Payable (See Note 6. Debt – Notes Payable), CD Financial has agreed to not receive any principal payments until all of the Company’s obligations to the Note Payable Holders have been repaid.

As of September 30 and June 30, 2011, accrued interest of $253 with respect to the Convertible Note Payable for each period is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets, including interest in arrears of $217 in each period.

The Convertible Note Payable may be converted, at any time and at the holder’s option, into shares of the Company’s common stock under the terms and conditions set forth in the CD SPA.  The conversion price is a formula that bases the conversion price on the greater of (i) 90% of the average Volume Weighted Average Price (the "VWAP") market price of the Company’s common stock for 20 trading days immediately preceding the conversion date and (ii) $2.00, subject to adjustment in the event of a stock dividend, stock split or combination, reclassification or similar event and upon certain issuances below the conversion price.

Also, in accordance with the CD SPA, the Company will issue and deliver to CD Financial, for no additional consideration, 50,000 shares of common stock, on a quarterly basis in arrears, until the Convertible Note Payable has been repaid in full, after which the Company's obligations to issue shares of common stock will no longer be applicable.

Debt discount of $324 in the three months ended September 30, 2010 was recorded in interest expense in condensed consolidated statement of operations.

Notes Payable, CD Financial LLC

On November 24, 2009, Manhattan Drug, a wholly owned subsidiary of the Company, entered into a $300 promissory note (the “CD Note”) with CD Financial.  The CD Note matured on November 24, 2010 and bears interest at the rate of 5%, which interest is payable quarterly.  Interest is accrued monthly and is payable upon maturity.  As of September 30, 2011, the Company is in default under the CD Note as a result of the Company’s failure to repay the CD Note on its scheduled maturity date.  Interest is paid quarterly.  The CD Note is expected to remain outstanding until the Company satisfies the Company’s obligations under the Notes Payable. (See Note 6. Debt – Notes Payable).

On July 29, 2010, Manhattan Drug entered into a second promissory note in the amount of $40 (the “CD $40 Note”) with CD Financial.  The CD $40 Note matured on October 29, 2010 and bore interest at the rate of 5%.  Manhattan Drug repaid the CD $40 Note on October 29, 2010.  Interest was accrued monthly and was paid on maturity.

The weighted average interest rate paid on the Company’s outstanding debt was 8.49% and 8.48% in the three months ended September 30, 2011 and 2010, respectively.

X
- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

+ Details
Name: us-gaap_DebtDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 41 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 5 - Property and Equipment, net
3 Months Ended
Sep. 30, 2011
Property, Plant and Equipment Disclosure [Text Block]
Note 5. Property and Equipment, net

Property and equipment, net consists of the following as of:

September 30,

June 30,

2011

2011

Land and building
$ 1,250 $ 1,250

Leasehold improvements
1,122 1,122

Machinery and equipment
4,697 4,696

Transportation equipment
68 68

7,137 7,136

Less: Accumulated depreciation

         and amortization
(5,618 ) (5,538 )

Total
$ 1,519 $ 1,598

Depreciation and amortization expense was $80 and $75 for the three months ended September 30, 2011 and 2010, respectively.

X
- Definition
The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13-14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

+ Details
Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 42 R15.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 9 - Related Party Transactions
3 Months Ended
Sep. 30, 2011
Related Party Transactions Disclosure [Text Block]
Note 9. Related Party Transactions

The Company has a verbal consulting agreement with Eugene Kay, a former employee of the Company and a brother of E. Gerald Kay, the Company’s Chief Executive Officer, Chairman of the Board, President, and majority shareholder. This agreement is on a month-to-month basis and provides for payment by the Company of a fee in the amount of approximately $1.3 per month. The total consulting expense recorded in connection with this verbal agreement was approximately $4 in each of the three months ended September 30, 2011 and 2010.

See Note 6. Debt. for related party securities transactions.

See Note 8(a). Leases for related party lease transactions.

X
- Definition
The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details
Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 43 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 7 - Significant Risks and Uncertainties
3 Months Ended
Sep. 30, 2011
Concentration Risk Disclosure [Text Block]
Note 7. Significant Risks and Uncertainties

(a) Major Customers. For the three months ended September 30, 2011, approximately 80% of total net sales were derived from one customer as compared to approximately 87% of total net sales derived from two customers in the three months ended September 30, 2010. Accounts receivable as of September 30, 2011 from this customer represented approximately 39% of total accounts receivable. The loss of this customer would have an adverse affect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales.

(b) Other Business Risks. Approximately 56% the Company’s employees, located in its New Jersey facility, are covered by a union contract. The contract was renewed in August 2010 for an additional one year term and was extended in August 2011 to December 31, 2011.

X
- Definition
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 21, 22, 24

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6442-108592

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13531-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6327-108592

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details
Name: us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 44 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 8 - Commitments and Contingencies
3 Months Ended
Sep. 30, 2011
Commitments and Contingencies Disclosure [Text Block]
Note 8. Commitments and Contingencies

(a) Leases

Related Party Leases. Warehouse and office facilities are leased from Vitamin Realty, which is 90% owned by the Chairman of the Company’s Board of Directors, a director and majority shareholder and certain of his family members. The lease provides for minimum annual rental payment of $324 through May 31, 2015 plus increases in real estate taxes and building operating expenses. On July 1, 2004, the Company leased an additional 24,810 square feet of warehouse space on a month-to month basis.

Rent expense for the three months ended September 30, 2011 and 2010 on these leases were $184 and $202, respectively, and are included in cost of sales in the accompanying Condensed Consolidated Statements of Operations. As of September 30, 2011 and June 30, 2011, the Company had an outstanding obligation of $715 and $738, respectively, included in accounts payable in the accompanying Condensed Consolidated Balance Sheet.

Other Lease Commitments. The Company has entered into certain non-cancelable operating lease agreements expiring up through May 31, 2015, related to office and warehouse space, equipment and vehicles.

The minimum rental commitment for long-term non-cancelable leases is as follows:

Related Party

Year ending

Lease

Lease

June 30,

Commitment

Commitment

Total

2012, remaining
$ 34 $ 243 $ 277

2013
15 324 339

2014
13 324 337

2015
- 297 297

Total
$ 62 $ 1,188 $ 1,250

Total rent expense, including real estate taxes and maintenance charges, was approximately $276 and $294 for the three months ended September 30, 2011 and 2010, respectively. Rent expense is included in cost of sales, selling and administrative expenses and income (loss) from discontinued operations in the accompanying Condensed Consolidated Statements of Operations.  The Company has a remaining lease commitment of $170 ($139 remaining in the fiscal year ending June 30, 2012) in relating to operations classified as discontinued.

(b) Legal Proceedings.

The Company is subject, from time to time, to claims by third parties under various legal theories.  The defense of such claims, or any adverse outcome of any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.  The Company believes that there are no significant legal matters pending that would have a material effect on the Company’s liquidity, financial condition or cash flows.

X
- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details
Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 45 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) (USD $)
In Thousands, except Share data
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings, Appropriated [Member]
Treasury Stock [Member]
Total
Balance, July 1, 2011 at Jun. 30, 2011 $ 42 $ 44,543 $ (52,181) $ (99) $ (7,695)
Balance, July 1, 2011 (in Shares) at Jun. 30, 2011 20,915,074 34,900
Issuance of Common Stock in connection with Convertible Note 4 4
Issuance of Common Stock in connection with Convertible Note (in Shares) 50,000
Stock based compensation 6 6
Net income 363 363
Balance, September 30, 2011 at Sep. 30, 2011 $ 42 $ 44,553 $ (51,818) $ (99) $ (7,322)
Balance, September 30, 2011 (in Shares) at Sep. 30, 2011 20,965,074 34,900
X
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details
Name: us-gaap_NetIncomeLoss
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
X
- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details
Name: us-gaap_ShareBasedCompensation
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: debit
Period Type: duration
X
- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details
Name: us-gaap_SharesIssued
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: instant
X
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details
Name: us-gaap_StockholdersEquity
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: instant
X
- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4, 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-30)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details
Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
Namespace Prefix: us-gaap
Data Type: xbrli:sharesItemType
Balance Type: na
Period Type: duration
X
- Definition
The gross value of stock issued during the period upon the conversion of convertible securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4, 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details
Name: us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
Namespace Prefix: us-gaap
Data Type: xbrli:monetaryItemType
Balance Type: credit
Period Type: duration
XML 46 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Note 4 - Inventories
3 Months Ended
Sep. 30, 2011
Inventory Disclosure [Text Block]
Note 4. Inventories

Inventories are stated at the lower of cost or market using the first-in, first-out method and consist of the following as of:

September 30,

June 30,

2011

2011

Raw materials
$ 2,031 $ 2,560

Work-in-process
1,114 1,058

Finished goods
1,364 1,749

Total
$ 4,509 $ 5,367

X
- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 3

-Section A

-Paragraph 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

+ Details
Name: us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: us-gaap
Data Type: nonnum:textBlockItemType
Balance Type: na
Period Type: duration
XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.15 Html 18 98 1 false 4 0 false 3 true false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://healthproductscorp.us/role/DocumentAndEntityInformation Document And Entity Information false false R2.htm 001 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://healthproductscorp.us/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://healthproductscorp.us/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets (Unaudited) false false R4.htm 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://healthproductscorp.us/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) Sheet http://healthproductscorp.us/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://healthproductscorp.us/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 006 - Disclosure - Note 1 - Principles of Consolidation and Basis of Presentation Sheet http://healthproductscorp.us/role/Note Note 1 - Principles of Consolidation and Basis of Presentation false false R8.htm 007 - Disclosure - Note 2 - Liquidity and Going Concern Sheet http://healthproductscorp.us/role/Note0 Note 2 - Liquidity and Going Concern false false R9.htm 008 - Disclosure - Note 3 - Assets and Liabilities Held for Sale and Discontinued Operations Sheet http://healthproductscorp.us/role/Note00 Note 3 - Assets and Liabilities Held for Sale and Discontinued Operations false false R10.htm 009 - Disclosure - Note 4 - Inventories Sheet http://healthproductscorp.us/role/Note000 Note 4 - Inventories false false R11.htm 010 - Disclosure - Note 5 - Property and Equipment, net Sheet http://healthproductscorp.us/role/Note0000 Note 5 - Property and Equipment, net false false R12.htm 011 - Disclosure - Note 6 - Debt Sheet http://healthproductscorp.us/role/Note00000 Note 6 - Debt false false R13.htm 012 - Disclosure - Note 7 - Significant Risks and Uncertainties Sheet http://healthproductscorp.us/role/Note000000 Note 7 - Significant Risks and Uncertainties false false R14.htm 013 - Disclosure - Note 8 - Commitments and Contingencies Sheet http://healthproductscorp.us/role/Note0000000 Note 8 - Commitments and Contingencies false false R15.htm 014 - Disclosure - Note 9 - Related Party Transactions Sheet http://healthproductscorp.us/role/Note00000000 Note 9 - Related Party Transactions false false All Reports Book All Reports Process Flow-Through: 001 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Process Flow-Through: 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) inbp-20110930.xml inbp-20110930.xsd inbp-20110930_cal.xml inbp-20110930_def.xml inbp-20110930_lab.xml inbp-20110930_pre.xml true true ZIP 48 0001016504-11-000017-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001016504-11-000017-xbrl.zip M4$L#!!0````(`%.*=3]FKH`,BU(``/)-!``1`!P`:6YB<"TR,#$Q,#DS,"YX M;6Q55`D``SW.RDX]SLI.=7@+``$$)0X```0Y`0``[%U9<]O&EGZ?JOD//;HU M*;M*E`AN$B6;5;06FXDLZ4K*-B\I$&B22$`T@P:TW%\_YW1C1Y,`"-!R7$XE MBH2ES]=G[],+WOU/JT4^4H>ZND=-,GTAUMD;;_F6M,@96Z[N#8M,'`_N&I[U M2.&:\TA=^!ON+SQO=7)X^/3T=&#`H]RP7,J9[QJ4XP72:HT(_O/?__4.B9RY M%$F>I:Y/GI>WP]WL)0GCY M@+GSPTZ[W3VT'.[ICD'WY),G>->J^+P9OY!\>'`H;X:/6LYT%3VXH+KM+58N M,WW#XP9S5P<^/T3\[6&W';[B\Y;WLJ)Q!V8ZGXKVPSOBE59;:W6U\"7;`-!1:+LUY'.]K$4/E$^()),\SDU#B8 ML\=#N*%H_SG7V:>N:%L;#H>'XF[T*%<]!QBTP]\^7]T;"[K46Y%X1Z!!A+S# M!DZXN'='9T0T>(*,?[_'K>7*1BZ*:PN7SM[OH8A;H1`/GKFY=Q@T9#`P@6>/ M6.;[/:/]QZ7+EMJ/OHW//K!N^YZN\->]D=1V_/F..I[EO8RB"W#),O'BS`+C M$:!HJDLAJ\XF/^V-VM"QMC;HMWOO#N/7DNT?Q@3"2ROJ6LQ,D01^N-XYF-U( MM;AO)R&L1W9B*Y,UAP)R0;II96I)9[9A9[:^= M6>T*S&HWQ*S.'V-^,_N:]4E:F)?2D/#:EIWN!IW^T7?^$9T>--'I7KK3?T"H M73+GWF/&7Y_I:#R^?O&W#S@Q:6`._,G'SQ;?&X6/Y7KX[E!)(@8!IA?B>G5Y]3/R M&INFY0$;=/M6M\R)44^W'&I>Z*YC M.7,^7D%BMW(M3%:_68$6=_H?)M6CC%0?8+3!??OD/D]OQNFSZ M>TQL,B:^^D!@N%;.WV/I%XJEKZX#VMJA<^D@_&VIPNM&X=?7!RT]X%6[_&]+ MY*\V#FIDL*YE2A1EG/>W);^O9"34C#2[&6E^]\*O/19J1JZ]C%S7#H:^+4&^ MZFBH&OI_X.]G<+77O%[H;3OK! M7=-ZA!ZG>H$O7/M+G.1F[BB^409"[">RK:3;/Z<.6UI.>$]%0\Q/GW"$RQ7] MC*EDVXHX'?>M@#.22,R4`@CJQD+WJ]N4W]%'ZOCT(V,FOZ8>P6?O<-H414H" M@8L+&V9(B4D-:ZG;_/U>J[LW.F[WCD!1WQUNHC2JC6?])&0&SZ#7'6Z!YXQQ M[V8F[M\SVVR$-8.!=IR"DB%2"T5IAO1[QUHU%!]=QOFMRV96,RJB]3IID20( MC+8B7;KSP_[Q>LIYI:2V#=FC7$ICCQUS;((%6]P#;V$]THOG%60UM!G=.,YH M:2G2"CNJ#;D\+U&-&H!\LT+O"V].'(,MZ15(I!&6'O72^!1T1K60E.94[[@8 M2)XMWH*ZU\QAZ:>;5+J6UNNGD6VDJ1#=UAA+\Z[5RW*O(L:8R4CQ#$!8C@^O M!5)@#O]`9\RE\KD'_9GRBV?06>::$*W=EPD,4SC00_@N$RHN5L]1WHPW[`_3 M,M@A7H66O1)W*HB_W?YR[%&P1K2`=:&F$I+6D:(_22JCZC)Z)454,FQ;G%54 M0L7"S4`W(3VWN"%?HF;\#DCB9@9R:<;3=KJ=#9@W(]@5^O+QJSVH`3Z%'2XW M'.:[@VX*7(I"/AR4!E!>'[7-]"O:"`Q^SRW;]Z@IQL`IB-'`>`M>=?9&[8-V MMXK99*!4-O!]T;AD-VTX"N)*<(KW:&E8%?K:KP_J56O,%<'+\"%R>TVL?"^@WLR1_ M^8WO84D0LJ9Y##@H06W!PLGUY=ZHTQYV!\=:P@E51)+SI\WVI!37@YX,.OWA ML=9<3\YTOH!!,_X/IT0>=5O,AGAGNNN^P`N_Z+:_<4B576J>3>\R<;(4O:P7 MJ0TRNS1\%R#'AL%\>.R.&A1>F=H4?,B9[[KP;@T&:L-!>BBRB8["Z+:%5<`R MK=/NUX$U<1[A!G-?"@8X!=SI]=O#3)(8MZM(@\H1+5*7[B`[%-A`]`[&>*YE M@#4&:H5/4G$H# M*+*=H^H`Y.U/U#8OF8N3"?7Y`#$QXUG6T,AYNBVP%+"D>]3IU,#2@%)H@^&Q M`D%$=CNJ19J@'?>[I:G>NEA]]%YN;=WQP'`P-JW0;NKY4*VOI7WH)CH*5[XM MK"+>]#,"J0CKG*X8MR!L"XYB[:V!6)Q6TG4D1O61%#%G.-P&B;Q=AP/=7B;@ MRB;59EFG@]U!7^6=LH2NF8 MGG:11Z]!&PSLQA6+G4WQ<%B:+5,$WL"2KBS]=I2HUM'<&=`-_&L>J"RECGUO MP5SK/S2Q*DY9T]W`1%')E=%ZC7RSM!3YS;:X-O!L%[@FG/NU>=5I#V$P<-3; M@$G248P"MT-4Q"5`I#6&J/Q$00E&==O:1EB9N8#FL!6S[/BX%K8U^Z7J./=> M/UM]4=/(CJ*K(RER];U^;QLDN0U'AN$O?9%BG=,9[E*IP9Y67\OF2,7T\CZT M'L8"QK7Z'2VSL'@;C*G]/G5SADQI)M]VSFU6(U\TK*E'7IIB34?4[0W78I`$ M"F10"D61R]D&A;BY8+9)72[WB-6QH*-NIJR=;WY4AWZ1=1P-,JOK"NDGDNNQ M8S;*C7SML(C8QJ%-97B5*X[5X55(,8H/[BI..M*91@T]J@1&,39I6*VK'9)5 M&$L;1K?%L4_%44NI7=OJ5IDCC`J<94$26XUC%?$(%F7"6"GKPVLK]#HO MMFU/VLFMXRW1^7)HOUS?2R\$WFGO@M5TU,2-ZM3A8FWB%Q!9>N&U&H;**U3& M6WZGVG:(RJ^[KG6B4.7%X5N[]A(GW1273S+.O89GKP:G9.90"U"UJCSW/M::^AU-:#^R.KIB+ M>P(OQ#D(C?B[.CMW-J(KVJJXHXY7V6>U_;:?XI[G5N:X0%TT@EN'E_C\?YJ+ M6L-TXK>!7'[)T#;`2G/YN+\EL.2MF]FEY>B.`1S&W?PX2!;BP04:C:#L9A:F ME26>7YAB_ND'2TP?V)J(D$C=\"<>_R\:WD&66`=.KA:]FYZ5/]AA5ST#NT=/ M3\^I_/_$.8=<^E'LZD]49AK:DI[;[EN&=O.(R[O)G),L!SCG`C]"]H'.]<;! MQ00WL]0JRVB)94/;4=.G8)2BG+/E^H#+,SFSVCTJ MR*PKW=RLT#`1=Y,G.RAJS3E"C2`JS2&MKTB459@*##G>U=*0PSGJY[:]KR?9 M&+X*NXN[C>(+=\@TY;"/,W+=2+'039=$5U[KVKU>%7A%^(1A!VN=BE=65S@T M:S/&/%G5QO):6*N=7[$%VD*\0?GM)5Q!WXQY=PO`9JF6@II9_-P,TD&GR-`S M9)N&6M4G5<-:1EOS:WX;2BJUHB1M#?E=P"Y_=%WNF).RH!7%5]SB!UD2'C5H M?GCYF4/*[T0'48WQ2X!R':?BZ(1FQEWI#*D>HORA(COJ7GF3Z!SEC@&IU4'% MQNL2;:F+,LVEA:AD?]HYWVL+Q*-%.XU(ZVU,C?D\.;.ROQ+V[!Y4 M@U)3E(@58_/&>9ZN9%2@OB/@Y4NJ[1K(2]FGW,[_9<)[J>!7$E!YU]E`#RLD MO5J_X4X6QC]%6XU&^&=^XECV^ST/,DC\,NZ7@K2!Z060RC/]5=6ZE@J_MKKF MF)[T3VER2L.>FD$>OGXWAST-7H4S0%^@6#3TDK994E();/=!CI86ER=4H/ETOTK M=.J*EEX[SC0"J?$XHT#URAJ]O?:^KJ8JM#)_T)MQK!+;#.E(KR_E*$$K7-G=8)VKUAKTF>U#[4,7<)Z:R^G*4+]V5.56Q M:9C93T)E1\3'O1HP36J=R.5E=W0NOCKA>-?ZDI95T]'D^N'BX]WXX>*D\GUV;O#=4TGV)8]+GG^A+:0KMQ">ZUK:F4-E`)M$Z23P3P>>E MR?Z.'WXJ:BW#0OGH+\SV'4]W7RXMF[KE*5ZS),%,*TI*XM89Z-F49>@\Z M`^^1J"\$]QGHSDN2?*KID8+VK]2V?W+8DW,/(9`YT-LI[@MC& M+N%*>>["ST[:*61:6DM+!OUJU/ZMJ6@E6AJIO)R\7]43X<_P4WMK6\N?/.7. M=2=8;@I#',YLRPR7R-Z"HX`&TDM1<6UC\'U),6RP&7X3[0$0?K#!O92&^X/M MG9K6(^'>BTW?__"WS[S3AXO?'EKCJ\G'ZQ-BTYEW2L25R?7YQ?7#"6FOX,KY MY/[V:OS["9DBN5/R>7SW<7+=NKJX#)\(KMQ-/GZ2EV3C/\SAOW\]FZ>1">$_ M"&,&D%,X+F^N'UKW#[]?79P0'+E;1H*NY=B60T^)>.AR_'ER!1X$=^\G_P2@L,.'F(/$_V7SXD[(`)Q`WZ?NH?AKTK!-",&`NR<.T&[ MN)#6FKWD!?0UB4?P.6)RB`Q$DF0S_BV^=F,M260I)#:5;U`,]5@>$WM8Y+1? M-PP9BS`L@4=`. M6@_8ENV;5+RJ!RMJ4(A>C";&$T3&`_(0$RK"M=`?*9E2ZF0[MW+I"O`@!&P# M\"]Q8\F3Y2W(G6]3@I],U1`+Y,1XJ`>JUWWKM\C4PX80>F*G)_;JXME8Z,Z< M(N*EQ7$C)GGS@[Y(*8#*SV1-7,#+32B!@U*95[%7G\GMZ]@O>IRM/B@2Y^K,C]$28 M+\\R":!`CNM:AGY`/K$G^DC=?3`GF^CQQ@#R!@"!VQ`DF0,D8C\=<0FY:4,/ M\1Q;?"[Q_EORM+",!>KM?@B*K2Q'\BW/<;`P?2X4;S_'_9ENN3G.)]4\;"0O M#<'HZ'-PD3!"DPNL2Z'@2`L8&-E`J$2F,"%.5<:3D5G"E/B"^;8)#0$"/;2; M/WW'$!B%X2"<3$N*AK`[0F>EEGMLGWAL3O&/I-HD^O(Y8FQH-]K1*2>8^?C2 MO+#-L:/;+S(:Q]X_C0+BMQGS]"Y6Z[A^L2^2)[%3,I#Y6D^4`C-V'!^$)A-Y MT#9R"9J%7N2G2%(SD7AF!?4"22^!T1K0^]%W*.FV]PEF9RF7$366=!R@\*`& M,#@P\Q`C>8"SD1XSW?A4MW$_#$B54H\\04,F[N-(-!4I)"2/)'3:*B>[3Z:^ M!WX*!)KT5&",:>:;4:+*087$L@M0IYA_9N@9>Q0,D,L2,F,/*:^9?*=4(F M[#[9X5DADH0W-*(T?UU>`<'9IH:G].#04G#YTXQD'*O82W,MX%6F88F=F3$X&+V^/^E%NFA<`"-0_\XGZ`R,1:(NZ2I5+S MN6[GN0Y&Q_SY`H+GG_#($A@'/]R_*,30.#KH+'M"PQ/RX"?D6O=\ MF9Q<,\?:3_Q]RY9T#D\!N_=5;27N2U\\/AM/PJA#W4<=O\ZY#QP#M0#O^2L\ MYV;3+I*@-[89)"'XD]SZF(_$MQX6NH4A&G2N%1X=0])E1)ZL"!5$AMT#Z-?Y.Y2^R& M4WP'PZ0N!A9H!^PN85SK+2FK3I%AP7N'+.X(V,P]!`BL%)#N`4G.?ZB@Q#G% MVS4^.CFR^UI'GU]7&4!HO4+PJ11.R>SOXWQ!#,LC%12?"329_EM'&PIQK#GE^ M-M*`T2[#Q`K'6/Y,-SQQYM%^'&+$7])IB%$<>"$,-ZIQ8Q!$`%8R1'!_!7EG M/$*![DWC["P!)O`%:SR3#S/#+*&VD%K@,`\U0B**9(1UC>#F(V3BS.7?<^PZ!<4D M395YK$EK@X$D/\G&YXGSX03R'=!-3P?5P>0PRCQSJ6WT8%;)B7@S[8-DWAK[ M&.AKZ"UDV2)V&*K.)7U(F/`*+0V]%,,4=8EYEDT?J1TX+%"Z?':$#FR%1Z78 MXK!UF=>V#+21E5R($:@J6N`OR;PXT*%3:95H5CAOB5*)=7CXJD76)2ES>F;R`3VF$E/G1]NLU9>E0% MA(@C1P+$`.>'%L0C.421.7)\8CS7$N.YY/AM\NDA#!&WD33#\("16<\S(:'4 MZ$-#C^GJ3Z#66)Q')&@%Y_>?R77><.)YLB3!38GRUZP<7U.2?`]X1?4!N)@3 MVSBNMMTR0`*90),\#R:.`SZ=DMT&O%<):[GZ'TF4V!T6:3^1LT"I] MLL`G"GJ1PTZY26]-$LECJ:9*IH$0(Q\(,$RJM+0OT>!F%P]/U+24\1?Q,U(`--T&`X&0:!%XF_II@67RO^C&5Q0 MBFQ['N9S(;%,\\ET#2\G4LXJY1MMOS,8[!^U!T0N^!,A32S8`PF`'KV%46]Z$)MH M)FQ%K.U+H=<].;,`<@^+I'QE.2TVF\F_H0MQ'$YW$*"._3GH(1A,^[AHP$G0 MRBG.PZ98G6L280NKM>`URQ7BP"#O4ABEX20]#$A%39DZK4%D9#$ M#$4J/.QQ_OK7#?``"9"2/+),RNW:PV.)(-#H_O6!1G?N2E;CTWDZDTA(P_R+ MUYA_<;^@IRA@"K:[Y\V9@UR3KK:?T@T_B>;,UC^Y=9UXFO[M]/#[]*\:Q3)B MQ((8/A`C;"*&]H>:YZN;5Q@7H?^N9Q"JIYB:[O[2=&6"9OK+T?OO!;/?AS>[+C]?7']__8`WG7Y?@ M[:X0]Y[XNSJ%.D^@M6!T:;4O/UY=O+K*R3;R&%C40#Q+9/DTA)**>3TU3,\= MJ(8)8'"GWNJL['QWX/Q':QDYZZJ8$<@3R+>`0&60'ZXFQ?L$\FO96(R+;:$] MOMT`3AA#&-,MC.D3QG1,A-9@)*JD+H(D]X^[&CAWD^)DBO-LW"?3S@0,,U!O M6>$99G9!4[TY^L-F!9(BSM^JA+9*+5-,EH2(A(B$B,P9G9I/R9S!W(4&KV3. M7"=+G53J'&#NDM%^(0.&L)>PM[U4(R$B(2(A>C@#IK2&$;._3,(@\9U=8#W0 MF-9_G?=?P\^/S219J[73&'(^6#)<]I0LHG=IEGJ=D%O6;G;]592T6N;&>X6) MUF(/J70+W/(`1+*<(!EY/+U5U0!]&R;?L\4A MQG63;?C-=%-X^1'MC\&1\5"V:^QF/3C5#O(37SLM:M473[1>Y!Z8T5(S97M7K'0=_V)UIGA$P\M MT1>[M*U[HL.J;?'T*4P#SPMSXKB0J12Z5.4_M2Q0:FJB&U?O`1'*C75Y0FUFM#9D,E\Y1$+(H2+.W)O_+0=B-1LQ2;*LZ# M&,9W1;LA!]>/O+0NQBWS:3"'P8:&QBZ4&YWF#'O%X#ZN? M_B'+9589`IYW=^7;8'J>.W/CM&L6=@B0EP+BD+,H">_4R>0#S'@\K>F/)K]2 M M/@&&B44+,.8KC:;D`UEEU+(4,E/[0+7`;%Y?-JTGNRJ__?3BH1J!%\WBLS?D MA5T?I&WXY@2D43PV7*OU@Z%U>+6&;KED;F,P:P54HG8RIFY+R_=QU-90:,N\ M0;30B5+?@%)U8UF*.4N$0'1@UQD)GI*P\NF+D!C M*#K?^-S0K\$2];BYTFX9]+CLN"Q*2!=Y&,9"UJ_S4NS*B,T%^P6<]=3V`#!G M^>ZJD9UVHG%*4\'V6S:L33;$!DA]MG]JKK)]IG=T%SI#K]YMGHX8_'1_8*+: MCE`Q4=J$-?_V_M%)2?G`[O)8DM(PEYJ,E^=B,QA86.$7L<]LCC!C.7SLVFZL M]0BW8):]_OY^KVC5673[8K%LHR(J,:M%PZMCI)6Z\T[4A3FGU/:6)JA8ZG'O MI']H:+^0-3G"_D;"./X0W$AJ#PZ1VOU3N3SL^B;;=(F>9";R\#%+O%@I'9Y5 M`,_VJS#\Q,?%$LQ,N7!-![W#?K]77D*53MB?@H_"!!O;#`<9_^2MO*T(>WW+ MUL-SCSL3KNCW8A2LRA^SS.A%([BN7T;*0BH13`R95D:O;6@Y%KV:(BMD:,`H MKQ?QC-@R-5>S,H8QSFOD>JA]X"LEM)+@5*5:AE5U;0:PN8-X1PIL!HBM#FGL MG%OI9R_Z1B@MVQ%D3>N:3&ZV:'5GS:%;IJI*U/ON,_"&MGD^9IYPW"^E9T@P5WF2NH,H#26W5 M/^G5\7^%?>6JRV/DPE!F?WRIIN?KP'XYUL4)@CPL.T%KX111E\1N+*)KX)V_ MNDF;7%RD9H:@?W4P_:4HU&!2329<](&&ST7P/W/NI^"[8>_$JI&F#U3M^%,R M8=[*84K=?K(85C;D!-%)Y2"&N@\##3NP/K7_NFUS+[4N=>)_$,]4WH0*63XC M7P$;D#4%00Q*?*R?H8^EB`/:>+8=)H+:3OI$T2E)&M!.VJ#;F!PN'A?VOFQS ME-F#.*E:4Z=,9$V15("6I5"[#-(N@[-&+Z0D'+G):.(T55>B&8.,[SHFS@]5 MBI39(B=Q1OX4O4HCF&T9T@GB91^K8?6/8#OCYAV8W$4!".+?GH?!/V#^LTG: M?=C$/P5"F#HXB;J:6:MZIG:&JHY3-(KB7V,NP_BHA?#JMFB?'4\QD"DGZX!U M+E`0^_IY59O(3MWAE#?W#"X7,HK*P:.Z/RX0N=TDXU1'K(VQM`\ MSPI^+&5Z-!!)U6`KV2%59V'ALH`2M6:%/A>UM>+YA:7:&4N9%65:&VV,A29% MC?(SV!>-!@4(C\;:&PWVA7Y**\-.Z:"RV6,0PJ*% MP*;!FT@*]UU!ARGW<&YUMF[5"+V'6;.D45,O7:'.;.J.Y4L)_.6QI78K2[)2 M+X*5X7H6L'Q^4-:S+B_/JP*1?UH2`W/#:[4!KS@:K,ZJL#8R2LZ8#'&9Q65V MU1TC_)XCV"K3`8KYDFH`'%,FA*"%4/;;LH$03"-A;PIZPD;E<7RC!`M=P/0F ML&/1<===0%]7/^,9G'QO1FV@"W"MCV$]V#8A!RKW".Y(]47%TV8-'5H;.[)J MDU,,Z^?E'1&"E>Y"'*1(:?-T(ZHL4&C%G!4EJS4KDFIX:@0F=)KUHDR_J@"4 M4^"^`?GK83)%,7=6/0+60+3JW1_?%B+:HOB:D^^%QE(S/>36=$E.1>W")S^N1=(O()7PJ;!@Q/7 M!E:%Z?CB]#\JCC+OLB,QG4HCS'?C$6`V/H)N2HA/.OR&>\$<7Y!_`Q6L:"BM MR7_V?BY6GZN(XLS>%7>P))5Q"&$"!S/%U,O!=AE36.2(Y8/G/:Y91:C2JZCQ\].\YLZ?&P)ME.A?.7/K>`LU8.-^*^UP7 M$`*@-H#8GG46F2FAG20LI,H"0E3QOBX^HY!&H83!B,P#FS)14B>%$DFH0'B5 M2"DQ3'#]"K>.J91+#SMD(O*.^]QP?K#P",,<7C!B2-,1AF;5[KAC$3[04^H7 MVHP]<"J\NSI323G)<*,,^_B?2>K`&*0NFXI,*]IQ,T(5'/!GXH;EC4K%!7@U M#3W"=X!$640!5)*DHG[<*1B@.#S/E;UH%\WEW`P2*3'8H![9 M"I:9:@KMB";BF)J7QDP+/01O!=/)R!#G=+:?H,Q1AL'4UPF0.O`!+P\1B9LHPB/<6V%]0/ MHLA579M\F'$`>RJ3?K,0=--91Z:7:Y(9ZB)#4GJ1[,)Z6/&(+K.()%E<^)H= MUYN=*R<\J=:BS'=:^=2D2-=N2J;^&4?YZ?_M[EK_\]O[?^[_[__\RYXG7W_W M#T^=OXYO)K_?^;]>)+=OCL/3XW\,__CU^B[RCF_LO_K>+_')K^>7GYS?_^WM M'_K_>\OWAW]^;ZS[]&MY'W[T]_'+V-SJ]F!U_%GQR?LS?C\SW]\O+JU__5[TO_#^?.3?_/^]"3^=?*UGYS\V[N( MW[Z]V7\SF]HGT;_>7QUYP>_)U9?SHZ_7WO$L^&I'SJ>#?[ZY&O]V>OC;*;?_ M]O;/X&_OKO[Z^C**__OO?_]?Z_SSU>ZNGHI>$.WC^#+P)Y<`1\Z98(*WW'/` MH?\,9F@GL]-507D`PV_E;/1]M%X$&B)J7;I24M`70$J+MN1U>1[!OZ3G<4*'":>3Q[D.TTX^Q.ER<,E& M-<%_VQ;'#!/OKNPW@RX'[8#J6!\1OU=XD@6_>`J_9%I/VL'FF171S^Q`=!0R MD6(^#P,PYWB,AX-^`AZIS9,8<]]-Y%&F4I>(O2B!J6Y.&>VR#(`LT5DL3\8] MTG8SIHEE-``2!6!E8XB]((?RIEZ1`6L:1H:3T2S(,OME2%EFP,P9VL7"7ID' MH3S>U4S5V@QUL3!Q`S\] M--T#7^EN=MT?:IZON\J5+7?=_>?K1NO./?5[5IEXQ$('G>VA\]3:,^=7K1HF ML-_O-7A)E9WL3@MG0@="!T*'QHW"*Z$$#%V5C:;R-@]C:C76_1H:*@=M`?"L ML3*:D4*=)]!:D'EQY2\@GB6NHC9$>8IY/34D%^D?"XN/=0ZJ]?ID)AGJO`@1 MQA#&$,;HVTX8TP8C<3U%TQ=:A=M?$+WQ7$\>X&W8WZ*0`C7M5BA"[C<)$0D1 M"1&9)SHUR3SAL3%=(OO!?/&:`_-IEH6$%P],I^%DX1`X$SBWEFHD1"1$)$0/ M9^&TO,5=R=0Y->39WL-B.MT&BZEXZSG6*MAH;'0]G9SHK'9)^-DX?=K2AFEQ MEZ6-DF7_Z-08(R5=MDE!(_"YMY`1^'07?`9''>P@O2W@LP9#^G;JQEPSH^MV MARSIQ["D\6I;XNLUMXH?694I+8C&8[-$DN5-RJ][].F$$CPD)?CX#$4@=&\A M(Q#:`A`ZI3!`ERUQ"FFWWA!_YV/ULT"4]%M"U,C";@5XDW+;`N76.SDQV=BD MV\C`[H*,$09U'X.&O?[09&(3!G7"OJ9(=_L-[(_8)*PIHS:O6E9_-8B,\#8" M/"G`[BO`T[Y1X$C_D0W>!1$C".H^!`T&!Q3D[K`13D'NUMO@K]VOIFX3Q4]6 MM=Z<:$+6=PNAG51?]U7?T3Y9WX_-3@1!]Q8Q@J`M@*`3@J#NVMX4`&^_\?W. MCYD_,?>R*G[(`G]T>23U]_34WZ`WZ)N,<-)_9()W0<8(@[8"@X;'A$%=M<$? M._YMJ.M;Z31HMLN?O&&^,#.E-B.E[>;X(OYX7+QKF;ILKI&>BE*3.GTJQ#/J MTE6H9]:UFT[Y--_K;+.RW>[:[81]A'VM)]Z68%_WSANW&_NVX0B@NC\'FO\Q M.-$=D)6=#QSD0;V/S;@?Z1_,Y:>O@UCILEWGD"Q3@[IA$*Q.;82!;KLU!UL$ M"P^FVH%(EA,D(X\OH=LW2[ZV%&-;B6YU6GVSI-OO'9V8>E9U2Z]OI0`3\!'P M$?`]'/`=&\,Y!'P==FA6.D^Y=_^;KA+XG@CY-$]_Z73\'GJ@9:?CU-JC+50C MQ"'$^5;Z$.(0XFQK5'QA+/6)-U>\=-G(]=RXKM3BPX6?27.1YOI6^I#F(LU% MB$.(0XA#B-,BJFTZX$JF\B9,Y7-9$]',FI;E%99T0S*(J05Y#;G)S":EUP[Z MD-(CI4>(0XA#B$.(TR*J=30D31=%-].L<\[NL%.GQ7PPP/%::5[5W&L.>GV^1D6@1Z!'H/?`H'=TU+4B M-=L->MV,_*_HD=#5T35='37X(]6C@UKGJCA2,)\HD!?3%DQX>@J];8'##BIV M\F9:RH<$?@1^;27>MH`?>37MXL-M/&A9]H+O$T]Z^L#CVKDLK'QC]$PZ[9=L MT[7P!U/-5-=A&^LZG-0TQNJ87MY*"2;D(^0CY'LHT@UZ_2_"?# MP?&/N%^QJ#D9]2SPTZ+(FH?!V(VM'0_^\5RD3(4\2CQAWE=(K%2VM#WP`=RQ M"U8_BVKK7][RD,/GU7F-`\\+;FMN1,@OE7R#\DZ*';9L[GESYCBN/TD)V4]W M`S^)YLS6/U%EZ=3H*]['?=+^4/-\'5?D`!$V"0555WJJB>5V@.RV`%P!F^>1A;W'>XL-J#6&@5#F^6LN>?&J9_YO.8ST:\J=SZ?K^WX=@T MG4)U$.2[KQC)=M9Q>;B:X.TO:3MWBB)D79(0D1"1$&VS]B87C5PTC4!K03%R MT;XQPZ\_,+7&(?>K$R)$&$,8TPF,Z1/&=$R$*,1#WBEYI^2=DA"1$+6"(B1$ M*U!M&>W=L>('=$MHJ5M"GT4J85,BC<_C#9^X4D[\QMU[RHE?2+9MR8D?]DZ& MIQW3L]N=$T_`1\!'P/?@I#OH'1T<$?"U2(#7X':L5IV`0HQ/,CI"I?T?3A%0 M:7\*)1'B?-OB"7$(<4KD(<19@6H4O'ZJP>LW>`&^(4U%7HU?R&`4NWY\Q*,0 MSD.2;5M".(/>_O"@8VIVNT,X!'P$?`1\#TZZTT-347$C<0CY.N-V4/":0DD4 M2J)0$H62VD8U0AQ"G&^E#R$.(0X%KREX71.\WKG$@JU-F=>N;P;Y&)B3,(\PCS'NPW.R^ M*3/;2!Q"O,?W3.1GADX-/[U(HMT)8_,?+L!@]8(H"?G'\67@3R[=&^Z& MT6QE-O=J)]'H<7P(8JW%Q,&>E9':Y34-J>5W2^Y#L>,MH+'53.5U->A0Z53: M6Q9R>"&+L9=&;,53;GG!+0^QO9X=1+$5A-:,A5]X;"61ZT_$-\9N&,6[KM^K M+D%^$"2Q->/Q-'!$1P]@^,C%D<;R8=%_`X=BV.7#V(=CX::MIPW'R;:VX3@Z MHG.TK8K:?E.)C$-JPT$EV[*N(SY&-5F71F:JR4IUGY>*X&U335;"&,(8PAC"F.TR$KMO6)/'O3&/NU,4 M(>^4A(B$B(2H7=J[-=G'!@N@AF&W/[.X>.L5NZV378U'NQ7V*%% M&<(4Z5L2?S9.GT=(=3OHP'6:8:^_;_)A29=UKA(%80]A3\>PY_#(U#>-L*<3 M=O1JM2#(D%X[._P6A%]V77]W'@8VC\P6,QG,I+0Z1Y\N**]!;S#H6F&W;5%> MA$&$081!B$%]8Y4UPJ!.&-"/$(A>.5/FJ=O8KUW?C:;E M6RG`!'P$?`1\#T6ZP][^T3$!7XL$N,F)D)\U5LAK*G'W<_JJO![>IQ"+/L=W MGSSFQV>^\^K/Q)W/X/GVUI1M[AGI617U1CRVF_N/IVR:LHF*`E MA&^F_+KJYF6TJY(52:H/:G?;BBWP7!( MRHT,Z[;1A#"(,(@PJ`L&-L6J']>^?L_L*3P?WC78UZ7;3R8#FRSL-J(W:;?N M:[>#WM%IUVY2;XMV(PPB#"(,DAAT1!C450N[=<7?J-JTH?A;R/QH'H0QB]W` M;[#%F^WPUAOB5'J52J]N2(MVKO3J,H,7WSZJ]']8W^D[7<%HF^M`J$FH2:A) MJ+GEJ+GIXX2G>\N-(EKWY0:*:-U'J[0LHG7<&^Q35)TPJ'4T(0QZ4AA$4?7. M&IJ4&+Y(>AX\,3R*?JB'-LLZL^UDEG@LYH[E\'G(;5<&US<<.'_2E^%)H3T9 MA4:5`]I"-4(<0IQOI0\A#B%.ZP*VE)SR**:VPC%K_DTIE&)(.Y\%8>S^56NT M4ZY+2V"`3FT?6S%W[M1VY[!W-#A9+-7MTMLM/'Y]OD8:$NP1[+65>%L#>X?[ M!'NM@+V.'@(TPBOU5:>^ZINB:QX8#ZJK=2@`GX"/@(^!X0 M^$Y-W@,!7QM/0.1GAK[JF[3`Z]II%Q.]!ZF7;ZA]H2;>E`F$5674$+_%O\ZY M'W'KED76LY.^^,*SXT-K'(2BPW8\#3FW9C#5:51%+NX[W+'RUK?8Q]+"YD5B M$/@%_AGR:,[MV+WAWMU>@S]0\@**3?OIQ7WZV_^<#OM3]O`%'YF^A^W$8_C' M%1___3N[_Y_7P,.#7Q(/UW`=[/=A9?CK=S^W@'<:&4=RPO7OE\`*+CA>KJW, MYE[,E/[AMU=RJB.L!9K/Z$,0\RHO'.U92.5Z-5.SPRT@[0*I?`3B1AI>?&)W M`M/60=[+=Q]>[;Y-7S[8&QZF6G>#%"_C]8,!X4?3I?[7?!0F++RSA@.$J_Y) M3P#=>3";,__.$DW@`-9*&-]2D)[R@`^SR8`DPA'H*OC MJ?5N!F#E)C/K/8M@..MUXCL]Z_+Z8L\RGKY*E`U@'J$U9R&^SMJQ`\_+L-.2 MZO-D..S_F`V>_VGPX_.>:7:W4]>>*BLP3A=PG\TDDH,Z^&C'0='%O!AJ<"!I M9>W`]Z,@>T223IG;YT]GI6E9\R2,$H!LPT8`?>4,5?*[493@N*A""]*+987!T(%QCB>F#N)WO][_=,)_OOLN?="-A(SM-`+*'-41\;ACB+ M\`UEG8[SPQ;6N8(W,\.S@6E@1GL,VXF8&#7 MA6RY,!$3! M%D4Q<(++/%!>\#_PQ^I@"F9G:#HX_A'D/8IJ9),VIFS69&_+^/H@A>>21D7X ME/_V\%Y&"+)T-D$435T\TQ[G6_P6;%,>1KVJ6?0Z"%%C"2S-C0E=&GLMBX[.IRHRERYUB.)NP+T#P\M-T($4.$H*0* M`OSA#FH<%HK/--M!/(NO#&RIJ&PA"I_!`7;'+M#N@H]9XL%P:$0Y?`P\X)CU MEW%Q8$U)Q8D3JQ.>,7,]$,C*>+!G(0=$%(^5A5B:8"C*"-FXT-1R$%:-MD@S MV6]=H"$0>>;ZPD81:P*M'WHNL"6\79"D,BF@S8[['*ABIZ;&(&/?'1?^CB.@ MTBXQ,RXO*H`_&PHP?@XX(VQO_+H-2L4'^`'&14-`Z!"YBRR;L^YC832`*7MB M7JN8G3H]6(9!BLH\@%-_=8.4@G^D;-!+C1K@5/FZG%$JBVM@FUI&`7^#&Z4; M#/2>S@4I8G#P/,:NG:[J@D>`>#),!*_61;`R%QCZN1SHBD_<*`[EHU=2A`IF M66VLSZ!)7,=%A^U-@BN-P<*7QAR+%*U2<*CBWYG01+I\H[LL%E86)H-I:P-9 M@"^0)&XLK`\Y(3>U34THTU-I7Q!?NF)W*C MU'V67>4V\1Y4_H+3"]F#90=V(NVSPKQW?6":Q"R<)?TSNBN!`N@Q\7^&B;IZ M!`#$W$>W&E@SQPM@M[*_K3FVHE8@LPTAU8ML)64JPZ1VW)L*C&6>=MF5K!C8 M`,5SY@I1L%DTK1`Q&($=PB2@:5*>#Z),MYB@--C@V0A1QNS^Y0:WEXE"-F3^ MLCIB'>\6K8FE<*N:6+78_M<-&00@323_IIW^TN>?-T5OP)X9/ MHCFS]4]<)_T#`/#$Q?\XR,*&(Y=^WW3HLM)!2-T?:IY?$#&+P_)I41S,&T]W MTK,G=?:_O;NX?ON#=7@PUX[8]-.82P^A7#B8VS\NP&)TO.;H'5O[25 M7_>:![;H=P;&W+J'(?0B4JX8?M@(@:ZK:BK[T;R:&5BY-DLB$7X8<`'<%$;LVOS;D+`)0%[B*VF2.UC*.[7/A,]F< M.Y%T8*($W(&(:6HI^QF[881@/V&HKD$K"%VEQ%:;]%-UL$H\`:86<338>[AV MI"(X7?">PMNJ#F!\FZ4K:^W!7"DV1$'S2.UPH#C6H3&F*G^F[(8#TW'?\H." MDN8XXSI%6S\15QYN/!)_7&6[VV^INB5]VT%]N\*5@.&3U+V`;?.%"K>RPYW6#%9HL/T&`M:1Y+)D:?W;0.^SWZX8(DAB#WR).5PP'[E'B MYR.#$08H"ZQJ_!CSR^LUZX/KAL8##)C MH^2U[HR>P[I!KV,P$,_:F&?F`]AQ#[O$%E0JJ&^*2XHOUQ),80+8_W^Z,9L! MT:\X\]#LB:(`LYDX[.#EWN7>^5[=..II;7D0=976SK.CDZ,TY)*?=-:S:7;J MF3KU]O/4,D'BZ'3HU>Q!$;K%IRLT-@R3ARYT6RYG11'UD$D#P/_BF`P&`F,/ MC\MDOI0L?[!\B#%L`UB;,VE*P8#Y MMVHH!<_^F`7R188!`Y")`LO#\`+L&IA6U5BJ>4X[=0'6/*3ZW.)?W2@-0KEZ MU"G[P="PZR>P>^6S%8F"X&7,,?8=QQ*_$&;JV4D_H=Q!2QX/.'>=+#3L!_XN ML\&I$8M<6(..3YJ4BP46\]+6EQZLUW&C9LG7J`5=Y&MDNXX?I;2: MDQN0W[6=5S?9O+:E=KZZPW7ST]2?"#;;.L,9C4*18[(Z*Y><$KP-$8=+M15BLER1S#9(W;C M),:UULY*8R*Q.)GH(L>)0W3YZ4*Y>,9O/J7*/4L\-J,7C*??1+S)D M$^@&F\B$".IGI9_F9MJ)H>D)DE-/H*:/"`U^6U1TBG>KAA%@0<."2:5)'Z> MCB838^M+\;G@I=T$-@`/QIID%*>'&F[$016,T\@,]\;2@S6DS&0_:O"FEWT[ M2^%Q0^6.7HT>BQ)P1J,H$-HKPJ0P-6O'XQ/0%B'>.8S0><2!:J-@M;E2=
J+0RN[MRTY5\RHB+)&(8 M6,]&K!UI@6/<#GW?OBMSY54]W-7A)%12FXN7BJ,=>7]'2$B><8Z<:CXGS^-$ MVF"U&>EI$$ZD;CAN9"=1)!.JYX+A3!S`;L`%$9B16["Y05N7\JRF;RA#\:^Q M/'/"N+R0O`4I;S+CS<#I$I1$!BR?N'8V?S5_.^2Q3&S`H*;K`V3&,U-4;L3\ M+QB'DA%*/IO+W@J+9J9[-PC<45PB$4@M*!`/)^$*KRL`\.'QG>4G,'6;)[%K MZ^<_HP3P#-1!KXG$%$B?):OZ'[)E03JC4,R#I0*_%,C=P-0*M23KPQY'8P\=V_N"D9 M:*P,@OX>WI$2GEXS[+7Y;DMYEH]]3UHY0-4G6#(F\D#UX,=2:+QG75Z>TXWJ MUM^HKN:WPQY6KAE+Z^;\PC2@LMW,0MM5W'!`\F"RGTS/*P[EU?S`8HPL3Z_I MRK)`+Y6]M(TIWV*N7%DN)01\%I>3):6X,?XB&#RUNDPI!C)!P9P3H)*RDH5@ MO-V\])4L2\MJ,-U_UC,7#$8^8F>DWH`':-+TL]M5T`?K:D)R1 M+\/5@FHKW'\TJ8G5[C]NAZ)8%Q:]J][$>,]`P,25>OT&9.E,M(Q(Z(SEXIH/ MQA1;"K837.34:A5W,O1#?-6!RL:HY2.04MR\7J-2]DGI84N_ZU:3,I6/4PBI-3CY MOA:W%))'X/TZ-0?UE8UMP`3?.DLFB2AXH$L`X2P(7>C MRA%`EM3V+THM8.8%YY M3.0]^#!(L_(XVAC%N=;*2>/ZS`KK`7'GQ>$:+:7I:T>"7GI?:H#*\, ME%(WFI=3!*=R,N"DX,5,7F!Z!IR-?U*6I"^*[-9[U%5I M\)ON,*IER\]%82SE'$'/=G6$-$H:'B9@R:O.\%HBR>!&Z MQDT1932>#??Z_9XVLZ*&DL4[,]5B8OD%S_),Y?"TK/(!Q%<2K""0` M+$;C'E,)IV9]Z$6!H:*%U#5!Z`AU4)AS%T5YD%*D6T2X2JE`A2_B@=TDSBO+ MH57D93]0"WBA*@(FDAZKSI"'?5&GSWP%5YQ/,NM/,%M!DH'Y14JT=D4BU56] MDE=3@ZSH0BB65M7D%[>7`&W'B!Q:S.__,_",="-/T*DBLC5WBM,S"W&I`=Z` M)Q=SD");5-Y9B]6WG1PMKBQI7.A&=N'D#@\R'%.+%]=5*]9N<6$5.SS:"5.K M+#>&LE+)KE]C8.F"%L7P]\PI4\,U#3929[>X385R*QY@S4%/]VG^8"7EBC"& MK/QZVK/>,Q_,KYCYUD683/#,XA;,3`#CX!;#17F:T5UEJ,KA2O4\Z-D^P/X\ M#&8NIAC=B;J0ZL%%08#2$9"(`!K.@(I=KX\B76B+C'W:4*OXDKI)5FSIW*UMK"H:^8AIG&JTK4U)7`I8\QH2XE%N34WJDRU M7LOE78W!O;J`E=P3#-PR$5OUS!'1.E,XK5Q7SBK(!@W$L4M!U=[RIW$0W*D MJQ2F[Q*5<=WJA;KF';A6)@+/HQZPT]M>LCZ%ODCU"K`>8LUJ,$4+[U,5`QH+ M793"7GMZC*Q,L/J`&5D<*T#C+PE(WO"TEX;9R[!813=9SZ0ZX2K:@+7]UFL9(LAE(^RLN(N^SE414\ M'8STXPZ=[!VGM(RXT*NOCJ@<\I(&@;%- MJ2B")NIT`9!A'60>`AY4E(1(V0I\;MGI[-+::W,62DNP,OYQ,7XE;2)_6?J> M-!OL-LB'CKX!W&1^Z9*B MC$*MJE)C."FW%IO&]++;TR#BRC?`7\X6(0*D,S2D1'F2@>1'WW"&4%M!CM!I M+>BTI&K9&3TW6*/B.,+ MME8<_Z998TC27Y#WJW&:,;/Q'!FS44-90CU/;$Q\/'%!NR1D=BRE+/L76F>5 M*`CW^:U\89H9)>*L);*,174@]7P`P?4.:_#CJ:*>KP$*&\W`_))&:?"!\;+X M-QETRUAJ/^?,H!AXLYDK#M.B,]\Y%Q=:)MA^A$?M,_56%>?6VWHG>Y:R`3+Q M4]V"+0QS;)CJA=66S>H2,S]-E.TX85NBGLS;<,4]0UVP3PPKOLD-J:BAW\1E M!RR++)**QF-,3$@17S8UT>/2\M*QM-[*-9ORZ'8DTRG$`4#I6ITRS/F4N>&, M^4UY$"\#%CJB(I,+UEPLKQH;SOGDAVDU,S"_,.BK7N00N2A%XP(T`&7]N;*& MDL7HHM16S&`X/Q&7FT51K#0?L,H]V:$C6.M!,IF*;-)4 M!1U:V)[UT9=12'G? MYJ"GGT1DH>9T#\NJ=GC0.QGTK0C#WN)ZFH@YWF8L4CW!GC.93,.D*[*+5<[P M%WD*3['C>MF_4G/V#D0/;R'?:' MY3!7KS24DCO!2\F(=B#3(*6OF@6H;5OR%;+C>78(7N4$>7PI@R98*]E:!A>3[%R8F0U&,02MGD>/^D2ABM+V%.G,S; MG1=)__7T*)&@/-#+-`7S,Z9@;F<:0*OUIG#8=#X3*E,U'2O:LWKW0#WDJ:!E MIGVPB*.->RUOIQI-Z46E#IY]'I212IY5D^JJ2A0 M[)2K38V".`YFAH4-AM\WO>F>/+1\E:#&B*J^KG(U$^N;5JXM7!^P@XNW`V3G M;/59<;0E2;)OH$GG*>('MR&;IQ.5_UB-*B;1%Z!^=OGNS8FAW[G+&QX-Y=ALD6[O$X=1&A*MM9Z-TK$[!ISE-;/Q:0$[D,U MDGV2?9)]DGV2??*B2(B6I]KFO:@215Y^O+IX=;7[\N/U]?7B3LP!L_A9BTEI0^ELDA\0& MRWEGQ^C;:-;]:"TC2IV7)((:@AJ"FMK=)Z@AJ"&H>4I0X"0,$M_9!=8+PA^L M_SKOOX:?'YM)DFZ.N@,%'>]O1MU`Q(^BYMX@1]'07>H8'^\LH>0(?`A\"'P*?-8//\3&!3X<=^=NI M&W/-C:_;'?+D'\*3-ZIO\M!)4W6./EW06(-#\M0?FYT(@NXM8@1!W8>@_:$Y M6D@@1"#4"2$C$-H"$-H_)1#JL.=.1_"/[K@;M3@Y[BT$9%)8W5=8YC@9J2NR MF3LA8@1!W8<@`$0!U'X"&IV0R/SY#$0C=6\@(A`B$JJ0A$%J!:MT\ M<&^L;7>P9%6N+KCVD@66Z?V[8K]2["R.[PRLFTWT'J2^%J3^`*2^6JI>O"8M(8?W\:]S[D>\!^^PO00;^,+? MF6?Q*&8QMV+V%5["?,?"HGXQ]YEOZXVH["D+)SSJ6;<,OCR?A\%7=P:/>W?6 ML^'QD7C^V?#TP!H'H15/8=AIR+DU@P5/HRK^<=_ACO69SV,^&_$0>UM9P_Y@ M($:!7^"?(8_FW([=&WC#GG6EK*,ZF!NE"X,A7=^R@RBV@K$5,0^G&W'/PQ7C MR,R9N;X;Q2'#<;5)R>$E*6#$8,:M'2^(HN?6&#C=?R'=84MZ4HS`B0P#)2Y5N8MR]!^CP;'/>MG6>#_5/E*:`?3GT,2P4& MN>,LS%H^EX4.>Y5ENS9\CH^%W(.9PA!QH!+']E@4N6,7ULJB\G14>NXU.-BE M*-E#"_?P>)W2O7K@<9'$-P8>=T;/*_MTR2>PCY_"P.8^V?B.FY\!S1S4:W@>"#S\"<`!X&S-HNFUM@+;FO77@:-;#]&W'/Y#9`S MGK(89Q3"I.&_?F!%P$Z`.#8#+I'DA;7`8J**;,PELLD1;HUK+ZU97Y^!"(O6 M#/N#2];'2FE09R?5R.9/+Y)H=\+8_(>B-U5TYCOG`E@G'%[/HPL`6M!C2QO7$$\K/O[[=W;_/Z]! M(`:_)!ZJ\.M@OP^*'7_][N<60$>;\/E#$&L`)2`AW/H'`V%E%70`,W8&.,UG3P=^,7P-9EKG4Y?#PU^YG:!-:GT<`W+Q ML`SS@.]S(41R MJT$G1QE#*%S`#%JK,J4#'(XS4)PI"ZB.3=63J=!'\VO69'Y=OOOP:O=MBC&# MO>%A&D39H(R7W>\'$_+/W+#1EH5(:AWM61=\%.$ES-,070N0#0">0))`.57 M#3;$"KR:=Z,,7]W9D5;LR[X';@>+)&!4]D7Q2LL/KV%;"EMH!5/F9SGP M3R^^CD+O9_'[_P%02P,$%`````@`4XIU/WU/CI\:"@``@'8``!4`'`!I;F)P M+3(P,3$P.3,P7V-A;"YX;6Q55`D``SW.RDX]SLI.=7@+``$$)0X```0Y`0`` M[5U=<^(X%GW?JOT/WLS+3G71AI#OZG05@8300P(-I"?IJ:DI8XN@CFPYDLQ' M__J5#"0VV-C8%B;IG8>>Q!B=ZW.NKJZN).?3?PH%I0XL0#0&#*4_56#UO\S\ M72DH56S:71TJ#8OQ3W4&1X!?LT:`\-_YYT/&[#-5'8_''W5^*]4A`10[1`=4 M7%`*A<^*^._?__HD0*H$"(@SY09;RBT>*?LE97__K%0Z*Y>5NUY5V2^62K,O M\6\@:#WU-0J4B8DL>K[G`9OT"?J(R:.Z7RR6U<6->[,[SR;B@N_^<=F]NW1Z M>JJZG[[<2F'0C;S9DGI_T^SJ0V!J!6A1IEFZ`*#PC+H7FUC7&,16#+N4T#O$ M;X7%;05QJ5#:+Y1+'R?4V/L\8TY1/A&,0`<,%-?T,S:UP?D>A::-A$7NM2$! M@_,]:/7M@N"P>%HNBC9^$U?^X8I1C*`AN&]87!?09?QG$UAL3Q%MWW4:+X\Q M!!IB0YM@P]$9U3&Q/SI4%7>IZ]I1I5A[H2'!>W<(0')3?8VX=F9M9E6CPRN$ MQXE-?&E`7?07;J"N(=U!KI,UN3D^0\&$`@+ MF_B//D57(\?\#I4ZINFV5H!\H8P,/TMT"VS M#`TM-@2$VX/]0!)#0@1B[J/DMA6.$&`UDJ3(>J*?+9]HD/<`'9\7KW12/27+ M3NXQH*U!0])4(P`E_W$]C;)^PL(Z8C))>)-RTV`_0/Y"!#[P9KTI?`J8132L M0:K/0('QBLG-;@VX(\B/BQ'X.4?(#>6+(C/;SG2I$8M["FT#TAUJ!%QH%.HR M%`L&2A>6UWD\QZE!Y#!@N'#Y#,[+1N3LB6O%WBR@K-";_:`;KT-L7>?-S'F; MBF](>4A(<@O?ZE+E^_-VZN&^=8+DQ8,*I8#1JD.(N[Z2O6_Y`?RYQH9E68T. M*Y:[^G#Y[,"1AGB+M,*J&B%3[@/?-.1(Z1[Q@+U#5!X](5!)7PTW'G]9QKF* MKF.'@W2`#CA@'P'>Q60ZVSJ\_//<2(G6\Y7Q='_$&\5D*FW&YVE_Y_N&GXTY MT>4LND"'S]@)U.?+IKS_"2C*Q!JFS+`;!S;W\[=<0W%Y'4['2,",?=I3CQMHG@+";/IICFZ3AQ@;"?J1B"^$9FB>,MX M-NIUA0Y`HO+;UHB+B#1*X0#RN?%VQIPH^/PSRNQK#59F<9(S MG2#$-]+GHG@+G?8FW!++L/XTQ(@W2L64@TVE;']=14FU.H)-$UMNH_(60I8Q M\IW`A^OD'U>7B5D[GW>/?OWUY\VW\M]_W>NV,WFP#D^-G\>CQX>I=5=SQO5C M-YW'\" MIY4_V_4&JJB#WDG15"^.6J.[YM,(5(Y/M/J@^OQ'JS/6[Q^O7\_/_U:JW<[\-%RR=-PPH!!/0V*+5,.J:C9D&I*2 MCX=`Y3\:Q7//4*HR7>WI`*9!"QB+Y7*>P#BFXXY]-3"`NIS#4#%0E;5/GGC3U9T%T[N%?HY_9 M&?<>O2)#Z;*L:->`38`.9^Q:1L444#_=7R6M#8;"Y3W\9Z_Y6G+#:]X)YZ6> MUEN#*VAIELXM%*?;Q:#O>IQ8'Y$R48V+G7M1+GN1X_,>6CY/6(?XX$:E/(H(_X5FZI=N^04*U+8\Q[](I4^8;7YQ'F#F%."&IC]OV'5`($C M]^R^9VX@*2N(!9W_.:_L!_QXG(=5^).]`DB#ED@R6I98/F@-?-N,7O88R1`Z M)O)[S.WBDCY7^CC+%QCHXLB#_+<6>&'>75<-Y'(NUDDFW=(-]"U;6""<0N:; M9X*1WE]R'4;I7+?3K/+JU3C^>H)E2R.F%_#==;X(?A?EDZ*L3&AQ/&9K^8\7 M\!=0T\?O0LWLWF2PA.:&\GDE7MX>_UBX^9;\MR%M$-D+A3/;NKX*VP6Z0R"; M+K9M;T?A%=1?H.^N,KV0-Z.UX%7(I6V\V]%V&?0]3E)B4+T0=Z5"E65P7MU? MNL4('0#^BX3I(-H7>J]6F:0OI.:[:/J&ID,A*XRIG";K0W\QC0E>])*RF3.5 M06\E(@3N"$TG1?BYPRSCP>RD^RYMK(AK4?),AR/J`!CNZF]`E=![`E3&7"TY[.4; MXMZ0YAND0;$]9AMI4(`Q^:9!\0W:R30HIFNDE&([:=#+7I&=28/B6I1-&N0] MK"@[Y_%A[6;E;D-W",MN_*QF^L=C.L">#ZFM01-;CSU`S/E.EJ8H-;3Z"#[* M<]I-X'&UL550)``,]SLI./<[*3G5X"P`! M!"4.```$.0$``.U=ZW/B.!+_?E7W/["Y+W=UQ4"2>22IF:TBD`<[R<"19!Z[ MM35E;`&>&(N1;`+SUY_D1[#!-K8E^3&C_;#)$-/=_G5+W2VU6F]_:S8;5\`$ M2+&`UABO&WKWW];\/XUFHPOGBSM5;_1-B_Q5M?0E()^92X#(O\G?9Y:U.&NU MGIZ>7JCD4:SJ"&!H(Q5@^D&CV?R]0?_[YS_>4B9=!"B+L\8M-!L?X+)Q=-@X M.CH[/#P[/FX\W'<;1^W#0_=+Y!N&;CZ.%0P:J[EAXG<'`6:K,3)>0#1M';7; MQRW_P0/WR;,5_2#T_-.Q\_3AZ>EIR_GK\Z-8CWJ0D#UL?;Z]N5-G8*XT=1-; MBJE2!E@_P\Z'-U!5+!V:*>1JQ#Y!_]7T'VO2CYJ'1\WCPQ,6?:J51*?UNVL0?*4]5PRJH+L9`/E%#1%QY!0IYM>A@@@@,V#I MJF)@+E)OT^3V$G^9UN[7"Q(6SA7=S"VK^^V`"8B0=D9((-4>@^8SYVP"1Q$(CFDA$#O0 M-.=@/@8H([ZAKV[F01%B*H:133CZA8U(Q%AU4Z>#ZX8P#XD%5A8P-:#Y@M%O ML\;X[I`@?`VHAI@9-&F"R.=E*&-@O#NP<7.J*"3(]`D0(4&?_(HCT7+>>:+@ ML?/BWI=;=)YJ`"X#R-7BP8#P1$),I_=T!0O+#)A1?" M(2P\=(_S3^K`(!]/W7T9@^3)'6U.WAI;2*';,!>K!9D2Q<2;Z3B'S::B.DF+ MHJ>NEPPAT6!!-]`(,S<;NB'&($([46R$I03<]!`)C@?Z*Q9/.[!F`'V`)@PS M$#@\]G"L@R_8!YJGF-=,KF&CZ4LB8I*4`3GX,)1,!][EY9`7RQ M(N.2,-=)=+9VI"="TK21O+[AB&D!!+`05R-2W,J[+J&Z\JSI36Y7&.`Z5'1- M4"P=P:46+BX*'0_R$P9WMM\DRAF%-7!V::#S-'3*XOO"?'HZ5EU60-MP(N8P MF!#C$*^L/?SKIK9]'N:'R%70DU-L0[IY0 M#OMRG,^V$&5,:HPFG\@RSQ;N-:SB?-3Z3^C)L*+M;DLX4)!)C$W M*K%#U'DK$3J.9E3YM"P&'Q_YXZ#]94/^$]"G,Z++SI+H>0H^V%34P22H83RP M+5KV3#*\J0B=9!4A:&85U5=F5'U-!M8=W[;"Q1J!^A?!51RA\N?\.\.RB$,6 M<>1`7A9QR"*.7[F(HX,QL'!T`LI'`ULS;$1O1X3!+4<:=* M(K]9V0`RZ6W#^_[Y2BP4/"/)!_U!3_$L%8/PP1VKJR"T)H'-1\6PA7C1=(Q+ MB13W&UBH&B,=@J%)/M^THJK0)J1'0`6$#?$Q)*'SQ!0RR23Q*VGY,9MJDA'C MD/7VS24A!=%:V$96@'X-QD(8C]#TE`O?$2"\=-4[OD=&&66`+3I98H&6GX9M M.>N_V=21"KY@>5/NK,LI0W`%$JB7""ZUF(>BT.%0IN12O`:&=@D1+<,4Z0SB M>)6V;IK>"\3"Q*-J2;C15\+>TYK<+N[;8+=9P!XB6N=DK8>&XAXX)`'7@DYG M@OQO(K]:[,`F(Q:>^W.II`<6$.MD!#K:IH5#XH9"+*_J)\#Q,(4=`8(L\=KNC-5ZH$+5IAN*89L<#()8I-V>%B M@BF%"I>B$.(1P?A+$N+1C^%4@[W7.(R"U<=Y#Y0Y#<]TNA)4S!C8P['<*K)D M8PP?.4L&CL?0<+-D544VT`+#5/AZ0BS'NBAG'W`\CL$&M3X"!BTR&"K(86,H M&#L;:`6YDGWLRTZ14^LM$Z;LBZD!TQA,=A)Y$5K;P[$NXVL?<%LKJ*S*$3B, M8B>YTK20SBACM!'G?G)D&AR2O!1I754CKU00A$XBY0R_G%I6RD?O&H!$\4Y>VXZ?=\>7H,W+O5RKN\*4!;KMTT3YE'2/@()MM!8[*T5PJ<4`B4)G MZY!0WF+1C;-QVP>+@#V"2\FPQYM;N%!T%QT.5:+Q2[?B5+"79ZD+4NG4L1^W M4(I=G=K_[2;B\BB`/`H@CP+(HP#R*$!!1P$"N1V9B@?($4IS'(U_$E!P$AS+ MMLKK$9G@X]1J\)F3>[BO8ULSB/0?0%#;P7AV-=BA2T2+?:5ZAWP?8[L@17BL M:I&=Q>+$H:YKA[;@,\2)_.JIC:CSP2SUOJ%DQ64A?*W"8U/]%:-(<"(*?(M- MS!)N2>*1V,AL3&9C&9!W+9#>!`A-YY":Z*PLDJ$PO8A(SZ(A8\X+MLB*2]"B M&170W3U-9I9DCZ'F*=%H,>WZ1GCMVY`3$A3'"^@Q M^V[B%)#,L,SH)K4N]F"VLP+-OEVY("'-`NDTY1:GF11<:Z&>-.BQ9\:A*%>< M4J+8U$(+D?B$LF%^[EK,E2RQ#EO\8FJJ"UF8?/;NI2QR\YA[)KQW?S(GZ()7 MXG:7WRH.<]2*&\/4[JC-)=>S$7$A0X!TZ"YVN^7W=)0.)H%2_#N@DB?IMK0P M^\\M4.7+[ACQ9K\5)IJ_:U954GA:B>HP9ADQ#RWBYI]%SQ4,-.H:B>?U+MP5 M-)_N M/7*(@7I@@8@K=]C2*V[GE,,/86L$2>S*:S=;B-X3D=[:3'W[6[/9^.O3[YZ8:$VZ`]@^VX! M7KYL&?]=K#_TKE]-3E38^M^K%5"&8ZC=:=^?QH_@M/-I>-4W.JW)_4E[WCI_ M/5@^W#PN0>?-B7(UZ7Y_/Q@]J9^_V.UOVO>AN;P]/;$>IJNV??*GT;.NKY?' M5_.9>H(_WXY>&_"+/7KLOE[=&V_F<*5B;?CRX]4MG@Z&+^>MI\/C/ZZAU>^@ MVW,\???N[T;W;M1L,G0^"B`\F%SJID+4:D[I9>;8N?X(N_T8A&S_I^5=8E?? M0JP^O1*XW"D?>J>8`H;`FBS]/SV[YH@CI@R$09Z?WC:8E,6EC31Y';J!#WK` M_=DW>P#I2^>"]\`A3$$A4RK6I36P*RH:2J<`'EU+K\C[4K$')NWU,IB$>M4^ M-ZH5H>R4G'_ZX#>M!L)U]/F[N]'NK?2>#/]V>OZ:C6+SY=%=;9HHY!;AO>IWQ32UW^]Q4E"J\H9P%CZUX M-SON&Y?I_\P$=L+72UNWRV))SW@GX<"C3>ANB+*YWJ>@R##(L#3GLM_>D@.[ M$&IB%.-?!U18R!YD6%O%A%#CT;MUEX43,X0N4"E&/Q%\RYK<6+44!6'0AW#2 ME%=]MO9O02A&3SM<:SN8=O%CZ=:Z1Z0VHZ=OEQCR\G;V.Y7^W":OK<:]Q8R( M;:9E+@VD,,#D0;&#H!CW'].7O$!7$\&\>OXFI=)BT60_^;>3R3Y@H!&.N_EL MU]T<)9]M=D<%5:.P2%3>-)I1S:S(<[H!.`7_Z)UQ$;IG$Z@FXYL1=?8CC>DM MK]SQ_3..9:9N0.&2*I>'>Z\KA^K,_>0JO]R7`1D>%S>0&,K?,E6_VSH"L34.3V\'8T*?B'%P6]I6( M:W/H+Q/$PE9M(X0N.:9-*U&I/B['^$CAXU(K0TQ,&\&^W)@VO4`EQK2,IL"H M"%$Q;80(Y\5G M@S.BB3RO,5G<9)Q-@"HG-#DAW:J(YSD..T00A-9DU(N[U385XPKOS61$<*<& MOM@F5#3[DI?EB1)8]IR2/:=DSRG9>GD MI9,OS,G?Z"3MT^B)G&(<=B*_6C1H3D9LMY5="7ZT+6\SE)Y4>E+I2:4G+O`:&=@D1K=42ZERSBE"#!>K,J.X4+-#89L6JDL6XB*QVI=*32D4I'*AUI`8XT]B11 M08XU$__JES9F@S/B:&TY;KZ7@+6SX&XZ)\;!RK6N2ML3A5 M)65MRS(FZ3VE]Y3>4WK/XKQG%YJ$NN4>+QKI^+$@5YJ*;XEG9U.>`DJ%WO9) MV++Z>P43/2_J'.F=`E/U.B<4XFHS25`#IYL- MT5NY!U:9O1#>/28A@K?OF!**YDZK_&M51&M"_NJ\^`E.=]OLSK0_*/,$7 M8Z"^F,(ET9/N2DM^V18REFIUBPKB@<@]Q5"2OH7=D^?8,0U1JVP0OOO>N^,\ M$XC>U7.79`I1C"]`01>FUB,2L`,:2[G2P"K2G1N^.2(:I%KMV"$: MB&`GOKSSL+-Y9/1)?+MZ#];+31#(R'NHG>6<-E_I':-BFI:#UI6X`Q`WP;;+UL.P=,#R,3UDL MVZ'5)0),(>(V6!T62K/G/$@.$CG.>FU"#936YY23[A,#_' M$:ZX+XS%PPIJM'8`R.HM7ZTO7! M:9BBW[JI?P?1S\([&*-_H]_?INGZ]<'!Y\^?OW+1T,3U8YA$F]B%"?X!&(^_ M`_@___U?WV`D1S'$*%Z#'Z,0G$=WX/$A>/SX]>'AZR=/P/75$7@\.3S,/D)? M!'[X:>$D$-RO@C#Y]D$%V?TB#KZ*XIN#QY/)DX-BX(-LY.M[_(/:^,]/R.C# M5Z]>'9#?ED,3GS80@3T\^.7'LTOW%JZ/QD\.O[A/OP7?9R@'P31P%\`(N`2']=;I=PV\?)/YJ M'6"*R,]N8[BD4Q+$\0'^_B"$-WCQ,997&,OAN@O213X'J;U,D7_OX)AFLR6LS66=<2\Y#IT-IZ/ M?CU=)"F6\/J"8G!C+)235T\F9+FZ(SBHS0J379M7L8%D%@MMQ@3F'.QW.7X/ M%@'9*PAB>(-8&8ZO+Q]\5X($59A@!Q1$2[`#"QZ6@!]]B'GS7KPP$NM@_Z9?_X&,! M_+=2%,#?7!@F1"E(*;I-,KYQG/7OETX`DPMX!\,-/(DB+SF'*=4HD&5:.LF" MK%7^^0'6;0'N1'Z)Q>/!E5&$V,>#0P%18:.0`C3BI"9%3,1 M#F$):IV=LFP<14DZ6Q)8EU'@Z1"+?12&)6(//=-:)2E62`E>84M*IX4G54&@ M34I9!D[B*$GF<;3TM:B%*OB^+5H:I4Y`\VHHR!F<)R/`F@RQS'@*(ZI,WY_+ M@;SO6RH2&*`?WV0173`-O:FW\D,?FQL#25E#.'=_3E..@8.G55:4EST7GRY=M)*LU2V#9(V6SJREO MC4FJ>YKM`FQ'.UOP0]N)8@@4XD*A`%L5YB"D3(3=8#+#%5&"E MN@@L`J0W.*\CT)'_:=6(-1)$E9_UH)S*F:J<-*@=^\$& M>2WCHQE#HJ5P!K_(!U1BC[XWPUHE#M-/P!B,`B7'1(>)T M1,;3WE0R>G0CVT36AKAR>5P51/;B=,@9_PS]FUM<:'>'9/D&GF]6"QC/EE4I M3F:;%%=V>PBY#MF3)>%@WYIJ3<9(4L<0U@(*<#(P-:E,0+0#0$0T`VM7+A4E MHRJQ*FM7T3D=:]G?.`&^CG!Y"V':9PE["]S>E:9\V3J?0KEJ]1P6R(!1:]0' M4IYDM(Z< MY'8:>OB/MW]N_#LGP#>SINF1$\=;Y*'_Y`0;+2DV,<1F(S\AFEC[%WUD-7J3 MXF3M7HWPK&55>&D.7#?:()@7T(4(_B*`YS#-Y5F+G\3#9]S$5#Y)R`N MO]DK7[-B]@6X6',"VB;>I:+M#@&)XJVVBL<*?+,ZJ(J:6=R8#?&M7[&A\:&> M2=^;C*H&N8#(WODN"M=R;84A)RFY1JQ1D8B@-7PG0H`DCMAD`X$?`O^-'XW` M:>A^-0)Q"=.J!9-@@\#[UT4XZOJ.MT:%BZCM:HL*KC9('"+QH-E%)/+ MYK;2BZ),:Z8R&-/M,0QY*3XAA0"P&#^,GB8BO*S*4>OTU<7J&*ZC MQ$=Q/!%5?/U,GZ9AXC)JF%A4,!L8H-_[2(Z\_#LB4!'Q;`:AA=HX6!4D[MR[ M6RE]YLE\Q5&&EVN,&B=8]HP0V_JHU@&19/*9[RS\P$]]F""U_Z,'2W4LFVQ3D*%L>41 M@_1"&IVYT&GX]WS*,5=!+;X]$5CJH&&QJCO M3R&`=9<5CP3Y4+L':ASFU*ZR,N;6R:W/S^;TBP8#D]E#-3H1;:>OZWTAL7KL MVBXHG%FJGKOE3>U]?'AK1I6T8#3>2)5'#;NNNO@(A.BK0I#PPP''X)T?.J'K MHS#S[.QH"%UIQ'A<[\3:NBH=#]M<-]Y`KV(1M1^\,3':Z'G'I(:MLO#XLO-F M)955)-:#'2RKA[QB_&V>V7%71%G:JN)[`0-<)3YW8@(^<)+$7_K0,^0WM:$W MG9J7H$W$U1HU=)_M4T`%WK/<,I'U44_E5X1^MFR<1^J0RQ:,AE4BGQJ!C!WS M\-F*W(FQLRIJ`@N@K`'-V%BF736<_!>VJ/53:9KQM"X\'-W$,9,*>;T>C@<$ M#@2,'@DH'0(,-NDOF1(62^R;R?JIY?&_C+Q][VSIT#,H[T*$4>B[TK&/PX04 ML9`S8W-R"Y^,&X'_F7PUF3Q&\7D,[O!'7X-GD]%D0OY7W-1W-NEM%/M_0>]K M\'@R>O7\V6CRXBF)L/`_#[-_YH/]),%QF)."2R09$-]^!T\FH^P!/_S)]YL0 MEC\9$0CH7X<[@"]?9O^D]`D0A&H]G4"7M'H"@<*L+E=O/<_';5F<`'?,/0V/ MG+6/[+>6?"8#E?%K)70Z6`F"I(05J\,D>0V*X2#)C#,R=VZ4I"/PY.GH56F/ M;>LK-A.KTL28NKJ6JCJ'N$HTW>J0'0H6*V%ZDPYNF,X-!VR_0L5D7.W%*?J$ M>\D9[I7]Z).>5IS]'_K*)'RH-''E2JI<;#B)(2[#&6DB]N*H'QV7/O[??5([JPZ&>G.0AEHC5^B-Q*DE"T6H:I0VQJ*,%N1B3(79L^$A]9^[EI&<]K M%K\&.L/-+-B4"$E;(_TQG+P"BY$,P:).OP>UEL$])2D?([*4HS*=:F#0(2-% M65[,^M%;"_.X\E.9M+I;UH"JN=,J%Y]U.6KOHDH5IDI.='@2U=(@M74-U&6K M%G-FP+7G%W(T1E-5%`)87OQ>1F$O@V`]?5!G$C-_4)FC^MT,6D-,XFR1/AFS M9=/[WX4V/;;254>I)1$AWVE7>0)R37AW:$"TI`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`M4&2;*6^OHU_B'+M9$XM;$N-;1)F^E8M+#&X,F M2M^Q=PNI/U/6YSIW>ZT#:T"<(IZ$W76'8?VD[).*A,WM2Q*&$(;K5 M+\B]/*?RC54W6H")>Z]V<*>N_-YJ!=!LF3?="V^.HB3%%_V(D.-&L3H$2QBW MX4MXHG1Q.FQ"(G#1$BR+KY'+@JSHAIACV^=ILDRO==:061SEJW@UWX71S*-R M0E^4,1`JM(AJ%WI,BV\'6ADB7;*9M%E(<'4(Z9&8E8IDC8Q$*D8:O=1M-9+I M+EWU;C,=5UQYGR"7!%__@,0*%;* M^Q;]"Q+I=OSB`C52XEX)@]'>T9JS*\/\/5=6>)VZ]+$Y+>M)ES<8\[R-6?(+,AB7)LK@JBQ'JH M!TRD+3A^Z4Q-+],F:DI@YV<7 M?TKM?,[G9H^6V80P$[#90')^0/[V"$F1Q2/>=DZ40M$R68.'KGQ*:#N6L>X# M.?SLC0E=CR/W@N`+Z$(4!2\"4RF3*D++B9(**6VOW<7E4,NQ@1`'^7F/_6EW MB1>:T$_#.Q2^1K&Q'%P5H;D2>B%Z6%<0=R,&F%&C,)`O3_L3[E>>2)2;O]-2 M?_5=KUA1\!J_&BY"%4/&9K7W[0:0,)/A+%_>&&M0F,5O_C$>@X\___C3D]\^ M_N*N-_OO+]>W-U\V(;7QYO/)R_B5R]^>/S']=4V"5[KIY_\R_?K-)[`TUDT MN5S#IT\/@O]=;\^/WS];OG2C@_][=@^=^2+R+KT_/R\^P5?3G^/-\=G=]]ND.3E^\=$Z61W_^,+OX[/[R83/YP_MS'M[]^.IE>GUS/]F\ M_#4X3M^_OWMRLKIU7R:__'CQ/(@^;"X^'3V_OPI>K*)[-_'F3W\ZF5Y^N#PY M?G?UPZ<7X1]7R:_^\?L_SF^^_?8W<'1Y,1[WZ2CD-WVWQW`=);ZI7=C`.@0- MOT\4Z^)N/@QX^;C*PY-[&W(HNI_%9/Z&I*Z'\M45MOL[Z1@YZN@TI!H\3AA" M\[#X!`4!3C1Z'%+E,JN(A-%^C^9\68F@Q)&/UAW)%I$=6R&=UV/M_[VEM M,Y9A'ZG1#HC"9,F_HCX02\#@*=\0T":O?H;)\/R:CQT;#`@HR$UVL1"F2OXI M;$:9QS"DL87Q`O$"8XDZY-(:]PBN$^@A;,W;!$=9T33ZV:YJ6H?,=J3(P@,D MW2AFO:Q-NQCS<).0BKU'U"LR8`S<$@&UNM_2O<,>)&SOHF+7]59^&D`,+_V. M@8[=THT@HZ]W=J%4>).06RZ,S3'4RR^]"%6M`WWGI39B4>Q:CV%;"AFK0!-W MRTD9>2%04_`=RGO*IB4$-D[_)WWT%6D'9[S01YBT]HXBN?^!_IL#H7<3L=EX M0IB?S:838@MDMOQ'BK:6+B)<[M'20_^Y7%3/',V=;7%CQ/USX\>P5OH\#3VM MY?$2V'O4,^(/PHK3QU`V639L\_ZNF37)]E(4T MCEP(/7+AF5*@KUU*)=";OLDA01M+1',(6;!17.IH$U8KLBHO!C5AE5PJ]2PI MP^.C*''+:2A1BH837`A2W!9P\'R']L33D((02:$2"$QDEKC/S!,%K]W,DSA! MMC-/PI1VW!<".:>AI)RDI:DMY22WQOVGG"CX[5J*85N%+I)N6Y[E)4!-K?>0 M;\+.5-F7H6NVJ0V8R=Z84I2UIYJ(<[UKPS*X/),@'YOY"9&5,6$>I:EJR2ZQ M&3:LU)).QBET]*<%6[CIBLY")"8NHW=96%0(A=TA_J!1>60[R*8QCA51-Z;< MYOI:0?0P"4F`9[3ZW?J"L(`Q5(95=J=[3/A0E:SGM(TK1:"AI M(&F!:DL#R2US_VD@"GZ[EF/85J(_BS#,]#]''-34?&>5/@T]_`<^2[MS`NQW M96^6[A>!Z]+@POC[O[;8)K8RY'$$MW(-B@BQ[72E"M?WU:S4LG0)+1D[P9R7 M(4>`X:Z]4L0Q6RG4Q7/4ZBX,2)^*.P?R2]6[PLF>([U,G3B55SM31'X<;Y'R M)P^O-1Z3CX@=;0W77$]1%TG3:QL>5E6F$#:^UT% M(R&^7B;*PO],_ATJOE0[BV^<,.\ZOWL^,GL+88ZXCM#5.]+CAMO%RY)8,011 MLHGA%;Q/WR`TGZ1.R;0A-UH!K&L6+'<)]WL_1!'K/$9>D[\.8/;8:14S*7%[ MXR0^^565"(LW_'6+6GD>I)4ARL='?5.EPY'KG4;#OE[?]+.Z'E70C"@[KXH* M;\`26?6!XATZ\!$C!`2CI3>)=0MIK:&T#B:I6;\S'QE5#_>4*<'.$3GN5LV> M28`SV.-2G"J>Q7F,+$X)B4CY280]K",L5'%H[4A-D8^EL9!ZJI]'#.MYO%+U62N>$EQV*GSFWT$O MZUSW'@;>NRC&5P2NR,-Y2NJM$P)#GD!G0GDZ\`G2@=-=F^Y*EP^`X9(N_1@R M^6TU:P)FU%2"A=9./HQQUK!;C.ZV+G%@, M!Q!`Q1[`H,9(YL?DAM5'PFBJ7K;R#*2:C-2>AE181:72XZ*U+>*A#A1:73JY17#I4&%">(U> M7A`@B/G<:^53(H_M/I:=&B8)9M=*F$371D$0[F_$Z\K2E)YV3JI2QFL>A2G%`5F M5:@,:>RWL]F"*Z!7+2E6%;&HJUCIM5-5MAXYPX*EZ]B)TSP;:(H[*QI M5>`:"W05B..IV%=(Q>8@`8$)JD!M'G-TX&ZI6U472SUXEL"H0ZG*H#<=9$O0 MQI!8MJ`.U$]5D(9Z;P6Y%>LBMCCX6L!8C[2V M8C6:L6ZGARF8V8>@^'($JM^"C]G7ULV[.)OK8BBT+%U.4;#7$(67*9)D?>+6 M1&*V$J:!G^,YHOB;#*2)CBW'D,J@?=^O.4'5RJI+%*H[L1]=A\D:NO[2A]YQ MM$*2J$,VV,@,7QM@$L)Z^[7*%[\MN MXJUF]4)#8]1\40A@"$TQDJEC;(@*ATU5(6'-LHOY*>]T%!(XO?>UW$ZG(S*9 MVZ!2P-(MQ=@1*$:#CWB\94GALJNF4)B3[9`ZFWJ>C]UP)Y@[OG<:YMW.]"D6 M/D*C*H9+"NL%SO(;@#\:^R'(/QN,7RS$TJI@M:]#+^H(%W^D6^16K:.09-1T MJR4J0J,2QB6E74]E7X'=9PV%95EE\5A*55W,=5`O_(G<#8:,JXO"%`$_#9=1 MO,KN/4I5_X@`,E<")$`-JZ(C_S0K,",?@\K7C,?0+10*27!N5RTDNBYFH^'L M\L+1)H[S%V%H[5&R02.0#[.]BVLT4^U"S`>@O^ZI?$(>I)+$8.8SMF^_8:MX$>:SD8U#Y MVI;TR+$3BY/$:AA.D$HU^Z7MZ!V(XB+7.$502I>0P`$S:H/D__SVR/OJ0G]. M4K(Y'+N'%3[BQG^I@!F!#!`H>Y8]+&`]LIW/--Q4;V(TR)=[.)#&T[)]>1J! M'`;8J\8?UULXFGKSYKB,/HS2K3KIG$%-Q4EJG%>Z8'[\+KHC%M"!SOP([!#0+VP/Z"> MCE;;HQO>BMW?]%,0D!+Z%RH@5M]05'ADI^)]DV+AX#3TX/T/<-M;Q+4'UI"6 M8Q+0$E9E@P$9#=!P*_:DE2E[<1-EAB8]L*)6`GF$)&[##1!=UOXO!F-W.8M; M1Z1CHFMW.U/G0-NEG,F:;^U4]L%I22U51@XFO]2DGK;I0]K$@-0DC:#^00,W_&]C:77@-VDD)Z(0WSNI9Z/`VGKAMM M<&IR]W8D@[?[&5K\P$3Q-9COO9UIC8W\Z3'8)K(FBN=T4[3!/;S)WP5.#T=R M=7!F3F0;>%F%/,48@`=9$@7FFA=*MSD3TS&(W&M0/64,;6M8DP]H6>7K4DO3;F$55EKVKD'52[M"X_IS MJPDT$Z9_'VF;!XW'6'>;JVN][RV7D[!1C\0O1+*\VS(B:!NG2KQ*76#-ZMW4QEK)P';QHV&J[,_.\.9P*:'/4MO89PG)_D; MBQ%X$`!%6A8T=M]0PH_F/,4B$-;ZF'95LYJRTR1!)I;ULEDV9@2R499O?E3H MI:UT1O@NO/WBF_9YJ^53NCMU[Y`/Z019 M`NX=^AGG^H2LA]<$;D,*LC`YKIU!`AD4J:5P\Y?QBR@@QUX MR]:[T])0O;#N:VW:$2Z/;'=."8OINV/LFM-FF8F4"=!8PYRGR5.JDQBAGVI(W9J"9@LLJUGZ)@$Z9.O'WG!VBC='=&Z&"-UQSN M$<"O.2P'@VRT-2O8RI=ZV2%MDB9W5JTY!O?A^7H+D-Q<67U@D0UZ MA`*$FRCNK;"[#M3\W=D:?C[CR5!0C+5/V]CZ-G2CV_!"Y M"J+%P0SJ-X+'($:=D#0CT"=`%!0,/C$ MLO+:JF6D.[+2^/D.-?7RF)7*R$?^RUE'R==%+YVV$P=K*8O6-!1K]IW\Q)]A M$/P01I_#2^2$1B'T2**#T_A+SH5@@3?O3#`HX;L5^*/Q)_P5*#[+\F.QQ1RR M$./J[@9O\@.]E='CC5/:38TOZ<:IX.K0=$8?ZVWZS'FON"#/I6Z/(5+COG3I M1?$Y*+ZWGA5HGZ)8U05]852.ES,E<0%O?-P_*TS/G54/QX94J,8.E6G8^Y7^)/E`-FF%.+']V5@']:V9'P=?H)T> M8[6-VRGV$>9SH9N+]7EDM-SFSX_YRX]`]M4`,NQ\GNW=[V=/O9?.JU?5VT1: M6JUF&.ST5KTJKCU1`\%\$/A(AME]TI3.$&JCU-VD>I&`,S^$))[7*@4[+.93 M`_LDM`L$'IHEC`;PL@"3453IJ,^RU-3Y--!O/Q5303]"_UH@BT3VYK\!4$L# M!!0````(`%.*=3_D*`!B&A0``$94`0`5`!P`:6YB<"TR,#$Q,#DS,%]P&UL550)``,]SLI./<[*3G5X"P`!!"4.```$.0$``.U=6W/;.+)^/U7G/VB] M+V?KE"+9SL5.)5.E2+'C$\?2R/9,,EM;4Q0)29Q0A`*0LI5??P!>+%(B*>(F MD![NPR:C2.C&UXW&AT8#>/>/=KMU"5R`#`]8K%B>6O: MK2O7(_]J>O8*D,_<%4#DO\F_SSUO^;;3>7AX>&&2KV+31@!#'YD`TP]:[?8O M+?J___ZO=U1('P$JXFWK"W1;-W#5.CENG9R\/3Y^>WK:NK_KMTZZQ\?AC\@O M'-O]/C$P:#TN'!>_/TH(>YP@YP5$L\Y)MWO:B;]X%'[S[2/](/7]A]/@V\?G MY^>=X%^?OHKMK"^29H\[7[];+Q&T?-/#)D3+%S[NT&]UBMKI*-'V@^%0W&_G`/"KFFHD MT%.EFG^.#$0`F0//-@T'2]%ZNTUIG;B=DX;GT+$`PA]_^+:WOB--G$!TRJ1W M03.=7^3#W3?P_,*!#]S8/C70B<.3N((WT`-,"@4_D&9)VEJ767Y7-@)=#AVZ MTIPD;(Y'A:[$`!:UR*5&H(=,)?BTZ$IV3`%-%+BHB#;2G55(&4EN.X"F3V?Q MGFM]=#T2OJ_<*42+@-\PJ5;84.S92$1R7>"#Z^)6BF%P:,'7`M8LU`,R7.H2P.HEB:8TR`\_Z(-&8!%Y.)(M'J4WMX.!TN*5DF^N-[U_`M MF_QS;X(]2I'+SF;\`C8F+]TA'[=GAD'F^UC$G3'9=HL(XX"@3@T\"5AJ],,. M[4('.!Z./PDZU>X>1V3UGSD2XL'"KRGQ$'!%_HJ5:KN1DH@V6[[:0^D.&,B, M=2)_33GJ+M./OM%9!DRN;[35&B8E*(H@A[5+\=C)1#R-3AIX/MRC!N]=O`2F/;6!-8`+PW:58)\K M+!5Y=)H@R_U2ELC'*[)&-ST,JNU/B1@8J7_R(D'1V-W)<``>@Q5P?7`)H85O M@*?$D[+D5,:)=F:6%/:9$"6=MH!)A%M#VNB2P0Q'B$XM96,I63SU9@'"^V20B,1M!AMXD'/ M<*Z?#,,9[H!#/IZ%*6Z'K$UZUL)V;4J=:$;[X^.2\BXE`;"<9&VIR!#DM75$DMU9N`B$EZHPK!98BI")PI-F`E/9*^7HL.3SV#>'*`;Z,*T M9@H'Y1Z)]9CW]L$6V?35P:?!C6-=D&Z1M2Q1SB?Z;5:O'\`4(A!^[\YX!/CC M(XD@1&&;:IOV$SB/# MMA2M<3*DU&0ZS$G,MD;!I.=AR9SP8PFK*Y51P\]0:`6DWL9\"(#GVF9Z],* M#FQLACH":Z,B<COOD5\_B^\#-++]N0`GX#([T4`M&T\+J$GXW4(E MSEMPY)8$1N8'`]LF6H2X'R>B;7;27T1%[^H<`V!^]`SI]45N(FQ;/(P1V& M39WGXSJ,9N!/>TMRHH\&7E5ZEZ:XZ(DED(DVQ49M'5GG:Y"S::0JMZ%5J5\R^&^JJFP*HI ML&H*K"K1F<,76/4P)F$D>W:2XT-;$BJ"="$?V@9%UKJ7C5SXB/:FR$!Y]"'S ME]6(F)FXYW15^TJ1GKXBBV7Z!STLMC(<6M_<\_H&0FM"A'\S'%$92HG6-/: MHM`Q4Q5OY>"34:K(&_U,$_I$IS$P`=&/!-\;X$7]4Q(+B^3IHYEE#5H,EXQZ M1O[$X(KH`-%:V=YYHOVJC[LT&/PEC<+#:PR(DK89G6,EH8!JAKW@E(C"459& MK"[^6MJ(I;"34;_(7PL7=D*A(3.D5#](9D'#7[=JM6&YY78R9'+["9\T!6$)LDU@1>!BM%E4W`'-EU2%#D@^4 M!$HB$##514J]^9-]CKD;'N7%1=;!=&T;$]NQ/1M@,KAO/6A^CV[<&8"I;=K` M-==,^2RF!JL\>MB0$3CLLI7^XLD[)G7E2#YF_;SZ&T%+I@J3\V"1T)242BCJ-Y<.9)J47"2AQ+_.1SA7%5T6:1- MDYJ'&6][).K>82WVY/3)]F+H=(W%,!-CFL@GXC:Q1'G"*E=B?4RZ#SH)N7[A MJ7`,'%H/,S)0H)IC8!QL[Q]HBMPG7OMBO+RUF5#5N)^0\,3A="=CI,+@>R36 M9T#O@T[7LOTP<3DW%FNT73EGSK&A].0GF_4D+.I++..KRV-++MU9#B?G+1DY MR6QPCH-JJ:Y&95M&A9?W^;CPGS)V./,K3[';LFP*D.'0,^U7;M]8VF1$*EDJ MYHC2'@-+KA;SD))P3%B@ML$SB-)6?%:&3,7^P@^X4Q@1%)4V[)5:Y00H"W@" MQXP%BQON$#"PC]9JXV>&E)J,QRQ\>(X0Y]W'P7L@83,GAU?[J[!:AA3M5LOW MUW0)^2X^$K>(A.G_UHZ(.A/NE:DYA5K.G/N1$RB?SMK_J\@YO>T71IIC>\VQ MO>;8'KLUFF-[19`WQ_::8WM5/K:72&20^7"(`D%60!;B2QL4YWQRQ5;&QT+/=^;0V3_W/`H16;=$5>+>H)"O.2<2Y)CQRN,_0/9,!*E M?77*:<$8*9WEP#M**;Y70V9=7&,E@O74^OJ4#?E>;U(3$5X2OFL7@R/ MA(-+&G('!:]\LL[(>]^ZVLV\;#8$%3VYQB929,@T68::91F$/9,E`2%JJE`I M^G(W=*G*RE,1F0(K$IOWKR&SX=HQBBC3^0+H[6^*Z4TDI"J+BR)/S"$W,4S9 MV0@II0#J+%$LL"(CHJQ1]J`G9X#L[%@O"?-8(IL&775V*B&U9L8J@^-VADP" MW5=GHBPQ-;-))E*)E9J`$;944)?RSA94C>V&LG;(`2NQ!JM&?S0\`_JWK>TH M^=Z=U-J.)4`VI$L)Y(E=CJ`ZY[F;Z*R\H;)RFQR9Z2P3"2S(B/>$.@U\1&;E M4=!ZL!D2GNW"!,?A-''.ZQ:8Y)NT^$390.16J!I![0/ M?;M*#E-6HWJ$#D'4Y:3>^>>!#T:0JUK09Q\#=)7-"+N2ZF'@')3D7![&=]RR M>0\KPU#9[V$)/6`JCQC_V3T@-:ZZI;+AX;]E(*1='UU+'B]69*\:E@!LH\)_ MB&[73''_-18QTVL\+QSX<,1Z#_B^?9ZX89E5RR7;%]^N:S86Z[>QN-_ARN\B M-D7,31%S4\1O&PUNN9_WE1S?)W\$Q,*%KVL%3#AOM[B!]V8'T6-X0 ME2]5RRCF=P,%L&M_(8?E)=B>YR%[XGMTGJ$`+"&B_?I(?J!F/T^>#%:QS>E::DGJZL;%U+EX-X1GD+R#C4PUEIF<`AIW`PL=%& M_Y^>V@ZZH*804T"?Y^U,0I;2]C`2@8!6TX$!"/^\<@<`V2O2\15(7-FAB.Z4 M$JTGWW`H)E,.?4GGFIC=X]*P7=K5H4LO>1Q.4T^A/+V#HL([2DI^WDRW+/S2 MMG3?_:/=;OW[]R^_G?[GWU_-I?_XS7UU;OU\LYI]6[OW`__A\@TZ?_/YY*_[ MNS5VWJS,GUWG_[RS^_[UR/KVAW/ZROTZ&?8'5^O+NQ\_)P_8^6/TU^M/N#]> MO/QNWWY:>J@+KH:P>[L$+U]VG/]=KF\&GUY-STS8^?75(S!&$VC=6C\>)M_! M>>_WT>65T^M,[\ZZB\Z'U\/5_?7W%>B].3,NI_T?GX?C!_/K-[_[E_5CY*Z^ MG)]Y][/'KG_VAS/P/GU:G5XNYN89_OIE_-J!W_SQ]_[KQSOGS0(^FM@:O?SM M\LUH,C%^M7N?/M^_7,U[@]?=;][YK^_?_Z?5OQVWV_S,+KB,FKYY0A\2?:25 M$4IVC++$/.-8F8FJA`OX^>L8ADN*+1V+"JV<(^DYK]CRP.7?8.=>K/7GACL# M^,J-WN1S+>YW9DJU5.G"KY)@R$KR,1EJPZ#B/YFL4_!S/5E;%K^CMBGJOY;G MX/,I[N8UY@,M*Y("]4R0^[VS>%60@DS7\R2[:L4/-Q]L@9@46$]+IB#3$BGS M=0L85NH-VL-8-4.NEJ`K:MLL_#0??=A5,BJQ7\KL1]9DF#;NO=F\.,N6VAVE)E)=RU>-CMP%PPLHNIN5J,?%B*0SS:5"(I*S$0TTA3C&9U# M%'8!ZB7GL8"2VF<7L*AP&S&%ZA!0!"'7>.:TO+?K#2C/+G@(/5PN%B@V!U," MY6AN`,LH*M_?7+7SS`RPR%I?J8 M_3LYA%G0Y5@0Y+WFQ.<)")H`6$%!:L96O7)78!"O_T`"GS>P(*SMN>?L62>C MJYI7"F4UTCQ/<`RK$B2@M#DD/C!41YA;2>8A-T)4%32,E>*`Y) M>L//WR;42$U,\"TW:!^?RMU%%QO[&JO,Z>?BM<9>3&3M]/`.Y*2#WD`/J-Q, MR)6E9]N.U7'S>&,:-IUGO\9@&:UNAM-KZ,[N`%I$AP2N:79C.''LF;IYG$6\ M_O4"A]69\.68G',6CS)GZ(P>:UXTE-5(\TS.,;9*S.2ES5'%14.&\GH7#>45 MTKIH$'0E05-4;M&0H;O>\/.W"37Z%@U)7R:+(/H'70BMR!*)5F0$-]=M;^.K MBB*EY5?DBJ+,%0`2 M\,.-^&W!E=[)9,10]*)72??KE])6S3VP##9_)E9_)C?'TM3*$8?/#=',<*,[ M.#;W=X97M8P2BC[=ST%O48BO]J2QTH'81^".Z/V!2/C.E,-4)KQYP_)Y7C6K MVEL/^9IEC-7;3-7;15O(LV;EAV)%+AA=)UK(SS%M(^^::1L5.EB1-V M69\/N+8)5;;H&;LG)$8$07/-1_$8FA-Y8*JA;%6E;.S^Q$3"&@[6<+"&@U6A M,X?G8!FA12F?*I17DYQ8,6822W)TKX6;G[#G2'Q$? M:_;0*C)_-7RHX4-5YD,L04:%AS')KXB5"LD2&Z"2WA+01)RZ/!7G`S`19DG[ MVFBR0<^/#I7TFR815(V)JB$^#?&I,O')"2=*=L!R1-4D_9.+5/TS/UWF\N@^ M=,FX\L)CP6,;?Q>E,DP-BM.%AMA4CMCPN%1YEM-PG(;C-!RG"ITY/,%8IN=48Y(7,IQQ^4FB05A+$7C?=AXN%';Y#3&]8""Y,F0'7C&[3$B-$7$TW MU.A94B,1-VM(4A4FM88D-22IVB2))<:HH4M,&E1CX.\A3FR8/@,*Q5$A/08. MO;UX9"!O?8<,%Y.YBUXV)\J@>-IM=LR>'WL2\*]F%ZT:DUU#GAKR5&7RQ!!B M5#@8B_B:[+8Q(5K?';@!-'V*!:V0(NS06U^Y4X@6@1".>NRBYM@JB\HTQ!I\ M+6#_&;8V!C.;-N)Z-\:B@"YA8+Z8P56'_#(<#>0OVX,@MU4]T8C%!-3A\T$1 MO&F1-APK^)XYRJC4MU($'W#0&6^&>&=&^CZAR%R0,&OO-,*&+:NC>>B3RW\Z)[GCH>]@S7(NLK65%DD(9 MM;)'&G;RGFIO`+")[&7`N^3!FVRU/G0D&Y3$[?"\="0* M1L%>LG-%^/+C9["6%K.WFM6UMA:(TMO`1)"?<20Z$JV&,_(8+"&B^6>Z_O(+ MW7J.04HQ29()S[@@3-O\;='P"`5I?V`Y`TM#?;K9^/K\#3+SJZ?). ME6&[07-]0CQG$$D+,>E&:\@#MU")L1998H8-_PX:GO,$F;G>SWKT@GTB( M[WD-UVABS<4F1EU@P9EN.[2J$N233=>'P1?`$X/_:D,J[SJTS8F!0?"? M_P]02P,$%`````@`4XIU/YW'/I4["```=CT``!$`'`!I;F)P+3(P,3$P.3,P M+GAS9%54"0`#/<[*3CW.RDYU>`L``00E#@``!#D!``#M6FUSVK@6_KXS]S]H M^;+M]!(;R!N9)C,I:1)V26"![";=V>D(6X`:(3F2S$M__95D#`9L\]+7"#*.)0(A=T)@!7WLC!6Y`'%3;P6@X&52I5JR/Q M$*EO=(BX^JW:^U)Z9Y8U&HT.'-55.)@CP7SN(*$_@'S^`NA___GEO1ZDPI$> MX@S<,0KNV1`4"Z!8/"L4SDHE\-"N@*)=*`1"2F(LSH331P,(Q@-"Q=FXPPD^ MST7&U%\.&.]91=LN69@*":F#YRYOB.%P[AWX`M+H[3+)3L<:"P6QAF50DP%Z_&NUC(VA'TQ M[7A;JJ>,;F`*H_F9.8&<+_*Z:0ZN"T7'2(4M9JB\784RN6R M95K#KBL]%^G0S1TH%!V(H`&B\IKQP17J0I_(\]R+#PGN8N3F(NRZ M>$3/&?.MSU'W/*=)RH M])MNMM28B-3FD'/6Q:O9XW'TW>U18PHU!0Q?2V:]'E$NZGYWP]28F.(8LU[+ M*`>2[VZ4&M/Q22Q9BV;IWFUE"-!_/#2K:R*;4:[V#\$(=O5.4*5JET`M-2], MA,@![`;V?T[K%8$1`IG3<*'"KMJ99KW-+D9=1(7:VZ):YUT$8%U0]_3^IQ0( M\.:!0M_%JL_;]]:R^I6A?:6X3B_,W\O3?"H^[;(*.RJ[.).6)4&Z\!)C2](S MTJP%UE;7WK?R^0$2O0.W^@@ED;G09=6;"T06-R-RJA(8G7OZ7H>^SPW(E2_Z M2&*%3FS`YK+$&G)+WTHN>+,X8!S;Z6[_&?EN]973^HRXB(N/+SZ6$ZVAR'@I M0G%*IWCC%I@]W"7^MB1SGJ=#_@:"0<$;E2]B!R/J3-ZN6==[JE.7=@6*_C5A MHX1U/&N.6S(+Y![M0JY6#[3^?73>CL)[)E&$,O-S35P]5J1<8>$0)GR.U`\M M!'1.U."8.ECEFP$G,[J4'(!4AUJ!35,CXNGXI;8G*H8H>XDI>_UJ.HDE2^<] M-:Q"H*N#H*;FAF':TY0YB"=0LF(N*#+.&A!@DRK%F=48NJK8#@_6^Q#WH:\K1)GKSWWE6-IT]E(E0Z5 M&QE77/T42:*Y;?WG[[N_2O_^\^AX_OB)'I7=KR?#WM.$/ESYHYL37C[YH_CE MH3T1Y&3H?+7)[_+TH5)KN$^?2.F(/G;JE:OJY*;]\K4S$N13X\OQK:@T!X?/ MN'7K26ZC:IW9+0\='EKDG3>YO[H]ZIXZS/KS:(Q@H\/Y?GP`5BK$,Z+2H MA7L4J],?5,>,)A;/P:[[H#,@"3&5";%\SU`20_$4;9(0%4JQ+)T&%<(!EL%! M3_-3,4E/3YW8X_G9TY-(3P(_:_.>PF$L.SH;:B)B3N,-J+>8-H=4Z"IN?"*Z M7SO+Y%PQQ]=3^Y*Z']6TEI,J54G^P&`)R$KML38OL%?R@E`?N-3I@-$((BI_ MGI3@O;50RPW*OM9*W7=6#L8#CW$)Z$H)/^V=0/"\H,8IZ;W>)&+W'G=[CU[OP*8W9_>]D14C\*RH&@EFW>YYRI;VK_KRI! MO:!S`$Y[G>)-]N[HK84XLN@6?2/JJ%!\A8FO9.Z1#&K1-29$`W&=_#!JBB79<<8. MF--<$.O;:-GOAYD0:T!/WVS$>,#GNLP87/UER,986(E61*XKU>2(5MOF-;;L M&+<5VNC.%TM=5%MF3$S!EDABUFG;@*B==Z"H[J`\/!_A1PE!N]NSE#)LZ;NP MO/O#Q.H-P:>L_%"HP=D0NRKZ3Z9)`.U=ZH?,68L&V^%-C!"7[A=?!/B2;A3VAG\#J$J;(ZA+=`NLF%E]S-KC&5&7K M6;=W'=*TC*?.>Y#BKP;*PF,D(D,RWQ?FM81N-Y0>BF@+K&EA?"9<[]88[=7P4"5'9D_0+U*N&=?O4=H: M8`9]\$WHTQ96^-ICDNE%LA'*Q!TO?#?0(#"H/H1/!S)M\TZH4_.83K8-7@
],F[D5VI1#V[R8K";'0BDYX^;OA#O9$=.ZK2G;1JNVF?;" M+J"3,_J4PFIV3-X(I;'1U"Z#RDT0SOX'4$L!`AX#%`````@`4XIU/V:N@`R+ M4@``\DT$`!$`&````````0```*2!`````&EN8G`M,C`Q,3`Y,S`N>&UL550% M``,]SLI.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`4XIU/WU/CI\:"@`` M@'8``!4`&````````0```*2!UE(``&EN8G`M,C`Q,3`Y,S!?8V%L+GAM;%54 M!0`#/<[*3G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`%.*=3_*C)?M:A(` M`"PH`0`5`!@```````$```"D@3]=``!I;F)P+3(P,3$P.3,P7V1E9BYX;6Q5 M5`4``SW.RDYU>`L``00E#@``!#D!``!02P$"'@,4````"`!3BG4_F!\U'LDA M``#WJP$`%0`8```````!````I('X;P``:6YB<"TR,#$Q,#DS,%]L86(N>&UL M550%``,]SLI.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`4XIU/^0H`&(: M%```1E0!`!4`&````````0```*2!$)(``&EN8G`M,C`Q,3`Y,S!?<')E+GAM M;%54!0`#/<[*3G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`%.*=3^=QSZ5 M.P@``'8]```1`!@```````$```"D@7FF``!I;F)P+3(P,3$P.3,P+GAS9%54 L!0`#/<[*3G5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``#_K@`````` ` end

Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Share data	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Sales, net	$ 8,047	$ 6,439
Cost of sales	6,618	5,481
Gross profit	1,429	958
Selling and administrative expenses	689	910
Operating income	740	48
Other expense, net (primarily interest expense)	(145)	(448)
Income (loss) from continuing operations before income taxes	595	(400)
Income tax expense, net		7
Net income (loss) from continuing operations	595	(407)
(Loss) income from discontinued operations	(232)	406
Net income (loss)	$ 363	$ (1)
Basic and diluted net income (loss) per common share:
Continuing operations (in Dollars per share)	$ 0.03	$ (0.02)
Discontinued operations (in Dollars per share)	$ (0.01)	$ 0.02
Basic and diluted net income (loss) per common share (in Dollars per share)	$ 0.02	$ 0.00
Weighted average common shares outstanding (in Shares)	20,936,813	20,625,981

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows provided by operating activities:
Net income (loss)	$ 363	$ (1)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss (income) from discontinued operations	232	(406)
Depreciation and amortization	90	85
Accretion of financing instruments		319
Financing costs in for stock issued in connection with Convertible Note Payable	4	5
Change in fair value of derivative liabilities	(10)	(6)
Gain on sale of fixed assets	(2)	(30)
Compensation expense for consulting services		49
Compensation expense for employee stock options	5	158
Decrease (increase) in:
Accounts receivable	(755)	(135)
Inventories	858	1,044
Other current assets	8	(70)
Security deposits and other assets	(3)
(Decrease) increase in:
Accounts payable	(625)	(1,350)
Accrued expenses and other liabilities	(116)	67
Net cash provided by (used in) operating activities - continuing operations	49	(271)
Net cash provided from operating activities - discontinued operations	168	757
Net cash provided by operating activities	217	486
Cash flows used in investing activities:
Purchase of property and equipment	(1)	(145)
Proceeds from sale of property and equipment	2	30
Net cash used in investing activities - continuing operations	1	(115)
Net cash used in investing activities - discontinued operations
Net cash used in investing activities	1	(115)
Cash flows from financing activities:
Proceeds from notes payable		40
Payments under capital lease obligations	(11)	(11)
Net cash (used in) provided by financing activities - continuing operations	(11)	29
Net cash provided by financing activities - discontinued operations
Net cash (used in) provided by financing activities	(11)	29
Net increase in cash	207	400
Increase in cash, discontinued operations	(207)	(494)
Cash at beginning of period, continuing operations	563	478
Cash at end of period, continuing operations	$ 563	$ 384

Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands	Sep. 30, 2011	Jun. 30, 2011
Current Assets:
Cash	$ 563	$ 563
Accounts receivable, net	1,960	1,205
Inventories	4,509	5,367
Investment in iBio, Inc., restricted	823	823
Other current assets	163	173
Assets held for sale	3,680	3,722
Total current assets	11,698	11,853
Property and equipment, net	1,519	1,598
Security deposits and other assets	192	199
Total Assets	13,409	13,650
Current Liabilities:
Notes Payable	7,805	7,805
Accounts payable	4,578	5,152
Convertible note payable - CD Financial LLC, net	4,500	4,500
Accrued expenses and other current liabilities	730	921
Notes Payable, CD Financial LLC	300	300
Liabilities held for sale	2,818	2,667
Total current liabilities	20,731	21,345
Common Stock, $0.002 par value; 50,000,000 shares authorized; 20,965,074 and 20,915,074 shares issued at September 30, 2011 and June 30, 2011, 20,930,174 and 20,880,174 shares outstanding at September 30, 2011 and June 30, 2011	42	42
Additional paid-in capital	44,553	44,543
Accumulated deficit	(51,818)	(52,181)
Less: Treasury stock, at cost, 34,900 shares	(99)	(99)
Total Stockholders' Deficiency	(7,322)	(7,695)
Total Liabilities and Stockholders' Deficiency	$ 13,409	$ 13,650

Document And Entity Information	3 Months Ended
Document And Entity Information	Sep. 30, 2011	Nov. 15, 2011
Document and Entity Information [Abstract]
Entity Registrant Name	INTEGRATED BIOPHARMA INC
Document Type	10-Q
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		20,965,074
Amendment Flag	false
Entity Central Index Key	0001016504
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2011
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q1

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Sep. 30, 2011	Jun. 30, 2011
Common Stock, par value (in Dollars per share)	$ 0.002	$ 0.002
Common Stock, shares authorized	50,000,000	50,000,000
Common Stock, shares issued	20,965,074	20,915,074
Common Stock, shares outstanding	20,930,174	20,880,174
Treasury stock, shares	34,900	34,900

Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) (USD $) In Thousands, except Share data	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings, Appropriated [Member]	Treasury Stock [Member]	Total
Balance, July 1, 2011 at Jun. 30, 2011	$ 42	$ 44,543	$ (52,181)	$ (99)	$ (7,695)
Balance, July 1, 2011 (in Shares) at Jun. 30, 2011	20,915,074			34,900
Issuance of Common Stock in connection with Convertible Note		4			4
Issuance of Common Stock in connection with Convertible Note (in Shares)	50,000
Stock based compensation		6			6
Net income			363		363
Balance, September 30, 2011 at Sep. 30, 2011	$ 42	$ 44,553	$ (51,818)	$ (99)	$ (7,322)
Balance, September 30, 2011 (in Shares) at Sep. 30, 2011	20,965,074			34,900